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C. Abstract 
 Current plastics are mostly derived from petrochemical sources, as it is a 
finite resource renewable replacements are sought after. Polymers derived from 
cyclic esters such as; lactide, valerolactone and caprolactone are of interest. An 
industrially viable method of producing stereocontrolled polylactide (PLA) from 
rac-lactide is desired. Previous work on poly(cyclic esters) is overviewed in 
chapter 1 with an emphasis upon PLA. 
  Chapter 2 reports the coordination of Ti(O
i
Pr)4 to homo/piperazine bridged 
bis(phenol) (salan) ligands. Under ambient conditions bimetallic structures were 
produced and a steric dependent equilibrium system is discussed. Forcing conditions 
resulted in monometallic homopiperazine salan complexes. Their application for the 
ring-opening-polymerisation (ROP) of rac-lactide is investigated. Homo/piperazine 
salan titanium catecholates were synthesised and their cytotoxicity investigated by 
collaborators. 
 Chapter 3 details the synthesis of monometallic homopiperazine salan 
zirconium/hafnium isopropoxide complexes. Their utility for the ROP of rac-lactide 
in solution and solvent free systems are discussed. Bimetallic or tetrametallic solid 
state structures from attempts to coordinate Zr(IV)/Hf(IV) metals to piperazine salan 
ligands are also discussed. 
 Chapter 4 discusses the complexation of AlMe3 with homopiperazine salan 
ligands. The resulting monometallic complexes were inactive for the ROP of lactide. 
Benzyl alcohol derivatives were synthesised and trialled for solvent free ROP of 
rac-lactide, δ-valerolactone, ε-caprolactone. Co-polymerisations were investigated 
and a tri-block polymer of poly(ε-caprolactone/δ-valerolactone/rac-lactide) was 
prepared. 
 Chapter 5, trans-1,4-DACH salen ligands were synthesised and investigated 
as ligands with Al(III), Ti(IV), Zr(IV), and Zn(II) metal centres. Bimetallic Al(III) 
and Ti(IV) structures were characterised and trialled for the ROP of rac-lactide. 
Isotactic PLA was reported for aluminium complexes, dependent upon phenoxy 
substituents, and these polymerisations were shown to be immortal in nature. 
 vii 
 Chapter 6 details the synthesis of trans-1,2-DACH salalen ligands which 
were complexed to AlMe3, these initiators were investigated for the solution ROP of 
rac-lactide. The further synthesis of benzyloxy derivatives is also reported and they 
were utilised for solution and solvent free polymerisations of rac-lactide. The 
initiator’s behaviour is discussed with respect to varying amine and imine groups.  
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1. Introduction  
1.1 Biopolymers 
Over the last century interest in plastics has developed considerably with 
much focus on synthetic polyolefins derived from petrochemicals.
1
 Although 
polyolefins have been very successful, they do have considerable drawbacks. 
Petrochemical derived plastics are associated with many environmental concerns, 
one such current issue is that petrochemical sources are being depleted and our 
present use of fossil fuels for plastic production is not sustainable.
2
 Furthermore, 
petrochemical plastics are becoming a major pollutant, polyolefin plastics are not 
readily decomposed and when considered with our common use of disposable 
plastics there is an inevitable disposal problem. In recent years replacement plastic 
sources are becoming commercially more viable due to the rising cost of oil and 
public environmental concern. As a consequence of these concerns much research 
has been focused in the last few decades on developing biodegradable and 
sustainable plastics to replace petrochemical derived materials.
3, 4
 
Biopolymers are polymers obtained from renewable resources which have 
acquired interest as replacements for petrochemical polymers, particularly within 
plastics. It should be noted not all biopolymers are biodegradable.
5
 A variety of 
biopolymers have been developed over the last few decades one such example is 
cellulose derived polymers.
6
 Cellulose is a major constituent of all plants therefore it 
is the most common naturally produced polymer, which is currently obtained from; 
wood pulp, algae and cotton.
6
 Although cellulose is mass produced by nature it is 
difficult to extract and obtain in a form which can be easily manipulated. A critical 
element of cellulose research is controlling the structure and hence the properties, 
such examples are the ester and ether derivatives of cellulose particularly cellulose 
acetates used for polymer coatings.
6
 Aliphatic polyesters such as polylactide (PLA) 
and polyglycolide (PGA) have received attention over the last few decades as 
suitable replacements for petrochemical polymers. Particular advantages of aliphatic 
polyesters include; suitable mechanical characteristics, renewable feedstocks, 
biodegradable, and biocompatible.
2
 
 3 
Degradability is another important aspect of plastic production; there are two 
common methods of engineering degradable polymers, introducing degradable 
substituents into the polymer chain or creating the polymer from inherently 
degradable monomers.
7
 Biodegradable monomer units can be introduced into 
petrochemical polymers to increase their degradability. As an example, hydrolytic 
degradation of poly(ethylene terephthalate) was increased by incorporation of lactide 
units.
8
 Introduction of metal substituents into polymers propagate its degradation to 
smaller polymer chains, these polymers are classified as oxo-degradable. Such 
oxo-degradable polymers breakdown on exposure to U.V. light and oxygen, this 
method only break-down polymers into shorter chain oligomers at which point 
biological processes may decompose the shorter chains.
9-11
 As stated 
oxo-degradation only reduces the polymers to shorter chains which still present an 
environmental issue. Additionally the metals incorporated in the polymer enhance 
the environmental issues as toxicology and metal leaching must be considered. 
Arguably more sought after are fully biodegradable polymers where the individual 
monomeric units of the polymer chain can decompose to water and carbon dioxide. 
Biodegradation of polymers often requires specific conditions such as; elevated heat, 
oxygen, and light, which are obtained in a composting facility.
12
 
As stated above polylactide and polyglycolide are biodegradable, renewable 
and characteristically suitable replacements, within certain applications, for 
petrochemical derived polymers. Polylactide and polyglycolide are derived from the 
base components lactic acid and glycolic acid respectively. Although the direct 
production of PLA and PGA by polycondensation from lactic acid and glycolic acid 
results in polymers of low molecular weight.
2
 As control over the aspects of the 
polymer is paramount within industry the dehydrated lactide and glycolide products 
are utilised to produce their respective polymers (Figure 1.01), consequently the 
dehydrated dimers have seen considerable attention.
2, 13, 14
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Figure 1.01: Formation of lactide and glycolide.2, 13, 14 
 
PLA is not a new polymer being first observed by Pelouze in 1845 by 
dehydrating lactic acid.
15, 16
 Within the last decade PLA has matured from a 
specialist chemical into an available commodity polymer. NatureWorks part of 
Cargill Dow LLC chemicals are the major producer of PLA with a facility in Blair, 
Nebraska capable of producing 140,000 tonnes of PLA per annum.
17
 PLA is derived 
from any sugar source such as sugar beet, corn or wheat which is first introduced into 
a fermentation faculty to extract lactic acid. Lactic acid is partially polymerised by a 
condensation reaction yielding low chain length polymers due to the equilibrium 
nature of the direct condensation reaction and the practicalities of removing the final 
remnants of water (Figure 1.02).
16
 Via use of a catalyst the oligomers are 
depolymerised into selective lactide units, which are sublimed before polymerisation 
using an organotin catalyst, in the NatureWorks process. 
Since the continuous lower cost production of PLA by NatureWorks this 
biodegradable polymer (PLA) has become viable as a disposable material, examples 
include; drinking cups, yogurt pots, and cutlery.
18
 Although PLA is considered as a 
remarkable biodegradable polymer as it is not limited to short term disposable 
applications, other applications include textile materials and paper coatings. Prior to 
large scale production of PLA its most notable use was for biomedical applications.
19, 
20
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Figure 1.02: Production of Polylactide (PLA) from lactic acid.16 
 
An exemplary aspect of PLA is its inherent biocompatibility attained from its 
base component lactic acid. Under physiological conditions PLA is hydrolysed to 
lactic acid, which is naturally found within the human body  
and consequently PLA is non-toxic. Medical applications require defined physical 
properties and degradation rates of polymers. Within PLA these characteristics are 
influenced by the steric orientation and crystallinity of the material. Fortunately 
lactide offers two chiral centres and by controlling the orientation of the chiral 
centres throughout PLA, its crystallinity, rigidity, and degradation can be tuned. 
Alternatively characteristics of PLA are tuned by co-polymerisation with other 
monomers. For example PLA and PGA co-polymer’s (PLGA) are utilised for 
surgical sutures.
21, 22
 Increasing the quantity of glycolide moieties reduces the 
resulting co-polymers rigidity and decreases its degradation rate. As a further 
example a blend of PLA and polyethylene-co-vinylacetate was investigated by 
Kenawy et al. as a media for drug delivery.
23
 Kenawy et al. showed the co-polymer 
gave a stable release of the antibiotic tetracycline hydrochloride, over a period of 5 
days, compared to negligible release from pure PLA.
23
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1.2 Ring-Opening-Polymerisation (ROP) of Lactide 
ROP of lactide often gives good control over the resulting PLA properties. In 
the presence of a catalytic initiator the ROP of lactide proceeds via a multitude of 
mechanistic pathways, which are generically grouped as; anionic, cationic, or 
coordination insertion mechanisms.  
1.2.1 Anionic mechanism  
 The anionic lactide mechanism is typically observed if the ROP catalyst 
contains a labile cationic metal such as; lithium, potassium, or magnesium. There are 
two mechanisms of initiation of anionic polymerisation shown in figure 1.03 and 
1.04.
2, 13
 The first initiation approach discussed is the direct nucleophilic attack of an 
ionic alkoxide to ring open lactide by acyl bond cleavage. This reaction yields a 
further lactide derived alkoxide unit and propagation ensues (Figure 1.03).  
Figure 1.03: Direct nucleophilic attack of anionic ROP mechanism.2, 13 
 
The alternative initiation method of anionic ROP begins with deprotonation 
of a lactide monomer. This deprotonated species can rearrange into a tautomeric 
metal-enol species (Figure 1.04).
24
 Both species are capable of initiating ROP by 
nucleophilic attack of a lactide monomer, consequently leading to acyl bond 
cleavage. The propagation step is less clear. One proposition is it proceeds via the 
direct nucleophilic attack mechanism (Figure 1.03) where the ring-opened lactide, an 
alkoxide, becomes the nucleophilic initiator for continued propagation.
2
 To elucidate 
the mechanism end-group analysis can be used, as the direct nucleophilic attack route 
will incorporate an alkoxide from the metal initiator or co-initiator.  
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Figure 1.04: Anionic ROP mechanism, via the deprotonation of lactide.2, 24 
 
1.2.2 Cationic mechanism 
 The cationic ROP mechanism is mostly observed for organic initiators and 
can also be referred to as a monomer-activated mechanism.
25
 Cationic acid catalysed 
ROP of caprolactone and valerolactone was established and proceeded using HCl as 
the acid catalyst.
26
 The polymerisation of lactide proceeds via a cationic mechanism 
utilising trifluoromethanesulfonic acid and methyl trifluoromethanesulfonate 
catalysts. The polymerisation initiates by cationic activation of lactide and then the 
triflate cleaves the alkyl oxygen, over the acyl oxygen bond, by a SN2 style 
mechanism (Figure 1.05).
2, 13
  
 
Figure 1.05: Cationic polymerisation mechanism, R = H, Me, or a growing lactide chain.2 
 8 
A later development by Bourissou et al. is the cationic acid catalysis of 
lactide utilising a trifluoromethanesulfonic acid catalyst in the presence of a protic 
solvent.
27
 Bourissou et al. proposed a mechanism based on the selective activation of 
a lactide unit over PLA (Figure 1.06), where the activated lactide is opened by acyl 
cleavage.  
 
Figure 1.06: Acid catalysed ROP of lactide, adapted from Bourissou et al.2, 27. 
1.2.3 Coordination insertion mechanism 
 Throughout the literature the coordination insertion mechanism is the 
prevalent ROP mechanism.
2, 13, 25
 The coordination insertion mechanism requires a 
catalytic initiator which contains an electropositive metal, where the metal does not 
readily dissociate as a cation. The mechanism proceeds by first coordinating the 
catalytic initiator, via the electropositive metal centre, to a carbonyl oxygen of the 
monomer (Figure 1.07).
2
 Secondly, the monomer inserts into the metal alkoxide 
bond by attack of the alkoxide to the carbonyl carbon. This is followed by cleavage 
of the acyl bond to ring-open the monomer, leaving the metal coordinated to a newly 
formed lactide alkoxide bond. Formation of an alkoxide allows the polymerisation to 
propagate further by insertion of monomer into metal-lactide bonds. Finally the ROP 
reaction is quenched by saturation of the polymerisation with a proton source, 
typically methanol, hydrolysing the resulting metal-PLA linkage. This mechanism 
has been experimentally studied by Kricheldorf et al. in 1988
28
 and further supported 
by Teyssié et al. in 1991
29
 both by the study of Al(O
i
Pr)3 as the ROP initiator.
2
 
Interestingly this mechanism allows the presence of a non-dissociative ligand bound 
to the active metal which appears to “spectate” within the reaction. This aspect of the 
mechanism can be exploited and the spectator ligand(s) can be used to impart control 
over the mechanism, inducing chirality over the metal centre. A renowned example 
was by Fiejen et al. using an Al-alkoxide initiator.
30
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Figure 1.07: Coordination-insertion mechanism.2 
 
1.2.4 Transesterification side reactions 
 Anionic, cationic and coordination insertion mechanism are all capable of 
transesterification side reactions. Transesterification is undesirable, an ester linkage 
within an existing polymer chain is attacked in preference to a lactide ester linkage. 
As a consequence transesterification reactions cause molecular weights to be lower 
or distributed over a larger molecular weight range. Transesterification can occur by 
two generic mechanisms, either intramolecular or intermolecular (Figure 1.08).
2
 
Intramolecular transesterification or backbiting is defined as when a growing 
polymer chain reacts with itself, hence reducing PLA molecular weight and forming 
cyclic compounds. Intermolecular transesterification is attack of one polymer to 
another chain thus causing wide disparity between polymer chains and high 
distribution of molecular weights. 
 10 
 
 
Figure 1.08: Schematic representations of intermolecular and intramolecular transesterification side 
reactions, within the ROP of lactide.2 
 
 An ideal ROP mechanistic scenario involves chain-end-control where the 
polymerisation proceeds by incorporating lactide monomers only at the end of a PLA 
chain. The chain-end control mechanism allows a tailored initiator to arrange each 
monomer inserted into the chain. In the circumstance that an initiator can further 
polymerise on addition of more monomer before quenching the polymerisation is 
known as “Living”.31 For a polymerisation to be considered living the above 
statement must be true but in addition the molecular weight of the polymer chain 
must coincide with the monomer-to-initiator ratio i.e. one polymer chain per 
initiation site. A living coordination-insertion polymerisation can be terminated by 
quenching of the reaction by hydrolysing the end group. In contrast immortal 
polymerisations cannot be quenched by addition of typical reagents, such as alcohols. 
 11 
The concept of living polymerisations was first observed and introduced for 
ring-opening polymerisation by Inoue et al.
32
 Immortal polymerisations share traits 
with living polymerisations, predominantly each reaction will continue to polymerise 
on addition of further monomer. As stated immortal polymerisation cannot be 
terminated on addition of alcohol as the polymer chains are rearranged. This 
rearrangement shortens the polymer chains to a degree, where the chain length is 
equal to the monomer:alcohol ratio.  
1.2.5 Immortal ROP mechanisms   
 
Figure 1.09: Schematic representations of the coordination-insertion based immortal mechanism for 
the ROP of lactide.33 
Within the immortal ROP of lactide the polymer chains grow in a uniform 
manner based upon the quantity of a secondary initiator source, which is typically a 
protic alcohol. Two methods are discussed herein; coordination insertion with rapid 
chain-end exchange mechanism,
33
 the second where propagation occurs via a 
transesterification method and an activated monomer mechanism.
33, 34
 The 
coordination insertion and rapid exchange reaction propagates through a coordination 
insertion mechanism (figure 1.09). During the propagation, rapid proton exchange 
between the terminating metal and a protic co-initiator/PLA chain occurs. The proton 
terminated PLA chain is still available for propagation and the LnM-OR species 
continues to polymerise. 
 12 
 
Figure 1. 10: Schematic representation of the activated monomer immortal mechanism for the ROP of 
lactide.33, 34 
 The activated monomer mechanism for the immortal ROP of lactide is 
depicted in figure 1.10.
33, 34
 A lactide carbonyl coordinates to the metal complex 
further polarising the carbonyl bond and activating it towards nucleophilic attack. A 
co-initiator, typically a protic alcohol, attacks the carbonyl carbon which is followed 
by acyl bond cleavage. The lactide chain is terminated by a proton and the metal 
complex transfers from the polymer chain to a lactide monomer activating the new 
monomer for propagation.  
1.2.6 GPC and determining polymer molecular weights 
 Polymers are characterised by either their physical characteristics or chemical 
structures. Gel permeation chromatography (GPC) can be utilised to determine 
structural characteristics of linear aliphatic polyesters. Herein is discussed two 
measurements; number average molecular weight (Mn), a measure directly related to 
the chain lengths within the polymer, and the polydispersity index (PDI), a measure 
of chain length distribution. GPC is a method of size exclusion chromatography 
where larger polymer chains will flow through the system at a much faster rate. The 
polymer must first be solubilised in a compatible solvent and the solution is then 
passed through a series of porous beads. Smaller polymer chains permeate the beads 
 13 
while larger chains flow around (Figure 1.11). As a consequence smaller chains take 
a much more turbulent route directly causing a higher retention time. 
 
Figure 1.11: GPC diagram depicting polymer flow paths. 
 
                               Equation: 1.01 
 
Equation: 1.02                                                Equation: 1.03 
 
Figure 1.12: Equations relating: polydispersity index (PDI), number average molecular weight (Mn), 
and weight average molecular weight (Mw). 
 
The polydispersity index (PDI) is calculated by the equation 1.01 
(Figure 1.12). It is dependent on the number average molecular weight (Mn) 
calculated by equation 1.02 (Figure 1.12) and the weight average molecular weight 
(Mw) given by equation 1.03 (Figure 1.12). Mn is a measure of the mean average 
molecular weight, while Mw accounts for the fact that larger individual molecules 
account for a higher percentage of the total weight. A direct comparison of Mn and 
Mw is PDI, PDI = 1 indicates uniform polymer chains, PDI > 1 indicates varied 
polymer chain lengths. Mi and Ni values are obtained from a GPC trace (Figure 1.13) 
by correlating inverse retention time and relative intensity. To determine Mi from 
retention time a GPC instrument is calibrated to polystyrene standards. To account 
for the difference in hydrodynamic volume between lactide and polystyrene 
standards a correction value of 0.58 can be applied.
35
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Figure 1.13: Typical GPC trace. 
 Mn and PDI values are related to the rates of individual mechanisms within 
the polymerisation. If the rate of initiation (kint) >> rate of propagation (kprop) the 
resulting polymer chains should all be uniform (PDI ≈ 1). Alternately if the opposite 
is true kint << kprop a polymer chain can grow significantly before an additional chain 
initiates resulting in higher chain distribution (PDI >> 1). The above assumes the 
initiator contains one initiation site or only propagates one polymer chain. If an 
initiator has more than one initiation site further chain distribution will result as a 
consequence of multiple kint values. For the coordination insertion mechanism where 
kint >> kprop then the polymer chain length can be predicted from conversion of 
lactide by equation 1.04.   
 
 
Equation: 1.04 
 
Figure 1.14: Equation used to calculate theoretical molecular weight from conversion of lactide for 
PLA. 
 
 Molecular weight control is not limited to the rate of propagation and rate of 
initiation as stated previously transesterification is detrimental to uniform chain 
length. If kprop >> kinter.trans (rate of intermolecular transesterification) uniform chain 
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growth ensues. In the case that kprop >> kintra.trans (rate of intramolecular 
transesterification) controlled growth is observed, where kprop << kintra.trans we get 
both high PDI and lower Mn.  
Molecular weight can be determined by other methods, which can be used in 
addition to GPC. A valuable method is MALDI-TOF mass spectrometry which gives 
the repeat unit of the polymers and is highly regarded for end group analysis. Mass 
spectrometry has limitation due to difficulties in ionising polymer chains, limiting 
the polymer samples to lower molecular weights. Methods which detect polymer 
concentration and can work in-situ with GPC include; refractive index, IR, and UV 
absorption. Other methods which can be utilised in-situ with GPC or possible to get 
measurements directly include low angle light scattering, viscosity, and multi angle 
light scattering detectors. 
1.2.7 Stereochemistry and characterisation by NMR spectroscopy 
 Lactic acid is present in the L and D forms (the S and R enantiomers 
respectively). As a result lactide can be isolated as a series of diastereomers. The 
commercially available lactide diastereomers are L-Lactide, D-Lactide, Meso-lactide 
and an mixture of L-lactide and D-lactide known as rac-lactide (Figure 1.15).
36
 Both 
L-lactide and D-lactide result in isotactic PLA with their respective stereochemistry 
throughout the polymer. rac-Lactide can yield different PLA arrangements, which 
are determined by the initiator and reaction conditions. The resulting PLA 
stereoforms from rac-lactide are; isotactic stereoblock PLA is the arrangement of 
L-lactide units as a block of PLA followed by a corresponding block of D-lactide 
units, heterotactic PLA is an alternating arrangement of L-lactide and D-lactide, and 
atactic PLA is the random arrangement of lactide monomers throughout the polymer 
chain. meso-Lactide also results in different stereo arrangements of PLA and like 
rac-lactide can also yield heterotactic and atactic PLA. In contrast to rac-lactide 
meso-lactide can produce syndiotactic PLA where each lactic acid (or each 
stereocentre) adopts the opposite conformation in an alternating manner. 
 Each stereo-arrangement of PLA has different physical properties. Isotactic 
PLA derived from L-lactide and D-lactide both have similar properties; they show a 
higher degree of crystallinity and as such are more brittle and ridged than other 
stereoforms of PLA. Atactic, syndiotactic and heterotactic lactide all have similar 
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properties due to lack of crystallinity within the respective polymers. Isotactic 
stereoblock PLA results in further crystallinity within the polymer displaying similar 
physical properties to isotactic PLA. Isotactic stereoblock PLA exhibits a higher 
melting temperature than isotactic PLA derived from pure L-lactide or D-lactide. 
This observation has been attributed to increased intermolecular interactions between 
L-PLA and D-PLA chains. Isotactic stereoblock PLA can be synthesised directly 
from rac-lactide via the use of certain initiators.
30, 37
 Blending L-PLA and D-PLA in 
differing quantities has been studied with the intention of mimicking isotactic 
stereoblock PLA with moderate success but cannot fully yield the same properties as 
isotactic stereoblock PLA.
18, 38
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Figure 1.15: Stereoforms of lactide and resulting PLA arrangements.36 
 
 NMR spectroscopy is used in PLA analysis to determine conversion, tacticity, 
and end group analysis of low molecular weight PLA. Conversion is obtained by 
comparing the relative integrals of lactide methines to PLA methines by 
1
H NMR 
 18 
spectroscopy. End group analysis by NMR spectroscopy is highly dependent on the 
end-group in question but it generally requires higher resolution and more 
concentrated polymer samples. Tacticity of PLA can be determined by two methods; 
1
H homonuclear decoupled NMR spectroscopy,
36
 and 
13
C{
1
H} NMR spectroscopy.
39
 
13
C{
1
H} NMR spectroscopic method for determining tacticity was developed 
by Kasperczyk in 1995
39
 and focused on the carbonyl region of the spectra and 
implemented a hexad system to determine tacticity. PLA tacticity determination by 
homonuclear decoupled methine region 
1
H NMR spectroscopy was later 
development by Thakur et al. in 1997 and utilised a tetrad model.
40
 
 A typical spectrum of a
 1
H homonuclear decoupled NMR spectrum of atactic 
PLA is shown in figure 1.16. By removing the coupling from the methine protons 
located at 1.62 ppm the methine region becomes five discrete resonances. The 
resonances are allocated to tetrad units, groups of four lactic acid units where; i = an 
isotactic linkage (R,R or S,S), and s = a syndiotactic linkage (R,S or S,R). Thus, it 
follows that the [iii] tetrad corresponds to an isotactic PLA tetrad with the respective 
lactic acid chirality of R,R,R,R or S,S,S,S. See figure 1.17.
36
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Figure 1.16: 1H homonuclear decoupled NMR spectrum of the methine region from atactic PLA. 
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Figure 1.17: PLA tetrads derived from rac-lactide. 
  
 Within the decoupled 
1
H NMR spectrum heterotactic PLA is observed as an 
equal combination of the [sis] and [isi] tetrads. Atactic PLA derived from rac-lactide 
yields all five tetrad possibilities (Figure 1.17). The relative integrals of the tetrad 
peaks within the homonuclear decoupled 
1
H NMR spectrum are; 
1[sis]:1[sii]:1[iis]:3[iii]:2[isi] for atactic PLA. The ratios for the eight possible tetrads 
are derived by Bernoullian statistics, which calculates the probability of each tetrad 
linkage occurring (Table 1.01). Out of the eight possibilities only five are possible 
for rac-lactide as neither L, or D-lactide units allow two adjacent syndiotactic 
linkages “s”. Bernoullian statistics are also applied for PLA derived from 
meso-lactide and disallow possibilities which contain two adjacent isotactic linkages 
“i”. Transesterification may cause the disallowed possibilities to occur as 
transesterification is not limited to lactic acid diads.  
 When considering rac-lactide the probability of racemic enchainment (Pr) is 
inversely proportional to the probability of isotactic enchainment (Pm) and can be 
calculated by rearrangement of equation 1.05 (Figure 1.18). To keep the calculations 
simplistic the [sis] relative integral is chosen to calculate Pr (Equation 1.06), which 
gives Pm via equation 1.05. Pr is a measure of the tacticity within PLA, when Pr = 1 
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the polymer has only racemic lactide linkages as such is heterotactic. It follows that 
when Pm = 0 there is no isotactic enchainment and the PLA is heterotactic. Therefore 
when Pr = 0 and Pm = 1 there is total isotactic enchainment of the PLA chains.
36
 
 
Tetrad 
Probabilities based on Bernoullian statistics 
rac-lactide meso-lactide 
[iii] Pm
2
 + Pr Pm / 2 0 
[iis] Pr Pm / 2 0 
[sii] Pr Pm / 2 0 
[sis] Pr
2
 / 2 (Pm
2
 + Pr Pm) / 2 
[sss] 0 Pr
2
 + Pr Pm / 2 
[ssi] 0 Pr Pm / 2 
[iss] 0 Pr Pm / 2 
[isi] (Pr
2
 + Pr Pm) / 2 Pm
2
 / 2 
 
Table 1.01: Tetrad probabilities based on Bernoullian statistics.36 
 
     Equation 1.05 
    Equation 1.06 
Figure 1.18: Equations derived from Bernoullian statistics to calculate probability of racemic 
enchainment (Pr). 
 
 Determination of tacticity is not limited to 
1
H NMR spectroscopy, differential 
scanning calorimetry can be used to determine tacticity in stereoregular PLA via 
melting points and crystallinity.
2
 
13
C{
1
H} NMR spectroscopy is also utilised in the 
determination of tacticity, the method is similar to 
1
H homonuclear decoupled NMR 
spectroscopy methine analysis in that the carbonyl region is separated into a series of 
hexads and the probability of enchainment is calculated through equations derived 
from pair addition Bernoullian statistics.
39
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1.3 Ring-Opening-Polymerisation Initiators for Lactide 
 The ROP of lactide requires an initiator which can be either metal based or 
non-metal based. The initiator is the key variant of the ROP reaction in obtaining 
stereoselectivity from rac-lactide and also determines the reaction rate and resulting 
PLA properties. Metal initiators with simple ligands rarely impart stereoselectivity 
over the ROP of rac-lactide, although there are examples contrary to this.
41, 42
 The 
need to control the polymerisation of rac-lactide has led to the use of metal 
complexes which utilise bulky, chelating or chiral ligands. Typical metal complex 
PLA initiators contain at least one or any combination of these properties. Design of 
metal complexes and thier associated ligand groups achieved improved 
stereo-control, molecular weight control and/or low PDI values, which is discussed 
throughout this chapter. A metal centre can control the tacticity of PLA resulting 
from the ROP of rac-lactide by chain-end-control where control over the tacticity is 
induced by the growing polymer chain. Another method of stereo-control involves 
forcing chirality over the metal centre via the ligand(s), referred to as enantiomorphic 
site control.
43
 
 Initiators for the ROP of lactide have been comprehensively reviewed 
before.
2, 4, 13, 18, 25, 44-48
 Herein, selected initiators are reported for their originality in 
the subject, importance to the field, stereoselectivity, activity, or relevance to the 
study that follows. Using these criteria groups of metal based initiators (sections 
1.3.1 - 1.3.7) are discussed with a short overview of organic based initiators (section 
1.3.8). Following this cyclic-ester co-polymers are briefly discussed (section 1.4). 
 
1.3.1 Tin initiators 
The current industrially favoured initiator for the ROP of lactide is Tin(II) 
2-ethylhexanoate or tin(II) octoate {Sn(Oct)2} as it is easy to handle, commercially 
available, and shown to polymerise at high ratios in solvent free conditions. It was 
shown that Sn(Oct)2) polymerises lactide at 110 °C to 98 % conversion after 24 h at 
very high monomer to initiator ratios.
49
 Furthermore, a significant increase in ROP 
control and rate was observed on the addition of a protic co-initiator.
50
 There was 
much speculation over the ROP mechanism but it has been shown that Sn(Oct)2 
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initiates by the coordination insertion mechanism with and without a purposefully 
added co-initiator (Figure 1.19).
2, 51
 
 
Figure 1.19: Computationally predicted mechanism of the ROP of lactide by Sn(Oct)2 in the presence 
of a protic co-initiator. a Computationally derived for R = Me.1,32 
 
Sn(Oct)2 contains high degrees of impurities, mostly water and octanoic acid, 
which have a significant effect on the ROP reaction rate and resulting molecular 
weight (Mn) of the PLA produced. The impurities were revealed to act in a similar 
fashion to a protic species and form a tin-alkoxide which becomes the active 
initiating species.
50, 52
 Although Sn(Oct)2 is the industrially favoured initiator it 
shows no stereoselectivity and although Sn(Oct)2 is non toxic, its related tin 
hydroxides are harmful, making them unsuitable for biomedical applications where 
conditions to produce tin hydroxides may occur.
53
 
 Gibson et al. has synthesised amino-phenol derived tin complexes for the 
polymerisation of lactide.
54
 The tridentate Schiff base ligands coordinate to Sn(II) 
then attack of the amide to the imine occurs to yield a tetra-dentate Sn(II) complex. 
This amide migration is a reversible process allowing access to both tetradentate and 
tridentate Sn(II) complex forms (Figure 1.20).
54
 This Sn(II) complex surprisingly 
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polymerises rac-lactide with a high degree of control despite its fluxional nature due 
to the amide migration mechanism. All the derivatives show little difference in their 
resulting rac-lactide polymerisation yielding > 90% conversion at 60 °C after 2 h at 
100:1 [monomer]:[initiator] ratio. All the polymerisations show good molecular 
weight control with low polydispersity index values (PDI ≈ 1.2).54 Interestingly 
NMR spectroscopy and MALDI-TOF mass spectrometry have both resolved the 
PLA end group as dimethylamide. It was suggested that the complex acts as a 
single-site initiator and further propagation proceeds via the lactide-Sn-ligand 
complex shown in figure 1.20. 
 
Figure 1.20: Sn(II) tridentate Schiff base complexes and amide migration to the Sn(II) tetradentate 
complex. Also depicted is a hypothesised polymerisation intermediate.54 
 
 Further work by Gibson has shown this amide migration to be present with 
similar ligands such as bidentate aminophenols.
55
 Under similar conditions (60 °C, 
100:1 [monomer]:[initiator] ratio) the bidentate aminophenol Sn(II) dimer 
(Figure 1.21) polymerised lactide to > 90 % conversion after 1 h. It was speculated 
that the dimer separates on inclusion of a lactide to produce a four-coordinate active 
species (Figure 1.21).
55
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Figure 1.21: Reaction of lactide with an aminophenol Sn(II) dimer showing a hypothesised 
propagation species.55 
 
 Tin β-diketiminate complexes have been established as efficient initiators for 
the polymerisation of rac-lactide (Figure 1.22).
56, 57
 Initial polymerisation studies of 
β-diketiminate tin complex Sn(1)OiPr with lactide displayed polymerisation in 
CH2Cl2 at ambient temperature to > 99 % conversion after 96 h at 100:1 
[monomer]:[initiator] ratio.
56
 Furthermore increasing the temperature to 60 °C 
(toluene) afforded an enhanced rate and achieved 85 % conversion after 4 h. Notably 
the higher temperature reaction yielded no loss of control over the polymerisation. 
Both the low and high temperature polymerisation gave good molecular weight 
control alongside low PDI values. All the Sn(II) complexes Sn(1-4)O
i
Pr produced 
moderately heterotactic polymer from rac-lactide Pr ≈ 0.65.
57
 By reducing the steric 
bulk of the aromatic substituent the reaction rate increased. At 60 °C (100:1 
[monomer]:[initiator] ratio), Sn(4)O
i
Pr attained 93 % conversion of rac-lactide after 
2 h with no loss of selectivity. Additionally the introduction of electron withdrawing 
substituents was shown to enhance reaction rate without selectivity loss.
57
 
 
Figure 1.22: Tin β-diketiminate alkoxide complexes.56, 57 
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Figure 1.23: tButylamidinate tin(II) complexes for the polymerisation of rac-lactide.58 
 
Gibson et al. investigated 
t
butylamidinate tin(II) complexes as initiators for 
the ROP of rac-lactide (Figure 1.23).
58
 As a comparison the Sn(II) complex 
Sn(5)O
i
Pr was significantly faster for the polymerisation of rac-lactide than its 
analogous β-diketiminate Sn(II) complexes {Sn(1-2)OiPr}. Under the same 
conditions (60 °C, toluene, 100:1 ratio) tin(II) complex Sn(5)O
i
Pr afforded > 85 % 
conversion after 90 mins compared to 4 h for Sn(1)O
i
Pr and 8 h for Sn(2)O
i
Pr.
57, 58
 
Although 
t
butylamidinate tin(II) complexes proved to be faster for the propagation of 
rac-lactide they yielded PLA with a similar heterotacticity to that observed by the 
Sn(II) β-diketiminate. Gibson et al. determined that this similar behaviour for both 
nitrogen binding bidentate Sn(II) ligand systems can be attributed to electronic 
effects of the Sn(II) metal. A 5s
2 
Sn(II) lone pair plays an important role in 
controlling the orientation of a coordinating lactide/PLA unit and furthermore 
influences the control over the propagation reaction.
57, 58
 
Chisholm et al. has reported Sn(IV) initiators for the polymerisation of 
L-lactide.
59
 Tin (IV) complexes of the basic formula Ph2SnX2 and Ph3SnX were 
synthesized and proven to be slow initiators for the polymerisation of L-lactide.
53
 
The bis(phenyl) Sn(IV) complexes were shown to be faster initiators than their 
tri(phenyl) Sn(IV) counter-parts with relative reaction rates; 
kprop {Ph2Sn(NMe2)2} = 3.8(2) × 10
−5 
s
-1
, and kprop (Ph3SnNMe2) = 2.8(4) × 10
−6
 s
-1
 
(80°C, toluene, [LA]0 = 0.084 M, [Sn]0 = 1.7 mM). These Sn(IV) complexes showed 
a very high degree of transesterification with a significant amount of cyclic esters 
produced during the polymerisation, to the extent that at 50 % conversion of 
L-lactide with Ph2Sn(NMe2)2 initiator the resulting product was mostly cyclic 
esters.
59
 The initiating group –X was shown to have a significant impact on the 
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polymerisation where X = O
i
Pr the polymerisation displayed a reduced amount of 
intramolecular transesterification than X = NMe2. 
 
1.3.2 Group 1 initiators 
 Group 1 metal complexes have proven to be active for the polymerisation of 
lactide. A notable simple initiator initially reported by Kasperczyk was LiO
t
Bu 
which polymerises rac-lactide at room temperature in tetrahydrofuran (THF).
39
 
LiO
t
Bu was shown to be a highly active initiator for the polymerisation of rac-lactide 
achieving 78 % conversion after 40 mins at 20 °C in THF at the [monomer]:[initiator] 
ratio of 250:1.
42
 Interestingly LiO
t
Bu yields heterotactic enriched lactide under the 
above conditions with reasonable control over the polymerisation. Further studies 
have indicated that lowering the temperature increases the heterotactic selectivity. It 
was also shown that heterotactic selectivity was much more significant at early 
reaction times and a Pr = 0.94 was reported at - 20 °C (THF) after 5 mins 
([monomer]:[initiator] ratio of 250:1). The reduced selectivity after longer reaction 
times was attributed to an increasing degree of transesterification reactions as the 
propagation reaction proceeds.   
 Potassium 
t
butoxide has been demonstrated as an active initiator for L-lactide 
polymerisation proving to be a fast initiator at ambient temperature.
60
 A significant 
reduction in rate is observed as the reaction approaches 80 % conversion. The control 
potassium 
t
butoxide exhibits over the ROP of L-lactide can be enhanced by the 
addition of 18-crown-6 ether decreasing the PDI from 1.42 to 1.17. While 
18-crown-6 ether addition gives enhanced polymerisation control it also decreases 
the ROP reaction rate, kprop (potassium 
t
butoxide) = 5.9 × 10
-3
 M
-1
 s
-1
, 
kprop {potassium 
t
butoxide + 18-crown-6 (1:1)} = 5.3 × 10
-4 
M
-1
 s
-1
. 
 Lithium is renowned for forming aggregates but Lin et al. synthesised a 
lithium dimer from the addition of 
n
BuLi and benzyl alcohol (BnOH) to 
2,2’-ethylidenebis(4,6-di-tert-butylphenol) (EDBP-H2).
61
 In the presence of THF the 
{(EDBP-H)-Li(BnOH)}2 dimer separates into lithium monomers with the formula 
{(EDBP-H)Li(BnOH)(THF)2} (Figure 1.24). The {(EDBP-H)-Li(BnOH)}2 dimer is 
a highly active initiator for the ROP of L-lactide at room temperature 
yielding > 99 % conversion after 1 h (CH2Cl2, 50:1 [monomer]:[initiator] ratio). 
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Experimental evidence suggested the dimeric species separated into monomers on 
coordination of an L-lactide moiety. The {(EDBP-H)-Li(BnOH)}2 dimer is still 
highly active for L-lactide ROP at reduced temperatures albeit displaying lower 
activity, at 0 °C after 2 h a conversion of 91 % was obtained (CH2Cl2, 50:1 
[monomer]:[initiator] ratio). While very active the {(EDBP-H)-Li(BnOH)}2 dimeric 
complex also displays good control over the ROP of L-lactide with linear correlation 
between molecular weight and monomer-to-initiator ratio alongside narrow PDI 
values (PDI = 1.04 – 1.16). Introduction of benzyl alcohol as a co-initiator revealed a 
dependency of molecular weight upon the benzyl alcohol (BnOH) ratio. The 
monomeric species {(EDBP-H)Li(BnOH)(THF)2} was also proven to be a highly 
active initiator for L-lactide polymerisation although it was shown to be less active 
than its dimeric counterpart {(EDBP-H)-Li(BnOH)}2. Furthermore, it was speculated 
that THF hinders the coordination of L-lactide units about the lithium metal centre.
61
 
 
Figure 1.24: Diagram showing 2,2’-ethylidenebis(4,6-di-tert-butylphenol) lithium benzyl alcohol 
dimer {(EDBP-H)-Li(BnOH)}2, and related THF derived lithium monomer 
{(EDBP-H)Li(BnOH)(THF)2}.
61 
 
1.3.3 Group 2 initiators 
 Magnesium β-diketiminate (BDI) complexes have been thoroughly studied 
for the ROP of lactide by Chisholm et al. alongside the corresponding calcium 
complexes.
36, 62-65
 Magnesium BDI alkoxides were obtained as dimers 
{Mg2(6)2(O
i
Pr)2} bridged by alkoxide groups (Figure 1.25) and have been proven to 
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be highly active initiators for the ROP of rac-lactide, achieving complete conversion 
after 2 mins at 20 °C (CH2Cl2) with a 200:1 [monomer]:[initiator] ratio.
36
 While the 
magnesium BDI complex Mg2(6)2(
i
Pr)2 is one of the most active initiators within the 
literature it showed a limited degree of control, affording molecular weights ~ 2.5 
times the predicted value and moderately broad PDI values of 1.59. Chisholm et al. 
speculated this reduced level of control is a consequence of a slow initiation rate 
compared to the rate of propagation.
36
 Interestingly the addition of a catalytic 
equivalent of 2-propanol significantly enhances the molecular weight control within 
the polymerisation giving lower PDI values of 1.29 under the same conditions. The 
dimeric magnesium BDI complexes do not exhibit stereocontrol over the ROP of 
rac-lactide.  
 
Figure 1.25: Magnesium BDI complexes for the ROP of lactide.36, 62 
 
 Magnesium BDI complexes are still active for the ROP of rac-lactide upon 
variation of the aromatic groups, a notable variation is the introduction of ether 
groups on the aromatic ring {Mg2(7)2(O
i
Pr)2} (Figure 1.25).
62
 Structurally the 
magnesium BDI complex Mg2(7)2(O
i
Pr)2 is a dimer like Mg2(6)2(
i
Pr)2, NMR 
spectroscopic evidence suggests the ether groups are in a fluxional coordination state 
with the magnesium metal centre. Magnesium BDI complex Mg2(7)2(O
i
Pr)2 was less 
active than Mg2(6)2(
i
Pr)2 achieving 91 % conversion after 20 mins at 20 °C (CH2Cl2) 
with a 100:1 [monomer]:[initiator] ratio. While less active there is also a decrease in 
molecular weight control, yielding ~7.5 times higher molecular weight than 
predicted with a high PDI value (PDI = 2.23). Although poor molecular weight 
control was observed with Mg2(7)2(O
i
Pr)2 it displayed enhanced stereoselectivity 
control over the ROP of rac-lactide (Pr = 0.61). Changing the solvent has a profound 
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effect upon the ROP of lactide.62 Using THF as the solvent lowered the activity of the 
reaction {90 % conversion, 90 mins, 20 °C (THF) with a 100:1 [monomer]:[initiator] 
ratio}, while also enhancing molecular weight control and heterotactic 
stereoselectivity (Pr = 0.90)  Ether and THF affect the ROP of lactide by reversibly 
coordinating to the magnesium metal, this creates a competitive coordination 
environment for lactide monomers. Due to coordinating THF or ethers the 
magnesium metal is less accessible thus creating stereoselective demands for a 
coordinating lactide. 
 
Figure 1.26: Magnesium BDI complexes with coordinated THF. 
 
 Chisholm also isolated monomeric magnesium BDI complexes with 
coordinated THF, one such is complex Mg(8)O
t
Bu.THF (Figure 1.26).
63, 64
 The 
active propagation species within the ROP of rac-lactide is a dimeric species 
{Mg(8)(lactide)}2 similar to the complex Mg2(6)2(O
i
Pr)2. As a result of the labile 
THF and the nature of the active propagation species the ROP of rac-lactide by 
Mg(8)O
t
Bu.THF did not significantly vary from Mg2(6)2(O
i
Pr)2. If THF was used as 
the solvent a noteworthy increase in stereoselectivity was observed (Pr = 0.93). THF 
also decreased the activity of the polymerisation of rac-lactide yielding 95 % conversion 
after 5 mins at 20 °C at 100:1 [monomer]:[initiator] ratio.   
β-diketiminate ligands were also complexed to calcium and trialled as 
rac-lactide ROP initiators. NMR spectroscopic evidence suggests the calcium BDI 
complex {Ca(8)N(SiMe3)2.THF} (Figure 1.27) is unstable as a monomer and a 
plethora of species are present in solution. The complex was still shown to be highly 
active towards the ROP of lactide yielding atactic PLA up to 90 % conversion after 
2 h at room temperature (THF) with a 200∶1 [lactide ]:[initiator] ratio.66 
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Figure 1.27: Monometallic BDI calcium complexes with coordinated THF. 
 
 
Figure 1.28: Group 2 tris-pyrazolyl borate complexes for the ROP of lactide. 
  
A tris(3-tert-butylpyrazolyl)borate magnesium alkoxide complex {Mg(9)OEt} 
(Figure 1.28) was investigated for the ROP of lactide and has proven to be a highly 
active initiator, akin to other magnesium initiators.
67, 68
 The magnesium tris-pyrazolyl 
borate complex Mg(9)OEt resulted in 90 % conversion of L-lactide after 1 h (20 °C, 
CH2Cl2, 500:1 [monomer]:[initiator] ratio). While a highly active initiator Mg(9)OEt 
also displayed good molecular weight control exhibiting linear relationship of Mn 
with conversion, a PDI value of ~1.2 is maintained up to a 1000:1 
[monomer]:[initiator] ratio.
67
 Mg(9)OEt showed a significant preference towards the 
ROP of meso-lactide over rac-lactide. A chiral tris-pyrazolyl borate magnesium 
complex was also synthesised and determined to give a 25 % preference for 
syndiotactic PLA from meso-lactide.
68
 
Chisholm et al. have utilised tris-pyrazolyl borate ligands for complexation to 
calcium and further investigated these complexes for the ROP of rac-lactide.
65, 66
 
Both the tris-pyrazolyl borate calcium complexes Ca(9,10)O-2,6-
i
Pr2C6H3 were 
isolated as five coordinate metal complexes (Figure 1.28), with THF completing the 
coordination sphere. With prolonged heating and reduced pressure the coordinated 
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THF was removed to yield the four coordinate complex Ca(9)O-2,6-
i
Pr2C6H3 
(Figure 1.28). This calcium complex is highly active towards the ROP of rac-lactide 
achieving 90 % conversion within 1 min (RT, THF, 200:1 [monomer]:[initiator] 
ratio). Introduction of an amide {Ca(9)N(SiMe3)2} as the initiating group did not 
have a detrimental effect on the rate of propagation for rac-lactide, under the same 
conditions. Initiators Ca(9)N(SiMe3)2, and Ca(9,10)O-2,6-
i
Pr2C6H3 are all highly 
active initiators for rac-lactide ROP but they exhibited moderate molecular weight 
control (PDI = 1.61 – 1.74). Both of these calcium initiators showed a high degree of 
heterotactic stereoselectivity in THF at room temperature (Pr > 0.93). The 
stereoselectivity was influenced by the steric demands of the HB(3-
t
Bupz)3 ligand as 
introduction of less sterically demanding groups, demonstrated by 
Ca(10)O-2,6-
i
Pr2C6H3, afforded atactic PLA under the same ROP conditions. 
 
Figure 1.29: Magnesium Scorpionate complexes used as initiators for the ROP of lactide.69, 70 
 
 Magnesium scorpionate complexes were investigated for the ROP of 
rac-lactide by Sánchez-Barba et al.
69, 70
 Mg(12)CH2SiMe3 was identified as the 
isomer (Figure 1.29), while the analogous complexes {Mg(14,15)CH2SiMe3} are 
isomers of each other. The less sterically bulky magnesium scorpionate complexes 
undergo a rearrangement at high temperature (90 °C, 4 days) to form “sandwich” 
complexes with two scorpionate ligands per metal.
69
 The methyl substituted 
magnesium scorpionate complexes Mg(11,12)CH2SiMe3 are significantly less active 
towards the ROP of rac-lactide than other reported magnesium complexes 
Mg2(6,7)2(
i
Pr)2, Mg(8)O
t
Bu.THF, and Mg(9)OEt {Mg(11)CH2SiMe3, 42 %, 72 h, 
70 °C, toluene, 100:1 [rac-lactide]:[initiator] ratio, PDI = 1.09}{Mg(12)CH2SiMe3, 
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31 %, 72 h, 70 °C, toluene, 100:1 [rac-lactide]:[initiator] ratio, PDI = 1.09}. 
Although less active for the ROP of lactide both magnesium complexes 
Mg(11,12)CH2SiMe3 gave good control over the polymerisation showing molecular 
weights (Mn) close to predicted values and low PDI values (PDI = 1.09), also an 
experiment with L-lactide revealed no epimerisation of the PLA chains. Addition of a 
catalytic equivalent of isopropanol as a co-initiator enhanced the activity of 
Mg(12)CH2SiMe3 (54 %, 48 h) under the same conditions, while slightly broadening 
the resulting PLA molecular weights (PDI = 1.13). These less sterically bulky 
magnesium scorpionate complexes {Mg(11,12)CH2SiMe3} afforded no 
stereoselectivity. It should be noted that magnesium complexes 
{Mg(11,12)CH2SiMe3} were also very active initiators for the ROP of 
caprolactone.
69
 
 The more sterically bulky magnesium scorpionate complexes 
Mg(13-15)CH2SiMe3 investigated by Sánchez-Barba et al.
70
 proved more stable in 
solution than Mg(11,12)CH2SiMe3 complexes,
69
 with no evidence of ligand 
rearrangement into “sandwich” complexes. As noted above Mg(14,15)CH2SiMe3 are 
isomers with each other and were synthesised with a relative isomeric ratio of 3:7, 
where the magnesium isomer Mg(15)CH2SiMe3 was the dominant product. Isomers 
Mg(14,15)CH2SiMe3 were individually isolated before investigation for the ROP of 
lactide and alongside magnesium complex Mg(15)CH2SiMe3 were revealed as highly 
active initiators for the ROP of rac-lactide. Magnesium complexes 
Mg(13,15)CH2SiMe3 achieved 49 % - 51 % conversion after 2 minutes (0 °C, THF, 
100:1 [rac-lactide]:[initiator] ratio) with excellent molecular weight distributions 
(PDI < 1.03), additionally polymerisation of L-lactide showed no epimerisation was. 
The sterically bulky magnesium scorpionate complexes {Mg(13-15)CH2SiMe3} 
yielded heterotactic PLA from rac-lactide (Pr = 0.70 – 0.79). Reducing the 
temperature slightly increased the selectivity, the isomer Mg(14)CH2SiMe3 afforded 
the highest selectivity with Pr = 0.79 at 0 °C.  
 The hybrid scorpionate/cyclopentadienyl magnesium complex shown in 
figure 1.30 was trialled for the ROP of L-lactide and rac-lactide.
71
 This hybrid 
scorpionate/cyclopentadienyl magnesium complex was an active initiator for the 
ROP of L-lactide affording 97 % conversion after 2.5 h (90 °C, toluene, 200:1 
[monomer]:[initiator] ratio), with good molecular weight control and low PDI values 
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(PDI = 1.05), and no epimerisation occurs. The ROP of rac-lactide was revealed to 
be less active under the same conditions yielding 59 % conversion after 8 h for the 
ROP of rac-lactide. Similar molecular weight control (PDI = 1.12) and a very slight 
heterotactic bias was reported. The hybrid scorpionate/cyclopentadienyl magnesium 
complex was tested for the “bulk” ROP of rac-lactide and a 41 % conversion was 
observed after 2 h, alongside a decrease in molecular weight control (PDI = 1.41). 
The hybrid scorpionate/cyclopentadienyl magnesium complex is comparable to the 
less sterically bulky magnesium scorpionate complexes Mg(11,12)CH2SiMe3,
69
 but 
far less active than the bulky magnesium scorpionates Mg(13-15)CH2SiMe3.
70
 
 
Figure 1.30: Hybrid scorpionate/cyclopentadienyl magnesium complex utilised as an initiator for the 
ROP of lactide.71 
 
 Lin et al. studied NNO-tridentate ketiminate magnesium complexes and 
demonstrated that they initiate the ROP of rac-lactide and L-lactide with high 
activities (Figure 1.31).
72
 Magnesium complex {Mg(16)OBn}2 afforded 90 % 
conversion of rac-lactide after 12 h, whereas the less active derivative 
{Mg(17)OBn}2 afforded 96 % conversion after 25 h under the same conditions 
(30 °C, THF, 100:1 [monomer]:[initiator] ratio). Both initiators displayed good 
molecular weight control with average chain lengths consistent with each dimeric 
initiator propagating two PLA chains. Small variance of chain length was also 
observed with PDI values of 1.10 and 1.13 for {Mg(16,17)OBn}2 respectively, under 
the conditions stated above. Magnesium NNO-tridentate ketiminate complexes 
displayed heterotactic selectivity, {Mg(16)OBn}2 gave a Pr of 0.85 (30 °C in THF), 
complex {Mg(17)OBn}2 gave a reduced Pr of 0.54 (30 °C in THF). Further ROP 
studies on {Mg(16)OBn}2 have shown stereoselectivity is reduced upon changing the 
solvent to CH2Cl2 (Pr = 0.64). Stereoselectivity of {Mg(16)OBn}2 was further 
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enhanced (Pr = 0.87) by reducing the temperature at the expense of activity (61 %, 
0 °C, THF, 100:1 [monomer]:[initiator] ratio). 
 
Figure 1.31: NNO-tridentate ketiminate magnesium complexes investigated as initiators for the ROP 
of lactide.72 
 
1.3.4 Group 3 and lanthanide initiators  
Group 3 and lanthanide metal complexes have been shown to initiate the ring 
opening polymerisation of lactide.
73, 74
 Early investigation of yttrium alkoxides 
revealed them as highly active potential initiators. The commercially available 
Y5(μ-O)(O
i
Pr)13 cluster species was trialled for the ROP of lactide but it took days to 
obtain appreciable conversion.
73, 75
 The monometallic tris(2,6-di-tert-
butylphenoxy)yttrium species was shown to ring-open L-lactide, albeit comparatively 
slowly reaching full conversion after 10 h.
74
 End group analysis of PLA resulting 
from tris(2,6-di-tert-butylphenoxy)yttrium initiation was indeterminate and no single 
end-group was detected, it was further speculated that impurities and solvents are 
mechanistically important for the ROP of lactide.
74
 Tris(2,6-di-tert-
butylphenoxy)yttrium activity towards the polymerisation of L-lactide is significantly 
enhanced in the presence of a less sterically hindered alcohol co-initiator, with an 
isopropanol co-initiator 100 % conversion was obtained after 2 mins at 22 °C at 
50:1:0.3 [monomer]:[alcohol]:[initiator] ratio. The resulting PLA revealed well 
defined molecular weights (PDI = 1.24) alongside identification of isopropoxide 
end-groups. It was deduced that tris(2,6-di-tert-butylphenoxy)yttrium with 
isopropanol as a co-initiator proceeds via a fast exchanging yttrium isopropoxide 
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intermediate (Figure 1.32),
73, 74
 which is not readily accessible to the bridging oxide 
yttrium cluster compound Y5(μ-O)(O
i
Pr)13. 
 
 
Figure 1.32: Reaction scheme depicting the ROP mechanism of lactide by 
tris(2,6-di-tert-butylphenoxy)yttrium with isopropanol as a co-initiator.73, 74 
 
 
Figure 1.33: Bis(thiophosphinic amido)yttrium initiators investigated for the ring-opening 
polymerisation of lactide.76 
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 Williams et al. reported bis(thiophosphinic amido)yttrium initiators as active 
candidates for the ROP of rac-lactide.
76
 It was shown that the backbone (X group) 
had little effect on the ROP polymerisation of rac-lactide, whereas the phosphorus 
moieties (R groups) had a profound influence (Figure 1.33). Steric influence had a 
minimal effect on the activity of the yttrium initiator. Sterically iso-propyl and 
phenyl are similar but a significant difference in activity was observed 
(R = iso-propyl, > 90 % conversion, 3.7-6.8 mins, 25 °C, CH2Cl2, 200:1 
[monomer]:[initiator] ratio) (R = phenyl, > 90 % conversion, 25-90 mins, 25 °C, 
CH2Cl2, 200:1 [monomer]:[initiator] ratio). It was deduced that the polymerisation 
reaction proceeds by a coordination insertion mechanism where the insertion step is 
rate limiting. An electron withdrawing phosphorus substituent increases the Lewis 
acidity of the yttrium metal and consequently increases the metal alkoxide bond 
strength, therefore hindering the insertion of a new lactide molecule. This justifies 
the experimental ROP activity for this series of yttrium initiators where iso-propyl > 
phenyl > ethoxy. ROP reactions revealed a linear relationship between molecular 
weight and conversion for all the bis(thiophosphinic amido)yttrium derivatives. From 
MALDI-TOF mass spectrometry it was determined that significant transesterification 
was occurring resulting in high PDI values (PDI > 1.5). A heterotactic bias was 
observed for bis(thiophosphinic amido)yttrium complexes with ethoxy phosphorus 
groups (X = ethylene, R = ethoxy, Pr = 0.68)(X = trans-1,2-cyclohexylene, 
R = ethoxy, Pr = 0.79).
76
 This stereoselectivity was attributed to the hemilabile 
ethoxy exerting coordination geometry control over the active yttrium metal. 
 
Figure 1.34: Group 3 and lanthanide diaminobis(phenoxide) borohydride complexes trialled for the 
ROP of L-lactide and rac-lactide.77 
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 Group 3 and lanthanide borohydride complexes utilising 
diaminobis(phenoxide) ligands {Y(18)BH4}2, {Sm(18)BH4}2, and {Nd(18)BH4}2 
were investigated by Mountford et. al. for the ROP of L-lactide and rac-lactide.
77
 
The complexes were identified as dimers (Figure 1.34), the Sm complex 
{Sm(18)BH4}2 has the structure depicted, the Y dimer {Y(18)BH4}2 contained an 
additional coordinated THF, and the Nd dimeric complex {Nd(18)BH4}2 contained 
two coordinated THF moieties (one THF per metal). Complexes ({Y(18)BH4}2, 
{Sm(18)BH4}2, and {Nd(18)BH4}2) were active at room temperature for the ROP of 
L-lactide and rac-lactide. Kinetic experiments revealed a first order dependence on 
rac-lactide concentration where the order of activity is {Sm(18)BH4}2 > 
{Y(18)BH4}2 > {Nd(18)BH4}2. Complexes {Y(18)BH4}2 and {Sm(18)BH4}2 
typically polymerised rac-lactide to ~70 % conversion after 1 h (25 °C, THF, 200:1 
[rac-lactide]:[initiator] ratio), whereas the neodymium complex {Nd(18)BH4}2 
achieved 33 % conversion after 2 h under the same conditions. THF promotes the 
activity of these complexes, as a result using toluene at elevated temperature (70 °C) 
revealed a significant reduction in initiator activity for the ROP of rac-lactide. PLA 
resulting from these diaminobis(phenoxide) lanthanide complexes displayed a 
significant degree of transesterification with lower molecular weights than expected 
and broader molecular weight distributions (PDI = 1.41 – 1.59). The samarium 
bimetallic complex {Sm(18)BH4}2 displayed the greater molecular weight control. 
PLA resulting from initiation of rac-lactide by yttrium and samarium complexes 
({Y(18)BH4}2 and {Sm(18)BH4}2) revealed a heterotactic bias 
{Pr {Y(18)BH4}2 = 0.87, Pr {Sm(18)BH4}2 = 0.72}. A significant decrease in activity 
of initiators {Y(18)BH4}2 and {Sm(18)BH4}2 was reported when utilised for the 
ROP of L-lactide, which is consistent with their preference in producing heterotactic 
PLA. The heterotactic selectivity of complexes {Y(18)BH4}2 and {Sm(18)BH4}2 was 
shown to be dependent on either the solvent and temperature of the polymerisation.
77
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Figure 1.35: Scheme representing the synthesis of a selection of lanthanide and group 3 complexes 
supported by alkoxy-amino-bis(phenolate) ligands.78, 79 
 
 Carpentier et. al. synthesised a series of group 3 and lanthanide complexes 
derived from alkoxy-amino-bis(phenol) ligands (Figure 1.35). Furthermore these 
alkoxy-amino-bis(phenoxy) lanthanide complexes were investigated for the ROP of 
rac-lactide under various conditions.
78, 79
 Initially the complexes 
Y(19)N(SiHMe2)2.THF and La(19)N(SiHMe2)2.THF were reported as highly active 
initiators for the ROP of rac-lactide, where the yttrium initiator achieved full 
conversion within 1 h at room temperature at a 500:1 [monomer]:[initiator] ratio.
78
 
The synthesised yttrium, lanthanum, and neodymium amides based on ligands 
(19-22)H2 ROP rac-lactide in THF to 100 % conversion within 20 mins at 200:1 
[rac-lactide]:[initiator] ratio.
79
 Lanthanide complexes of these 
alkoxy-amino-bis(phenol) ligands polymerise lactide in a living manner with 
molecular weights consistent with one PLA chain per metal centre and narrow 
molecular weights (PDI = 1.19 – 1.34). The molecular weight distribution was 
slightly higher than expected for a truly living polymerisation, which was attributed 
to transesterification side reactions. Initially PLA derived from initiators 
Y(19)N(SiHMe2)2.THF and La(19)N(SiHMe2)2.THF revealed a heterotactic bias 
giving Pr = 0.80 for Y(19)N(SiHMe2)2.THF, and Pr = 0.65 for 
La(19)N(SiHMe2)2.THF. A solvent comparison between toluene and THF proved 
that THF is necessary to obtain heterotactic PLA. Substituting the methoxy group for 
an amide {Y(20)N(SiHMe2)2.THF} has minimal effect on the activity but a profound 
effect on the stereoselectivity yielding PLA with a reduced Pr = 0.60. This is to be 
expected as the structure of Y(20)N(SiHMe2)2.THF is ambiguous. 
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Y(21)N(SiHMe2)2.THF initiated the ROP of rac-lactide to yield PLA with a 
Pr = 0.56. One suggested reason for this decrease in heterotactic selectivity, was the 
structural ambiguity due to a formation of aggregates. Secondly, the reduction in 
steric bulk about the active metal centre imparts less coordination geometry control 
over the active metal-lactide propagating species. The highest heterotactic 
stereoselectivity (Pr = 0.90) for this series of complexes was achieved by the 
complex Y(22)N(SiHMe2)2.THF. By the same principle the bulky –Me2Ph group 
imparts additional steric control over the yttrium metal centre enhancing 
coordination geometry control over the active metal-lactide propagating species. The 
larger metals La and Nd result in less heterotactic stereoselectivity due to less steric 
control, Pr {La(19)N(SiHMe2)2.THF} = 0.65, Pr {Nd(19)N(SiMe3)2.THF} = 0.49. 
The addition of isopropanol as a co-initiator to the ROP of rac-lactide by yttrium 
initiators {Y(19)N(SiHMe2)2.THF, Y(22)N(SiHMe2)2.THF} was shown to yield 
narrower PLA chain distribution (PDI = 1.06 – 1.24). Stereoselectivity was retained 
upon addition of isopropanol. Addition of excess isopropanol is directly proportional 
to the PLA average chain length. Furthermore isopropanol is an effective chain 
transfer agent within the polymerisation reactions as the presence of cyclic esters was 
not detected. 
 
Figure 1.36: Further group 3 and lanthanide diamino-bis(phenoxy) complexes utilised for the ROP of 
rac-lactide.80 
 
 Following on from Mountford’s77 and Carpentier’s78, 79 work, Cui et al.80 
investigated further diamino-bis(phenoxy) derivatives complexed to group 3 and 
lanthanide metal alkys and investigated these for the ROP of lactide (Figure 1.36). 
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Y/Lu(23)CH2SiMe3.THF and Y(24)CH2SiMe3.THF were very active initiators for 
the ROP rac-lactide achieving > 90 % conversion after 1 h (20 °C, THF, 300:1 
[monomer]:[initiator] ratio). Y(23)CH2SiMe3.THF and Lu(23)CH2SiMe3.THF 
displayed similar activities although by increasing the amide alkyl chain tether (n = 3) 
the yttrium complex became inactive for the ROP of rac-lactide at 20°C, showing no 
conversion after 6 h under the same conditions. Molecular weights showed some 
variance from the predicted values and moderate PDI values were obtained 
(PDI = 1.32 – 1.59). The yttrium and lutetium complexes {Y/Lu(23)CH2SiMe3.THF} 
(excluding when n = 3) yielded elevated heterotacticity, Pr > 0.94, from the ROP of 
rac-lactide. Y(23)CH2SiMe3.THF also yielded heterotactic PLA under the same 
conditions giving a Pr = 0.90. It was shown that THF as the ROP solvent enhances 
the heterotactic stereoselectivity. X-ray determined complexes 
Y/Lu(23)CH2SiMe3.THF (for n = 2) adopted a twisted octahedral geometry about the 
metal. Y(24)CH2SiMe3.THF adopted a less twisted octahedral geometry. A trend was 
revealed where a more twisted octahedral geometry about the metal resulted in 
higher activity and stereoselectivity.  
 
 
Figure 1.37: Group 3 and lanthanide salan80 and piperazine salan81 complexes investigated for the 
polymerisation of lactide. 
 
 The yttrium salan complex {Y(25)CH2SiMe3.THF} (Figure 1.37) was 
synthesised and investigated for the ROP of rac-lactide it was shown to be highly 
active resulting in > 100 % conversion after 1 h (20 °C, THF, 300:1 
[monomer]:[initiator] ratio).
80
 Unlike the analogous aluminium salan {see figure 1.63, 
Al(90)Me}
82
 Y(25)CH2SiMe3.THF gave little polymerisation control (PDI = 1.64) 
and a small degree of heterotactic stereoselectivity was observed (Pr = 0.65). 
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 Group 3 and lanthanide metals were complexed to piperazine salan ligands 
(Figure 1.37) and investigated for the ROP of L-lactide and rac-lactide.
81
 For all the 
listed metals (Figure 1.37) a monometallic complex was obtained with the piperazine 
salan ligand (26H2), where the piperazine ring adopted a boat configuration. The 
lanthanide complexes M(26)CH2SiMe3.THF displayed very high activity for the 
ROP of L-lactide achieving 97 % conversion within 4 minutes (70 °C, toluene, 700:1 
[monomer]:[initiator] ratio). Molecular weights were consistent with one chain per 
metal although some deviation was reported, PDI was dependent upon the metal 
{PDI (Yb) = 1.12 – 1.15, PDI (Y) = 1.12 – 1.25, PDI (Lu) = 1.27 – 1.41, 
PDI (Gd) = 1.21 – 1.40}. Only the yttrium complex Y(26)CH2SiMe3.THF was 
reported for the ROP of rac-lactide, it was shown to ROP rac-lactide to 100 % 
conversion within 2 h (20 °C, THF, 700:1 [monomer]:[initiator] ratio). Although an 
active initiator towards the ROP of rac-lactide Y(26)CH2SiMe3.THF yielded much 
broader molecular weight distribution than reported for L-lactide, with a PDI = 1.61 
for rac-lactide under the above conditions. Alongside broader PDI values little 
stereocontrol was observed, Pr = 0.48 – 0.61.  
 
 
Figure 1.38: Group 3 complexes bound to phosphido-diphosphine pincer ligands used as initiators for 
the ROP of lactide.83 
 
 Complexes of group 3 metals utilising phosphido-diphosphine pincer ligands 
have been reported as initiators for the ROP of lactide (Figure 1.38).
83
 The yttrium 
initiator displayed a high activity towards the ROP of lactide at room temperature. 
The yttrium initiator Y(27)(CH2SiMe3)2.THF achieved 65 % conversion after 
15 mins (THF) at 20 °C with a 200:1 [monomer]:[initiator] ratio. By introducing less 
electron donating substituents to the phenyl ring {Y(28)(CH2SiMe3)2.THF} the 
yttrium metal becomes more Lewis acidic. This caused an enhancement in activity 
where initiator Y(28)(CH2SiMe3)2.THF gave a conversion of 92 % after 15 mins 
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under the same conditions. The scandium initiators were much slower with 
Sc(27)(CH2SiMe3)2.THF achieving 38 % conversion after 20 h under the same 
conditions, this was attributed to scandium being a smaller metal hindering lactide 
coordination and further lactide insertion. Despite two possible initiation sites per 
metal it was revealed that at room temperature phosphido-diphosphine complexes of 
group 3 metals propagate one PLA chain per metal centre. They displayed good 
control over molecular weight being almost a controlled living polymerisation. 
Molecular weight distributions of the resulting polymers were relativity low with 
PDI values between 1.20 - 1.28 for initiators Y(27,28)(CH2SiMe3)2.THF and 
Sc(27)(CH2SiMe3)2.THF under the above conditions. The deviation from a 
controlled living polymerisation (PDI < 1.10) was acknowledged as 
transesterification side reactions. PLA resulting from the ROP of rac-lactide by the 
yttrium initiators Y(27,28)(CH2SiMe3)2.THF was identified as having a heterotactic 
bias, with respective Pr {Y(27)(CH2SiMe3)2.THF} = 0.63, 
Pr {Y(28)(CH2SiMe3)2.THF} = 0.64. Scandium initiators {Sc(27)(CH2SiMe3)2.THF 
and Sc(28)(CH2SiMe3)2.THF2} revealed a heterotactic bias, with respective 
Pr {Sc(27)(CH2SiMe3)2.THF} = 0.60 and Pr {Sc(28)(CH2SiMe3)2.THF2} = 0.62. 
Solvent free conditions (130 °C) complicated the ROP of lactide, typically showing 
broader PDI values and as each yttrium metal propagated two PLA chains at the 
highly elevated temperature.  
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Figure 1.39: A dicationic yttrium complex and a zwitterionic yttrium complex synthesised and 
trialled for the ROP of rac-lactide.84 
 
 Dicationic and zwitterionic yttrium complexes were synthesised by 
Mountford et. al.
84
 who investigated their properties as initiators for the ROP of 
rac-lactide (Figure 1.39). The dicationic yttrium complex {[Y(29)O
i
Pr.THF3]
2+ 
2[BPh]
-
} was moderately active towards the ROP of rac-lactide yielding high 
conversions after 12 h (70 °C, 100:1:5 [monomer]:[initiator]:[co-initiator]). The 
direct polymerisation of rac-lactide by [Y(29)O
i
Pr.THF3]
2+
 was shown as a living 
polymerisation system. Furthermore addition of 5 eq. of co-initiator (
i
PrOH or 
BnNH2) resulted in proportionally lower molecular weights, consistent with an 
immortal polymerisation system. Analysis of the resulting PLA revealed an atactic 
microstructure. The zwitterionic yttrium complex Y(30)2H was shown as highly 
active for the ROP of rac-lactide resulting in high conversion after 20 mins (RT, 
THF, 100:1:5 [monomer]:[initiator]:[BnOH]). While Y(30)2H is a neutral complex it 
possesses a Lewis acid yttrium centre and a Brønsted acidic proton, both are capable 
of coordinating or enhancing the coordination of lactide. The zwitterionic yttrium 
complex was also identified as an immortal initiator for the ROP of lactide resulting 
in very controlled molecular weights and low PLA chain distribution (PDI = 1.17, 
for the above conditions). Additionally the resulting PLA was highly heterotactic 
(Pr = 0.93) and negligible transesterification was observed. 
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Figure 1.40: Iminophosphorane neodymium(III) Complexes investigated as initiators for the ROP of 
lactide.85 
 
 Monometallic iminophosphorane neodymium(III) amide complexes 
Nd(31,32)(N(SiMe3)2)2 were shown to be highly active initiators for the ROP of 
lactide (Figure 1.40).
85
 The monometallic neodymium(III) complexes 
{Nd(31,32)(N(SiMe3)2)2} both yielded > 95 % conversion of rac-lactide within 
5 mins (25 °C, THF, 200:1 [monomer]:[initiator] ratio). A linear molecular weight 
increase proportional to conversion was observed with moderate chain length 
distribution (PDI ~1.3), although molecular weights were about 10 times the 
expected value implying only 10 % of initiators were active. Furthermore, 
intermolecular transesterification was indentified by MALDI-TOF, alongside amido 
and hydroxyl end groups. An analogous bis(alkoxide) of Nd(32)(N(SiMe3)2)2 was 
synthesised from the neodymium(III) bis(phosphorus-amide) and further shown to 
decompose after 2h, following this polymerisation experiments were conducted by 
adding 
i
PrOH in-situ as a co-initiator. The in-situ generated alkoxide derivatives of 
Nd(31,32)(N(SiMe3)2)2 achieved > 95 % conversion after 6 mins (25 °C, THF, 
200:1:2 [monomer]:[initiator]:[
i
PrOH] ratio). The in-situ polymerisation displayed 
molecular weights consistent with 2 PLA chains from each metal, also very low 
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molecular weight distributions were observed (PDI = 1.05 – 1.07). Furthermore, the 
resulting polymer displayed a slight heterotactic bias (Pr = 0.57 – 0.60). Treatment of 
iminophosphorane potassium complex with 0.5 Eq. of neodymium (III) iodide 
resulted in a bis(iminophosphorane) neodymium (III) iodide complex, further 
addition of a base produced the neodymium (III) carbene complex Nd(31)2I 
(Figure 1.40). Formation of bis(iminophosphorane) neodymium (III) iodide was 
dependent on steric bulk of the nitrogen substituents. The Nd (III) carbene complex 
Nd(31)2I was investigated for the ROP of rac-lactide but it was proven to be inactive. 
Addition of 
i
PrOH to Nd(31)2I resulted in the decomposition into neodymium (III) 
alkoxides and free ligand, which consequently produced PLA, albeit with a lack of 
control. Interestingly addition of 
i
PrOH or KOEt to a mixture of Nd(31)2I and 
rac-lactide resulted in the moderately fast polymerisation (
i
PrOH = 81 %, 
KOEt = 0.85 %, 60 mins, RT, THF, 200:1:1 [monomer]:[initiator):[
i
PrOH/KOEt]), 
molecular weights were consistent with one polymer chain per neodymium and low 
chain length distributions (PDI = 1.05 – 1.11) were observed. A monomer activated 
mechanism was proposed,
85
 where neodymium activates the monomer for 
alcohol/alkoxide attack. After the polymerisation reaction reaches completion the 
alcohol/alkoxide terminated polymer chains proceed to attack the neodymium 
complex to yield free ligand. Chain length could not be controlled by addition of 
excess 
i
PrOH as the additional alcohol decomposed the neodymium initiator.  
 
1.3.5 Group 4 initiators 
Group 4 metal complexes are successful initiators for the ROP of lactide, of 
particular note due to their relevance to this study are the salen, salan, and salalen 
(-ONNO-) group 4 complexes. Tris-phenolates and other C3 symmetric group 4 
complexes have been investigated for the ROP of lactide and yielded a high degree 
of stereo-selectivity. Although titanium is the most prominent throughout the 
literature zirconium and hafnium initiators are often more active, or more 
stereoselective than their titanium counterparts.  
 
 46 
 
Figure 1.41: Scheme depicting chiral Schiff bases complexed to Ti(IV) and Zr(IV) alkoxides 
investigated for the ROP of rac-lactide.86 
 
Chiral Schiff base ligands (33-36)H2 were complexed with Ti(IV) and Zr(IV) 
isopropoxides by Davidson et al. and investigated as initiators for the ROP of 
rac lactide (Figure 1.41).
86
 Pure chiral R,R and S,S complexes were synthesised 
alongside racemic mixtures (S,R and R,S), NMR spectroscopic analysis showed the 
complexes were fluxional in solution at room temperature. All the Ti(IV) Schiff base 
complexes {Ti(33-36)2(O
i
Pr)2} were inactive in solution at 80 °C, whereas the 
Zr(33-36)2(O
i
Pr)2 initiators ring opened rac-lactide with moderate activities 
achieving 45 – 69 % conversion after 24 h (20 °C, 100:1, [rac-lactide]:[initiator] 
ratio). Under these conditions Zr(IV) Schiff base complexes {Zr(33-36)2(O
i
Pr)2} 
displayed good chain length control (PDI < 1.12) and resulted in heterotactic biased 
PLA (Pr = 0.68 – 0.76). Ti(IV) Schiff base complexes {Ti(33-36)2(O
i
Pr)2} were 
active for the ROP of rac-lactide in solvent free conditions (130 °C, 30 mins, 300:1 
[rac-lactide]:[initiator] ratio) and afforded good molecular weight control but yielded 
atactic PLA. Utilising melt conditions the Zr(IV) Schiff base initiators gave a 
reduced degree of chain length control (PDI = 1.39 – 2.49) but retained their 
heterotactic bias (Pr = 0.68 – 0.73). These Schiff base initiators were shown to have a 
degree of tolerance to water and impurities, and were capable of the polymerisation 
of lactide under such conditions.  
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Figure 1.42: Salen supported titanium (IV) bis(alkoxide) complexes trialled for the ROP of 
rac-lactide.87 
 
Salen supported titanium(IV) bis(alkoxide) complexes {Ti(37)(O
i
Pr)2} 
(Figure 1.42) were shown to be moderately active initiators for the ROP of 
rac-lactide.
87
 The salen complexes {Ti(37)(O
i
Pr)2} adopted a solution stable 
trans octahedral geometry. As initiators for the ROP of rac-lactide they achieved 
between 66 - 97 % conversion after 24 h (70 °C, toluene, 100:1 
[rac-lactide]:[initiator] ratio). The variance in activity was dependent upon the 
para-substituent, where the more electron withdrawing substituents resulted in lower 
activities. A significant induction period before the propagation stage of the 
polymerisation was observed and the authors speculated that the initial metal-lactide 
coordinated species is relatively stable towards propagation. Although two likely 
alkoxide initiation sites are present in the titanium salen complexes {Ti(37)(O
i
Pr)2} 
only one PLA chain per metal was observed alongside well defined molecular 
weights (PDI = 1.15 – 1.21), the resulting PLA was atactic.  
Further 1,2-diaminocyclohexane (1,2-DACH) salens were complexed to 
titanium, yielding a monomeric species {Ti(38)(O
i
Pr)2}, and zirconium/hafnium 
resulted in bimetallic complexes {Zr2(38)(O
i
Pr)6, Hf2(38)(O
i
Pr)6} (Figure 1.43).
87, 88
 
Unlike the related Ti(37)(O
i
Pr)2 structures the titanium DACH salen {Ti(38)(O
i
Pr)2} 
adopted an α-cis octahedral structure. Titanium DACH salen {Ti(38)(OiPr)2} was 
less active than its analogous Ti(IV) salen {Ti(37)(O
i
Pr)2} achieving 57 % 
conversion after 24 h (70 °C, toluene, 100:1 [rac-lactide]:[initiator] ratio). Although 
slightly less active towards the ROP of rac-lactide, slightly lower molecular weight 
distribution was observed (PDI = 1.11) whilst atactic PLA was obtained. 
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Figure 1.43: Group 4 alkoxide complexes supported by R,R-DACH salen ligands trialled for the ROP 
of rac-lactide and cyclic esters.87, 88 
 
The bimetallic Zr(IV)/Hf(IV) R,R-DACH salens {Zr2(38)(O
i
Pr)6, 
Hf2(38)(O
i
Pr)6} were trialled for the ROP of rac-lactide in solvent free conditions, 
reaching completion after 48 mins {Zr2(38)(O
i
Pr)6}, and 66 mins {Hf2(38)(O
i
Pr)6} 
(140 °C, 200:1 [rac-lactide]:[initiator] ratio).
88
 Very good molecular weight control 
was observed for both Zr(IV) and Hf(IV) initiators {Zr2(38)(O
i
Pr)6, Hf2(38)(O
i
Pr)6} 
resulting in PDI = 1.02 and molecular weights consistent with one PLA chain per 
bimetallic complex. Although atactic PLA was obtained the ROP of rac-lactide 
proceed by a living mechanism and retained molecular weight control upon addition 
of further monomer. Other cyclic esters including; caprolactone, valerolactone, and 
rac-butyrolactone were investigated for ROP using Zr2(38)(O
i
Pr)6 and 
Hf2(38)(O
i
Pr)6} as solvent free ROP initiators. The ROP of caprolactone, 
valerolactone, and rac-butyrolactone proceeded at 80 °C and retained the good 
molecular weight control (PDI < 1.08) observed for rac-lactide. 
 
Figure 1.44: Diamine-bis(phenol) (salan) ligands complexed to group 4 metal alkoxides and utilised 
for the ROP of L-lactide and rac-lactide.89, 90 *Not all combinations of complexes were synthesised. 
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Group 4 metal alkoxides have been complexed to diamine-bis(phenol) (salan) 
ligands and investigated for the ROP of L-lactide and rac-lactide by Davidson et al.
89
 
and Kol et. al.
90
 (Figure 1.44). Titanium and zirconium salan complexes 
{Ti(39-42)(O
i
Pr)2, Zr(39-42)(O
i
Pr)2} adopt chiral (Δ, Λ) α-cis pseudo octahedral 
isomers with pseudo C2 symmetry. Kol et al. synthesised chloro and 
t
Bu derivatives 
Ti(39,42)(O
i
Pr)2 and Ti(39,42)(O
i
Pr)2 and reported moderate activity for the ROP of 
L-lactide under solvent free conditions.
90
 Davidson et al. showed Zr(40)(O
i
Pr)2 was 
the only initiator in the series to ROP rac-lactide in solution (> 99 %, 110 °C, toluene, 
100:1 [monomer]:[initiator] ratio).
89
 Titanium initiators polymerise rac-lactide to 
yield atactic lactide with 62 – 74 % conversion after 2 h under solvent free conditions 
(130 °C, 300:1 [monomer]:[initiator] ratio). Zr(IV) and Hf(IV) salan initiators 
{Zr(39-42)(O
i
Pr)2, Hf(39-42)(O
i
Pr)2} resulted in isotactic biased PLA under the 
same conditions (Pr = 0.25 – 0.30), the most selective salan derivative in this initiator 
series was Zr(40)(O
i
Pr)2. The origin of stereoselectivity was attributed to the induced 
Δ, Λ chirality about the metal centre. Furthermore, back-chelation of PLA lactate 
units was considered to influence stereoselectivity of following lactide units. The 
lack of stereoselectivity observed for Ti(39-42)(O
i
Pr)2 initiators was attributed to the 
inability of titanium to increase it coordination sphere to allow chelation of a lactate 
unit.
89
 
 
Figure 1.45: Group 4 alkoxide complexes supported by amine−bis(phenolate) ligands utilised for the 
ROP of L-lactide and rac-lactide.89, 90 
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Kol et al. synthesised amine-bis(phenoxy) titanium and zirconium complexes 
with a coordinated dimethylamine side arm {Ti(43,44)(O
i
Pr)2, Zr(43,44)(O
i
Pr)2} 
(Figure 1.45), where Ti(43,44)(O
i
Pr)2 and Zr(43,44)(O
i
Pr)2 adopted Cs symmetry.
90
 
The Ti(IV) alkoxide complexes initiated the ROP of L-lactide to low conversions 
after an extended reaction time under solvent free conditions (130 °C, 300:1 
[monomer]:[initiator] ratio). The Ti(43)(O
i
Pr)2 derivative was more active than 
Ti(44)(O
i
Pr)2 and both resulted in well defined PLA chain distributions 
(PDI = 1.21 - 1.28). Zr(43,44)(O
i
Pr)2 complexes both initiated the ROP of L-lactide 
under the same conditions but revealed enhanced reactivity. The phenoxy 
substituents had the reverse effect upon activity where Zr(44)(O
i
Pr)2 displayed a 10 
fold activity increase over the related Zr(43)(O
i
Pr)2 complex. Similar control over the 
ROP of L-lactide was observed for the initiator Zr(43)(O
i
Pr)2 whereas initiator 
Zr(44)(O
i
Pr)2 resulted in higher PDI = 1.56.  
Davidson et al. synthesised amine-bis(phenol) ligands with a pyridine derived 
side arm and complexed them to Ti(IV), Zr(IV), and Hf(IV) alkoxides 
{Ti(45-47)(O
i
Pr)2, Zr(45-47)(O
i
Pr)2, and Hf(45-47)(O
i
Pr)2} (Figure 1.45).
89
 Solution 
ROP of L-lactide were attempted with these complexes and only Zr(45)(O
i
Pr)2 was 
active, good activity was revealed achieving > 99 % conversion after 2 h with narrow 
PDI values (PDI = 1.13) (110 °C, toluene, 100:1 [monomer]:[initiator] ratio). 
Investigations into the solvent free ROP of rac-lactide were reported, Ti(45)(O
i
Pr)2 
was shown to be active achieving 75 % conversion after 2 h (130 °C, 300:1 
[monomer]:[initiator] ratio). The Zr(45-47)(O
i
Pr)2, and Hf(45-47)(O
i
Pr)2 initiators 
were also moderately active revealing 10 – 45 % conversion under the same 
conditions, although the sterically bulky R = 
t
Bu phenol substituents displayed a 
reduced activity requiring 24 h reaction time for low conversion. The Zr(IV) 
initiators Zr(45,47)(O
i
Pr)2 resulted in PLA with an isotactic bias (Pr = 0.35 – 0.45) 
whereas the bulky 
t
Bu substituents {Zr(46)(O
i
Pr)2} yielded atactic PLA alongside 
Ti(45-47)(O
i
Pr)2 initiators. Although PLA with an isotactic bias was observed it is 
less than the related Zr(IV) bis(phenoxy) complexes Zr(39-42)(O
i
Pr)2,
89, 90
 this was 
attributed to the non-chiral symmetry of Zr(45-47)(OiPr)2. The unsymmetrical 
complexes Zr(47)(O
i
Pr)2/Hf(47)(O
i
Pr)2 revealed no stereoselectivity enhancement 
over Zr(45)(O
i
Pr)2/Hf(45)(O
i
Pr)2 complexes with -Me phenoxy substituents. 
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Figure 1.46: Scheme showing the synthesis of group 4 salalen alkoxides utilised for the ROP of 
rac lactide.91 
 
 Salalen ligands were complexed to group 4 metal alkoxides by Jones et. al. 
and utilised for the ROP of rac-lactide (Figure 1.46).
91
 The group 4 salalen 
complexes were shown to adopt a pseudo octahedral fac-mer geometry by X-ray 
diffraction and was confirmed in solution by NMR spectroscopy, with the exception 
of Hf(50)(O
i
Pr)2 which was shown as two isomers in solution both present in equal 
proportions. The salalen group 4 complexes initiated the ROP of rac-lactide in 
solution and revealed good activities achieving > 96 % conversion after 24 h (80 °C, 
toluene, 100:1 [monomer]:[initiator] ratio). The Zr(IV) and Hf(IV) salalen complexes 
typically displayed better molecular weight control over the solution ROP of 
rac-lactide (PDI = 1.07 – 1.13), while Ti(48,49)(OiPr)2 and Hf(50)(O
i
Pr)2 yielded 
broader PDI values (PDI = 1.42 - 1.62). Ti(48,49)(O
i
Pr)2 and Hf(50)(O
i
Pr)2 resulted 
in atactic PLA, Zr(48)(O
i
Pr)2 and Zr(49)(O
i
Pr)2 resulted in a slightly heterotactic 
biased PLA (Pr = 0.56 – 0.60), Hf(48)(O
i
Pr)2 and Hf(50)(O
i
Pr)2 resulted in an 
isotactic biased PLA (Pr = 0.30) using the above conditions. Studies were also 
conducted without the presence of solvent, it was shown that Ti(IV) and Zr(IV) 
salalen initiators gave atactic lactide with good conversions (52 – 98 %) after 
15 mins (130 °C, 300:1 [monomer]:[initiator] ratio). Hafnium initiators were slower 
for the ROP of rac-lactide in solvent free conditions with high conversion obtained 
after 2 days {Hf(48)(O
i
Pr)2}, 1 day {Hf(49)(O
i
Pr)2} and 15 mins {Hf(50)(O
i
Pr)2}. 
Hf(48)(O
i
Pr)2 and Hf(50)(O
i
Pr)2 still retain their isotactic selectivity at elevated 
temperature in solvent free conditions. Although isotactic stereoselectivity was 
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observed Hf(50)(O
i
Pr)2 displayed a lack of molecular weight control with lower Mn 
values than expected. This was attributed to the lower steric bulk about the metal 
allowing propagation of multiple PLA chains, also transesterification was thought to 
be more prevalent as a consequence of its higher activity. The ROP of rac-lactide 
using Hf(50)(O
i
Pr)2 was also conducted at a lower temperature which resulted in an 
enhanced isotactic bias (Pr = 0.25) and 99 % conversion within 6 h (20 °C, CH2Cl2, 
100:1 [monomer]:[initiator] ratio). Additionally more molecular weight control was 
observed (PDI = 1.25) consistent with one PLA chain per metal.  
Group 4 complexes supported by dithiodiolate ligands {(51,52)H2} 
(Figure 1.47) were trialled for the ROP of L-lactide and rac-lactide in toluene and 
solvent free conditions.
92
 The titanium structure Ti(51)(O
i
Pr)2 was isolated and 
characterised by X-ray diffraction and showed the complex adopts a pseudo α-cis 
octahedral geometry. It was reported that the complexes Ti(51,52)(O
i
Pr)2, 
Zr(51,52)(O
t
Bu)2, and Hf(51,52)(O
t
Bu)2 are fluxional in solution inter-converting 
between two isomers, where the M(52)X2 complexes gave greater fluxionality. The 
group 4 dithiodiolate complexes are very active initiators for the ROP of rac-lactide. 
The activity was more dependent upon the metal than the sulphur bridging group 
which, displayed minimal effect upon activity. Titanium complexes Ti(51,52)(O
i
Pr)2 
were very active initiators for the ROP of rac-lactide under solvent free conditions 
achieving high conversion within 35 and 17 mins respectively (130 °C, 300:1 
[monomer]:[initiator] ratio). Zirconium initiators Zr(51,52)(O
t
Bu)2 were more active 
reaching high conversion in < 4 mins under the same condition. Hafnium initiators 
Hf(51,52)(O
t
Bu)2 were reported to have slightly higher activities than their 
zirconium analogues obtaining high conversion in < 2 mins. Furthermore the 
hafnium initiator Hf(52)(O
t
Bu)2 was shown to polymerise rac-lactide to high 
conversion within 5 minutes at 3000:1 [monomer]:[initiator] ratio. Moderate 
molecular weight control was observed with a range of PDI values (PDI = 1.17 - 1.75) 
and molecular weights were significantly lower than expected, attributed to more 
than one PLA chain being propagated per metal and transesterification side reactions. 
Additionally under melt conditions initiators, Zr(51,52)(O
t
Bu)2 and 
Hf(51,52)(O
t
Bu)2 yielded PLA with a heterotactic bias (Pr ≈ 0.70). By using toluene 
as a solvent and lowering the reaction temperature (75 °C) the stereoselectivity was 
enhanced, the highest heterotactic bias was obtained by Zr(52)(O
t
Bu)2 (Pr = 0.89). 
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Figure 1.47: Group 4 alkoxide complexes bearing dithiodiolate ligands which were investigated as 
initiators for the ROP of rac-lactide.92 
 
Titanium tetra-isopropoxide was investigated for the ROP of L-lactide and 
rac-lactide. Furthermore the isopropoxide moieties were substituted by chloride 
ligands to varying degrees [Ti(O
i
Pr)4-xClx].
93, 94
 All these complexes from X = 3 
though to X = 0 were active for the ROP of rac-lactide in solvent free conditions 
(130 °C) and in toluene (70 °C). Activity decreased with increasing degrees of 
chloride substitution although increasing chloride substitution resulted in narrower 
molecular weight distributions. With larger degrees of chloride substitution (X = 2, 3) 
the ROP of rac-lactide resulted in PLA with a heterotactic bias.  
Bimetallic {Ti(53)(O
i
Pr)}2, trimetallic Ti3(54)2(O
i
Pr)6, and tetrametallic 
Ti4(55)2(O
i
Pr)10 titanium complexes were investigated as initiators for the ROP of 
rac-lactide and L-lactide in both solution and solvent free conditions (Figure 1.48).
93, 
94
 The dimeric complex {Ti(53)(O
i
Pr)}2 utilises triethanolamine ligands and is an 
active initiator for the ROP L-lactide and rac-lactide. Moderate activities were 
achieved 70 % conversion after 1.5 days (70 °C, toluene, 300:1 [monomer]:[metal] 
ratio).
94
 Under these conditions {Ti(53)(O
i
Pr)}2 yields PLA with very narrow 
molecular weight distributions with PDI values < 1.15 and molecular weights 
consistent with one polymer chain per-metal centre. Elevated temperature (130 °C) 
resulted in a higher activity but also a slight increase of molecular weight distribution 
(PDI = 1.35). Under solvent free conditions at the same elevated temperature (130 °C) 
a significant increase in molecular weight distribution was observed 
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(PDI = 1.69 -1.70), although at above 90 % conversion transesterification reactions 
are thought to further increase PDI = 2.55 – 3.68.93 
 
 
Figure 1.48: A series of bi, tri, and tetra titanium isoproxide complexes, supported by tri(alcohol) 
ligands, trialled for the ROP of lactide.93, 94 
  
 The triphenoxy supported titanium complex Ti3(54)2(O
i
Pr)6 was synthesised 
as the kinetic and thermodynamic product. The solid state structure shown in 
figure 1.48 deviates slightly in solution, where the phenoxy groups do not bridge 
between titanium metals. The initiators were moderately active for the ROP of 
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lactide in toluene, achieving 95 % conversion after 12 h (130 °C, toluene, 200:1 
[monomer]:[metal] ratio).
94
 The ROP reaction also revealed good molecular weight 
control with one PLA chain being propagated per-metal and low molecular weight 
distributions (PDI = 1.12 – 1.36).  
 The tetrametallic titanium alkoxide complex {Ti4(55)2(O
i
Pr)10} was studied 
as an initiator the ROP of lactide alongside {Ti(53)(O
i
Pr)}2 and Ti3(54)2(O
i
Pr)6.
94
 
Ti4(55)2(O
i
Pr)10 was shown to be relatively stable at ambient temperature although at 
elevated temperature it was demonstrated as slightly unstable. As an initiator for the 
ROP of lactide it achieved 99 % PLA yield after 24 h (70 °C, toluene 400:1 
[monomer]:[metal] ratio). Ti4(55)2(O
i
Pr)10 revealed good control over molecular 
weight with a linear increase of Mn with increasing monomer concentration, although 
as molecular weight increased the PDI increased in a linear relationship 
(PDI = 1.33 - 1.52). Unlike titanium complex Ti3(54)2(O
i
Pr)6 which propagated one 
PLA chain per metal despite the presence of six potentially initiating isopropoxides. 
The ROP of lactide by Ti4(55)2(O
i
Pr)10 resulted in PLA molecular weights consistent 
with a PLA chain being propagated per isopropoxide. While most of the study 
focused on the ROP of L- lactide, the ROP of rac-lactide by Ti4(55)2(O
i
Pr)10 yielded 
atactic PLA. 
 
 
Figure 1.49: Scheme over-viewing the synthesis of group 4 trisphenolates which were investigated 
for the ROP of lactide.90, 95 
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 Group 4 trisphenolates were first investigated by Kol et al. for the ROP of 
L-lactide.
90
 The trisphenolate group 4 complexes adopted a chiral C3 symmetric 
penta-coordinate structure (Figure 1.49). The titanium complexes Ti(56-58)O
i
Pr 
were shown to polymerise L-lactide. Increasing the steric bulk of the phenoxy 
substituents was detrimental to the titanium initiators activity. Furthermore, 
investigation of Ti(56)O
i
Pr for the ROP of rac-lactide resulted in atactic PLA under 
solvent free conditions (130 °C).
95
 While Kol et. al.
90
 demonstrated Zr(56)O
i
Pr as an 
active initiator for the ROP of L-lactide, Davidson et. al. reported Zr(56)O
i
Pr to be 
seven times faster for the ROP of rac-lactide.
95
 The Zr(IV) trisphenolate {Zr(56)O
i
Pr} 
yields strongly heterotactic PLA from the ROP of rac-lactide hence the ROP of 
L lactide is slower due to the inability to insert alternating enantiomers of the 
monomer. Both Zr(56)O
i
Pr, and Hf(56)O
i
Pr polymerised lactide to high conversion 
within 30 mins (130 °C, solvent free, 300:1 [monomer]:[initiator] ratio) and maintain 
control over the molecular weight (PDI = 1.19 – 1.22). The Hafnium trisphenolate 
Hf(56)O
i
Pr also results in heterotactic PLA under melt conditions 
(Pr {Hf(56)O
i
Pr} = 0.88, Pr {Zr(56)O
i
Pr} = 0.96).
95
 It was suggested that zirconium 
and hafnium trisphenolates control the geometric orientation of a propagating lactide 
by inversion of the axial chirality about the metal centre during propagation. 
Although it is currently unclear if the heterotactic selectivity is induced from the 
ligand steric bulk, via a chain-end control mechanism.
95
 
 
 
Figure 1.50: Group 4 metal alkoxide complexes supported by tetradentate bis(sulfonamide)amine 
ligands investigated for the ROP of rac-lactide.96 
  
Group 4 metal tetradentate bis(sulfonamide) complexes were trialled for the 
ROP of rac-lactide by Mountford et al (Figure 1.50).
96
 Forcing conditions were used 
in the coordination synthesis of the tetradentate bis(sulfonamide) ligands to group 4 
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metal alkoxides, requiring either elevated temperature or alcohol removal by vacuum 
in solvent free conditions. The resulting zirconium complexes initiated the ROP of 
rac-lactide with good activities for group 4 metals, although initiator Zr(59)(O
i
Pr)2 
was less active than initiator Zr(60)(O
i
Pr)2. The zirconium initiator Zr(60)(O
i
Pr)2 was 
further studied and achieved 95 % conversion within 5.5 h (70 °C, toluene, 100:1 
[monomer]:[initiator] ratio). The ROP reaction was well controlled in solution and 
molecular weights were linear with conversion and molecular weight distributions 
were consistently low (PDI = 1.12 – 1.14). Conversely MALDI-TOF mass 
spectrometry revealed transesterification reactions were also present and NMR 
spectroscopy showed the resulting PLA was atactic. Studies using solvent free 
conditions proved initiator Zr(60)(O
i
Pr)2
96
 was very active and gave comparable 
reaction rates to group 4 trisphenolates {Zr/Hf(56)O
i
Pr}.
95
 Titanium derivatives of 
tetradentate bis(sulfonamide) complexes Zr(59,60)(O
i
Pr)2 were synthesised and also 
trialled for the ROP of caprolactone alongside the zirconium initiators 
Zr(59,60)(O
i
Pr)2.
96
 
Further sulphonamide group 4 initiators were synthesised by Mountford et al. 
and trialled for the ROP of caprolactone and rac-lactide (Figure 1.51).
97
 The titanium 
complexes Ti(61,62)(O
i
Pr)2 proved unstable for prolonged ROP of rac-lactide and 
the reaction was halted before full conversion was obtained. While limited 
conversion was obtained the titanium initiators revealed low PDI values 
(PDI = 1.13 - 1.22). The four coordinate sulphonamide complex Ti(61)(O
i
Pr)2 
exhibited little variation upon rates between R = toluene and R = Mes. The five 
coordinate titanium sulphonamide complex Ti(62)(O
i
Pr)2 displayed higher activity 
for R = Me over R = Tol. Zirconium tris(sulphonamide) complexes 
{Zr(63)CH2SiMe3} were also investigated for the ROP of rac-lactide and it was 
found that alkoxides generated in-situ gave a significant activation enhancement. The 
five coordinate zirconium complex Zr(63)CH2SiMe3 was less active than its 
previously investigated six coordinate sulphonamide relative Zr(60)(O
i
Pr)2. Unlike 
the titanium sulphonamides {Ti(61,62)(O
i
Pr)2} the zirconium sulphonamides 
Zr(63)CH2SiMe3 achieved high conversion 89 - 95 % within 24 h (70 °C, toluene, 
100:1 [monomer]:[initiator] ratio). Increasing the steric demands of the 
sulphonamide groups within Zr(63)CH2SiMe3 decreased the rate of the reaction in 
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the order R = Me > toluene > Ar
F
. All the group 4 sulphonamides complexes 
reported here have resulted in atactic lactide.  
 
 
Figure 1.51: Further group 4 sulphonamide-supported complexes trialled for the ROP of cyclic 
esters.97 
 
Figure 1.52: Group 4 complexes supported by sulphur and tellurium bridged bis(phenol) ligands, 
which were utilised for the ROP of L-lactide.98, 99 
 
Harda et al. investigated titanium complexes, bridged by bis(phenol) ligands 
which contain a sulphur or tellurium bridging atom {Ti(64)(NEt)2 and (Ti(65)Cl2)2}, 
for the ROP of L-lactide.
98, 99
 Other titanium bis(phenoxy) complexes of this type 
were synthesised but were mainly trialled for the ROP of caprolactone and other 
cyclic esters. The sulphur bridged bis(phenoxy) titanium amide complex 
{Ti(64)(NEt)2} (Figure 1.52) was an active initiator for the ROP of L-lactide 
although it was slow affording 96 % yield after 120 h (100 °C, toluene, 200:1 
[monomer]:[initiator] ratio).
99
 Ti(64)(NEt)2 exhibited linear molecular weight growth 
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with conversion but a slightly linear increase in PDI was also observed, which led to 
speculation about the presence of transesterification/back-biting reactions.  
 The dimeric titanium chloride complex {(Ti(65)Cl2)2} containing a 
bis(phenol) ligand bridged by tellurium was active for the ROP of L-lactide without 
the addition of a co-initiator.
98
 (Ti(65)Cl2)2 (Figure 1.52) achieved 98 % conversion 
of L-lactide after 48 h (100 °C, anisole, 200:1 [monomer]:[metal] ratio) with good 
molecular weight control (PDI = 1.04 – 1.13) throughout the polymerisation reaction. 
Linear growth of PLA molecular weight was observed alongside conversion and 
further addition of lactide to a completed ROP reaction indicating a living 
polymerisation. Further experiments were conducted into co-polymerisation of 
lactide with caprolactone.
98
 
 
1.3.6 Zinc initiators 
 
Figure 1.53: β-Diketiminate zinc complexes utilized for the ROP of rac-lactide.36 
 
 Zinc complexes have been tested for the ROP of lactide and many zinc 
complexes are coordinated to analogous ligands as group 2 metals. Some 
β-diketiminate (BDI) ligands which have been complexed to group 2 metals 
{(Mg(6)(
i
Pr))2,
36, 62
 (Mg(7)(O
i
Pr))2,
36, 62
 Mg(8)O
t
Bu.THF,
63, 64
 and 
Ca(8)N(SiMe3)2.THF}
66
 were discussed earlier in this report. The BDI zinc 
complexes {(Zn(66-68)O
i
Pr)2} were isolated as dimers in the solid state and shown 
to retain their dimeric structure in solution (Figure 1.53).
36
 BDI zinc complexes 
{(Zn(66-68)O
i
Pr)2} are active initiators for the ROP of rac-lactide. Substitution of 
the -O
i
Pr initiating groups for -N(SiMe3)2, -Et, and OAc resulted in a decrease in 
polymerisation control. The zinc BDI complexes achieved high conversion (97 %) 
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within 20 mins when R = 
i
Pr (20 °C, CH2Cl2, 200:1 [monomer]:[zinc] ratio). The 
reaction activities were dependent upon the “R” substituents where the ROP 
activities order follows R = 
i
Pr > Et > 
n
Pr, to the extent that when R = 
i
Pr the ROP is 
~33 times faster than R = 
n
Pr. (Zn(66-68)O
i
Pr)2 complexes exhibited good molecular 
weight control over the ROP of rac-lactide (PDI = 1.09 – 1.18), furthermore the ROP 
has living polymerisation characteristics. The resulting PLA was revealed as 
heterotactic with a Pr = 0.90 for initiator (Zn(66)O
i
Pr)2. When substituting the 
aromatic substituents for -Et, or -
n
Pr a significant decrease in selectivity was 
observed (Pr = 0.76 – 0.79) although the PLA was still highly biased towards 
heterotactic PLA.  
 
 
Figure 1.54: Monometallic BDI zinc complexes investigated for the ROP of lactide.63, 64, 100 
 
 Chisholm et al. isolated monometallic BDI zinc complexes {Zn(69)X} with 
bulky initiating alkoxides and amides (Figure 1.54).
63, 64
 The complex Zn(69)O
t
Bu 
resulted in 95 % conversion within 10 mins (20 °C, CH2Cl2, 100:1 [monomer]:[zinc] 
ratio) and displayed good control over the molecular weight distributions 
(PDI = 1.15). The mono-coordinate ligand “X” has a large effect upon the initiators 
activity and the degree of control the complex exhibits upon the ROP reaction. 
Substitution of X = O
t
Bu to N
i
Pr2 or OSiPh3 significantly decreased the activity and 
molecular weight control of complex Zn(69)X, for example when X = OSiPh3 the 
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91 % conversion was obtained after 70 h under the same conditions. Zinc BDI 
complex {Zn(69)X} resulted in heterotactic PLA to a similar degree as the closely 
related zinc BDI complexes (Zn(66-68)O
i
Pr)2. Interestingly the ROP of rac-lactide 
proceeded slower in THF but the stereoselectivity observed was not affected, unlike 
the analogous magnesium complexes.
62-64
 
 Gibson et al. studied the zinc BDI complex Zn(71)O
i
Pr, which contains two 
ortho-methoxyphenyl substituents, for the ROP of lactide.
100
 Additionally Chisholm 
et al. investigated analogous zinc complexes {Zn(70)X} containing one 
ortho-methoxyphenyl substituent for the ROP of lactide.
62
 Zn(69)OSiPh3 achieved 
high conversion for the ROP of lactide in 30 h, whereas zinc complex Zn(70)OSiPh3 
reached high conversion in 30 mins under similar conditions.
64, 100
 The zinc BDI 
initiators become more active with a higher degrees of ortho-methoxyphenyl 
substitution thus the general zinc BDI initiator activity order follows Zn(71)O
i
Pr > 
Zn(70)X > Zn(69)X. While more active Zn(70)X gave a much lower degree of 
molecular weight control with molecular weights over four times higher than 
expected, although PDI remained low for Zn(70)X and Zn(71)O
i
Pr. The resulting 
PLA was predominantly atactic with a slight heterotactic bias (Pr = 0.59 – 0.67).
62
 
While it was speculated that zinc BDI complexes Zn(69)X initiated the ROP of 
lactide by first reacting with impurities within the lactide. Analogous complexes 
Zn(70)X were shown to polymerise lactide without such impurities, 
furthermore -OSiPh3 and -N(SiMe3)2 PLA end groups were identified via 
1
H NMR 
spectroscopy. It was concluded that the ortho-methoxyphenyl substituents did not 
coordinate to the zinc metal centre. Decreasing molecular weight control could be 
attributed to the reduced steric demands of ortho-methoxyphenyl substituents over 
isopropylphenyl substituents.
62
 
A zinc (NNO-tridentate diaminophenolate) alkoxide complex {(Zn(72)OEt)2} 
was investigated for the ROP of rac-lactide by Hillmyer and Tolman et al.
101
 Zinc 
complexed to NNO-tridentate diaminophenolate ligand (72H2) formed a dimeric 
structure in the solid state (Figure 1.55), while the solution structure was identified as 
a monometallic species. (Zn(72)OEt)2 is a highly active initiator for the solution 
polymerisation of rac-lactide achieving 93 % conversion after 18 mins at high 
monomer to initiator ratios (25 °C, CH2Cl2, 1500:1 [monomer]:[metal] ratio). A 
linear molecular weight increase with conversion was established, although the 
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molecular weight was lower than anticipated. This was attributed to impurities which 
deactivate the initiators or act as propagating chain exchange agents. Chain exchange 
agents were experimentally shown to reduce molecular weights by the addition of 
benzyl alcohol to the ROP reaction. 
 
 
Figure 1.55: Dimeric zinc alkoxide complexes supported by a NNO-tridentate diaminophenolate 
ligand (72H2)
101 and NNO-tridentate Schiff base ligands {(73-77)H2}.
102 
 
  Similar NNO-tridentate Schiff base ligands were coordinated to zinc alkyls 
and further reacted with benzyl alcohol to yield the zinc alkoxide complexes 
(Zn(73-77)OBn)2 (Figure 1.55).
102
 The zinc complexes {(Zn(73-77)OBn)2} were 
demonstrated to be dimeric species in the solid state as shown in figure 1.55. The 
dimeric structures adopted an equilibrium in solution between three zinc complex 
species. Zinc complexes {(Zn(73-77)OBn)2} were active initiators for the ROP of 
L-lactide and rac-lactide and all the phenyl substituents resulted in well controlled 
molecular weights with low PDI values (PDI = 1.06 – 1.26). The initiators 
{(Zn(73-77)OBn)2} activity increased when electron donating substituents are 
present upon the phenoxy ring. Although the presence of steric bulk hinders lactide 
monomer units approach to the zinc metal and hence has a negative influence on the 
ROP reaction rate. A first order dependence on both lactide and the initiator was 
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shown and from this the authors proposed a monometallic structure as the active 
propagating species. The NNO-tridentate Schiff base zinc complexes 
(Zn(73-77)OBn)2 resulted in PLA with a heterotactic bias in CH2Cl2 at 25 °C, the 
highest selectivity was obtained by the bulky 4,6-di-
t
Bu phenyl substituents 
{(Zn(77)OBn)2} (Pr = 0.74). The selectivity was increased further 
{Pr (Zn(73-77)OBn)2 = 0.91} by cooling the reaction to -55 °C although at the 
expense of initiator activity.  
 
 
Figure 1.56: Reaction scheme depicting the synthesis of a dimeric zinc guanidinate investigated for 
the ROP of lactide.103 
 
 A dimeric zinc acyclic guanidinate complex {(Zn(78)N(SiMe3)2)2} 
(Figure 1.56) was investigated for the ROP of rac-lactide by Hitchcock and Coles.
103
 
The polymerisation was shown to proceed at room temperature with moderate 
activities achieving 95 % conversion within 2 h (CDCl3, 85:1 [monomer]:[initiator] 
ratio). While the initiation time for –N(SiMe3)2 groups is often slow for the ROP of 
lactide, initiation for zinc complex (Zn(78)N(SiMe3)2)2 proceeded rapidly. The ROP 
was proven as a living reaction and preceded to further polymerise lactide after 
completion. Atactic PLA was obtained and linear molecular weight control was 
demonstrated with respect to conversion. 
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Figure 1.57: Hybrid scorpionate/cyclopentadienyl zinc complexes investigated for the ROP of 
lactide.71 
 
 The hybrid scorpionate/cyclopentadienyl ligands discussed earlier for 
magnesium (Figure 1.30)
71
 were also coordinated to zinc {Zn(79)R} (Figure 1.57) 
and trialled for the ROP of lactide.
71
 The solid-state structure is given in figure 1.57, 
and the solution studies have shown the η1-cyclopentadienyl to undergo fast 
haptotropic exchange. The zinc complexes Zn(79)R were active for the ROP of 
L-lactide (92 %, 18 h, toluene, 200:1 [monomer]:[initiator] ratio, 
R = 2,4,6-Me3C6H2O) albeit less active than its related magnesium initiator 
(Figure 1.30) (97 %, 2.5 h, toluene, 200:1 [monomer]:[initiator] ratio).
71
 The zinc 
initiators Zn(79)R gave good control over the polymerisation reaction yielding one 
PLA chain per metal and low PDI values (PDI = 1.07 – 1.19). 
 
 
Figure 1.58: Chiral scorpionate zinc complexes investigated for the ROP of lactide.104 
 
Further chiral scorpionate zinc complexes were synthesised and investigated 
for the ROP of both L-lactide and rac-lactide.
104
 The zinc initiators 
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(Zn(80-82)CH2SiMe3)2 were moderately active and were shown to achieve 85 % 
conversion after 3.5 h (50 °C, THF, 100:1 [monomer]:[metal] ratio). The dimeric 
zinc structure shown in figure 1.58 was confirmed as the solid state structure for 
(Zn(80-82)CH2SiMe3)2 complexes. The solution state structure was ambiguous and a 
possible equilibrium process is present between monomeric and dimeric structures. 
Despite the ambiguity the initiators (Zn(80-82)CH2SiMe3)2 exhibited good control 
over the ROP of lactide (PDI = 1.08 – 1.12). The resulting PLA was moderately 
heterotactic (Pr = 0.67 – 0.77) additionally increasing the reaction temperature 
reduced the selectivity {Pr (50 °C) = 0.77, Pr (65 °C) = 0.70}. Also the tacticity was 
enhanced when THF was used as the solvent over toluene {Pr (THF) = 0.72, 
Pr (toluene) = 0.64}. The ROP is initiated by nucleophilic alkyl attack upon the 
monomer, which was proven by mass spectrometry and NMR spectroscopy 
identification of a (CH3)3CC(O)– end group.  
 
1.3.7 Group 13 initiators 
 
Figure 1.59: Aluminium porphyrin initiators for the ROP of D-lactide.105 
 
Aluminium complexes were some of the earliest initiators investigated for the 
ROP of lactide. One of the first reported aluminium complexes investigated for the 
ROP of lactide were aluminium porphyrin complexes Al(83)R (Figure 1.59) 
investigated by Inoue et al.
105
 The ROP of D-lactide by the complexes of basic form 
Al(83)R were similar in ROP activity and control, their activity was relativity slow 
achieving 94 % conversion after 96 h {R = (OCH(CH3)CH2)nCl (n = 20), CH2Cl2, 
100 °C, 100:1 [monomer]:[initiator] ratio}. While slow these aluminium porphyrin 
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initiators revealed living character and well defined molecular weight control (PDI ≈ 
1.12). The initiator Al(83)R (R = Cl) was also trialled for the ROP of D-lactide but 
showed no activity. 
The relativity simple aluminium complex Al(O
i
Pr)3 proved an effective 
initiator for lactide polymerisation.
29, 106
 Furthermore Al(O
i
Pr)3 exists as two 
aggregates; a trimer (Al(O
i
Pr)3)3, and a tetramer (Al(O
i
Pr)3)4. The two aggregates 
were investigated independently and the trimer was found to initiate the ROP of 
lactide faster than the tetramer. Although, as the polymerisation proceeds, the 
propagation rates become equal and the propagating species for both aggregates is 
believed to be a monomeric compound. 
 
 
Figure 1.60: Aluminium complex supported by R-(+)-1,1’-binaphthyl-2,2’-diamine linked bis(phenol) 
ligand reported for the ROP of lactide.37 
 
Imine bis(phenol) ligands have been prominent throughout the ROP of lactide 
by aluminium complexes. Spassky et al. developed a R-(+)-1,1’-binaphthyl-2,2’-
diamine linked bis(phenol) ligand coordinated to aluminium {Al(84)OMe} 
(Figure 1.60) for the ROP of lactide.
37
 The aluminium complex was slow for the 
ROP of rac-lactide at 70 °C reaching 90 % conversion after 113 h (toluene 75:1 
[monomer]:[initiator] ratio). Although slow the resulting PLA was isotactic with well 
defined molecular weight distributions (PDI = 1.10 – 1.15). A preference for the 
ROP of D-lactide was demonstrated with significant conversion up to 38 % within a 
relatively short time period (3.5 h). After the preferential conversion of D-lactide 
(~ 40 %) from rac-lactide, L-lactide is then polymerised as it is the prevalent 
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monomer remaining. Investigation of the racemic complex Al(84)OMe for the ROP 
of rac-lactide has shown the formation of stereoblock PLA polymer chains, where 
each chiral R or S binaphthyl derived aluminium initiator {Al(84)OMe} individually 
propagates a D-PLA or L-PLA chain.
107
 During the ROP process an exchange 
process transfers the PLA chains between chiral initiators allowing the formation of 
stereoblock PLA chains. Additional in-situ investigations where chiral “S” 
binaphthyl linked bisphenol ligand and Al(O
i
Pr)3
 
were used to ROP rac-lactide 
resulted in ~50 % conversion of lactide to L-PLA, upon which addition of the “R” 
binaphthyl linked bisphenol ligand resulted the formation of a D-PLA stereoblock, 
with an enhanced melting tempreture of 210 °C.
108
 Thus, demonstrating an exchange 
mechanism is determining the formation of stereoblock PLA. 
 
 
Figure 1.61: Aluminium alkyl/alkoxide complexes supported by salen ligands investigated for the 
ROP of Lactide. *Not all derivatives were synthesised.109, 110 
 
Salen aluminium alkyl/alkoxide complexes Al(85)R
3
 (Figure 1.61) were 
studied by Nomura et al. for the ROP of lactide.
109, 110
 These aluminium salen 
complexes yielded PLA with an isotactic bias to varying degrees. The highest 
stereo-selectivity (Pr = 0.02) from this series of complexes was obtained from the 
initiator Al(85)R
3
 (R
1
 = 
t
BuMe2Si, R
2
 = H, R
3
 = OBn, X = CH2CMe2CH2) which 
resulted in 96 % conversion after 14 h (70 °C, toluene, 100:1 [monomer]:[initiator] 
ratio). While the above binaphthyl linked bis(phenoxy) aluminium complexes 
{Al(84)R
3
} exhibited stereo-control through enantiomorphic site control the salen 
aluminium complexes {Al(85)R
3
} control selectivity via a chain end control 
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mechanism. Further solvent free polymerisation studies were performed using the 
same initiator, 97 % conversion was obtained after 1 h (130 °C, 300:1 
[monomer]:[initiator] ratio). Aluminium initiator Al(85)R
3
 still displayed isotactic 
selectivity to a lesser extent (Pr = 0.08 – 0.10) under solvent free conditions.  
Chiral R,R-, S,S-, rac- diaminocyclohexane (DACH) linked salen aluminium 
complexes {Al(86)O
i
Pr} were trialled for the ROP of rac-lactide by Feijen et al. 
(Figure 1.62).
30, 111
 Rac-Al(86)O
i
Pr is a slow initiator for the ROP of rac-lactide 
requiring 12 days to achieve 85 % conversion (70 °C, toluene, 62:1 
[monomer]:[initiator] ratio).
30
 Although slow the polymerisation was highly selective 
yielding isotactic PLA (Pr = 0.07) and low molecular weight distributions 
(PDI = 1.06). Stereoselectivity was also retained under solvent free conditions to a 
lesser degree (Pr = 0.12), while activity was significantly enhanced reaching 95 % 
conversion after 2 days (130 °C, 200:1 [monomer]:[initiator] ratio). R,R-Al(86)O
i
Pr 
displayed a strong preference towards the ROP of L-lactide over D-lactide with 
respective rate constants kapp = 0.902 day
-1
 and kapp = 0.067 day
-1
.
111
 Furthermore the 
rate constant for the ROP of L-lactide (kapp = 0.509 day
-1
) by racemic complex 
rac-Al(86)O
i
Pr, as expected, was approximately half of the R,R-Al(86)O
i
Pr L-lactide 
ROP rate constant. Stereoselectivity is controlled by an enantiomorphic site control 
mechanism, and similar to aluminium complexes Al(84)OMe a polymer exchange 
mechanism ensures the formation of isotactic stereoblock PLA from the ROP of 
rac-lactide by rac-{Al(86)O
i
Pr}.
111
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Figure 1.62: Aluminium alkoxide complex coordinated to a chiral diaminocyclohexane (DACH) 
linked bis(phenol) ligands, utilised for the ROP of lactide.30, 111, 112 
 
Later work by Feijen et al. included the investigation of a similar reduced 
form {Al(87-89)Et} (imine to amine) of their previous DACH salen aluminium 
complex Al(86)O
i
Pr (Figure 1.62) for the ROP of lactide.
112
 The alkyl aluminium 
salan complexes Al(87-89)Et contained a further two chiral centres upon the nitrogen 
atoms, thus the proceeding complexes were present as stereoisomers. The complexes 
Al(87-89)Et were active initiators for the ROP of lactide with the addition of 
isopropoxide as a co-initiator. The activity for the ROP of rac-lactide was dependent 
upon the phenyl ring substituents, the order of activity follows; H > Cl > Me. 
Although slow initiators, rac-Al(87)Et achieved 89 % conversion in 9 h (toluene, 
70 °C, 50:1 [monomer]:[initiator] ratio), and the polymerisation was well defined 
(PDI = 1.09 - 1.12). Tacticity was also dependent upon the phenyl ring substituents, 
isotactic biased PLA was obtained when R = H (Pr = 0.34 – 0.38), and heterotactic 
biased PLA was obtained when R = Cl, Me (Pr = 0.55 – 0.73). Furthermore it was 
demonstrated that the R,R-(DACH)-Al(87)Et initiator was 10.1 times more active 
towards the ROP of L-lactide over D-lactide. Evidence suggested these initiators 
proceed via a combination of chain exchange mechanisms and site control 
mechanisms.  
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Figure 1.63: Salan aluminium alkoxide complexes investigated for the ROP of lactide.82 
 
Further salan ligand systems have been coordinated with aluminium and their 
resulting complexes {Al(90)Me} investigated for the ROP of rac-lactide 
(Figure 1.63).
82
 These aluminium complexes {Al(90)Me} were active, albeit slow 
initiators, for the ROP of rac-lactide in the presence of benzyl alcohol co-initiator. 
The reaction activity increased with decreasing steric influence from the phenyl ring 
substituents, interestingly the presence of chloro-phenyl substituents showed an 
enhanced rate over the methyl-phenyl substituents indicating possible electronic 
effects. Good molecular weight control was observed (PDI = 1.04 - 1.11), along with 
a varying stereocontrol. A strong isotactic bias was observed when R
2
 = H 
(Pr = 0.21 – 0.32), when R
2
 = Me, 
t
Bu, or Cl heterotactic biased PLA was obtained 
(Pr = 0.61 – 0.96). The chloro-phenyl substituents yielded the highest degree of 
heterotactic selectivity indicating stereocontrol is not entirely sterically dependent. 
The amino nitrogen groups amplified any observed tacticity when the benzyl amine 
substituent was present (R
1
 = CH2Ph). 
 
Figure 1.64: Salalen aluminium alkyl investigated for the ROP of rac-lactide in solution.113 
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Monometallic salalen aluminium {Al(91)Me} (Figure 1.64) complexes were 
investigated by Jones et al. for the ROP of rac-lactide in solution.
113
 While active in 
the presence of a catalytic equivalence of benzyl alcohol the ROP reaction was slow. 
Well defined PLA chains were produced with molecular weights consistent with one 
propagating chain per metal and limited evidence of transesterification reactions 
occurring. In contrast to the related salan and salen aluminium initiators {Al(85)R
3
, 
Al(90)Me} only minor-moderate stereocontrol was reported, additionally the 
stereocontrol exhibited was more dependent upon the amine substituents than the 
phenyl substituents. When R
1
 = Me (except for Al(91)Me, R
2
 = R
3
 = 
t
Bu) the 
resulting PLA was biased towards heterotactic stereoselectivity (Pr = 0.59 – 0.75), 
and a slight isotactic bias was observed when R
1
 = Ph (Pr = 0.40 - 0.50). 
In more recent years indium has been investigated for the ROP of lactide and 
the homoleptic complex InCl3 was shown as a moderately active initiator for the 
ROP of rac-lactide achieving 96 % conversion in 5 h (25 °C, CH2Cl2, 203:1:1:2 
monomer:initiator:BnOH:NEt3).
41, 114
 All three initiating components are required as 
exclusion of the InCl3, BnOH, or NEt3 renders the ROP reaction inactive. Excellent 
molecular weight control was reported with a linear relationship of molecular weight 
with varying rac-lactide, or varying BnOH ratio with respect to all other components. 
InCl3 yields highly heterotactic PLA from the ROP of rac-lactide, this 
stereoselectivity was observed upon variation of initiator ratios and exposure to air. 
Although a very robust system an increase in temperature was detrimental to 
stereoselectivity and so is excess InCl3 with respect to BnOH and NEt3. The 
formation of an in-situ indium lactate complex as the active initiating/propagating 
species was speculated upon. 
 
Figure 1.65: A dimeric indium complex supported by (NNO) asymmetrically substituted 
trans-diaminocyclohexane ligands.115 
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 A dimeric indium complex bearing (NNO) asymmetrically substituted 
trans-diaminocyclohexane (DACH) ligands (92H2) (Figure 1.65) was the first 
reported example of the ROP of lactide by an indium complex.
115
 The indium 
complex {(In(92)Cl)2(μ-OEt)(μ-Cl)} is a dimeric structure in solution and the solid 
state. Moreover, the chiral DACH groups are exclusively RR,RR or SS,SS pairs 
within the dimer, no evidence was present to suggest an RR,SS or SS,RR dimer. The 
indium complex {(In(92)Cl)2(μ-OEt)(μ-Cl)} is active for the ROP of lactide 
achieving 90 % in 30 mins (25 °C, CH2Cl2, 200:1 [monomer]:[initiator] ratio). The 
following ROP was living in character until high conversion was reached yielding 
low molecular weight distributions (PDI = 1.09 – 1.20). The resulting PLA was 
revealed as slightly isotactic (Pr = 0.38 – 0.47). While not dissociative at room 
temperature the indium complex {(In(92)Cl)2(μ-OEt)(μ-Cl)} separates in the 
presence of a coordinating species, such as lactide, into the active species 
In(NNO)ClOEt and an inactive species In(NNO)Cl2. There was a marked difference 
in the ROP activities towards rac-lactide between the racemic and enantiopure 
resolved indium structures, with respect to the DACH groups. Consequently 
enantiomorphic site control is thought to be significant for these indium initiators.  
 
1.3.8 Non-metal initiators 
 4-Dimethylaminopyridine (DMAP) (93) was amongst the first non-metal 
based initiators reported for the ROP of lactide (Figure 1.66).
116
 A protic alcohol was 
required as a co-initiator for the polymerisation to proceed. Furthermore the degree 
of polymerisation was dependent on the stoichiometric amount of alcohol utilised. 
Complete conversion was obtained after 50 h at 35 °C in CH2Cl2 at 120:1:2 
[lactide]:[initiator]:[alcohol] ratio. These organic based initiators resulted in well 
defined molecular weight distributions (PDI = 1.08 – 1.13) and no indication of 
transesterification side reactions. The nucleophilic DMAP (93) is thought to activate 
the lactide monomer which allows the protic alcohol in initiate the polymerisation 
via attack of the activated DMAP-lactide species. 
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Figure 1.66: Non metallic based initiators for the ROP of lactide.116-119 
 
 Hillmyer and Tolman et al. reported the use of carbenes for the ROP of 
rac-lactide.
117
 The carbene 94 (Figure 1.66) was investigated at reduced temperature 
(-20 °C, CH2Cl2) and obtained good conversion (71 %) within 20 mins at 150:1 
[rac-lactide]:[initiator] ratio in the presence of benzyl alcohol. A moderate isotactic 
bias (Pr = 0.25) was observed for the reduced temperature polymerisation of 
rac-lactide by 94. Upon increasing the polymerisation temperature (25 °C) a 
reduction in selectivity was observed (Pr = 0.41). Further work on carbenes was 
conducted by Waymouth and Hedrick et al. for the ROP of rac-lactide and 
meso-lactide.
118
 The carbene 95 (Figure 1.66) was investigated at variable 
temperatures and resulted in a similar degree of isotacticity (Pr = 0.28) at -15 °C.
118
 
The polymerisation proceeded at -70 °C achieving 91 % conversion after 2 h at 100:1 
[rac-lactide]:[initiator] ratio, under these condition a high isotactic (Pr = 0.10) bias 
was reported. 
 A dimeric phosphazene base (96) (Figure 1.66) was reported for the ROP of 
rac-lactide and was demonstrated to be highly active resulting in high conversion 
(85 %) after 3 mins with a catalytic equivalence of 1-pyrenebutanol co-initiator 
(25 °C, toluene, at 100:1 [rac-lactide]:[initiator] ratio).
119
 At reduced temperature 
(-75 °C) the reaction required 3 h to achieve full conversion (> 99 %) and the 
resulting PLA was highly isotactic (Pr = 0.05). The polymerisation was controlled 
with no evidence of transesterification side reactions occurring at -75 °C and a low 
PDI value was obtained (PDI = 1.11). From experimental evidence it was postulated 
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that the ROP initially proceeded via activation of the alcohol by the phosphazene 
base (96).  
 
1.4 Co-Polymers 
1.4.1 Poly(lactide-co-glycolide) 
 The physical properties of polylactide can be tuned through 
co-polymerisation of lactide and glycolide. Adjusting the glycolide to lactide ratio 
within poly(lactide-co-glycolide) (Figure 1.67) co-polymer adjusts the physical 
properties, in particular the biodegradability. Both lactide and glycolide are 
biocompatible along with their resulting polymers as they degrade into lactic acid 
and glycolic acid respectively under biological conditions. Poly(lactide-co-glycolide) 
co-polymers have seen use within the medical industry for sutures and backbone 
pins.
7, 120
 Surgical applications of poly(lactide-co-glycolide) co-polymers contain 
higher proportions of glycolide (70 % – 92 %). Co-polymer blends containing lower 
proportions of glycolide (20 % - 50 %) have seen use within drug delivery systems 
typically in the form of polymer implants.
2
 The polycondensation reaction of 
glycolic acid and lactic acid yields low molecular weight polymers. As a 
consequence the dehydrated cyclic starting reagents (lactide and glycolide) procured 
interest. As high molecular weight polymers could be produced together with 
potential control over the monomer sequence. A large degree of variation is possible 
of the co-polymers as not only can glycolide be varied the stoichiometry of L-, 
D-lactide isomers can tuned.  
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Figure 1.67: Scheme depicting the formation of poly(lactide-co-glycolide).2 
 
1.4.2 Poly(lactide-co-ε-caprolactone) 
Co-polymers of lactide with ε-caprolactone have been reported through the 
literature, each polymer has been investigated individually for medical and 
pharmaceutical applications.
121
 The co-polymerisation of ε-caprolactone and lactide 
allows physical aspects of each polymer to be varied in the resulting co-polymer 
(Figure 1.68). Poly(lactide-co-ε-caprolactone) combines the good degradation in 
physiological media of PLA with the high permeability towards drug molecules that 
poly(ε-caprolactone) displays.89, 121, 122 PLA has good mechanical properties and poor 
elasticity while poly(ε-caprolactone) has poor mechanical properties, good elasticity, 
and enhanced thermal properties.
89, 121, 122
 The co-polymer properties can be adjusted 
by the; stoichiometry of the incorporated cyclic esters, molecular weight, and 
monomer sequence (block and random polymer).
122
 Block co-polymers of 
poly(lactide-co-caprolactone) have been reported, Davidson et al. reported that the 
order of addition was critical to prepare a block-co-polymer. For example, 
caprolactone must be polymerised first, if lactide is polymerised first only a 
homopolymer was isolated.
89
 A random co-polymer microstructure in a 1:1 ratio of 
lactide and caprolactone where equal proportions of each were introduced into the 
polymer chains was reported by Nomura et. al.
123
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Figure 1.68: Scheme depicting the formation of poly(lactide-co-ε-caprolactone).123 
 
1.4.3 Poly(lactide-co-δ-valerolactone) 
 Polymeric material formed from cyclic esters have been used for 
pharmaceutical and medical purposes for the biocompatibility and biodegradable 
properties of these polymers, including poly(δ-valerolactone).121 
Poly(δ-valerolactone) has similar properties to poly(ε-caprolactone) and 
co-polymerisation with lactide monomers can selectively vary the physical properties 
of the polymers. The melting point (Tm) of poly(δ-valerolactone) is 62 °C and 
co-polymer blends with lactide reduce the Tm of the co-polymer dependent upon the 
quantity of lactide introduced into the polymer, to widen the application of both 
polymers.
124
 The microstructure of the co-polymerisation of δ-valerolactone and 
lactide is dependent upon the initiator.
124, 125
 Where the initiator preferred the 
incorporation of the one monomer over the other a tapered co-polymer can be formed. 
The degree of polymerisation of a block of a single monomer within random 
poly(lactide-co-δ-valerolactone) (Figure 1.69) was dependent upon the stoichiometry 
of the valerolactone and lactide. The co-polymerisation of δ-valerolactone has been 
conducted using L-lactide
124
 and rac-lactide.
125
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Figure 1.69: Scheme depicting the formation of poly(lactide-co-δ-valerolactone).124  
 
1.5 Aims and Objectives 
The development of initiators for the ROP of lactide and investigation of their 
behaviour is reported herein. The aim is to develop stereoselective initiators which 
preferably produce highly isotactic stereoblock PLA from rac-lactide for its 
enhanced thermal properties and crystallinity.
45
 High activity and polymer molecular 
weight control is desired for applicability within industry.
44, 45
 Meeting these 
requirement under relatively environmentally favoured solvent free conditions is 
desired. The initiators should use non-toxic and bio-compatible materials to fully 
exploit the uses of PLA.
44
 Where possible abundant and cheap materials should be 
investigated to enhance the initiators industrial appeal.
44
  
This thesis focuses upon metal based initiators around group 4 and aluminium. 
Piperazine/homopiperazine amine bis(phenol) ligands were complexed with group 4 
and aluminium metals. Their relation to group 4 salan complexes {M(39-42)(O
i
Pr)2}, 
which have previously reported moderate isotacticity led to our interest.
89, 90
 Also 
aluminium salan complexes {Al(90)Me} have reported interesting stereoselectivity, 
which is dependent upon the phenoxy substituents.
82
 Furthermore, 1,4-DACH based 
salen ligands were investigated, which are a derivative of the 1,2-DACH salen 
ligands that previously resulted in highly isotactic selective aluminium initiator 
 78 
{Al(86)O
i
Pr}.
30, 111
 Further work was conducted with 1,2-DACH salalen aluminium 
initiators, as stated above, 1,2-DACH salen aluminium complexes previously 
resulted in high stereoselectivity. The salalen ligand system allows the systematic 
study of the amine and imine influence upon the ROP of lactide. Additionally 
aluminium salalen complexes {Al(91)O
i
Pr} have previously shown promise as 
initiators for the ROP of lactide.
113
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2. Titanium (IV) Homo/Piperazine Salan Complexes and 
Their Application for the ROP of rac-Lactide 
2.1 Introduction 
Metal complexes derived from tetradentate amine bis(phenol) ligands 
(Figure 2.01) have been extensively utilised for the ROP of lactide.
1-7
 Aluminium 
tetradentate imine bis(phenoxy) complexes containing flexible backbones have been 
used to produce highly isotactic enriched PLA from rac-lactide.
8, 9
  Related 
aluminium tetradentate amine bis(phenoxy) complexes have also been reported for 
the ROP of rac-lactide, the stereoselectivity obtained was shown to be reliant upon 
the phenoxy substituents.
2
 Although they were all slow, moderately isotactic biased 
PLA was reported ranging to highly heterotactic PLA.  
 
 
 
Figure 2.01: Examples of flexible tetradentate amine bis(phenol) ligands and ridged 
piperazine and homopiperazine bis(phenol) ligands. 
 
 Group 4 metals complexed to tetradentate imine bis(phenol) ligands have 
been reported for the polymerisation of lactide, these initiators produced atactic PLA 
from the ROP of rac-lactide.
10, 11
 Although no stereoselectivity was obtained the 
initiators proved moderately active and resulted in well defined molecular weight 
PLA. The related group 4 tetradentate amine bis(phenoxy) complexes investigated by 
Davidson et al.
5
 and Kol et al.
4
 proved to be more stereoselective for the ROP of 
 85 
rac-lactide. Limited activity was observed in the solution state but all the initiators 
proved to be moderately active initiators for the solvent free polymerisation of 
lactide. Moderate isotacticity was reported for these bis(phenoxy) complexes that 
contain a flexible bridging diamine.
5
 Herein is reported the synthesis and 
polymerisation activity of related compounds where the flexible bridging diamine 
has been substituted with a ridged piperazine and homopiperazine diamines. 
 Piperazine salan ligands complexed to aluminium have previously been 
utilised for the ROP of rac-lactide with little success (Figure 2.01).
12
 Bimetallic
13
 
and monometallic
14
 complex coordination geometries have been reported and shown 
to be highly active initiators for the ROP of ε-caprolactone. Yao et al.15, 16 have 
reported the synthesis of piperazine salan ligands for the coordination to lanthanides 
with various monometallic and bimetallic configurations being adopted. The 
formation of lanthanide-lithium multi-metallic piperazine salan complexes were also 
developed by Yao et al.
15, 16
 The lanthanide metal complexes were shown to be 
highly active initiators for the ROP of lactide at > 1000:1 [monomer]:[initiator] 
ratios. Furthermore, the resulting PLA form rac-lactide exhibited moderate 
heterotactic selectivity. Mountford et al.
17
 previously reported the coordination of 
similar piperazine bridged bis(phenylamino) ligands to titanium resulting in 
monometallic titanium imido structures. 
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2.2 Homo/Piperazine Salan Ligands 
2.2.1 Synthesis of homo/piperazine salan ligands 
 
Figure 2.02: Reaction pathway detailing the synthesis of piperazine and homopiperazine salan ligands. 
 
The piperazine salan ligands were synthesised according to literature 
methods.
18
 With the exception of 11H2, which was adapted from the synthesis 
procedure reported by Balakrishna et al.
19
 The reaction is a one pot synthesis which 
requires heating (Figure 2.02), the pure ligands are obtained in good yields by 
filtration and washing with methanol. Specifically for 11H2 the reactive iminium ion 
is first produced then the phenol is introduced under less thermodynamic conditions. 
This method limits the probability of attack upon both ortho-positions of the 
4-
t
Bu-phenol.  
 
2.2.2 Characterisation of homo/piperazine salan ligands 
All the ligands isolated were fully characterised by 
1
H and 
13
C{
1
H} NMR 
spectroscopy and high resolution ESI-TOF mass spectrometry. 1H2 (Figure 2.03) 
3H2 and 8H2 (Figure 2.04) were characterised by X-ray crystallography. In all cases 
the solid-state structure showed the ligands adopt the chair configuration. A 
hydrogen bond exists between the phenol and the amine nitrogen, in all cases the 
hydrogen bond length was found to be between 1.8204 and 1.9954 Å. 
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Figure 2.03: Solid-state structure for 1H2. Ellipsoids are shown at the 30 % probability level, 
hydrogens have been omitted for clarity. 
 
Figure 2.04: Solid-state structure for 8H2. Ellipsoids are shown at the 30 % probability level, 
hydrogens have been omitted for clarity. 
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Figure 2.05: a) 1H NMR spectrum of 3H2, b) 
1H NMR spectrum of 8H2 
 
 The 
1
H and 
13
C{
1
H} NMR spectra for (1-15)H2 were consistent with the 
solid-state structures. The 
1
H NMR spectra for piperazine bridged salan 3H2 is shown 
in figure 2.05a. The aromatic proton region shows two proton resonances and a 
singlet for the N-CH2-Ar protons at 3.72 ppm, these observations are consistent 
across ligands (1-5)H2. The piperazine ring is fluxional on the NMR timescale where 
the equatorial and axial protons are interconverting, this is represented by the 
corresponding broad region between 2.20 – 3.10 ppm (Figure 2.05a).  
The homopiperazine bridged salan ligands {(6-11)H2} revealed similar trends, 
a representative 
1
H NMR spectrum of 8H2 is given in figure 2.05b. The aromatic 
protons (6.70 – 7.30 ppm), N-CH2-Ar (3.70 – 3.90 ppm), and the phenoxy 
substituent regions (~ 1.00 – 2.00 ppm) were well defined throughout compounds 
(6-11)H2 (Figure 2.05b). For compounds (6-11)H2 the homopiperazine ring proton 
region showed three resonances (2.87, 2.81, 1.95 ppm), this was attributed to a fast 
homopiperazine ring-flipping process on the 
1
H NMR timescale. The fast 
a) 
b) 
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homopiperazine ring-flipping process causes the axial and equatorial ring protons to 
be observed as equivalent. 
The 
1
H NMR spectra for compounds (12-15)H2 were more complex due to 
their unsymmetrical nature. Two phenol O-H environments were observed clearly 
indicating the two phenyl rings are not chemically equivalent. The N-CH2-Ar 
protons were observed as a multiplet and a broad region, indicative of inequivalent 
proton environments alongside the influence of fluxionality. A broad region was 
observed for the methyl substituted piperazine ring –CH2 protons. In contrast to the 
single broad resonance for 3H2 (Figure 2.05a), broad regions were observed at 
2.10 - 2.60 ppm, and 2.60 - 3.00 ppm 
 
2.3 Synthesis of Titanium Piperazine Salan complexes 
 
Figure 2.06: Reaction scheme detailing the synthesis of piperazine and homopiperazine titanium 
monometallic and bimetallic complexes. 
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2.4 Titanium Bimetallic Complexes 
2.4.1 Synthesis 
 The room temperature complexation of Ti(O
i
Pr)4 to piperazine salan ligands 
resulted in an incomplete reaction when a 1:1 ratio of ligand and metal was utilised. 
The species produced were not identified although it was clearly observed that 
unreacted ligands were still present in solution. Further attempts to isolate a pure 
complex were fruitful when two equivalents of Ti(O
i
Pr)4 were introduced. The 
titanium metal centres were bound to each phenoxy resulting in the 2:1 metal to 
ligand complexes {Ti2(1-5,8-9,12-13)(O
i
Pr)6} depicted in figure 2.06. These LM2 
style complexes have been previously reported for piperazine salan ligands by Fulton 
et. al.
12
 who complexed them to aluminium and reported X-ray crystallographically 
determined structures. Attempts to isolate LM2 complexes containing less steric bulk 
in the ortho phenoxy position and a homopiperazine ring {Ti2(6,7,11)(O
i
Pr6)} or a 
methyl substituted piperazine ring {Ti2(15)(O
i
Pr6)} were unsuccessful, the resulting 
complexes proved very soluble in all common organic solvents and purification was 
problematic. Ligands containing amyl phenol substituents with a homopiperazine 
ring and methylated piperazine ring (10,14H2) were complexed to Ti(O
i
Pr)4 under 
ambient conditions, NMR spectroscopy evidence suggests the formation of the LM2 
structural geometry but the enhanced solubility of said complexes caused difficulties 
in the separation from significant Ti(O
i
Pr)4 impurities. All of the titanium complexes 
produced at room temperature in CH2Cl2 at a 2:1 ratio were recrystallised from 
hexane to yield a complex of the general formula, LTi2(O
i
Pr6), in the solid state. The 
solid-state structure was confirmed by X-ray crystallography or supported by CHN 
analysis. Structures were determined for Ti2(2-5,8,12-13)(O
i
Pr)6 via X-ray 
diffraction studies. Additionally an isolated titanium 2:2 species {Ti2(1)2(O
i
Pr4)} was 
determined by  X-ray crystallography, although further analysis showed this L2M2 
structure was not consistent with the bulk material. The Ti2(1)(O
i
Pr)6 complex was 
isolated in a repeated reaction, as determined by CHN analysis. 
1
H and 
13
C{
1
H} 
NMR spectroscopy was consistent with the stated LM2 titanium complexes when the 
ortho phenoxy group substituents were sterically bulky 
t
Bu or amyl groups. Where 
the ortho substituents were methyl groups the 
1
H and 
13
C{
1
H} NMR spectra revealed 
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the presence of an equilibrium, which is later discussed in more depth 
(see  section 2.4.3).  
 
2.4.2 Solid-state characterisation by X-ray crystallography 
At room temperature the titanium salan complexes synthesised primarily 
resulted in crystals of the LM2 form, which were characterised by X-ray diffraction. 
Figure 2.07 displays a representative structure for the LM2 titanium piperazine salan 
complexes that contain a 6 membered bridging piperazine ring {Ti2(2-5)(O
i
Pr)6}. 
These structures contain an inversion centre situated within the molecule as such the 
local environments around individual titanium metal centres are crystallographically 
equivalent. Selected bond lengths (Å) and angles (°) about the titanium metal centre 
are given in table 2.01. The piperazine ring adopts the favoured chair configuration. 
Each titanium metal centre resides in a distorted trigonal bipyramidal structure, with 
three isopropoxide groups, an amine nitrogen, and a phenoxy coordinating to the 
titanium. The axial-isopropoxide (1.7758 - 1.7838 Å) is shorter than the 
equatorial-isopropoxide groups (1.8003 - 1.8360 Å). The cis-phenoxy titanium bonds 
(Ti1-O4, 1.8649 - 1.8883 Å) are longer than the isopropoxide groups and as expected 
the axial nitrogen titanium bonds (2.3499 - 2.3567 Å) are longer than the alkoxide 
bonds. The angle between the two axial moieties (N1-Ti1-O1 = 173.06 - 177.20 °) 
deviates from the ideal trigonal bipramidal value of 180 °. Additionally the angle 
between equatorial oxygens and the axial nitrogen (79.86 - 84.62 °) deviates from the 
idealistic value of 90 °, this is consistent with the axial nitrogen titanium bond being 
longer than the axial isopropoxide causing all the equatorial oxygens to converge 
towards the nitrogen. An analogous LM2 aluminium alkyl complex reported by 
Fulton et al.
12
 has a shorter phenoxy-metal bond length {1.7586(12) Å} and a shorter 
nitrogen-metal bond length {2.0631(14) Å}. 
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Figure 2.07: Solid-state structure for Ti2(3)(O
iPr)6. Ellipsoids are shown at the 30 % probability level, 
hydrogen atoms and isopropoxide –CH3 moieties have been removed for clarity. 
 
 Ti2(2)(O
i
Pr)6 Ti2(3)(O
i
Pr)6 Ti2(4)(O
i
Pr)6 Ti2(5)(O
i
Pr)6 
Ti1-O1 1.7813(18) 1.7758(17) 1.7838(17) 1.7803(17) 
Ti1-O2 1.8080(18) 1.8131(17) 1.8003(16) 1.8127(17) 
Ti1-O3 1.8360(18) 1.8317(17) 1.8340(17) 1.8308(17) 
Ti1-O4 1.8883(17) 1.8735(17) 1.8810(15) 1.8649(16) 
Ti1-N1 2.3499(18) 2.3547(19) 2.3516(17) 2.3567(18) 
N1-Ti1-O1 175.03(9) 177.20(8) 173.06(7) 176.55(7) 
N1-Ti1-O2 84.39(7) 83.08(7) 84.62(7) 82.70(7) 
N1-Ti1-O3 80.99(7) 81.00(7) 81.88(7) 80.85(7) 
N1-Ti1-O4 79.86(7) 81.07(7) 79.29(6) 80.49(6) 
 
Table 2.01: Selected bond lengths (Å) and angles (°) for LM2 titanium salan complexes, as 
determined by X-ray crystallography. 
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Figure 2.08: Solid-state structure for Ti2(8)(O
iPr)6. Ellipsoids are shown at the 30 % probability level, 
hydrogen atoms and isopropoxide –CH3 moieties have been removed for clarity. 
 
 
Figure 2.09: Solid-state structure for Ti2(12)(O
iPr)6. Ellipsoids are shown at the 30 % probability 
level, hydrogen atoms and isopropoxide –CH3 moieties have been removed for clarity. 
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 Ti2(8)(O
i
Pr)6 Ti2(12)(O
i
Pr)6 Ti2(13)(O
i
Pr)6 
Ti1-O1 1.7801(18) 1.789(3) 1.796(5) 
Ti1-O2 1.8141(19) 1.816(3) 1.791(6) 
Ti1-O3 1.8322(18) 1.817(3) 1.832(2) 
Ti1-O4 1.8622(17) 1.869(3) 1.8691(19) 
Ti1-N1 2.3775(19) 2.357(3) 2.357(2) 
Ti2-O5 1.7890(18) 1.740(6) -
a
 
Ti2-O6 1.8076(19) 1.850(7) -
a
 
Ti2-O7 1.8396(18) 1.788(6) -
a
 
Ti2-O8 1.8823(17) 1.875(3) -
a
 
Ti2-N2 2.3525(19) 2.391(3) -
a
 
N1-Ti1-O1 173.81(8) 177.25(13) 165.3(8) 
N1-Ti1-O4 80.26(7) 81.73(11) 79.80(7) 
N2-Ti2-O5 175.12(8) 177.3(3) -
a
 
N2-Ti2-O8 81.28(7) 80.78(12) -
a
 
 
Table 2.02: Selected bond lengths (Å) and angles (°) for LM2 titanium salan complexes, as 
determined by X-ray crystallography. a The piperazine ring methyl was located in the inverse 
symmetry position in a 50:50 ratio, values are the same due to an inversion centre. 
 
Selected bond lengths (Å) and angles (º) for titanium salan complexes of the 
general structure LM2 containing an unsymmetrical bridging piperazine ring is 
shown in table 2.02. A single homopiperazine based salan titanium complex was 
characterised by X-ray crystallography {Ti2(8)(O
i
Pr)6} (Figure 2.08). Both titanium 
salan complexes bridged by a methyl substituted piperazine ring were modelled with 
a degree of disorder. For Ti2(12)(O
i
Pr)6 (Figure 2.09) the piperazine methyl group 
was disordered over three positions in a 60:20:20 ratio, additionally the isopropoxide 
and tert-butyl substituents were disordered. Ti2(12)(O
i
Pr)6 was modelled with an 
inversion centre, although the piperazine methyl substituent was disordered over two 
positions in a 50:50 ratio, furthermore the isopropoxide groups were disordered. 
Akin to the symmetrical piperazine salan LM2 titanium complexes (table 2.01) the 
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bridging homo/piperazine ring adopts a chair configuration and the titanium metal 
centres adopt a distorted trigonal bipyramidal structure. The titanium bond lengths 
and angles for unsymmetrical homo/piperazine salan titanium complexes (table 2.02) 
are similar to their analogous bond lengths and angles for symmetrical piperazine 
salan titanium complexes (table 2.01).  
The titanium centres within the homopiperazine salan LM2 titanium complex 
{Ti2(8)(O
i
Pr)6} (Figure 2.08) are not in crystallography equivalent environments, 
albeit the differences are inconsequential. Notably, the titanium amine bonds are 
different, Ti1-N1 = 2.3775(19) Å, Ti2-N2 = 2.3525(19) Å. Also the phenoxy bonds 
are significantly different, Ti1-O4 = 1.8622(17) Å, Ti2-O8 = 1.8823(17) Å. 
Furthermore, there is a difference in the chelating phenoxy-titanium-nitrogen angle, 
N1-Ti1-O4 = 80.26(7) °, N2-Ti2-O8 = 81.28(7) °. The two titanium metal centres are 
not in equivalent environments for the methyl substituted piperazine ring derivative 
{Ti2(12)(O
i
Pr)6}. Markedly the chelating phenoxy-titanium-nitrogen angles 
{N1-Ti1-O4 = 81.73(11) °, N2-Ti2-O8 = 80.78(12) °} are also different.  
 
Figure 2.10: Solid-state structure for Ti2(1)2(O
iPr)4. Ellipsoids are shown at the 30 % probability level, 
hydrogen atoms and isopropoxide –CH3 moieties have been removed for clarity. 
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Ti2(1)2(O
i
Pr)4 
Ti1–O1 1.7749(4) Ti2–O7 1.8500(4) 
Ti1–O2 1.8173(5) Ti2–O8 1.8624(4) 
Ti1–O3 1.8587(4) Ti2–N2 2.3609(6) 
Ti1–O4 1.8569(3) O1–Ti1–N1 178.60(10) 
Ti1–N1 2.3526(6) O5–Ti2–N2 177.15(12) 
Ti2–O5 1.7715(4) O4–Ti1–N1 81.29(9) 
Ti2–O6 1.7950(5) O8–Ti2–N2 81.29(9) 
 
Table 2.03: Selected bond lengths (Å) and angles (°) for Ti2(1)2(O
iPr)4, as determined by X-ray 
crystallography. 
 
 An isolated Ti2(1)2(O
i
Pr)4 crystal was characterised by X-ray diffraction 
(Figure 2.10) and selected bond length (Å) and angles (°) are given in table 2.03. 
This structure contains two titanium metal centres and two ligands, where each 
ligand coordinates to two titanium metals via independent phenols. Both ligands 
adopt a chair configuration and the ligands are significantly twisted in comparison to 
the ligands in the LM2 structures, as a consequence of geometric strain. Each 
titanium metal adopts a distorted trigonal bipyramidal structure with two 
coordinating phenoxy groups, two coordinating isopropoxide groups, and one 
coordinating amine, also one amine per ligand is un-coordinated. The Ti-Oisopropoxide 
bond lengths (1.8500 - 1.8624 Å) are similar to the bond lengths reported for LM2 
Ti-Oisopropoxide (1.8003 - 1.8810 Å). When considering a single titanium metal centre 
the chelating phenoxy exhibited longer bond lengths (Ti1-O2 = 1.8173(5) Å, 
Ti2-O6 = 1.7950(5) Å) than the non-chelating phenoxy (Ti1-O1 = 1.7749(4) Å, 
Ti2-O5 = 1.7715(4) Å). The equatorial oxygen atoms are deviated towards the axial 
nitrogen with an angle below 90 ° {O4-Ti1-N1 = 81.29 (9), O8-Ti2-N2 = 81.29 (9)}. 
No evidence of this structure has been observed in further analysis when a more 
sterically bulky 
t
Bu groups were present in the ortho-position of the phenol. It was 
proposed that the increased steric demands of 
t
Bu groups make the L2M2 type 
structure geometrically unfavourable. 
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2.4.3 Characterisation by solution NMR spectroscopy 
 The titanium complexes {Ti2(1-5,8-9,12-13)(O
i
Pr)6} reported herein were 
characterised by 
1
H NMR and 
13
C{
1
H} NMR spectroscopy. The solution state 
characterisation for Ti2(3-5,8-9,12-13)(O
i
Pr)6 was consistent with the solid state 
structures being maintained in solution. For Ti2(1-2)(O
i
Pr)6 the NMR spectroscopic 
characterisation was contradictory to a LM2 or L2M2 structures being solely present. 
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Figure 2.11: 1H NMR spectrum for Ti2(3)(O
iPr)6 in CDCl3. 
 
  A representative 
1
H NMR spectrum for Ti2(3-5)(O
i
Pr)6 is given in figure 2.11. 
Only two aromatic proton environments are present, as two doublets 
(6.95, 7.19 ppm), showing the two phenoxy rings are in equivalent environments. 
The septet at 4.91 ppm corresponds to six methine isopropoxide protons, the fact 
only one environment is present is indicative of the isopropoxide groups being highly 
fluxional. The N-CH2-Ar protons are associated with a singlet at 4.15 ppm, a slight 
broadening of this resonance indicates the presence of a fluxional process on the 
NMR timescale. The axial and equatorial protons of the piperazine ring are observed 
as two very broad regions between 2.00 – 4.00 ppm, further supporting a fluxional 
process on the NMR timescale.   
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Figure 2.12: 1H NMR spectrum for Ti2(3)(O
iPr)6 at 233 K in CDCl3. 
 
 Upon cooling of the complexes in solution the fluxional processes become 
slower, the 
1
H NMR spectrum for Ti2(3)(O
i
Pr)6 at 233 K is shown in figure 2.12 as a 
representative example for Ti2(3-5)(O
i
Pr)6 complexes. The aromatic region separates 
into four environments, it should be noted that in the example given an Ar resonance 
is located under the solvent. The single resonance assigned to the isopropoxide 
methine region (figure 2.11) separates into three broad methine resonances 
{5.04, 4.92, 4.75 ppm (figure 2.12)}. These observations show the complexes 
undergo conformational locking and reduced fluxionality at 233 K on the NMR 
timescale. The CH2 ring protons display distinct resonances at lower temperature 
demonstrating a slower ring flipping mechanism on the NMR timescale. 
 The 
1
H NMR spectra (CDCl3) for titanium isopropoxide complexes supported 
by homopiperazine salan ligands {Ti2(8-9)(O
i
Pr)6} were consistent with the 
characterised solid-state structures. The solution NMR spectra revealed similar 
trends to those observed for Ti2(3)(O
i
Pr)6, a truncated representative 
1
H NMR spectra 
(CDCl3) for Ti2(8-9)(O
i
Pr)6 is given in figure 2.13a. The methine isopropoxide 
region septet, upon cooling (213 K, in d8-toluene) this region separates into three 
broad resonances, demonstrating a similar fluxional process. The homopiperazine 
ring CH2 protons are represented by three broad resonances, the resonances are more 
defined than the piperazine ring CH2 protons of the Ti2(3)(O
i
Pr)6 complex 
(Figure 2.11). The homopiperazine based salan titanium complexes are more 
fluxional than the piperazine based salan titanium complexes, where the 7 membered 
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ring undergoes a faster ring inversion mechanism. The fluxional nature of the ring is 
reduced, upon cooling the ring CH2 region of the 
1
H NMR spectrum became more 
complex. The resonances were still less defined than analogous piperazine based 
LM2 complexes, even under less thermodynamic conditions.  
 
4.704.754.804.854.904.955.005.05 ppm
6
.0
0
4.704.754.804.854.904.955.005.05 ppm
6
.0
0
3.903.954.004.054.104.154.204.25 ppm
4
.0
0
3.903.954.004.054.104.154.204.25 ppm
1
.9
9
2
.0
0
 
Figure 2.13: 1H NMR spectrum showing the isopropoxide methine and N-CH2-Ar regions for; a) 
Ti2(8)(O
iPr)6, b) Ti2(12)(O
iPr)6 in CDCl3.  
 
 The methyl substituted piperazine ring salan ligands (12-13)H2 are 
asymmetric, which is represented in their NMR spectra (previously discussed 2.1.2). 
The asymmetric nature is retained for the titanium complexes Ti2(12-13)(O
i
Pr)6, part 
of a representative 
1
H NMR spectrum is given in figure 2.13b. The methine 
isopropoxide region contains two resonances, presumably three protons from the 
each titanium centre. A quartet and a singlet were observed for the N-CH2-Ar region, 
both visual representations demonstrating asymmetry. Furthermore, four singlets are 
identifiable in the aromatic region of the 
1
H NMR spectrum. As expected low 
temperature studies resulted in more complex spectra. The isopropoxide methine 
broadened and presumably the isopropoxide groups are fluxional on the 
1
H NMR 
timescale. 
a) 
b) 
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 When ortho methyl groups are present on the phenol ring (1-2)H2 the 
resulting titanium complexes form an equilibrium system in solution. The 
Ti2(1-2)(O
i
Pr)6 structural motif was predominantly formed and isolated after a room 
temperature reaction, this was confirmed by CHN analysis and the structure 
demonstrated by X-ray diffraction {Ti2(2)(O
i
Pr)6}. An isolated crystal was obtained 
for the L2M2 motif but the structure was not consistent with the bulk solid material 
obtained from room temperature synthetic conditions. Equilibrium systems with 
titanium alkoxides have been previously reported by Sharpless
20
 {titanium tartrate 
complexes} and Boyle
21
 {titanium binaphtholate complexes}. 
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Figure 2.14: 1H NMR spectrum showing the isopropoxide methine and aromatic regions for 
Ti2(1)(O
iPr)6 in CDCl3 at a) 298 K, b) 233 K.  
 
 
Figure 2.15: Proposed equilibrium scheme for Ti2(1-2)(O
iPr)6 in solution. 
a) 
b) 
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The 
1
H NMR spectrum for Ti2(1)(O
i
Pr)6 in CDCl3 at 298 K is given in 
figure  2.14, the aromatic region shows two dominant singlets which correspond to 
the LM2 structural motif. The aromatic region also shows a significant amount of 
broad/multiplets resonances, these were assigned to the L2M2 structural motif. The 
isopropoxide methine region shows a significant amount of free Ti(O
i
Pr)4 (4.45 ppm) 
and titanium isopropoxide groups coordinated to the LM2 complex. Upon cooling the 
isopropoxide methine region shows a clear shift in concentration of free Ti(O
i
Pr)4 
and ligand coordinated titanium isopropoxide groups, with the equilibrium shifted 
towards LTi2(O
i
Pr)6. At room temperature the complexed isopropoxide 
groups:titanium tetra-isopropoxide groups ratio is approximately 1:1 which changes 
to 3:1 when cooled to 233 K. Additionally the relative integral of the aromatic 
regions changed by a comparable degree when low temperature 
1
H NMR 
spectroscopy was performed. Alongside a ratio change in relative integrals the 
resonances related to L2M2 structural motif became more defined at lower 
temperatures. From analysis of the NMR spectra under varying conditions the 
equilibrium given in figure 2.15 was proposed. Equilibrium constants of 
Ti2(1-2)(O
i
Pr)6 in CDCl3 were calculated from 
1
H NMR spectroscopy at different 
temperature intervals. The Van’t Hoff equation (Figure 2.16) was used to 
quantitatively determine thermodynamic values (Table 2.04), from a plot of lnK 
against 1/T (Figure 2.17). The thermodynamic values are comparable to those 
reported for previous titanium equilibria.
20, 21
 Higher temperatures favour the 
formation of multiple products, thus lower temperature entropically favour the 
Ti2(1-2)(O
i
Pr)6 structural motif. 
 
 
Figure 2.16: Van’t Hoff equation.22 
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ΔG 
(kJ mol
-1
) 
ΔH 
(kJ mol
-1
) 
ΔS 
(J K
-1
 mol
-1
) 
Ti2(1)(O
i
Pr)6 5.3(5) 37.3(20) 108(7) 
Ti2(2)(O
i
Pr)6 11.0(3) 30.7(19) 66.2(7) 
 
Table 2.04: Thermodynamic values determined by the Van’t Hoff equation, ΔG calculated at 298 K  
 
 
Figure 2.17: Van’t Hoff plot for; Ti2(1)(O
iPr)6 and Ti2(2)(O
iPr)6 an NMR scale sample was used of 
concentration 0.022 mmol/ml in CDCl3. 
 
 The addition of excess Ti(O
i
Pr)4 to the equilibrium resulted in the almost 
exclusive formation of the LM2 structural motif and Ti(O
i
Pr)4 in the solution, in 
accordance with Le Chatelier's Principle. The location of the equilibrium was 
affected by changing the solvent with a preference for LM2 structural motif in 
d8-THF. The presence of Ti(O
i
Pr)4 and ligand complexed species in solution was 
further confirmed by diffusion ordered spectroscopy (DOSY) NMR spectroscopic 
investigations. 
Ti2(1)(O
i
Pr)6 
Ti2(2)(O
i
Pr)6 
1/ T 
  
  
  
ln
K
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Figure 2.18: DOSY NMR spectrum for Ti2(1)(O
iPr)6 
 
 The synthesis of homopiperazine and methyl piperazine salan titanium 
complexes was attempted at room temperature, where the ortho phenoxy substituents 
were methyl groups. The 
1
H NMR spectra for these complexes suggested the 
presence of an equilibrium system but the complexes could not be isolated to a 
degree of purity where conclusive characterisation could be conducted. 
 
2.5 Elevated Temperature Synthesis of Titanium Piperazine Salan 
Compounds  
2.5.1 Synthesis 
 
Figure 2.19: Reaction scheme depicting the synthesis of Ti2(1)2(O
i
Pr)4 
Ti2(1)(O
i
Pr)6 + 
Ti2(1)2(O
i
Pr)4 
 
 
Ti(O
i
Pr)4 
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Further synthetic methods were trialled in an attempt to isolate 1:1 titanium 
piperazine salan complexes. Most reactions using a 1:1 titanium to ligand ratio 
yielded partially reacted products or mixtures, which often contained free ligands. 
Prolonged heating (80 °C) of Ti(O
i
Pr)4 and 1H2 under a dynamic inert gas flow 
resulted in the exclusive formation and isolation of the L2M2 structural motif 
(Figure 2.19). Under these conditions any liberated isopropanol was gradually 
removed, therefore kinetically forcing the equilibrium. It was speculated that 
isopropanol groups dissociate the phenoxy groups from the titanium permitting the 
coordination of other phenoxy groups, allowing a dynamic system. This species was 
confirmed by CHN elemental analysis, 
1
H and 
13
C{
1
H} NMR spectroscopy. 
Attempts to replicate this method for 2H2 proved unsuccessful and a mixture of 
products were still obtained, including Ti2(2)(O
i
Pr)6.  
The same reaction method was utilised for homopiperazine salan ligands, 
(6-11)H2. The removal of isopropanol from the reaction formed products with a 1:1 
metal to ligand ratio. The additional heating (80 °C) allowed the homopiperazine 
ring backbone to adopt a boat type configuration and furthermore coordinate both 
phenols to a single titanium metal centre (Figure 2.20). These complexes were 
characterised by CHN elemental analysis, 
1
H and 
13
C{
1
H} NMR spectroscopy. 
DOSY NMR spectroscopy was used to confirm the presence of the L2M2 and LM 
structural motifs in solution.  
 
 
Figure 2.20: Reaction scheme depicting the synthesis of titanium monometallic complexes supported 
by homopiperazine salan ligands  
. 
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2.5.2 Solid-state characterisation by X-ray crystallography 
 
Figure 2.21: Solid-state structure for Ti(7)(OiPr)2 in the β-cis configuration. Ellipsoids are shown at 
the 30 % probability level, hydrogen atoms and isopropoxide –CH3 moieties have been removed for 
clarity. 
 
 
Figure 2.22: Solid-state structure for Ti(11)(OiPr)2 in the trans-configuration. Ellipsoids are shown at 
the 30 % probability level, hydrogen atoms and isopropoxide –CH3 moieties have been removed for 
clarity. 
 
 X-ray crystallography was used to determine the structure of monometallic 
complexes Ti(7,9-11)(O
i
Pr)2, while the Ti2(1)2(O
i
Pr)4 structure is discussed 
previously (Figure 2.10). The titanium metal centres of complexes containing Me, 
t
Bu, or Amyl ortho-phenol substituents were shown to adopt a pseudo octahedral 
configuration, contrasting to the prior determined titanium piperazine salan structures 
in this chapter. The structure obtained for Ti(7)(O
i
Pr)2 is given as a representative 
example (Figure 2.21), these solid-state structures adopted a β-cis configuration 
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(Figure 2.23). Less steric bulk in the ortho-phenol position resulted in the isolation of 
a pseudo trans-octahedral titanium complex supported by a homopiperazine salan 
ligand, Ti(11)(O
i
Pr)2 (figure 2.22). 
 
 
Figure 2.23: Binding modes of piperazine salan ligands.23 
 
 Selected bond length (Å) and angles (°) are given in table 2.05 for the 
crystallographically characterised titanium homopiperazine complexes. Those 
complexes which adopted a β-cis configuration {Ti(7,9-11)(OiPr)2} revealed similar 
bond length and angles. There was no significant difference in the isopropoxide 
metal (Ti1-O1, Ti1-O2) bond lengths, but phenoxy-metal bond lengths (Ti1-O3, 
Ti1-O4) were significantly different where the phenoxy trans to an isopropoxide 
exhibited a longer bond length. The two Ti-N bonds have different lengths; the 
nitrogen which is trans to an isopropoxide is longer. The amine bond length can be 
compared to the trans Ti-O bond, a longer phenoxy titanium bond (Ti1-O4) results in 
a shorter bond for the trans titanium nitrogen (Ti1-N1). The complexes adopted a 
distorted octahedral conformation, which is demonstrated by the deviation of the 
titanium angles from 90° or 180°, for cis or trans angles respectively. A high degree 
of variation from the idealistic 90° angle was observed between N1-Ti1-N2, giving 
angles between 67.90(13) - 68.08(7) ° (Table 2.05).  
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 The less sterically hindered salan with a hydrogen at the ortho position 
adopted a distorted trans-octahedral structural configuration {Ti(11)(O
i
Pr)2} 
(Figure  2.22). The two phenoxy-titanium bonds (Ti1-O1, Ti1-O2) are equivalent in 
length, additionally the two nitrogen-titanium bonds (Ti1-N1, Ti1-N2) are equivalent 
in length. This is indicative of the structures symmetrical nature. Similar to β-cis 
configurations the trans-octahedral structure deviates from an ideal octahedral 
environment. 
  
 Ti(7)(O
i
Pr)2 Ti(9)(O
i
Pr)2 Ti(10)(O
i
Pr)2 Ti(11)(O
i
Pr)2 
Ti1-O1 1.8310(17) 1.836(4) 1.812(3) 1.8490(18) 
Ti1-O2 1.8375(16) 1.833(3) 1.838(3) 1.8323(17) 
Ti1-O3 1.9568(16) 1.931(3) 1.939(3) 1.9175(19) 
Ti1-O4 1.8834(17) 1.873(3) 1.892(3) 1.9106(18) 
Ti1-N1 2.285(2) 2.293(4) 2.298(4) 2.255(2) 
Ti1-N2 2.349(2) 2.346(4) 2.334(4) 2.268(2) 
N1-Ti1-O1 101.94(7) 102.78(16) 103.54(15) 86.18(8) 
N1-Ti1-O2 92.39(7) 89.46(16) 89.09(14) 90.87(8) 
N2-Ti1-O1 168.57(8) 170.35(16) 171.26(14) 88.51(8) 
N2-Ti1-O2 84.54(7) 86.07(15) 86.41(14) 87.99(8) 
N1-Ti1-N2 68.08(7) 67.91(15) 67.90(13) 70.09(8) 
 
Table 2.05: Selected bond lengths (Å) and angles (°) for Ti(7,9-11)(OiPr)2, as determined by X-ray 
crystallography. 
 
2.5.3 Characterisation by solution NMR spectroscopy 
 Under these more thermodynamic forcing conditions Ti2(1)2(O
i
Pr)4 was 
isolated as the bulk product. The 
1
H NMR spectrum of this complex is given in 
figure 2.25b, a comparative 
1
H NMR spectrum of Ti2(1)(O
i
Pr)6 and the resulting 
solution equilibrium is shown again in figure 2.25a. The isopropoxide -CH3 
resonances of Ti2(1)2(O
i
Pr)4 are present in each spectrum as sets of doublets at 
0.93 ppm, 0.96 ppm and 1.14 ppm respectively. It was assumed the doublet at 
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1.28 ppm (Figure 2.25b) is located under the broad resonance at a similar chemical 
shift in the equilibrium spectra (Figure 2.25a). Similarly the –CH isopropoxide septet 
resonances {4.47 ppm, 4.92 ppm (Figure 2.25b)} coincide almost directly with the 
isopropoxide –CH 1H NMR resonances from both Ti2(1)(O
i
Pr)6 and Ti(O
i
Pr)4 within 
the equilibrium spectra (4.47 ppm, 4.89 ppm) (Figure 2.14b), a subtle shoulder upon 
the broad resonance at 4.89 ppm supports this observation. It is difficult to 
distinguish resonances at 2.25 - 4.25 ppm as the -CH2- region is inherently complex, 
due to ring flipping and fluxionality mechanisms. The aromatic region shows four 
singlets in both spectra, it should be noted a slight shoulder upon the resonance at 
6.83 ppm is indicative of two overlapping resonances. Parallel observations are 
observed in variable temperature 
1
H NMR spectra. The NMR spectrum of 
Ti2(1)(O
i
Pr)6 afforded two diffusion rates for the piperazine salan titanium 
complexes (Figure 2.18), the larger Ti2(1)2(O
i
Pr)4 diffuses more slowly. The DOSY 
spectra for the isolated Ti2(1)2(O
i
Pr)4 complex diffused at a rate of 5.09 × 10
-10
 m
2
 s
-1
 
and comparison to the determined diffusion rates for Ti2(1)(O
i
Pr)6 confirmed the 
presence of  Ti2(1)2(O
i
Pr)4 in each solution spectra. The Stokes-Einstein equation 
(Figure 2.24)
22
 was used to obtain predicted radii of the molecules within solution 
(Table 2.06), although these complexes significantly deviate from the ideal spherical 
shape which is assumed for the Stokes-Einstein equation. While a perfect 
comparisons to the solid-state structures were difficult the radii shows the 
Ti2(1)2(O
i
Pr)4 species is larger than the Ti2(1)(O
i
Pr)6 species in solution, therefore 
further supporting the formation of Ti2(1)2(O
i
Pr)4 over Ti(1)(O
i
Pr)2. 
 
 
Figure 2.24: Stokes-Einstein equation.22 
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Figure 2.25: a) 1H NMR spectrum of Ti2(1)(O
iPr)6, and resulting equilibrium in CDCl3 (233 K). b) 
1H 
NMR spectrum of Ti2(1)2(O
iPr)4 in CDCl3 (233 K). 
 
 
Diffusion Rate 
(10
-10
 m
2
 s
-1
) 
Calculated 
spherical 
radius (Å) 
Ti2(1)2(O
i
Pr)4
a 5.11 7.47 
Ti2(1)(O
i
Pr)6
a 5.65 6.76 
Ti2(1)2(O
i
Pr)4 5.09 7.50 
 
Table 2.06: Diffusion rates obtained from DOSY spectra for titanium isopropoxide (1) complexes and 
spherical radii calculated from by the Stokes-Einstein equation22 from the diffusion rates. a Data 
obtained from the solution 1H NMR spectrum of Ti2(1)(O
iPr)6. Data obtained in CDCl3 at 294 K. 
  
 
 
 
 
a) 
b) 
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The NMR spectra for the monometallic titanium piperazine salan complexes 
Ti(6-10)(O
i
Pr)2 show that the complexes adopt multiple conformations, unlike the 
X-ray crystal structures where a single β-cis conformation was present. 
Representative 
1
H NMR spectra for complexes Ti(6-7)(O
i
Pr)2 are given in 
figure 2.26a, these ortho methyl containing complexes show two conformations in 
solution. One of the two species in solution is comparatively well defined where as 
the other is fluxional. For example isopropoxide –CH3 resonances were located at 
0.42 ppm and 1.16 ppm and a proportional quantity was identified as a broad region 
between 0.50 - 1.50 ppm (Figure 2.26a). The fluxional nature is supported by VT 
NMR spectroscopy (233 K) where the resonances become more defined at lower 
temperatures. These complexes can adopt the α-cis, β-cis, and trans octahedral 
conformations. Although the Δ and Λ forms of α-cis and β-cis conformations are 
possible they are indistinguishable by conventional NMR spectroscopy (Figure 2.23). 
It should be noted that although three octahedral conformations are present the 
orientation of the homopiperazine ring can further complicate the NMR spectra. 
 The more sterically hindered complexes Ti(8-10)(O
i
Pr)2, with respect to the 
ortho-phenoxy positions, primarily adopted two conformations. The two 
conformations can be observed in their NMR spectra, a representative 
1
H NMR 
spectrum example is given in figure 2.26b. The isopropoxide -CH3 region shows two 
doublets at 0.39 ppm and 1.01 ppm which are related to one conformation. The 
analogous doublets resonances are present from different conformations at 0.55 ppm, 
0.73 ppm, 0.94 ppm, and 0.97 ppm. The two species were present in an approximate 
1:0.9 ratio. The same can be observed in the aromatic region where resonances at 
6.88 ppm, and 7.25 ppm were attributed to the slightly dominant conformation. The 
1
H NMR resonances are relatively well defined for each conformation at room 
temperature, it was speculated that the increased steric demands of the ligands reduce 
fluxionality within the complex when compared to Ti(6-7)(O
i
Pr)2. The same 
conformations can be adopted as discussed above for Ti(6-7)(O
i
Pr)2 (Figure 2.23).  
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Figure 2.26: a) 1H NMR spectrum of Ti(6)(OiPr)2 in CDCl3 (298 K). b) 
1H NMR spectrum of 
Ti(8)(OiPr)2 in CDCl3 (298 K). 
 
The less sterically hindered Ti(11)(O
i
Pr)2 exclusively formed the trans 
octahedral conformation in solution and the solid-state, as determined by 
1
H/
13
C{
1
H} 
NMR spectroscopy and X-ray crystallography. A truncated 
1
H NMR spectrum for 
Ti(11)(O
i
Pr)2 is given in figure 2.27, specifically concentrating on the –CH3 
isopropoxide region, and the -CH2/CH region. The isopropoxide –CH3 protons 
afforded only two resonances at 0.63 ppm and 1.15 ppm thus consistent with a 
trans octahedral geometry being formed exclusively. This is further supported by the 
presence of two isopropoxide septets at 3.84 ppm and 4.82 ppm.  
DOSY spectra mostly showed one diffusion rate, or 2 similar diffusion rates 
for Ti(7-11)(O
i
Pr)2. When considered alongside the X-ray crystallography evidence 
for these complexes it was concluded that the structures in solution adopt varying 
monometallic octahedral structures in preference to a dimeric (L2M2) structural motif. 
 
 
a) 
b) 
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Figure 2.27: 1H NMR spectra showing selected regions for Ti(11)(OiPr)2 in CDCl3 (298 K). 
 
2.6 Ring-Opening-Polymerisation of rac-lactide  
The titanium homo/piperazine based salan complexes 
{Ti2(1-5,8-9,12-13)(O
i
Pr)6} were trialled for the ROP of  rac-lactide in solvent and 
solvent free conditions. Conversion (%) was calculated by 
1
H NMR spectroscopy 
from which the theoretical molecular weight was derived by equation shown in 
figure 2.28, which assumes the linear growth of one PLA chain per metal. Number 
average molecular weight (Mn) and polydispersity index (PDI) was determined by 
GPC in THF which was referenced to polystyrene standards. The probability of 
racemic enchainment (Pr) was calculated from the methine region of a methyl 
decoupled 
1
H NMR spectra by Bernoullian statistics.
24
 
 
 
Figure 2.28: Equation showing the calculation of theoretical PLA molecular weight for titanium 
isopropoxide complexes. 
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2.6.1 Bimetallic titanium initiators for the solution ROP of rac-lactide  
The ROP of rac-lactide was performed in toluene (10 ml) at 80 °C using 
1.0 g of lactide. A 100:1 rac-lactide to initiator ratio was used, which equated to 50:1 
rac-lactide to metal ratio. The mass of catalyst required was determined by the solid 
state LM2 structure for consistency reasons, although the preservation of the LM2 
structure within solution at 80 °C was not assumed. The solution polymerisation data 
is given in table 2.07.  
 
 
Time 
(hours) 
Conv.  
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d 
Ti2(1)(O
i
Pr)6 24 96 7000 1750 1.72 0.50 
Ti2(1)(O
i
Pr)6
e
 24 95 20600 12950 1.38 0.54 
Ti2(2)(O
i
Pr)6 24 95 6900 5550 1.37 0.57 
Ti2(3)(O
i
Pr)6 24 95 6900 5850 1.37 0.46 
Ti2(3)(O
i
Pr)6
e
 24 96 20800 11300 1.48 0.55 
Ti2(4)(O
i
Pr)6 24 96 7000 1500 1.51 0.51 
Ti2(5)(O
i
Pr)6 24 94 6850 4200 1.34 0.57 
Ti2(8)(O
i
Pr)6 24 94 6850 1200 2.31 0.49 
Ti2(9)(O
i
Pr)6 24 95 6900 1400 1.36 0.52 
Ti2(12)(O
i
Pr)6 24 91 6600 1200 2.21 0.54 
Ti2(13)(O
i
Pr)6 24 96 7000 3750 1.28 0.53 
 
Table 2.07: Solution ROP of rac-lactide for Ti2(1-5,8-10,12-14)(O
iPr)6 in 10 ml of toluene at 80 °C in 
a 100:1 [rac-lactide]:[initiator]. a Conversion ascertained by 1H NMR spectroscopy. b Theoretical 
molecular weight calculated from conversion (Conv. × 100/2 × 144.13 + 60.10) (rounded to the 
nearest 50), 
c
 Molecular weight and PDI determined by GPC (THF) using polystyrene standards 
without applying a correction factor. d Pr as calculated from 
1H NMR homonuclear decoupled 
spectroscopy in CDCl3. 
e
 300:1 [rac-lactide]:[initiator]. 
 
High conversions were obtained after 24 h under solution conditions at 100:1 
[rac-lactide]:[initiator] ratio for all initiators tested. The initiators Ti2(1,3)(O
i
Pr)6  
were trialled at a 300:1 [rac-lactide]:[Initiator] ratio under the same conditions and 
resulted in high conversion. Generally the average molecular weight determined by 
GPC was lower than the theoretical molecular weight Mn(theo). The reduced Mn values 
were attributed to the presence of more than one potentially initiating isopropoxide 
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group present on each metal centre, with a total of six possible initiating 
isopropoxide groups per complex. The large degree of possible polymerisation sites 
contributes to the high distribution of molecular chain lengths (PDI = 1.28 – 2.31). It 
was previously established that these complexes are not fixed in one geometric 
structure, notably Ti2(1-2)(O
i
Pr)6 forms an equilibrium system in solution. 
Furthermore Ti2(8-10)(O
i
Pr)6 were shown to form a monometallic structural motif 
under similar conditions. High temperature 
1
H NMR spectroscopy scale analysis of 
the complexes showed these initiators in a contained system formed, to a small 
degree, the LM structural motif. Both the equilibrium and new structure formation 
contributes to the high PDI values observed. The initiators were shown to be highly 
fluxional complexes and there is evidence indicating high liability between titanium 
metals and ligands. As such a small degree of stereo-selectivity was observed with a 
very slight heterotactic bias being observed for the majority of initiators (see Pr in 
table 2.07). 
  
2.6.2 Bimetallic titanium initiators for the solvent free ROP of rac-lactide  
 The ROP of rac-lactide was attempted in solvent free conditions using 1.0 g 
of lactide in a 300:1 [rac-lactide]:[initiator] ratio at 130 °C. As there are two metals 
per initiator the ratio of [rac-lactide]:[metal] is 150:1. The solvent free 
polymerisation data for Ti2(1-5,8-9,12-13)(O
i
Pr)6 is given in table 2.08.  
At 130 °C high conversion was obtained after 30 mins for all of the titanium 
homo/piperazine salan complexes. The initiators Ti2(1,3)(O
i
Pr)6  also attained high 
conversion at a 300:1 [rac-lactide]:[Initiator] ratio under the same conditions. The 
molecular weights were more consistent with one PLA chain per metal centre than 
the analogous solvent polymerisation (Table 2.07). However, there was some 
reduction in number average molecular weights (Mn) when compared to the 
theoretical Mn values. This observation is similar to the solution polymerisations 
where the lower molecular weight were attributed to the presence of multiple 
isopropoxide groups on each metal, which are all potential PLA initiation sites. The 
PDI values were higher, and the Pr values were closer to atactic (Pr = 0.5) than 
observed for the solution polymerisations. These multiple possible initiating 
isopropoxide groups contribute to high PDI values. The true behaviour of these 
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initiators under these conditions is difficult to monitor, and it was further assumed 
that the initiating species was the LM2 structural motif, although the possibility of 
other structures was also considered. 
 
 
Time 
(hours) 
Conv.  
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d 
Ti2(1)(O
i
Pr)6 0.5 96 20800 15950 1.86 0.52 
Ti2(1)(O
i
Pr)6
e
 0.5 97 62900 55450 1.56 0.51 
Ti2(2)(O
i
Pr)6 0.5 97 21050 23900 1.53 0.51 
Ti2(3)(O
i
Pr)6 0.5 95 20600 20900 2.01 0.52 
Ti2(3)(O
i
Pr)6
e
 0.5 97 62900 56750 1.57 0.52 
Ti2(4)(O
i
Pr)6 0.5 99 21450 23650 2.01 0.51 
Ti2(5)(O
i
Pr)6 0.5 95 20600 13200 1.56 0.52 
Ti2(8)(O
i
Pr)6 0.5 99.9 21650 14200 2.03 0.51 
Ti2(9)(O
i
Pr)6 0.5 96 20800 20400 1.63 0.53 
Ti2(12)(O
i
Pr)6 0.5 96 20800 13600 1.52 0.52 
Ti2(13)(O
i
Pr)6 0.5 97 21050 20400 1.63 0.54 
 
Table 2.08: Solvent free ROP of rac-lactide for Ti2(1-5,8-10,12-14)(O
iPr)6 at 130 °C in a 300:1 
[rac-lactide]:[initiator]. a Conversion ascertained by 1H NMR spectroscopy. b Theoretical molecular 
weight calculated from conversion (Conv. × 300/2 × 144.13 + 60.10) (rounded to the nearest 50), c 
Molecular weight and PDI determined by GPC (THF) using polystyrene standards without applying a 
correction factor. d Pr as calculated from 
1H NMR homonuclear decoupled spectroscopy in CDCl3. 
e
 
900:1 [rac-lactide]:[initiator]. 
 
2.6.3 Monometallic titanium initiators for the solution ROP of rac-lactide  
 The isolated Ti2(1)2(O
i
Pr)4 and Ti(6-11)(O
i
Pr)2 complexes were trialled for 
the ROP of rac-lactide in toluene (10 ml) at 80 °C at a 100:1 [rac-lactide]:[Initiator] 
ratio (Table 2.09). Limited activity was observed for this initiator series under these 
conditions typically achieving low conversions after 24 h. The molecular weights 
were consistent with one PLA chain per metal; additionally PDI values were lower 
indicating a more controlled polymerisation system than the LM2 counterparts. The 
monometallic system is stable at 80 °C therefore it was assumed the monometallic 
species were initiating the polymerisation reaction. Due to the low activity of the 
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monometallic initiators it was concluded that the monometallic species potential 
contribution to the Ti2(1-5,8-10,12-14)(O
i
Pr)6 solution polymerisations (Table 2.07) 
was minor. Where the initiators were active enough to obtain reliable Pr values a 
slight isotactic bias was observed.  
 
 
Time 
(hours) 
Conv.  
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d 
Ti2(1)2(O
i
Pr)4
*
 24 75 10850 15600 1.60 0.49 
Ti(6)(O
i
Pr)2 24 23 3400 1250 1.63 -
e
 
Ti(7)(O
i
Pr)2 24 8 1200 - - -
e
 
Ti(8)(O
i
Pr)2 24 27 3950 4700 1.17 -
e
 
Ti(9)(O
i
Pr)2 24 12 1800 700 1.01 -
e
 
Ti(10)(O
i
Pr)2 24 50 7250 8200 1.06 0.44 
Ti(11)(O
i
Pr)2 24 32 4650 6950 1.11 0.44 
 
Table 2.09: Solution ROP of rac-lactide for Ti2(1)(O
iPr)4, Ti(6-11)(O
iPr)2 in 10 ml of toluene at 
80 °C in a 100:1 [rac-lactide]:[initiator] *200:1 [rac-lactide]:[initiator]. a Conversion ascertained by 
1H NMR spectroscopy. b Theoretical molecular weight calculated from conversion (Conv. × 100 × 
144.13 + 60.10) (rounded to the nearest 50), c Molecular weight and PDI determined by GPC (THF) 
using polystyrene standards without applying a correction factor. d Pr as calculated from 
1H NMR 
homonuclear decoupled spectroscopy in CDCl3.
e Pr could not be accurately determined, strong 
tacticity was not observed. 
 
2.6.4 Monometallic titanium initiators for the solvent free ROP of rac-lactide  
 Ti2(1)2(O
i
Pr)4 and Ti(6-11)(O
i
Pr)2 titanium salan complexes were trialled for 
the ROP of rac-lactide without solvent at 130 °C at a 300:1 [rac-lactide]:[Initiator] 
ratio (Table 2.10). Under solvent free conditions these initiators were comparatively 
slow, typically achieving 41 - 60 % conversion after 24 h, when compared to the 
Ti2(1-5,8-9,12-13)(O
i
Pr)6, which achieved > 94 % conversion after 30 mins. 
Molecular weights were consistent with two PLA chains propagating per metal 
centre. Despite the presence of two potentially initiating isopropoxide groups per 
metal the PDI values remained low (PDI < 1.25) at the elevated temperature. The 
more resolved structure permits the formation of controlled PLA chains but the lack 
of flexibility within the molecules causes the initiators to be more hindered thus 
leading to reduced activity. The Ti2(1)2(O
i
Pr)4 and Ti(6-11)(O
i
Pr)2 titanium 
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piperazine salan complexes produced PLA with a slight heterotactic bias 
(Pr = 0.51 - 0.63). 
 
Time 
(hours) 
Conv.  
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d 
Ti2(1)2(O
i
Pr)4 24 74 32050 21250 1.25 0.51 
Ti(6)(O
i
Pr)2 24 54 23400 12050 1.07 0.56 
Ti(7)(O
i
Pr)2 24 50 21700 7900 1.19 0.63 
Ti(8)(O
i
Pr)2 24 42 18200 7050 1.14 0.53 
Ti(9)(O
i
Pr)2 24 41 17800 6750 1.10 0.63 
Ti(10)(O
i
Pr)2 24 60 26000 10900 1.14 0.61 
Ti(11)(O
i
Pr)2 24 51 22100 6850 1.23 0.55 
 
Table 2.10: Solvent free ROP of rac-lactide for Ti2(1)(O
iPr)4, Ti(6-11)(O
iPr)2 at 130 °C in a 300:1 
[rac-lactide]:[initiator] *600:1 [rac-lactide]:[initiator]. a Conversion ascertained by 1H NMR 
spectroscopy. b Theoretical molecular weight calculated from conversion (Conv. × 100/2 × 144.13 + 
60.10) (rounded to the nearest 50), c Molecular weight and PDI determined by GPC (THF) using 
polystyrene standards without applying a correction factor. d Pr as calculated from 
1H NMR 
homonuclear decoupled spectroscopy in CDCl3. 
 
2.7 Titanium Homo/Piperazine Salan Catecholates  
2.7.1 Introduction 
 Catechol is a bidentate, chelating ligand; the initial proposal was to observe 
the effect of a chelating agent upon the titanium piperazine salan equilibrium system. 
A series of monometallic piperazine salan catecholates complexes were isolated and 
characterised. Prior titanium catechol complexes were reported by Davidson et al.
25
 
the catecholate complexes form bimetallic structures {Ti(catechol)2(HOiPr)2}2 where 
the catecholates both chelate to a single titanium and bridge two titanium metals. The 
titanium homo/piperazine catecholates reported herein proved ineffective for the 
ROP of rac-lactide this is presumably due to the lack of labile ligand to initiate the 
polymerisation. 
 Although inactive for the ROP of rac-lactide these titanium homo/piperazine 
catecholates were investigated for their cytotoxicity towards tumour cells. Cisplatin 
was the first metal compound to be utilised as an anticancer reagent, following this 
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derivatives have also been commercially used as anticancer treatments over the last 
decade.
26
 While Cisplatin is an effective cancer treatment compound its effectiveness 
is limited to a small range of cancer types, particularly ovarian and testicular cancers. 
Additionally Cisplatin is a highly toxic compound, as such the dosage is limited to 
minimise adverse effects. Titanium compounds have been investigated for 
cytotoxicity with some promise towards different tumour cell lines which are either 
susceptible or resistant to treatment by Cisplatin (Figure 2.29, left) and its derivatives. 
Budotitane {cis-diethoxybis(1-phenylbutane-1,3-dionato)titanium(IV)} (Figure 2.29, 
centre) showed good toxicity towards tumour cells but the complex was proven to be 
unstable, as a consequence of the labile ligands, also the unsymmetrical ligands give 
rise to multiple geometric configurations.
27, 28
 Titanocene dichloride (Cp2TiCl2) 
(Figure 2.29, right) was also investigated as an anticancer compound but it was 
deemed inefficient due to its high toxicity.
27, 28
 Titanium compounds have a 
promising range of toxicity towards different cell lines but active compounds 
typically decompose quickly making it difficult to analyse and indentify the active 
species, or study the compound in mechanistic manner.
27, 28
  
 
  
Figure 2.29: Notable anticancer compounds. left – Cisplatin,  Centre – Butotitane, Right – Titanocene 
dichloride. 27, 28 
 
 Cytotoxic salan titanium (IV) complexes have been investigated by Tshuva et 
al.
29
 for their applicability as anticancer compounds (Figure 2.30a). These complexes 
proved to be more cytotoxic towards colon HT-29 and ovarian OVCAR-1 cell lines 
than Cisplatin and other reported titanium (IV) compounds (Budotitane / Titanocene 
dichloride) (Figure 2.29). The salan titanium complexes proved to be resilient 
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towards hydrolysis with a maximum half life of hydrolysis (t½) of 32 h. The 
hydrolysis product, a trimer, was shown to be inactive by conventional in-vitro cell 
treatment. More recent studies revealed the trimeric hydrolysis product as active; the 
limiting factor is reported as cell penetration effects which were overcome by 
nano-particulate encapsulation of the complex.
30
 Ligand lability is not essential, even 
detrimental,
31
 for titanium complexes to be cytotoxic towards tumour cells
32
 
advocating the use of the relatively non-labile catecholates ligands. A titanium salan 
catecholate was synthesised and reported as cytotoxic for HT-29 and OVCAR-1 cell 
lines, albeit with slightly reduced activity than the isopropoxide containing analogue 
(Figure 2.30a).
29
 The titanium salan catecholate was more stable towards hydrolytic 
degradation. Furthermore, a titanium salen catecholate has been investigated for the 
same cell lines (Figure 2.30b), negligible hydrolytic decomposition was observed, 
and the complex proved active towards the investigated cell lines, although the 
titanium salen isopropoxide analogue was more effective.
33
 
 
 
Figure 2.30: Titanium bis(phenoxy) complexes investigated as anti-tumour compounds a) Titanium 
salan isopropoxide/catecholate,29 b) Titanium salen isopropoxide/catecholates.33 
 
 
 
 
 
 
 
a) b) 
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2.7.2 Synthesis 
 
Figure 2.31: Reaction scheme detailing the initially desired homo/piperazine salan titanium 
catecholates. 
 The initial premise was the introduction of catechol to the titanium piperazine 
salan complexes would reduce the number of titanium coordinated isopropoxide 
groups. The ideal product would have resulted in one catechol per titanium thus 
leaving one lactide ROP initiating isopropoxide group per metal (Figure 2.31). It was 
anticipated that this would dictate the PLA chain growth leading to well defined 
molecular weights and PDI values. Additionally the effect of the chelating catechol 
upon the L2M2 titanium complexes and the equilibrium was an area of interest.  
 
 
Figure 2.32: Reaction scheme detailing the synthesis of piperazine and homopiperazine salan titanium 
catecholates. 
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At room temperature the introduction of catechol, homo/piperazine salan 
ligand and Ti(O
i
Pr)4 in a 1:1:1 ratio yielded monometallic complexes (Figure 2.32). 
The formation of a monometallic complex at lower temperature is presumably a 
consequence of the reduced steric demands of catechol when compared to two 
isopropoxide moieties. The investigation of this complex series was limited to 
methyl substituents as the presence of large alkyl groups is normally detrimental to 
water solubility, which is a consideration particularly in administration of a potential 
drug.
34
 For comparison reasons a single complex was synthesised which contained 
t
Bu groups in the para position of the phenoxy rings {Ti(2)Catechol}. Due to the 
limitations upon the piperazine salan phenoxy moieties a variety of readily available 
catechols with varying substituents were utilised for the synthesis. Additionally 
homopiperazine and piperazine complexes were investigated. Excess Ti(O
i
Pr)4 or 
catechol still resulted in the formation of monometallic homo/piperazine salan 
titanium catecholates. The room temperature synthesis of piperazine salan titanium 
catecholates resulted in pure products and high yields which were characterised by 
1
H NMR spectroscopy, 
13
C{
1
H} NMR spectroscopy, and CHN analysis. 
Recrystallisation from hot toluene or CH2Cl2 resulted in crystals suitable for X-ray 
crystallography, for Ti(1)Catechol, Ti(1)-3,5-di-tert-butylcatechol, Ti(1)-4-NO2-
catechol, and Ti(6)-4-NO2-catechol. The isolation of Ti(6)-3,5-di-tert-butylcatechol 
was attempted but the complex could not be supported by NMR spectroscopy 
although the formation of multiple isomers was a possibility. 
 
2.7.3 Solid-state characterisation by X-ray crystallography 
 A representative example {Ti(1)Catechol} of a modelled X-ray 
crystallography structure for the 6 membered piperazine bridged salan titanium 
catecholates {Ti(1)Catechol, Ti(1)-3,5-di-tert-butylcatechol, Ti(1)-4-NO2-catechol} 
is given in figure 2.33. The solid-state structure for Ti(6)-4-NO2-catechol is 
displayed in figure 2.34. All the structures were determined as six coordinate pseudo 
octahedral geometries, specifically β-cis geometric configurations are adopted 
(Figure 2.23). Both Λ and Δ forms are present according to the X-ray crystallography 
data as all the crystal structures contain centres of inversion.  
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Figure 2.33: Solid-state structure for Ti(1)Catechol. Hydrogen atoms have been removed for clarity 
ellipsoids are shown at the 50 % probability.  
 
 
 
Figure 2.34: Solid-state structure for Ti(6)-4-NO2-catechol. Hydrogen atoms have been removed for 
clarity ellipsoids are shown at the 50 % probability. The NO2 group was found in the 4 and 5 positions 
of the catechol ring at a 50:50 ratio. 
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Ti(1)Catechol 
Ti(1)-3,5-di-
tert-
butylcatechol 
Ti(1)-4-NO2-
catechol 
Ti(6)-4-NO2-
catechol 
Ti1-O1 1.934(3) 1.920(3) 1.939(2) 1.9607(15) 
Ti1-O2 1.975(3) 1.944(3) 1.991(2) 1.9583(15) 
Ti1-O3 1.864(3) 1.888(3) 1.8589(19) 1.8486(14) 
Ti1-O4 1.855(3) 1.861(3) 1.8395(19) 1.8539(14) 
Ti1-N1 2.207(3) 2.219(3) 2.206(2) 2.2514(17) 
Ti1-N2 2.230(3) 2.232(3) 2.211(2) 2.2677(18) 
N1-Ti1-O1 93.05(12) 95.63(12) 95.86(9) 94.00(6) 
N1-Ti1-O2 98.47(12) 94.40(12) 97.49(9) 94.55(6) 
N1-Ti1-O3 79.56(12) 78.84(12) 79.35(8) 80.55(6) 
N1-Ti1-O4 146.30(12) 147.81(13) 146.54(9) 153.41(7) 
N1-Ti1-N2 65.87(12) 65.32(13) 66.04(8) 69.92(6) 
 
Table 2.11: Selected bond lengths (Å) and angles (°) for Ti2(1)2(O
iPr)4, as determined by X-ray 
crystallography. 
Selected bond lengths and angles for the homo/piperazine titanium 
catecholates are given in table 2.11. Typically the catechol Ti-O bonds (Ti-O1, Ti-O2) 
are longer than titanium phenoxy Ti-O bonds (Ti-O3, Ti-O4) with respective bond 
ranges of 1.920 – 1.991 Å and 1.854 – 1.888 Å. There is little effect upon bond 
length from the trans component, which is contrasting to the observation made for 
Ti(6-11)(O
i
Pr)2 complexes. The N1-Ti1-O4 angle deviates from the idealist value of 
180 ° giving angles between 146.30 - 153.41 °, the N1-Ti1-O3 angle deviates from 
the idealist value of 90 ° giving angles between 78.84 – 79.56 °. The homopiperazine 
complex allows for a larger bite angle between the two nitrogen groups where the 
N1-Ti1-N2 angles were 66.04 ° and 69.92 ° for Ti(1)-4-NO2-catechol and 
Ti(6)-4-NO2-catechol respectively. 
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2.7.4 Characterisation by solution NMR spectroscopy 
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Figure 2.35: 1H NMR spectrum of Ti(1)Catechol in CDCl3 (298 K). 
  
Without utilising forcing conditions the monometallic titanium catechols 
were isolated and the 
1
H/
13
C{
1
H} NMR spectroscopy characterisation was consistent 
with the structures identified by X-ray crystallography and CHN analysis. A 
representative 
1
H NMR spectrum for Ti(1)Catechol is given (Figure 2.35) for the 
piperazine salan catechols {Ti(1)Catechol, Ti(1)-3,5-di-tert-butylcatechol, 
Ti(1)-3-Methoxycatechol, Ti(1)-4-NO2-catechol}. The ring –CH2 protons were 
observed as discrete multiplets at 2.18, 2.63, 3.22, and 3.80 ppm. Two distinct 
doublets at 3.38 and 4.52 ppm were assigned to the N-CH2-Ar protons. Although the 
aromatic region of the spectra is sharp the region was complicated by overlapping of 
the four proton resonances at 6.62 ppm.  
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Figure 2.36: 1H NMR spectrum of Ti(6)Catechol in CDCl3 (298 K). 
 
 A representative 
1
H NMR spectrum {Ti(6)Catechol} is shown in figure 2.36 
for the homopiperazine based salan titanium catechols {Ti(6)Catechol, 
Ti(6)-3-Methoxycatechol, Ti(6)-4-NO2-catechol}. The spectrum is consistent with 
the X-ray crystallography determined solid state structure (Figure 31). The 
1
H NMR 
spectra for the homopiperazine salan titanium catecholates shows a distinct 
broadening of resonances when compared to their analogous piperazine complexes. 
The N-CH2-Ar protons resulted in distinctive doublets at 3.22 and 4.38 ppm. The 
homopiperazine ring-CH2 protons displayed a significant degree of complication 
(2.02, 2.39, 2.56, 3.15, and 4.14 ppm) including a noteworthy broadening of the 
resonance at 4.14 ppm.  The aromatic region shows three resonances (6.40, 6.65, and 
6.93 ppm) where four protons (two equivalent environments) are overlapping at 
6.65 ppm.  It was deduced that the broadening of the spectra is related to the higher 
degree of fluxionally typically observed for the homopiperazine compounds in 
comparison to the piperazine compounds. 
 
2.7.5 Stability and cytotoxicity 
 Stability and cytotoxicity studies were performed by Dr. Edit Tshuva at The 
Hebrew University of Jerusalem, the investigation is currently ongoing at the date of 
writing. Preliminary cytotoxicity data was investigated with HT-29 and OVCAR-1 
tumour cells lines, IC50 values are outlined in table 2.12. Stability of complexes 
towards hydrolysis was also investigated and the half lives (t½) are given in 
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table 2.12. The titanium isopropoxide complex Ti2(1)(O
i
Pr)6 was investigated and the 
compound proved non-toxic towards the cell lines, additionally the equilibrium 
complicated half life studies. Ti(1)Catechol was evidently toxic towards the 
investigated cell line with IC50 values rivalling other titanium compounds and 
enhanced toxicity compared to Cisplatin, the stability was lower than previously 
investigated catecholates. The nitro subsistent upon the catechol ring enhanced the 
stability. The low stability of the compounds was attributed to the strained piperazine 
ring, as a boat configuration is less favourable. Upon introducing a homopiperazine 
ring the stability was significantly enhanced presumably due to the reduced steric 
strain of the 7 membered homopiperazine ring. Additionally Ti(6)-4-NO2-catechol 
gave an increase toxicity towards the investigated cell lines.  
 
 
IC50 value for HT-29 
(M) 
IC50 value for 
OVCAR-1 (M) 
t1/2(min) 
Ti2(1)(O
i
Pr)6 Inactive Inactive * 
Ti(1)Catechol 21.9±4.6 27.8±4.6 16 
Ti(1)-4-NO2-catechol 20.7±7.3 25.6±3.0 25 
Ti(6)-4-NO2-catechol 11.5±4.3 7.2±3.4 92 
 
Table 2.12: Preliminary IC50 values for HT-29 and OVCAR-1 cell lines, and half life stability of the 
complexes towards hydrolysis. 
 
2.8 Conclusion 
Tetradentate salan ligands containing homo/piperazine backbones were 
coordinated to titanium (IV) tetra-isopropoxide resulting in Ti2(1-5,8-9,12-13)(O
i
Pr)6 
complexes. Their reliance upon backbone rigidity, reaction conditions, and steric 
requirements are discussed and their relevance in determining the structural motif 
obtained. Ti2(2-5,8,12,13)(O
i
Pr)6 were isolated as crystals and characterised as LM2 
structures by X-ray crystallography. From the same conditions a Ti2(1)2(O
i
Pr)4 
crystal was obtained and characterised by X-ray crystallography, although a bulk 
solid compound of Ti2(1)(O
i
Pr)6 was obtained in further synthesis. A titanium 
piperazine salan equilibrium based upon steric requirements was investigated for 
Ti2(1,2)(O
i
Pr)6. The equilibrium position was shown to vary upon temperature 
changes, solvent, and excess reagents. The more flexible homopiperazine structures 
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were complexed to Ti(O
i
Pr)4 produce monometallic structures {Ti(6-11)(O
i
Pr)2} 
after exposure to extended thermal conditions. X-ray crystallography characterisation 
was successfully conducted for Ti(7,9-11)(O
i
Pr)2. 
1
H NMR spectroscopy revealed 
titanium metal centres were present in solution as multiple pseudo octahedral 
conformations. 
 The titanium LM2 complexes {Ti2(1-5,8-9,12-13)(O
i
Pr)6} were trialled for 
the ROP of rac-lactide and were shown to be active in both solvent and solvent free 
conditions. Ti2(1-5,8-9,12-13)(O
i
Pr)6 initiators achieved high conversion of 
rac-lactide to PLA within 24 h at 80 °C in toluene at 100:1 [rac-lactide]:[initiator] 
ratio.  The solvent free polymerisation obtained high conversion within 30 mins at 
130 °C at 300:1 [rac-lactide]:[initiator] ratio. The resulting PLA typically had lower 
molecular weights than expected and high PDI values were generally exhibited, it 
was speculated that more than one isopropoxide per metal was initiating the 
propagation of a PLA chain. The resulting PLA was generally atactic with slight 
variations of Pr about 0.5. The LM complexes {Ti(6-11)(O
i
Pr)2} were poorly active 
under the same conditions for the ROP of rac-lactide. The solution ROP of 
rac-lactide required 24 h for low conversion to be obtained, the solvent free ROP 
required 24 h for moderate conversions to be obtained. The resulting PLA was 
predominantly atactic where slight deviations were observed towards isotactic or 
heterotactic lactide. 
The favourable formation of monometallic catecholates is discussed along 
with their characterisation. The ligands (1,2,6)H2 were investigated and four variants 
of catecholate were complexed to Ti(O
i
Pr)4. Ti(1)Catechol, Ti(1) 3,5-di-tert-
butylcatechol, Ti(1)-4-NO2-catechol, and Ti(6)-4-NO2-catechol solid-state structures 
were determined by X-ray crystallography. These catecholates did not display any 
activity towards the ROP of rac-lactide. These titanium piperazine salan catecholates 
have been preliminarily revealed as moderately promising compounds as anti tumour 
reagents by Dr. Edit Tshuva.  
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2.9 Future Work 
 The equilibrium observed for Ti2(1,2)(O
i
Pr)6 poses on interesting area, thus 
further investigation into the nature of the equilibrium under various conditions 
would be of interest. Other derivatives of these ligands could be investigated to better 
constitute the requirements for an equilibrium system. The mechanistic details of 
these titanium complexes could be investigated further, beginning with kinetic 
experiments at low monomer:initiator ratio. Further-work is being conducted on the 
anti-tumour properties of the titanium piperazine salan catecholates. Depending upon 
the trends observed other derivatives of these complexes could be investigated.  
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3. Zirconium/Hafnium (IV) Homo/Piperazine Salan 
Complexes and Their Application for the ROP of 
rac-Lactide 
3.1 Introduction 
Group 4 tetradentate amine bis(phenoxy) complexes have been previously 
reported for the ROP of rac-lactide.
1-4
 Zirconium and hafnium metals can form 
complexes in different manners with tetradentate -(ONNO)- ligands compared to 
titanium. For example, zirconium and hafnium metals have a stronger preference 
towards bridging to form dimers.
5, 6
 Zirconium and hafnium complexes typically 
exhibit an enhancement for the ROP of lactide in terms of activity,
1, 7
 and/or 
molecular weight control.
2, 7
 Also stereoselectivity is often observed with zirconium 
and hafnium initiators over titanium initiators, due to the ability of lactide to chelate 
to the larger zirconium/hafnium metal. For example, isotactic enriched PLA was 
produced from rac-lactide by Davidson et al. with the -(ONNO)- initiators given in 
figure 3.01.
2
 Furthermore, hafnium and zirconium trisphenolate initiators have 
resulted in strong heterotactic stereoselectivities (Figure 3.02).
1, 8
 Reported herein is 
the synthesis of zirconium and hafnium piperazine and homopiperazine based salan 
complexes and their use as initiators for the ROP of rac-lactide. This follows prior 
titanium piperazine salan work (Chapter 2).
9
 
 
Figure 3.01: Zirconium and hafnium -{ONNO}- based bis(phenoxy) initiators.2 
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Figure 3.02: Zirconium and hafnium trisphenolate initiators.1, 8 
3.2 Synthesis of Zirconium/Hafnium (IV) Homopiperazine Salan 
complexes 
 
Figure 3.03: Reaction scheme for the synthesis of homo/piperazine salan zirconium/hafnium 
complexes. 
 
The homo/piperazine salan ligands (1-15)H2 discussed in chapter 2 
(Figure 2.02) were complexed to Zr(O
i
Pr)4.HO
i
Pr and Hf(O
i
Pr)4.HO
i
Pr. The 
complexation of zirconium and hafnium isopropoxide to the piperazine based salan 
ligands (1-5,12-15H2) was conducted with limited success (Figure 3.03). The 
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complexation of zirconium with (1-5,12-15)H2 at elevated or ambient temperature, 
resulted in a plethora of species being observed; furthermore purification by 
recrystallisation either yielded mixed zirconium species and/or ligand. In two cases 
recrystallisation of zirconium piperazine salan complexes from hot hexane afforded 
crystals suitable for X-ray diffraction studies. A complex with a 4:1 metal to ligand 
ratio was isolated {(Zr4(1)(O
i
Pr)14.(HO
i
Pr)2}. A 2:1 metal to ligand ratio complex 
was also observed {Zr2(15)(O
i
Pr)6}, with a differing structural motif than the 
previously discussed titanium complexes. The solution NMR spectroscopic analysis 
for these structures was not consistent with the structure being maintained in solution.  
The complexation of Hf(O
i
Pr)4.HO
i
Pr with (1-5,12-15)H2 at room 
temperature also resulted in the production of a mixture of species (Figure 3.03). 
Recrystallisation attempts from small amounts of hexane yielded crystals for 
{Hf2(1,3)(O
i
Pr)6}, these complexes displayed the same structural motif. The 
bimetallic structure was observed in the solution state NMR spectra as the major 
product, but the high solubility of the all the products made purification difficult and 
any isolated material contained significant degrees of impurities. The synthesis of 
zirconium and hafnium six membered piperazine salan complexes lacked the 
repeatability required for systematic study.  
 The complexation of Zr/Hf(O
i
Pr)4.HO
i
Pr to the homopiperazine salan 
ligands {(6-10)H2} proved fruitful (Figure 3.03). Monometallic complexes were 
obtained at room temperature and furthermore recrystallisation from hexane resulted 
in crystals suitable for X-ray diffraction studies for Zr(6-7,10)(O
i
Pr)2, and 
Hf(6-8,10)(O
i
Pr)2. The synthetic methodology was repeatable and a pure product was 
consistently obtained, which was characterised by 
1
H/
13
C{
1
H} NMR spectroscopy 
and CHN analysis. Analysis by 
1
H/
13
C{
1
H} NMR spectroscopy and CHN analysis 
was consistent with the solid-state structure remaining in solution. Utilising heat and 
longer reaction times enhanced the obtained yields, presumably assisting to 
overcome the energy barrier between the chair and boat configurations of the 
bridging homopiperazine ring. The introduction of THF to the synthesis of 
Zr(6)(O
i
Pr)2 lead to the determination of a crystal structure with a partially 
coordinated THF bound to the zirconium metal centre {Zr(6)(O
i
Pr)2.0.5THF.0.5IPA}. 
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3.3 Characterisation by X-ray Crystallography 
 
 
Figure 3.04: Solid-state structures of a) Zr4(1)(O
iPr)14.(HO
iPr)2 b) Zr2(15)(O
iPr)6. Ellipsoids are 
shown at the 30 % probability level, hydrogen atoms and iPr –CH3 groups have been omitted for 
clarity. 
 
 Two structural motifs were obtained by X-ray crystallography for the 
zirconium piperazine salan complexes; Zr4(1)(O
i
Pr)14.(HO
i
Pr)2 (Figure 3.04a), 
Zr2(15)(O
i
Pr)6 (Figure 3.04b). The tetramer Zr4(1)(O
i
Pr)14.(HO
i
Pr)2 has two unique 
zirconium environments (Figure 3.04a), the complex has an inversion centre hence 
there are two pairs of equivalent zirconium centres. Both zirconium metals adopt a 
pseudo octahedral environment where both are bound to a bridging phenoxy group 
{Zr1-O1 = 2.168(3) Å, Zr2-O1 = 2.257(3) Å}, and a bridging isopropoxide moiety 
{Zr1-O1 = 2.184(3) Å, Zr2-O1 = 2.223(3) Å}. Zr1 is bound to three isopropoxide 
a) 
b) 
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groups with bond lengths ranging between 1.939(3) - 2.034(3) Å, and one chelating 
nitrogen {Zr1-N1 = 2.523(3) Å}. Zr2 also coordinated to three terminal isopropoxide 
groups with bond lengths ranging between 1.944(3) - 1.953(3) Å. An isopropanol 
was bound to Zr2 {Zr2-O6 = 2.287(3) Å}, the isopropanol hydrogen bonds to an 
isopropoxide oxygen (O6). The bridging groups favour binding to Zr1, which is an 
artefact from the stronger coordination of a neutral isopropoxide ligand to Zr2 over 
the coordination of a neutral nitrogen to Zr1. The bridging phenoxy oxygen (O1) is 
trans to two terminal isopropoxide groups of each Zr metal giving angles; 
O1-Zr1-O3 = 159.43(11) °, O1-Zr2-O7 = 160.89(12) °, both cases significantly 
deviate from the idealistic trans octahedral angle. Di(amine/imine) bridged 
bis(phenol) ligands have previously resulted in bimetallic zirconium complexes 
although examples typically include two ligands and two zirconium metals unlike 
Zr2(15)(O
i
Pr)6.
10, 11
 No previous tetrametallic bis(phenoxy) complexes have been 
reported as a bulk material or crystallographically determined.  
 The bimetallic Zr2(15)(O
i
Pr)6 has two zirconium metal centres, the piperazine 
salan ligands adopt the boat configuration and coordinate as a tetradentate ligand to 
Zr2 (Figure 3.04b). The piperazine methyl substituents are disordered over two 
positions in a 50:50 ratio, which are shown in figure 3.04b. Zr1 adopt a six 
coordinate pseudo octahedral structure and is only directly bonded to the piperazine 
salan ligand by a single bridging phenoxy group {Zr1-O2 = 2.286(4) Å}. Three 
terminal isopropoxide groups are coordinated to Zr1 with bond lengths ranging 
between 1.931(6) – 1.959(4) Å. The two zirconium metals are bridged by two 
isopropoxide groups with bond lengths between 2.153(4) - 2.327(5) Å, with the 
bridging oxygen bonds to Zr2 being shorter. Zr2 coordinates to the piperazine salan 
ligand through two phenoxy groups {Zr2-O1 = 2.043(4) Å, Zr2-O2 = 2.199(4) Å} 
and two amine groups {Zr2-N1 = 2.481(5) Å, Zr2-N2 = 2.450(6) Å}. Zr2 is 
coordinated to a single terminal isopropoxide moiety to give a final seven coordinate 
metal centre which adopts a pseudo pentagonal bipyramidal structure. Seven 
coordinate zirconium complexes have been previously reported to adopt pseudo 
pentagonal bipyramidal conformations.
12, 13
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Figure 3.05: Solid-state structure of Hf2(1)(O
iPr)6. Ellipsoids are shown at the 30 % probability level, 
hydrogen atoms and iPr –CH3 groups have been omitted for clarity. 
 
 Two hafnium piperazine salan structures {Hf2(1,3)(O
i
Pr)6} were 
characterised by X-ray crystallography and a representative structure for 
Hf2(1,3)(O
i
Pr)6 is given in figure 3.05. The piperazine ring adopts the boat 
configuration and each hafnium metal centre is bridged by two isopropoxide groups, 
selected bonds length are shown in table 3.01. Each hafnium metal adopts a pseudo 
octahedral structure chelating to one half of the piperazine salan ligand (a phenoxy 
and an amine) along with two terminal isopropoxide groups. The terminal 
isopropoxide Zr-O bonds are typically shorter, 1.891(11) – 1.964(9) Å, than the 
bridging isopropoxide Zr-O bonds, with bond lengths ranging between 
2.122(9) -2.204(10) Å. A slight deviation from an idealistic octahedral structure was 
observed where the trans angles (N1-Hf1-O1), and cis angles (N1-Hf1-O2, 
N1-Hf1-O4) revealed deviations from 180 ° and 90 ° respectively. Bimetallic 
hafnium structures coordinated to diamine linked bis(phenol) ligands have been 
previously reported,
14
 although they are not prevalent in the literature. Further 
bimetallic hafnium structures have been reported with -ON(N)O- based bis(phenol) 
ligands.
15
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Table 3.01: Selected bond lengths (Å) and angles (°) for piperazine salan hafnium complexes 
{Hf2(1,3)(O
i
Pr)6}, as determined by X-ray crystallography. 
 
 The homopiperazine salan ligands {(6-10)H2} were complexed to zirconium 
which resulted in monometallic structures, a representative solid-state structure is 
displayed in figure 3.06a. Selected bond lengths (Å) and angles (°) for Zr(6)(O
i
Pr)2, 
Zr(7)(O
i
Pr)2, Zr(10)(O
i
Pr)2, and Zr(6)(O
i
Pr)2.0.5THF.0.5IPA are given in table 3.02. 
The zirconium metal centre adopts a pseudo trans-octahedral structure (Chapter 2.5.2, 
figure 2.23) where the homopiperazine salan ligand chelates equatorially, the 
phenoxy groups were orientated cis to each other, and the amines are also cis 
orientated. The two terminal isopropoxide ligands are trans to each other in the axial 
position with no significant difference in bond length between the two axial moieties. 
The axial isopropoxide groups revealed a slight deviation from 180 °, with O1-Zr-O2 
angles between 173.5(2) - 175.9(2) °. A large deviation (from 90 °) between the two 
cis phenoxy groups was observed with the O3-Zr-O4 angles being ~120 °. The two 
phenyl rings are orientated towards the same isopropoxide, the angle between the 
planes of the phenyl rings ranges between 73.7 – 81.2 °.  
A solid-state structure of Zr(6)(O
i
Pr)2 with a coordinated THF/isopropanol 
group was determined by X-ray crystallography. The resulting structure is given in 
 Hf2(1)(O
i
Pr)6 Hf2(3)(O
i
Pr)6 
Hf1-O1 1.908(9) 1.917(7) 
Hf1-O2 1.913(10) 1.929(9) 
Hf1-O3 1.995(9) 2.009(6) 
Hf1-O4 2.204(10) 2.152(10) 
Hf1-O5 2.122(9) 2.180(11) 
Hf1-N1 2.548(12) 2.534(9) 
N1-Hf1-O1 173.9(4) 169.6(3) 
N1-Hf1-O2 80.1(4) 87.1(3) 
N1-Hf1-O4 80.9(4) 84.4(3) 
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figure 3.06b with selected bond lengths (Å) and angles (°) specified in table 3.02. 
The zirconium metal centre is seven coordinate and adopts a pseudo pentagonal 
bipyramidal structure, where the THF was found in a 50:50 ratio with an isopropanol 
moiety. The isopropoxide groups remains in the axial position of the complex 
although the trans isopropoxide angle was more acute {O1-Zr1-O2 = 169.18(7) °}. 
The introduction of the neutral coordinating oxygen group elongates the amine 
zirconium bonds (Zr1-N1 and Zr1-N2). The angle between the two phenoxy groups 
becomes more obtuse {O3-Zr1-O4 = 137.96(6)} to allow the introduction of an extra 
coordinating group.  
 
 
Figure 3.06: Solid-state structures of a) Zr(6)(OiPr)2 b) Zr(6)(O
iPr)2.0.5THF.0.5IPA. Ellipsoids are 
shown at the 30 % probability level, hydrogen atoms and iPr –CH3 groups have been omitted for 
clarity. 
 
 
a) 
b) 
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Table 3.02: Selected bond lengths (Å) and angles (°) for monometallic zirconium complexes, as 
determined by X-ray crystallography. a The molecule contains a mirror plane; Zr1-O3 = Zr1-O4, 
Zr1-N1 = Zr1-N2. 
 
Figure 3.07: Solid-state structure of Hf(6)(OiPr)2. Ellipsoids are shown at the 30 % probability level, 
hydrogen atoms and iPr –CH3 groups have been omitted for clarity. 
 
 Similar monometallic structures were identified by X-ray crystallography for 
the hafnium isopropoxide homopiperazine salan complexes {Hf(6-8,10)(O
i
Pr)2}. The 
structures for Hf(6)(O
i
Pr)2, Hf(7)(O
i
Pr)2, Hf(8)(O
i
Pr)2, and Hf(10)(O
i
Pr)2 were 
obtained. The structure of Hf(6)(O
i
Pr)2 is given in figure 3.07 as a representative 
example. Selected bond lengths (Å) and angles (°) determined by X-ray 
 Zr(6)(O
i
Pr)2 Zr(7)(O
i
Pr)2 Zr(10)(O
i
Pr)2 
Zr(6)(O
i
Pr)2.0.5
THF.0.5IPA 
Zr1-O1 1.9689(14) 1.968(4) 1.962(6) 1.9708(17) 
Zr1-O2 1.9665(14) 1.964(4) 1.966(5) 1.9652(16) 
Zr1-O3 2.0476(15) 2.041(2) 2.047(6) 2.0950(17) 
Zr1-O4 2.0567(14) -
a
 2.027(6) 2.1292(15) 
Zr1-O5 - - - 2.469(10)
b
 
Zr1-N1 2.3958(18) 2.387(3) 2.391(8) 2.4831(19) 
Zr1-N2 2.3876(18) -
a
 2.381(8) 2.4945(18) 
N1-Zr1-O1 87.20(6) 86.25(14) 87.8(3) 84.05(7) 
N1-Zr1-O4 152.67(6) 153.50(8)
a
 152.8(3) 142.89(6) 
O1-Zr1-O2 174.71(6) 173.5(2) 175.9(2) 169.18(7) 
O3-Zr1-O4 121.40(6) 119.57(13) 120.6(2) 137.96(6) 
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crystallography can be found in table 3.03. These structures all adopt a pseudo 
trans-octahedral geometry (Chapter 2.5.2, figure 2.23) where the homopiperazine 
ligand coordinates via two amines and two phenoxy groups to the equatorial 
positions of the hafnium metal centre. The isopropoxide groups coordinates in the 
axial positions, while trans to each other a slight deviation from 180 ° was observed 
{O1-Hf1-O2 = 172.7(4) - 176.36(13) °}. Similarly the phenyl rings are both 
orientated towards the -(CH2)3- group of the homopiperazine ring, where the angle 
between planes of the two phenyl rings ranged between 71.8 – 81.1 °. The trans 
octahedral geometry is not prevalent in the literature for Zr(IV) or Hf(IV) (-ONNO-} 
bis(phenoxy) isopropoxide complexes. Titanium has been reported to adopt the trans 
octahedral configuration in solution.
16
 However, the trans octahedral geometry is 
favourable in the presence of metal coordinated chloride moieties.
12, 17
 
 
 
Table 3.03: Selected bond lengths (Å) and angles (°) for homopiperazine salan hafnium complexes, as 
determined by X-ray crystallography. a The molecule contains a mirror plane; Zr1-O3 = Zr1-O4, 
Zr1-N1 = Zr1-N2. 
 
 
 Hf(6)(O
i
Pr)2 Hf(7)(O
i
Pr)2 Hf(8)(O
i
Pr)2 Hf(10)(O
i
Pr)2 
Hf1-O1 1.960(4) 1.957(7) 1.982(3) 1.969(2) 
Hf1-O2 1.955(4) 1.993(6) 1.966(3) 1.964(2) 
Hf1-O3 2.030(4) 2.040(2) 2.037(3) 2.040(3) 
Hf1-O4 2.041(4) -
a 
2.037(3) 2.035(3) 
Hf1-N1 2.364(5 2.363(3) 2.340(4) 2.355(4) 
Hf1-N2 2.357(5) -
a
 2.349(3) 2.359(3) 
N1-Hf1-O1 87.14(16) 88.06(17) 87.95(12) 88.09(11) 
N1-Hf1-O4 153.63(16) 155.00(9)
a
 153.88(12) 154.66(13) 
O1-Hf1-O2 174.83(16) 172.7(4) 176.36(13) 175.55(11) 
O3-Hf1-O4 119.17(15) 117.34(13) 119.36(12) 118.82(11) 
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3.4 Characterisation by NMR Spectroscopy 
 
1
H NMR spectroscopy was utilised to analyse the products from the 
complexation reaction of zirconium and hafnium isopropoxide to piperazine salan 
ligands (1-5,12-15)H2. The 
1
H NMR spectra were typically indeterminable and 
acidic phenol protons were often observed indicating incomplete reactions. The 
isolated hafnium piperazine salan {Hf2(1,3)(O
i
Pr)6} product contained several 
impurities. These 
1
H NMR spectra indicated the formation of structures with a 
metal-to-ligand ratio of 2:1, as determined by X-ray crystallography, but significant 
degrees of impurities were observed in the recrystallised product.  
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Figure 3.08: 1H NMR spectra for Zr(7)(OiPr)2, top 298 K, bottom 233 K. 
 
The solution NMR spectra for Zr(6-10)(O
i
Pr)2 were consistent with the X-ray 
crystallographically determined structures being maintained in solution. A 
representative room temperature 
1
H NMR spectrum for Zr(7)(O
i
Pr)2 is given in 
figure 3.08 alongside a low temperature 
1
H NMR spectrum. The room temperature 
1
H NMR spectra are typically broad around the CH2 regions and the CH 
isopropoxide region (2.00 - 4.50 ppm). There are two broad isopropoxide CH3 
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resonances at ~ 0.38 ppm and ~ 1.10 ppm, the broad regions are indicative of 
fluxionality in the isopropoxide moieties and the backbone of the homopiperazine 
salan ligand. Upon cooling (233 K) the aromatic region remains defined with two 
doublets at 6.83 ppm, and 7.11 ppm, whereas the lower chemical shift regions 
become more distinct. The homopiperazine ring system displays a significant 
sharpening of resonances at 3.53
 
ppm, 3.27 ppm, 2.88 ppm, 2.25 ppm, 2.18 ppm 
(partial overlap with the CH3 resonances), and 1.73 ppm. A pronounced 
enhancement is observed for the isopropoxide moieties; both CH isopropoxide 
groups were located at 3.28 ppm and 4.43 ppm, although in this specific example 
(Figure 3.08) both resonances are located in the same region as the CH2 group 
resonances. The CH3 isopropoxide resonances are present at 0.15 ppm and 1.22 ppm, 
the resonance at 1.22 ppm coincides with resonances attributed to 
t
Bu groups. The 
resonance at 0.15 ppm is significantly shifted upfield than typical zirconium bound 
isopropoxide CH3 groups. It was deduced that this isopropoxide orientated towards 
the -(CH2)3- homopiperazine region and is profoundly shielded by the phenoxy 
aromatic rings orientated in the same direction. 
Subsequent NMR spectroscopy investigations of the homopiperazine salan 
hafnium complexes {Hf(6-10)(O
i
Pr)2} evidently proved the solution state structures 
were of the same pseudo trans-octahedral geometry as determined by X-ray 
crystallography (Figure 3.07). A representative 
1
H NMR spectrum of Hf(7)(O
i
Pr)2 
under ambient conditions is provided, accompanied by a low temperature 
1
H NMR 
spectrum of the same complex (Figure 3.09). Similar to the analogous zirconium 
complex {Zr(7)(O
i
Pr)2} the 
1
H NMR spectrum for Hf(7)(O
i
Pr)2 revealed a 
broadening of the homopiperazine salan CH2 resonances and the CH/CH3 
isopropoxide resonances. Upon cooling the phenoxy substituent resonances 
(1.21 ppm, 2.17 ppm) and aromatic resonances remain relatively unchanged. The 
CH2 piperazine ring protons results in defined resonances, 1.17 ppm, 2.15 ppm 
(partial overlap with the CH3 resonance), 2.35 ppm, 2.95 ppm, 3.35 ppm, and 
3.54 ppm. The isopropoxide CH resonances become defined, 4.51 ppm and 
3.35 ppm, although the latter resonance coincides with a CH2 resonance. Similar to 
the Zr(7)(O
i
Pr)2 
1
H NMR spectrum a single isopropoxide moiety reveals a significant 
upfield shift, as a consequence of the proximity of two phenoxy groups orientated 
towards a particular isopropoxide moiety. 
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Figure 3.09: 1H NMR spectra for Hf(7)(OiPr)2, top 298 K, bottom 233 K. 
 
3.5 Ring-Opening-Polymerisation of rac-Lactide  
 The zirconium and hafnium homopiperazine salan complexes were trialled 
for the ring opening polymerisation (ROP) of rac-lactide in both solution and solvent 
free conditions. Furthermore no co-initiator was required and selected complexes 
were investigated at different monomer to initiator ratios.  
 
3.5.1 Solution ROP of rac-lactide 
 The ROP of rac-lactide was investigated in toluene (10 ml) at 80 °C typically 
allowing 24 h reaction time. In all cases 1.0 g of rac-lactide was used and the 
initiator was added in a 100:1 [rac-lactide]:[initiator] ratio, no co-initiator was 
required for the ROP reaction to proceed. The polymerisation typically achieved high 
conversion after 24 h at which point the reaction was quenched with methanol 
(Table 3.04). Lower conversions were obtained for initiators that contain an 
ortho-
t
Bu ring substituent {Zr(8-9)(O
i
Pr)2, Hf(8-9)(O
i
Pr)2}. This is presumably a 
 144 
steric effect of the bulkier 
t
Bu substituents hindering access to the zirconium or 
hafnium metal centre. The hafnium complexes containing 
t
Bu groups on the 
ortho-position of the phenoxy ring {Hf(8-9)(O
i
Pr)2} gave lower conversions than 
their zirconium counterparts. Complexes containing amyl phenoxy ring substituents 
did not show same degree of reduction in activity, it was speculated that the bulky 
amyl groups may destabilise the complex during the ROP reaction. Hence, higher 
conversions were observed despite the increased steric demands of amyl groups 
compared to 
t
Bu moieties. It should be noted that erroneous CHN analysis of 
Zr/Hf(10)(O
i
Pr)2 were obtained, although solution state and X-ray diffraction 
analysis supports the proposed structure.  
 Polylactide (PLA) molecular weights (Mn) were determined by GPC in THF 
(Table 3.04), the molecular weights were relatively consistent with the theoretical 
molecular weights, calculated from conversion, for the propagation of one PLA chain 
per metal centre. The majority of complexes investigated revealed narrow PDI values 
(PDI = 1.05 – 1.69). The zirconium complexes displayed increased molecular weight 
distributions in comparison to their hafnium analogues. ortho-Methyl substituents 
upon the phenoxy ring {Zr(6-7)(O
i
Pr)2, Hf(6-7)(O
i
Pr)2} resulted in higher PDI values, 
which was presumably a consequence of reduced steric hindrance, the effect was 
even more pronounced for the zirconium complexes.  
 The complexes {Zr(6-10)(O
i
Pr)2} propagated rac-lactide to produce PLA, 
which revealed a slight to moderate isotactic bias (Pr = 0.38 – 0.45) (Table 3.04) as 
determined by homonuclear decoupled 
1
H NMR spectroscopy. The zirconium 
complexes containing ortho-methyl phenoxy ring substituents {Zr(6-7)(O
i
Pr)2} 
displayed the stronger isotactic selectivity. The hafnium homopiperazine salan 
complexes {Hf(6-10)(O
i
Pr)2} also resulted in PLA with a slight to moderate isotactic 
bias (Pr = 0.35 – 0.5). Likewise the hafnium initiators with ortho-methyl phenoxy 
ring substituents {Hf(6-7)(O
i
Pr)2)} revealed slightly enhanced isotactic selectivity 
(Pr = 0.35 – 0.37). 
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Time 
(hours) 
Conv. 
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d 
Zr(6)(O
i
Pr)2 24 96 13900 10000 1.69 0.38 
Zr(6)(O
i
Pr)2 24
 e
 97
e 
42000
 e
 45700
 e
 1.59
 e
 0.38 
Zr(7)(O
i
Pr)2 24 93 13450 10550 1.55 0.42 
Zr(8)(O
i
Pr)2 24 79 11450 7950 1.21 0.45 
Zr(9)(O
i
Pr)2 24 26 3800 4400 1.22 - 
Zr(10)(O
i
Pr)2 24 87 12600 10400 1.15 0.45 
Hf(6)(O
i
Pr)2 24 95 13750 12850 1.68 0.37 
Hf(6)(O
i
Pr)2 24 95
 e
 41150
 e
 52100
 e
 1.20
 e
 0.35 
Hf(7)(O
i
Pr)2 6 83 12000 9250 1.11 0.37 
Hf(8)(O
i
Pr)2 24 12 1800 1650 1.05 - 
Hf(9)(O
i
Pr)2 24 22 3250 2550 1.26 0.52 
Hf(10)(O
i
Pr)2 24 89 12900 9500 1.12 0.43 
 
Table 3.04: Solution ROP of rac-lactide for Zr(6-10)(OiPr)2 and Hf(6-10)(O
iPr)2  in 10 ml of toluene 
at 80 °C in a 100:1 [rac-lactide]:[initiator] ratio. a Conversion ascertained by 1H NMR spectroscopy. 
b Theoretical molecular weight calculated from conversion (Conv. × 100 × 144.13 + 60.10) (rounded 
to the nearest 50), c Molecular weight and PDI determined by GPC (THF) using polystyrene standards 
without applying a correction factor. d Pr as calculated from 
1H NMR homonuclear decoupled 
spectroscopy in CDCl3. 
e 300:1 [rac-lactide]:[initiator] ratio. 
 
The homonuclear decoupled 
1
H NMR spectrum of PLA synthesised from 
rac-lactide initiated by Hf(6)(O
i
Pr)2 in a 300:1 [rac-lactide]:[Initiator] ratio after 24 h, 
in toluene, at 80 °C is displayed in figure 3.10. There is an enhancement of the [iii] 
tetrad resonance at 5.16 ppm. Alongside this is a decrease in intensity of the [sis] and 
[isi] tetrads resonances, at 5.22 ppm and 5.15 ppm respectively. The probability of 
racemic enchainment (Pr) was calculated using Bernoullian statistics
18
 using the 
relative integrals fraction of the [sis] resonance against all the methine resonances, 
1/15.99, gives a Pr = 0.35 from equation 1.06 (Figure 1.16). The homonuclear 
1
H 
NMR spectrum given in figure 3.10 is a representative example for the isotactic bias 
determined for initiators given in table 3.04.  
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Figure 3.10: 1H NMR homonuclear decoupled spectrum showing tetrad resonances for the ROP of 
rac-lactide by Hf(6)(OiPr)2 in a 100:1 [rac-lactide]:[Initiator] ratio, after 24 h in toluene at 80 °C 
(Table 3.04). 
Figure 3.11: MALDI- TOF mass spectra of PLA produced using initiator Zr(8)(OiPr)2, at 80 °C after 
24 h. 
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 The MALDI-TOF mass spectrum of polymer resulting from PLA produced 
by initiator Zr(8)(O
i
Pr)2 is given in figure 3.11 for the major series of peaks. The 
spacing between signals was ~ 72 g mol
-1
, this value is typical of half a lactide unit 
indicative of a degree of transesterification occurring during the ROP reaction. 
Analysis of peaks and splitting patterns allowed the identification of -H 
and -isopropoxide ends groups. The peak pattern at 4262.3 Mw (Figure 3.11) 
corresponded to the enchainment of 29 lactide units, a terminal hydrogen, a terminal 
isopropoxide and ionised with a sodium ion.  
 
3.5.2 Solvent free ROP of rac-lactide 
 The homopiperazine salan zirconium {Zr(6-10)(O
i
Pr)2} and hafnium 
{Hf(6 10)(O
i
Pr)2} complexes were trialled as initiators for the ROP of rac-lactide in 
solvent free conditions using 1.0 g of lactide at 130 °C. All initiators were used 
without a co-initiator at a 300:1 [rac-lactide]:[initiator] ratio, with selected trials at 
900:1 [rac-lactide]:[initiator] ratio. High conversions were obtained for initiators 
containing ortho methyl or amyl phenoxy substituents {Zr(6-7,10)(O
i
Pr)2, 
Hf(6-7,10)(O
i
Pr)2} after 0.5 hours, whereas initiators with ortho-
t
Bu phenoxy 
substituents {Zr(8-9)(O
i
Pr)2, Hf(8-9)(O
i
Pr)2} required 3 h to obtain high conversion 
(Table 3.04). At the higher rac-lactide to initiator ratios (900:1) the longer reaction 
time of 6 h resulted in partial conversion.  
 The Hf(6-10)(O
i
Pr)2 initiators were relatively consistent with one PLA chain 
per metal. There was some deviation in molecular weight (Mn) from the conversion 
calculated theoretical molecular weights. Moderately low PDI (PDI = 1.12 – 1.39) 
values were obtained with little noted difference between initiators containing ortho-
methyl and ortho-
t
Bu phenoxy substituents, which is contrasting to the related 
solution ROP observations. The solvent free ROP of rac-lactide by Zr(6-10)(O
i
Pr)2 
and Hf(8-10)(O
i
Pr)2 resulted in the production of predominantly atactic PLA (Pr = 
0.44 – 0.56) (Table 3.05). Akin to the solution ROP reactions the ortho-methyl 
phenoxy substituted hafnium complexes {Hf(6-7)(O
i
Pr)2} yielded PLA with a 
moderate isotactic bias (Pr = 0.37 – 0.39), to a similar degree to the lower 
temperature solution ROP of rac-lactide (Pr = 0.35 – 0.37) (Table 3.04).  
 
 148 
 
Time 
(hours) 
Conv. 
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d 
Zr(6)(O
i
Pr)2 0.5 97 42000 45000
 
1.39 0.44 
Zr(7)(O
i
Pr)2 0.5 79 34200 15200 1.17 0.51 
Zr(8)(O
i
Pr)2 3 86 37250 20900 1.22 0.51 
Zr(8)(O
i
Pr)2
 e
 6
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 62300 31950
 e
 1.12
 e
 0.56
 e
 
Zr(9)(O
i
Pr)2 3 89 38550 19300 1.31 0.47 
Zr(10)(O
i
Pr)2 0.5 93 40250 34850 1.26 0.55 
Hf(6)(O
i
Pr)2 0.5 91 39400 47800 1.33 0.37 
Hf(7)(O
i
Pr)2 0.5 96 41550 37150 1.28 0.39 
Hf(8)(O
i
Pr)2 3 87 37700 26000 1.14 0.5 
Hf(8)(O
i
Pr)2
 e
 6
 
 41 53250 28850
 e
 1.15
 e
 0.56
 e
 
Hf(9)(O
i
Pr)2 3 90 39000 35600 1.32 0.5 
Hf(10)(O
i
Pr)2 0.5 83 35950 27400 1.22 0.49 
 
Table 3.05: Solvent free ROP of rac-lactide for Zr(6-10)(OiPr)2 and Hf(6-10)(O
iPr)2  at 130 °C in a 
300:1 [rac-lactide]:[initiator] ratio. a Conversion ascertained by 1H NMR spectroscopy. b Theoretical 
molecular weight calculated from conversion (Conv. × 100 × 144.13 + 60.10) (rounded to the nearest 
50), c Molecular weight and PDI determined by GPC (THF) using polystyrene standards without 
applying a correction factor. d Pr as calculated from 
1H NMR homonuclear decoupled spectroscopy in 
CDCl3. 
e 900:1 [rac-lactide]:[initiator] ratio. 
 
 Independent ROP reactions were performed with Zr(8)(O
i
Pr)2 and 
Hf(8)(O
i
Pr)2 initiators in solvent free conditions. The individual polymerisations 
were allowed to achieve varying conversions, a dual plot of Mn against conversion 
and PDI against conversion is displayed in figure 3.12. The molecular weight growth 
shows a linear increase with conversion as expected for the controlled propagation of 
PLA chains. PDI was plotted against conversion, for the entire range the PDI values 
were low but a slight increase is present as conversion increases. The linear trend of 
molecular weight is indicative of a living polymerisation reaction, although 
transesterification and slowly increasing PDI values with conversion signify 
deviation from an idealistic living polymerisation.  
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Figure 3.12: Mn (squares) and PDI (triangles) vs. conversion, from individual solvent free ROP 
reactions of rac-lactide, at 130 °C, 300:1 [rac-lactide]:[initiator] ratio. Initiators utilised; 
Zr(8)(OiPr)2 (Blue), Hf(8)(O
iPr)2 (Red). 
 
3.5.3 Kinetic investigation of the solution ROP of rac-lactide 
 NMR spectroscopy scale kinetic experiments were performed to investigate 
the apparent rate of propagation (kapp) for the ROP of rac-lactide using the 
homopiperazine salan initiators {Zr(6)(O
i
Pr)2, Hf(6)(O
i
Pr)2}. The NMR spectroscopy 
scale experiments were performed using 50 mg of rac-lactide in d8-toluene (0.6 ml) 
at 80 °C, in both cases a 100:1 [rac-lactide]:[initiator] ratio was used. The kinetic 
experiments were allowed to run until high conversion was obtained. Spectra were 
recorded at 15 min intervals with the initiator Zr(6)(O
i
Pr)2, and at 30 min intervals 
with the initiator Hf(6)(O
i
Pr)2, both cases are truncated due to diffusion rate 
limitations at high conversions. ln([LA]0/[LA]t) was plotted against time (Figure 3.13) 
to present linear plots where the slope relates to the apparent pseudo first order rate 
constant (kapp) (Table 3.06). The zirconium catalyst was ~3 times more active 
towards the ROP of rac-lactide than the related hafnium complex. Zirconium 
Mn – Zr(8)(O
iPr)2 
Mn – Hf(8)(O
iPr)2 
PDI – Zr(8)(OiPr)2 
PDI – Hf(8)(O
i
Pr)2 
M
n
 
Conversion (%) 
P
D
I 
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catalysts have been previously reported as more active than corresponding hafnium 
complexes for the ROP of rac-lactide.
6, 8, 19, 20
 
 
Figure 3.13: Pseudo first order plots for the ROP of rac-lactide by Zr(6)(OiPr)2 (Blue), and 
Hf(6)(OiPr)2 (Red), 50 mg of rac-lactide in 0.6 ml of d8-toluene at 80 °C at 100:1 
[rac-lactide]:[initiator] ratio. 
 
 
kapp × 10
-3
 
(min
-1
)
 R
2
 
Zr(6)(O
i
Pr)2 24.9(11) 0.9928 
Hf(6)(O
i
Pr)2 8.00(2) 0.9956 
 
Table 3.06: kapp values and R
2 values for ROP of rac-lactide by Zr(6)(OiPr)2 and Hf(6)(O
iPr)2 
initiators. 
 
3.6 Conclusion 
 The synthesis and characterisation of zirconium and hafnium complexes 
bearing strained homopiperazine based salan ligands {Zr(6-10)(O
i
Pr)2, 
Hf(6-10)(O
i
Pr)2} is reported herein. Zr(6-7,10)(O
i
Pr)2 and Hf(6-8,10)(O
i
Pr)2 were 
isolated as crystals and characterised by X-ray crystallography, each structure was 
monometallic and adopted a pseudo octahedral trans configuration. An informative 
Zr(6)(O
i
Pr)2.0.5THF.0.5IPA complex was characterised by X-ray crystallography 
Hf(6)(O
i
Pr)2 
 
Zr(6)(O
i
Pr)2 
ln
{[
L
A
] 0
/L
A
] t
} 
Time (mins) 
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where this seven coordinate variant of Zr(6)(O
i
Pr)2 demonstrated a possible 
coordination site a lactide unit could adopt. The synthesis of piperazine salan 
{(1-5,12-15)H2} Zr(IV) and Hf(IV) complexes was attempted but generally a 
plethora of species was obtained and purification of a bulk material was unsuccessful. 
Isolated crystals of Zr4(1)(O
i
Pr)14.(HO
i
Pr)2 and Zr2(15)(O
i
Pr)6 were characterised by 
crystallography showing a tetrametallic structure and an interesting bimetallic 
structure where the ligand chelates to one metal. Consistent bimetallic structures 
were observed for the X-ray determination of Hf2(1,3)(O
i
Pr)6 complexes. The 
difficultly in isolating a monometallic piperazine salan Zr(IV) or Hf(IV) structure 
was attributed to the increased conformational ring strain associated with the 
piperazine backbone in comparison to a homopiperazine backbone. 
 Zr(6-10)(O
i
Pr)2 and Hf(6-10)(O
i
Pr)2 were investigated as initiators for the 
ROP of rac-lactide in solvent free and solution conditions. High conversion was 
typically obtained after 24 h at 80 °C in toluene at a 100:1 [rac-lactide]:[initiator] 
ratio. Higher activity was observed for complexes containing ortho-methyl phenoxy 
substituents over the sterically bulky ortho-
t
Bu phenoxy substituents. An 
isopropoxide moiety was identified by MALDI-TOF mass spectrometry as the chain 
end group, which supports a coordination insertion mechanism. Good molecular 
weight control was observed but a degree of transesterification was identified via 
MALDI-TOF mass spectrometry. An isotactic bias (Pr = 0.35 – 0.5) was generally 
observed for these complexes which was enhanced for complexes bearing 
ortho-methyl phenoxy substituents (Pr = 0.35 – 0.42). Hf(6,7)(O
i
Pr)2 resulted in a 
small increase in stereoselectivity over Zr(6,7)(O
i
Pr)2 complexes. The solvent free 
ROP was conducted at 130 °C at a 300:1 [rac-lactide]:[initiator] ratio. 
Zr(6,7,10)(O
i
Pr)2 and Hf(6,7,10)(O
i
Pr)2 achieved high conversion after 0.5 h, where 
as the ortho-
t
Bu phenoxy containing complexes {Zr(8,9)(O
i
Pr)2, Hf(8,9)(O
i
Pr)2} 
required 3 h to obtain appreciable conversion. Lower molecular weights were 
obtained for the solvent free ROP of rac-lactide experiments where the increased 
thermal conditions activate both isopropoxides for the initiation of PLA chain growth. 
Controlled molecular weight growth was demonstrated with increasing conversion 
with minimal increase in PDI, this supports a chain-end control mechanism. NMR 
spectroscopy scale kinetic investigations resulted in pseudo first order apparent rate 
constants for Zr(6)(O
i
Pr)2 and Hf(6)(O
i
Pr)2 from which the zirconium complex was 
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demonstrated as approximately three times more active than its direct hafnium 
analogue for the ROP of rac-lactide.  
 
3.7 Future Work 
 The piperazine hafnium solid-state structures {Hf2(1,3)(O
i
Pr)6} show promise 
and further-work could be conducted into isolating these as pure materials, although 
extensive efforts were made. Variation of the homopiperazine salan ligands could be 
conducted particularly in the area of halide phenoxy substituents (Cl, Br) to ascertain 
their effect upon complexes and consequently the ROP of rac-lactide. Further-work 
into unsymmetrical homo/piperazine salan ligand sets could be attempted where 
substituents on each phenol are different. The effect of conformational hindered 
(6/7 membered ring backbones) diamine bridging groups upon salan complexes was 
conducted and future work could include 8 membered bridging ring groups 
(Figure 3.14). 
 
 
Figure 3.14: 8 membered ring diamines. 
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Chapter 4 
 
 
 
4. Aluminium (III) Homopiperazine Salan Complexes and 
Their Application for the ROP of Cyclic Esters. 
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4. Aluminium (III) Homopiperazine Salan Complexes and 
Their Application for the ROP of Cyclic Esters. 
4.1 Introduction 
 Aluminium tetradentate -(ONNO)- bis(phenoxy) complexes have been 
previously investigated as ROP initiators for lactide.
1
 Specifically aluminium diimine 
bis(phenoxy) (salen) complexes have seen much use for the ROP of lactide 
throughout the past few decades,
2-6
 many of which produce isotactic PLA or isotactic 
biased PLA. These stereoselective initiators typically required a time scale of days 
for appreciable conversion to be obtained. Whereas good control over molecular 
weight and stereoselectivity was observed in solution, a strong degree of isotactic 
stereoselectivity was retained in solvent free conditions for aluminium complexes 
supported by bis(phenol) ligands containing 1,2-diaminocyclohexane (1,2-DACH) 
and (NCH2CMe2CH2N) linkers.
5
   
 Aluminium diamine bis(phenoxy) (salan) complexes have also been 
previously investigated as initiators for the ROP of lactide (Figure 4.01).
7, 8
 Many 
aluminium salan complexes contain alkyl initiating groups and hence a co-initiator 
(typically an alcohol) is often introduced to the polymerisation. The aluminium salan 
complexes (Figure 4.01) gave varying stereoselectivities ranging between a strong 
isotactic bias to heterotactic (Pr = 0.21 – 0.96).
7
 An isotactic bias was reported when 
R2 = H and a heterotactic bias was reported when R2 = Me, 
t
Bu, or Cl, where the Cl 
subsistent resulted in the strongest heterotactic selectivity.  
 
 
 
Figure 4.01: Aluminium diamine bis(phenoxy) (aluminium salan) complexes investigated for the 
ROP of lactide.7 
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 Piperazine salan group 4 complexes for the ROP of rac-lactide have been 
previously reported and are discussed in chapters 3 and 4 of this thesis.
9, 10
 
Furthermore aluminium piperazine salan complexes were initially synthesised by 
Fulton et al.
11
 who reported the synthesis of bimetallic and monometallic structures. 
The same piperazine ligand was utilised throughout the study and the monodentate 
aluminium substituents were varied.
11
 The complexes were trialled as initiators for 
the ROP of lactide under solution conditions and were reported as inactive, although 
these complexes were reported as active initiators for the ROP of ε-caprolactone 
(Figure 4.02).
11
 Yao et al.
12
 reported similar bimetallic aluminium salan complexes 
and their high activity towards the ROP of ε-caprolactone at high monomer to 
initiator ratios. Molecular weights were shown to be dependent upon benzyl alcohol 
co-initiator concentration, whilst high molecular weights were obtained a range of 
PDI (distribution of molecular weights) values were also reported (PDI = 1.19 - 2.01). 
The ROP of ε-caprolactone was also investigated using monometallic aluminium 
piperazine salan derivatives developed by Yao et al.
13
 While active initiators for the 
ROP of ε-caprolactone the monometallic aluminium initiators were significantly less 
active than their bimetallic counterparts. The monometallic aluminium piperazine 
salan initiators gave greater control over the ROP of ε-caprolactone resulting in 
lower PDI values (PDI = 1.17 - 1.52). 
 
 
Figure 4.02: Aluminium piperazine salan complexes investigated for the ROP of cyclic esters.11-13 
 
 Prior investigations of piperazine salan and homopiperazine salan ligands 
complexed to group 4 metals (Chapter 2, and 3) revealed the two ligand sets can 
coordinate in differing manners.
9, 10
 Herein the benzyloxy derivatives of aluminium 
methyl homopiperazine salan complexes were synthesised and their ROP activity for 
lactide, ε-caprolactone and δ-valerolactone is reported. 
 
 157 
4.2 Synthesis of Aluminium Homopiperazine Salan Complexes 
 
 
Figure 4.03: Reaction scheme for the synthesis of homopiperazine salan methyl aluminium 
complexes. 
 
 The homopiperazine ligands synthesised and discussed in chapter 2 
(Figure 2.02) were complexed to AlMe3, Conrad Langridge is acknowledged for his 
contribution to the development of these complexes.
14
 The addition of aluminium 
was conducted at elevated temperature (50 °C) until the initial effervescence had 
slowed, at which point the temperature was increased (80 °C) to ensure complete 
reaction (Figure 4.03). The thermally energetic conditions were required to 
kinetically facilitate the homopiperazine ring formation of the boat type 
configuration. The aluminium complexes were recrystallised from toluene and 
hexane solvent mixtures, using thermal and diffusion based recrystallisation methods. 
Crystals suitable for X-ray diffraction were obtained for Al(7,8,11)Me. Attempts to 
synthesise aluminium complexes using 10H2 were unsuccessful presumably an 
artefact of the increased steric demands of the ortho-phenoxy ring amyl substituents. 
The complexes Al(6-9,11)Me were characterised by 
1
H/
13
C{
1
H} NMR spectroscopy 
and CHN analysis, in all cases the complexes were consistent with the solid-sate 
structures.  
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 Figure 4.04: Reaction scheme detailing the synthesis of homopiperazine salan benzyloxy aluminium 
complexes. 
 
 Aluminium methyl complexes typically require a co-initiator, normally an 
alkoxide, to enhance their properties as initiators for the ROP of cyclic esters. The 
direct incorporation of a co-initiating benzyl alcohol (BnOH) was attempted and the 
presumably active initiating species containing benzyloxy aluminium bound 
substituents were isolated. Firstly, the synthesis of a homopiperazine complex 
{Al(6-9,11)Me} was conducted and the complex rapidly purified by addition of 
hexane to a toluene solution. An excess of benzyl alcohol (3-5 equivalents) was 
required to fully substitute the aluminium bound methyl groups (Figure 4.04). 
Despite the use of excess benzyl alcohol at elevated temperature (70-80 °C) 
prolonged reaction times were required to ensure complete conversion of 
Al(6-9,11)Me to Al(6-9,11)OBn (Figure 4.04). High conversion was required as 
purification of Al(6-9,11)OBn in the presence of Al(6-9,11)Me impurities was 
difficult. The complexes were purified by recrystallisation from toluene and hexane 
mixes but no crystals suitable for X-ray diffraction were obtained. Hexane washes 
and toluene/hexane crystallisation was conducted to ensure the complete removal of 
benzyl alcohol. The complexes were isolated and characterised by 
1
H/
13
C{
1
H} NMR 
spectroscopy and CHN analysis. 
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4.3 Solid-state characterisation by X-ray crystallography 
Aluminium homopiperazine salan complexes Al(7)Me, Al(8)Me, and 
Al(11)Me were characterised by X-ray crystallography; Al(8)Me crystals were 
initially obtained by Conrad Langridge as part of the Jones group.
14
 Similar 
aluminium piperazine based salan structures determined by X-ray crystallography 
were reported by Fulton et al.
11
 and Yao et al.
13
 The crystallographic determined 
structures are specifically compared with the literature structures; Al(3)Me 
(R1 = R2 = 
t
Bu)
11
 and Al(4)Et (R1 = 
t
Bu, R2 = Me).
13
 
 
 
Figure 4.05: Solid-state structures for a single disordered crystal where two structures were obtained; 
a) Al(8)Me cis-(CH2CH2)-, b) Al(8)Me cis-(CH2CH2CH2)-. Ellipsoids are shown at the 30 % 
probability level, hydrogen atoms have been removed for clarity.14 
a) 
b) 
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 The crystal structure for Al(8)Me was solved with a significant degree of 
disorder about the homopiperazine ring. The homopiperazine ring disorder could be 
extrapolated to generate two isomers which were present in the unit cell in a 50:50 
ratio. One structure has the aluminium bound methyl orientated cis to 
the -(CH2CH2)- moiety of the homopiperazine ring (Figure 4.05a), the alternative 
structure has the aluminium bound methyl cis to the -(CH2CH2CH2)- homopiperazine 
ring moiety (Figure 4.05b). Selected bond lengths (Å) and angles (°) for both 
Al(8)Me structures alongside other aluminium homopiperazine salan structures are 
given in table 4.01. Both Al(8)Me isomers are five coordinate, the Al(8)Me 
cis-(CH2CH2)- structure adopts a pseudo square pyramidal structure with a τ value of 
0.08
15
 (square pyramidal τ = 0, trigonal bipyramidal τ = 1).15 The Al(8)Me structure 
where the methyl was cis to the -(CH2CH2CH2)- homopiperazine moiety is 
indeterminate between a square pyramidal geometry and a trigonal bipyramidal 
structure with a τ value of 0.50.  
 
Table 4.01: Selected bond lengths (Å) and angles (°) for piperazine salan aluminium complexes, as 
determined by X-ray crystallography. a methyl orientated cis to -(CH2)2- homopiperazine ring group, 
b methyl orientated cis to -(CH2)3- homopiperazine ring group. 
 
 Al(7)Me Al(8)Me
a
 Al(8)Me
b
 Al(11)Me 
Al1-C1 1.980(3) 1.980(3) 1.960(5) 1.962(7) 
Al1-O1 1.7873(19) 1.7873(19) 1.798(3) 1.784(4) 
Al1-O2 1.7975(18) 1.7975(18) 1.768(2) 1.796(5) 
Al1-N1 2.132(2) 2.188(7) 2.077(5) 2.108(5) 
Al1-N2 2.108(2) 2.07(2) 2.171(18) 2.103(5) 
O1-Al1-O1 91.79(9) 91.79(9) 89.90(13) 90.1(2) 
N1-Al1-N2 73.74(8) 70.5(8) 76.1(7) 74.56(19) 
O1-Al1-C1 114.29(13) 114.29(13) 104.6(2) 111.6(3) 
O2-Al1-C1 106.86(12) 106.86(12) 116.85(16) 107.6(3) 
N1-Al1-C1 100.09(12) 96.7(3) 117.6(2) 101.8(3) 
N2-Al1-C1 103.63(12) 105.3(9) 99.2(7) 103.3(3) 
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Al(8)Me the Al1-C1 bonds (1.960 – 1.980 Å) are of a similar distance to the 
analogous bonds lengths reported for Al(3)Me {1.974(3) Å}
11
 and Al(4)Et 
{2.004(4) Å}.
13
 A significant difference in bond length can be observed between the 
two aluminium phenoxy bonds (Al1-O1, Al1-O2} of the Al(8)Me structures, 
additionally a distinct difference was observed between the aluminium amine bonds 
lengths (Al1-N1, Al1-N2). Similarly a significant difference between analogous bond 
lengths was reported for the literature structures Al(3)Me
11
 and Al(4)Et.
13
 This 
inherent asymmetry is supported through the bond angles between 
C1-Al1-O1/C1-Al1-O2 and C1-Al1-N1/C1-Al1-N2 (Table 4.01).  
 
 
 
Figure 4.06: Solid-state structures a) Al(7)Me, and b) Al(11)Me Ellipsoids are shown at the 30 % 
probability level, hydrogen atoms have been removed for clarity. 
 
a) 
b) 
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 The X-ray crystallographically determined structures for Al(7)Me and 
Al(11)Me are depicted in figure 4.06, selected bond lengths and angles are given in 
table 4.01. Both structures adopted the geometry where the aluminium bound methyl 
was orientated cis to the -(CH2CH2)- homopiperazine moiety. The complexes are 
five coordinate and adopt a distorted square pyramidal geometry {Al(7)Me; τ = 0.18, 
Al(11)Me; τ = 0.09}. The Al(11)Me structure was less distorted from the idealistic 
square pyramidal structure, presumably an artefact of the less sterically bulky 
ortho-phenoxy hydrogen substituents. The aluminium phenoxy bonds (Al1-O1, 
Al1-O2) and aluminium amine bonds (Al1-N1, Al1-N2) were significantly different 
for Al(7)Me, contrastingly the analogous bonds of Al(11)Me are statistically the 
same length. Both structures displayed significant variation between the 
C1-Al1-O1/C1-Al1-O2 and C1-Al1-N1/C1-Al1-N2 angles. 
 
 
Figure 4.07: Solid-state space-filling structures showing van der Waals radii, a) Al(7)Me b) Al(8)Me 
(cis -(CH2CH2)-) c) Al(11)Me. 
a) 
b) 
c) 
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 The two phenyl rings of Al(7,11)Me structures are both orientated away from 
the aluminium bound methyl moieties to a similar degree (Figure 4.07a,c). Whilst the 
Al(8)Me complex demonstrates a puckered orientation of the phenyl rings. This 
configuration is presumably a consequence of the sterically bulky ortho-
t
Bu 
substituents, the puckered and steric nature is demonstrated by space filling diagrams 
based on van der Waals radii in figure 4.07. The aluminium metal centre is also 
appreciably contained by the coordinated substituents.  
 
4.4 Computational Investigation 
 To investigate the two isomers for Al(8)Me, quantum mechanical 
calculations were performed using the ORCA electronic structure program.
16
 The 
crystallographically determined structures for Al(8)Me cis-(CH2CH2)-, and Al(8)Me 
cis-(CH2CH2CH2)- were initially optimised via TightSCF conversion calculations. 
Initial calculations utilised the BP86
17, 18
 functional with RI
19, 20
 approximation using 
the def2-svp
21
 basis set. The structures were further refined iteratively by the 
B3LYP
22, 23
 functional with the RIJCOSX
24
 algorithm; firstly using the def2-svp 
basis set and finally the def2-TZVPP
25
 basis set. Empirical van der Waals corrections 
(VDW)
26
 were applied alongside COSMO
27
 solvent effects at infinite dielectric 
constant to more closely emulate solvated conditions. A 1.3 kcal mol
-1
 energy 
difference between the structurally optimised final single point energies was 
observed, at this degree of computational accuracy this energy disparity is not 
considered significant. The Al(8)Me (cis -(CH2CH2)-) complex was the favourable 
conformation although it is possible to isolate both structures in a crystal 
environment, which is consistent with a small energy disparity.  
 
4.5 Characterisation by NMR Spectroscopy 
 The aluminium homopiperazine salan complexes Al(6-9,11)Me, and 
Al(6-9,11)OBn were characterised by 
1
H and 
13
C{
1
H} NMR spectroscopy. Room 
temperature spectroscopy resulted in broad resonances in the CH2 region of the 
Al(6-9,11)Me 
1
H NMR spectra. A 
1
H NMR spectrum for Al(8)Me is given in 
figure 4.08. The majority of CH2 related resonances are shown in the truncated 
spectra of Al(8)Me where a distinctive sharpening of the resonances is observed 
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upon cooling of the complex in solution (d8-toluene). At high temperature it is not 
possible to distinguish between axial and equatorial protons for the CH2 ring groups, 
due to the highly fluxional nature on the NMR timescale. Axial and equatorial CH2 
proton resonances become independent signals upon cooling (Figure 4.08), an 
artefact of conformation locking of the complexes under less thermally energetic 
conditions. Al(8)Me was characterised by X-ray crystallography as two geometric 
configurations, where the aluminium bound methyl was either cis to the -CH2CH2- or 
-CH2CH2CH2- homopiperazine ring groups (Figure 4.05). The isomers isolated are 
dependent upon the crystallisation conditions. The presence of two conformations in 
the solution-state was an isolated case for the Al(8)Me crystals. Further synthetic 
attempts of Al(8)Me synthesis resulted in the formation of a single isomer, best 
represented by a single Al-Me proton resonance. The two isomers do not appear to 
interconvert upon heating in solution. A single isomer was characterised by NMR 
spectroscopy for complexes Al(7-9)Me, however Al(6)Me was isolated as both 
isomers due to two Al-Me resonances being observed.  
        2.42.52.62.72.82.93.03.13.23.33.43.53.63.73.83.94.04.1 ppm 
Figure 4.08: Variable temperature 1H NMR spectra showing the methylene region for Al(8)Me 
233K (bottom) ranging 20 K intervals to 353 K. 
 
 Benzyl alcohol derivatives Al(6-9,11)OBn of Al(6-9,11)Me were 
characterised by NMR spectroscopic methods. The complete disappearance of the 
aluminium bound methyl proton resonances required prolonged elevated temperature 
conditions and excess benzyl alcohol. Ambient conditions or stoichiometric 
233 K 
253 K 
273 K 
293 K 
313 K 
333 K 
353 K 
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quantities of BnOH yielded mixtures of Al(6-9,11)OBn and Al(6-9,11)Me, unusual 
considering the high reactivity of aluminium methyl groups and the entropically 
favourable evolution of methane. A distinctive resonance at ~5 ppm was attributed to 
the CH2 protons of an aluminium bound benzyloxy ligand. Stringent purification was 
required to ensure uncoordinated BnOH was removed from the compound. The 
complex Al(8)OBn (Figure 4.09) was significantly less fluxional at room 
temperature than the Al(8)Me complex. The aromatic region becomes more defined 
at reduced temperatures, overlap with solvent peaks complicated the analysis of this 
region.  
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Figure 4.09: 1H NMR spectra for Al(8)OBn, Top 298 K, Bottom 233 K. 
 
4.6 Investigation of the ROP of Cyclic-Esters 
 Prior aluminium piperazine salan complexes have been investigated for 
solution ROP of rac-lactide and were shown to be unsuccessful initiators.
11
 Further 
solution ROP reactions of ε-caprolactone have been conducted and aluminium 
piperazine salan complexes were proven to be active initiators.
11-13
 The ROP of the 
cyclic esters; rac-lactide, ε-caprolactone, and δ-valerolactone (Figure 4.10) by 
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aluminium homopiperazine salan initiators Al(6-9,11)OBn is herein reported. A 
focus upon the environmentally favourable solvent free ROP conditions was 
conducted to complement the prior literature solution ROP reported for similar 
structures.
11-13
 The initiators with coordinated benzyloxy derivatives {Al(6-9,11)OBn} 
were utilised in preference to the aluminium methyl analogues {Al(6-9,11)Me} to 
remove in-situ co-initiator complications. The synthesis of the benzyloxy aluminium 
complexes Al(6-9,11)OBn from Al(6-9,11)Me was challenging, hence the 
assumption of rapid coordination and generation of the active alkoxide species in-situ 
was not possible. Additionally these initiators were trialled for co-polymerisation 
reactions with the aforementioned cyclic-ester monomers. 
 
Figure 4.10: Synthetic schemes depicting the ROP of lactide, ε-caprolactone, and δ-valerolactone 
including their resulting polymers. 
 
4.6.1 Investigation of the ROP of rac-lactide 
 The aluminium alkyl initiators Al(6-9,11)Me were initially trialled in solution 
(toluene) at 80 °C, with benzyl alcohol as a co-initiator, for the ROP of rac-lactide 
but no signs of the formation of polymer were observed. The low activity in solvent 
at 80 °C was thought to be linked to the difficultly of substituting a benzyl alcohol 
group into the aluminium coordination sphere, thus the formation the in-situ initiator 
is restricted. This observation was extrapolated as an indication of the difficult 
coordination of a rac-lactide monomer to the aluminium centre. The benzyloxy 
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aluminium complexes Al(6-9,11)OBn were investigated as initiators for the ROP of 
rac-lactide in solvent free conditions at 130 °C. Respectable conversions were 
obtained under these conditions after 2 h, although Al(11)OBn resulted in a reduced 
conversion (Table 4.02). Molecular weights (Mn) were typically higher than expected 
for the formation of one PLA chain per metal centre; this is supposedly a product of 
low rate of initiation relative to the rate of propagation. The exception is Al(11)OBn 
which resulted in lower molecular weight PLA than expected, a consequence of 
reduced steric demands about the metal centre. Only moderate control over the PLA 
molecular weights (Mn) was observed with PDI values ranging between 1.08 – 1.42. 
The resulting PLA was slightly heterotactic (Pr = 0.53 – 0.57) with a stronger bias 
observed for initiators with ortho-
t
Bu substituents (Pr = 0.57). 
 
 
Time 
(hours) 
Conv. 
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d
 
Al(6)OBn 2 87 37750 42100 1.42 0.54 
Al(7)OBn 2 81 35150 56400 1.40 0.55 
Al(8)OBn 2 87 37750 54400 1.31 0.57 
Al(9)OBn 2 88 38150 58200 1.40 0.57 
Al(11)OBn 2 56 24300 16800 1.08 0.53 
 
Table 4.02: Solvent free ROP of rac-lactide for Al(6-9,11)OBn at 130 °C in a 300:1 
[rac-lactide]:[initiator] ratio. a Conversion ascertained by 1H NMR spectroscopy. b Theoretical 
molecular weight calculated from conversion (Conv. × 300 × 144.13 + 108.14) (rounded to the nearest 
50), c Molecular weight and PDI determined by GPC (THF) using polystyrene standards without 
applying a correction factor. d Pr as calculated from 
1H NMR homonuclear decoupled spectroscopy in 
CDCl3. 
 
4.6.2 Investigation of the ROP of ε-caprolactone 
 The ROP of ε-caprolactone was conducted in solvent free conditions at 
130 °C, in a 300:1 [ε-caprolactone]:[initiator] ratio using the benzyloxy aluminium 
initiators {Al(6-9,11)OBn}. High conversions were obtained after 30 mins, with the 
exception of Al(9)OBn (Table 4.03). Conversion was calculated from the 
1
H NMR 
spectra methylene proton resonances Ha (monomer) and Hb (polymer) at 4.20 and 
4.03 ppm respectively (Figure 4.11). The high relative activity when compared to 
rac-lactide is consistent with literature which reported inactivity of similar piperazine 
 168 
aluminium complexes towards lactide and high activity towards ε-caprolactone.11 
The molecular weights (Mn) were consistent for high conversion polymers 
(Conv. > 90%), albeit higher then expected. This is indicative of a slow initiation 
step compared to the rate of propagation or not all of the aluminium centres initiate 
PCL chain growth. Al(11)OBn resulted in a lower molecular weight polymer, which 
was similarly observed for the ROP of rac-lactide investigation (See section 4.6.1). 
Similarly moderate molecular chain length control was observed with PDI values 
ranging from 1.15 – 1.63.  
 
 
Table 4.03: Solvent free ROP of ε-caprolactone for Al(6-9,11)OBn at 130 °C in a 300:1 
[ε-caprolactone]:[initiator] ratio. a Conversion ascertained by 1H NMR spectroscopy. b Theoretical 
molecular weight calculated from conversion (Conv. × 300 × 114.14 + 108.14) (rounded to the nearest 
50), c Molecular weight and PDI determined by GPC (THF) using polystyrene standards without 
applying a correction factor. 
  
 
Figure 4.11: 1H NMR spectra (CDCl3) for the ROP conversion of ε-caprolactone to 
poly(ε-caprolactone) using the initiator Al(11)OBn. 
 
Time 
(hours) 
Conv. 
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Al(6)OBn 0.5 94 32300 54100 1.42 
Al(7)OBn 0.5 94 32300 71900 1.63 
Al(8)OBn 0.5 97 33300 73100 1.54 
Al(9)OBn 0.5 30 10400 11400 1.15 
Al(11)OBn 0.5 83 28550 25800 1.48 
3.853.903.954.004.054.104.154.204.254.304.35 ppm
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4.6.3 Investigation of the ROP of δ-valerolactone 
 Homopiperazine salan aluminium benzyloxy initiators were utilised for the 
ROP of δ-valerolactone in solvent free conditions at 130 °C, at a 300:1 
[δ-valerolactone]:[initiator] ratio (Table 4.04). High conversion was obtained for the 
majority of initiators after 1 h with Al(9)OBn yielding lower conversion, similarly 
observed with caprolactone. Also Al(11)OBn resulted in a slightly lower conversion, 
an observation consistent with the ROP of rac-lactide and caprolactone. The 
conversions are calculated from the 
1
H NMR spectra methylene proton resonances 
Ha (monomer) and Hb (polymer) (Figure 4.12), 4.31 and 4.05 ppm respectively. The 
determined molecular weights (Mn) were consistent across Al(6-9)OBn initiators, the 
obtained molecular weight were somewhat consistent with one polymer chain being 
propagated by each metal centre. Similarly previously discussed ROP investigations 
of Al(11)OBn also resulted in lower than expected molecular weights. It was 
speculated that the lower steric demands of Al(11)OBn was allowing the propagation 
of more than one valerolactone chain. The molecular chain length distributions were 
moderately high with PDI values ranging between 1.12 – 1.77.  
 
 
Table 4.04: Solvent free ROP of δ-valerolactone for Al(6-9,11)OBn at 130 °C in a 300:1 
[δ-valerolactone]:[initiator] ratio. a Conversion ascertained by 1H NMR spectroscopy. b Theoretical 
molecular weight calculated from conversion (Conv. × 300 × 100.12 + 108.14) (rounded to the nearest 
50), c Molecular weight and PDI determined by GPC (THF) using polystyrene standards without 
applying a correction factor. 
 
 
 
Time 
(hours) 
Conv. 
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Al(6)OBn 1 90 27150 39600 1.50 
Al(7)OBn 1 94 28350 33000 1.54 
Al(8)OBn 1 88 26550 24800 1.77 
Al(9)OBn 1 31 9400 10100 1.12 
Al(11)OBn 1 81 24450 16000 1.25 
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Figure 4.12: 
1
H NMR spectra (CDCl3) for the ROP conversion of δ-valerolactone to 
poly(δ-valerolactone) using the initiator Al(8)OBn. 
 
4.6.4 Investigation of co-polymerisations of cyclic-esters 
 Co-polymer investigations were trialled using these aluminium benzyloxy 
homopiperazine salan complexes as initiators Al(6-9,11)OBn. All ROP reactions 
were conducted in an inert atmosphere environment at 130 °C in solvent free 
conditions. Direct ROP attempts of rac-lactide/ε-caprolactone or 
rac-lactide/δ-valerolactone mixes were not successful with no polymerisation being 
observed. The sequential addition of monomers to complete reactions led to high 
conversion of each sequential monomer given time for each monomer to polymerise. 
The insertion of a ε-caprolactone/δ-valerolactone monomer into an Al-PLA linkage 
did not occur hence the sequential polymerisations starting with rac-lactide were not 
successful. It should be noted that the presence of un-reacted monomer from the 
prior step has a detrimental effect upon the subsequent ROP steps.  
 Sequential tri-block poly-esters were synthesised using Al(7-9)OBn initiators, 
the polymer sequence followed ε-caprolactone/δ-valerolactone/rac-lactide. Each 
monomer was present in 100:1 ratio of [monomer]:[initiator] and the time allowed 
for each addition was 0.5 h/1 h/2 h to obtain high conversion for each subsequent 
step (Table 4.05). Al(8)OBn gave high conversion of each subsequent monomer, 
conversion was calculated from the 
1
H NMR spectra (CDCl3). The conversion of 
Ha 
Hb 
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rac-lactide was calculated by direct comparison of the monomer/polymer methine 
resonances. The poly(ε-caprolactone), and poly(δ valerolactone) resonances 
(4.03 ppm and 4.05 ppm respectively) used for calculation of conversion overlap, the 
conversion was calculated from the monomer and polymer integrals with the 
assumption that the total amount of methylene (Ha/Hb) protons of each monomer 
were in a 50:50 ratio. Al(7)OBn resulted in good conversion of both ε-caprolactone 
and δ-valerolactone but not rac-lactide. Al(9)OBn was comparatively poorly active 
towards caprolactone and valerolactone this is followed within the tri-block 
polymerisation results. The ROP of rac-lactide still proceeded with Al(9)OBn 
initiator with no detrimental effect observed for the presence of ε-caprolactone and 
δ-valerolactone monomer. The tri-block polyester molecular weights (Mn) were 
consistent with the expected values through comparison with homopolymer ROP 
data (table 4.02, 4.03, 4.04). The molecular weight values are much higher than 
expected for 100:1 homopolymer conversions indicative of the formation of 
co-polymers. The GPC traces were also unimodal demonstrating the formation of 
co-polymers over multiple homopolymers.  
 
 
 
 
 
Table 4.05: Sequential solvent free ROP of ε-caprolactone/δ-valerolactone/rac-lactide for 
Al(7-9)OBn at 130 °C in a 100:100:100:1 [ε-caprolactone]:[δ-valerolactone]:[rac-lactide]:[initiator] 
ratio. a Conversion ascertained by 1H NMR spectroscopy. b Molecular weight and PDI determined by 
GPC (THF) using polystyrene standards without applying a correction factor. 
 
4.7 Conclusion 
 Aluminium methyl homopiperazine salan complexes Al(6-9,11)Me have 
been synthesised and characterised by NMR spectroscopy, X-ray crystallography, 
and CHN elemental analysis. X-ray crystallography indentified pseudo square based 
pyramidal monometallic structures for Al(7,8,11)Me. Two configurations were 
 
Time 
(hours) 
Conv. 
(%)
a Mn
b 
PDI
b 
Al(7)OBn 0.5/1/2 99/95/17 47800 1.76 
Al(8)OBn 0.5/1/2 99/95/98 42400 1.66 
Al(9)OBn 0.5/1/2 88/43/64 29500 1.63 
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identified for Al(8)Me one where the aluminium bound methyl was cis to 
the -(CH2CH2)- homopiperazine group, and one where the aluminium bound methyl 
was cis to the -(CH2CH2CH2)- homopiperazine ring group. The majority of 
complexes were isolated where methyl was cis to the -(CH2CH2)- homopiperazine 
ring segment. Structural optimisation calculations were preformed and revealed a 
slight preference for the Al(8)Me cis -(CH2CH2)- structure, with a final point energy 
difference of 1.3 kCal mol
-1
. The complexes were typically indentified in solution as 
a single isomer and were found to be structurally stable at higher temperatures.  
Direct isolation of the commonly assumed in-situ aluminium benzyloxy 
complexes Al(6-9,11)OBn was achieved and their characterisation by NMR 
spectroscopy discussed. The Al(6-9,11)OBn complexes were shown to be highly 
active initiators for the production of homopolymers by a ROP mechanism for 
rac-lactide, ε-caprolactone, and δ-valerolactone. The ROP of the cyclic esters was 
conducted at 130 °C at a 300:1 [monomer]:[initiator] ratio in solvent free conditions. 
The ROP of rac-lactide achieved 56-88 % conversion after 2 h and resulted in 
predominantly atactic PLA. ε-Caprolactone attained 30-97 % conversion after 
30 mins and δ-valerolactone attained 31-94 % conversion after 1 h. The molecular 
weights determined by GPC (THF) were typically higher than expected, presumably 
not all of the aluminium initiators were initiating a polymerisation. Investigations 
into co-polymer synthesis were conducted and the formation of sequential co-block 
polyesters was achieved, up to tri-block polyesters of poly(ε-caprolactone/ 
δ-valerolactone/rac-lactide). 
 
4.8 Future Work 
 Further derivatives of homopiperazine salan ligands could be synthesised 
with an emphasis of varying the electronic effect of the phenol rings using halide 
substituents. Investigating an 8 membered diamine ring bridging group is another 
interesting variation upon this ligand set. Further investigations into solution 
polymerisations could be conducted to elucidate the ROP mechanism. Indium has 
proved a promising candidate for the ROP of lactide.
28-31
 Indium is a promising 
metal for coordination to homo/piperazine salan ligands due to its relation to 
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aluminium. It would be interesting to compare the reactivity of indium piperazine 
salan complexes. 
 
4.9 References 
1. P. J. Dijkstra, H. Du and J. Feijen, Polym. Chem., 2011, 2, 520-527. 
2. N. Spassky, M. Wisniewski, C. Pluta and A. Le Borgne, Macromol. Chem. 
Phys., 1996, 197, 2627-2637. 
3. N. Nomura, R. Ishii, M. Akakura and K. Aoi, J. Am. Chem. Soc., 2002, 124, 
5938-5939. 
4. N. Nomura, R. Ishii, Y. Yamamoto and T. Kondo, Chem. Eur. J., 2007, 13, 
4433-4451. 
5. Z. Zhong, P. J. Dijkstra and J. Feijen, Angew. Chem., Int. Ed., 2002, 41, 
4510-4513. 
6. Z. Zhong, P. J. Dijkstra and J. Feijen, J. Am. Chem. Soc., 2003, 125, 11291-
11298. 
7. P. Hormnirun, E. L. Marshall, V. C. Gibson, A. J. P. White and D. J. 
Williams, J. Am. Chem. Soc., 2004, 126, 2688-2689. 
8. H. Du, A. H. Velders, P. J. Dijkstra, J. Sun, Z. Zhong, X. Chen and J. Feijen, 
Chem. Eur. J., 2009, 15, 9836-9845. 
9. S. L. Hancock, M. F. Mahon and M. D. Jones, Dalton Trans., 2011, 40, 2033-
2037. 
10. S. L. Hancock, M. F. Mahon, G. Kociok-Kohn and M. D. Jones, Eur. J. Inorg. 
Chem., 2011, 4596-4602. 
11. N. C. Johnstone, E. S. Aazam, P. B. Hitchcock and J. R. Fulton, J. 
Organomet. Chem., 2010, 695, 170-176. 
12. W. Li, W. Wu, Y. Wang, Y. Yao, Y. Zhang and Q. Shen, Dalton Trans., 
2011, 40, 11378-11381. 
13. W. Li, Y. Yao, Y. Zhang and Q. Shen, Chin. J. Chem., 2012, 30, 609-615. 
14. S. L. Hancock, M. D. Jones, C. J. Langridge and M. F. Mahon, New J. Chem., 
2012, 36, 1891-1896. 
15. M.-A. Munoz-Hernandez, T. S. Keizer, P. Wei, S. Parkin and D. A. Atwood, 
Inorg. Chem., 2001, 40, 6782-6787. 
16. F. Neese, ORCA, Version 2.8.0, (2011) Universita  t Bonn. 
17. A. D. Becke, Phys. Rev. A, 1988, 38, 3098-3100. 
18. J. P. Perdew, Phys. Rev. B, 1986, 33, 8822-8824. 
19. K. Eichkorn, O. Treutler, H. Ohm, M. Haser and R. Ahlrichs, Chem. Phys. 
Lett., 1995, 240, 283-289. 
20. F. Weigend, M. Haser, H. Patzelt and R. Ahlrichs, Chem. Phys. Lett., 1998, 
294, 143-152. 
21. A. Schafer, H. Horn and R. Ahlrichs, J. Chem. Phys., 1992, 97, 2571-2577. 
22. C. T. Lee, W. T. Yang and R. G. Parr, Phys. Rev. B, 1988, 37, 785-789. 
23. A. D. Becke, J. Chem. Phys., 1993, 98, 5648-5652. 
24. F. Neese, F. Wennmohs, A. Hansen and U. Becker, Chem. Phys., 2009, 356, 
98-109. 
25. F. Weigend and R. Ahlrichs, Phys. Chem. Chem. Phys., 2005, 7, 3297-3305. 
26. S. Grimme, J. Comput. Chem., 2006, 27, 1787-1799. 
 174 
27. S. Sinnecker, A. Rajendran, A. Klamt, M. Diedenhofen and F. Neese, J. Phys. 
Chem. A, 2006, 110, 2235-2245. 
28. A. Pietrangelo, M. A. Hillmyer and W. B. Tolman, Chem. Commun., 2009, 
2736-2737. 
29. A. F. Douglas, B. O. Patrick and P. Mehrkhodavandi, Angew. Chem., Int. Ed., 
2008, 47, 2290-2293. 
30. M. Normand, V. Dorcet, E. Kirillov and J.-F. Carpentier, Organometallics, 
2013, 32, 1694-1709. 
31. M. P. Blake, A. D. Schwarz and P. Mountford, Organometallics, 2011, 30, 
1202-1214. 
 
 
 175 
 
 
 
 
Chapter 5 
 
 
 
5. Titanium (IV) and Aluminium (III) trans-1,4-DACH 
Salen Complexes and Their Application for the ROP of 
Lactide. 
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5. Titanium (IV) and Aluminium (III) trans-1,4-DACH 
Salen Complexes and Their Application for the ROP of 
Lactide. 
5.1 Introduction 
Aluminium imine bis(phenoxy) complexes have been investigated for the 
ring-opening-polymerisation (ROP) of lactide. Although active these initiators 
typically displayed low activity (see section 1.3.6).
1-3
 These ROP investigations 
resulted in a high degree of molecular weight control alongside the production of 
highly isotactic PLA from the ROP of rac-lactide. Stereoselectivity observed for 
these complexes was retained under solvent free conditions for various aluminium 
imine bis(phenoxy) initiators. Imine mono(phenol) ligands have been coordinated to 
aluminium in monometallic structural motifs (Figure 5.01).
4, 5
 Solution 
polymerisations using these monometallic aluminium imine mono(phenoxy) 
initiators required forcing conditions to attain high conversion (70 °C/14 h, 
100 °C/48 h). Only moderate molecular weight control was observed 
(PDI = 1.12 - 1.69) and predominately atactic lactide was reported from the ROP of 
rac-lactide.
4, 5
 Depending upon the substituents isotactic enriched PLA was obtained, 
although a direct probability of racemic enchainment (Pr) was not reported a 
1
H 
NMR example was given showing slightly isotactic enriched PLA.
5
 
 
 
 
Figure 5.01: Monometallic aluminium imine mono(phenoxy) complexes trialled for the ROP 
of lactide.4, 5 
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Titanium imine bis(phenoxy) complexes (Figure 1.40, 1.41) have been 
utilised for the ROP of rac-lactide,
6
 they were proven to be active initiators and 
resulted in a high degree molecular weight control. In comparison to the aluminium 
analogues atactic PLA was produced with perhaps a slight heterotactic bias. Imine 
mono(phenol) ligands have been coordinated to group 4 metals resulting in 
monometallic complexes with two chelating ligands (Figure 1.39).
7
 These initiators 
resulted in a moderate heterotactic bias for zirconium based catalysts from 
rac-lactide. Similar monometallic titanium imine mono(phenoxy) complexes, 
containing coordinating chloride ligands have been reported as initiators for the ROP 
of lactide. Despite the lack of an alkoxide initiator group these titanium imine 
mono(phenoxy) complexes gave moderate molecular weight control and yielded 
predominately atactic lactide.
8
 
 1,2-Diaminocylohexane (1,2-DACH) bridged bis(phenol) ligands have been 
complexed to group 4 metals and aluminium, these complexes have been utilised for 
the ROP of lactide (Figure 5.02).
6, 9-11
 Titanium 1,2-DACH bis(phenoxy) complexes 
were active for the ROP of rac-lactide albeit these initiators revealed low activity.
6, 9
 
They gave a good degree of molecular weight control but no significant 
stereoselectivity was reported. Aluminium 1,2-DACH bis(phenoxy) complexes were 
reported as poorly active initiators for the ROP of lactide.
10, 11
 In contrast to their 
titanium analogues they resulted in the production of highly isotactic PLA. While 
1,2-DACH bis(phenoxy) complexes have been synthesised and investigated as 
initiators for the ROP of lactide 1,4-DACH bis(phenoxy) complexes have not been 
previously synthesised. The following chapter discusses the synthesis and reactivity 
of various 1,4-DACH bis(phenoxy) complexes. 
 
Figure 5.02: Previous DACH based complexes used for the ROP of lactide, Left - 1,2-DACH salen 
titanium complex,
6, 9
 Right - 1,2-DACH salen aluminium complex.
10, 11
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5.2 Synthesis of trans-1,4-DACH Salen Ligands 
 
Figure 5.03: Scheme for the synthetic preparation of trans-1,4-DACH salen ligands. 
 
 trans-1,4-Diaminocyclohexane (1,4-DACH) salen ligands {(16-18)H2} were 
synthesised via a condensation reaction of trans-1,4-DACH and two equivalents of 
3,5-subsituted salicylaldehyde (Figure 5.03). The ligands {(16-18)H2} were isolated 
as pure solid compounds from the reaction solvent (MeOH), at which point they 
were filtered and further washed (MeOH). The resulting ligands were characterised 
by 
1
H/
13
C{
1
H} NMR spectroscopy and high resolution ESI-TOF mass spectrometry. 
trans-1,4-DACH and 3,5-
t
Bu-salicylaldehyde were commercially obtained while 
3-
t
Bu-5-Me-salicylaldehyde and 3-trityl-5-Me-salicylaldehyde were synthesised 
before use. 3-
t
Bu-5-Me-salicylaldehyde was synthesised by a less moisture sensitive 
deviation than reported in the literature.
12
 3-trityl-5-Me-phenol was first synthesised 
by literature methods and then converted to 3-trityl-5-Me-salicylaldehyde via a 
deviation of the Duff formylation reaction.
13
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5.3 trans-1,4-DACH Titanium Isopropoxide Complexes 
5.3.1 Synthesis 
  
Figure 5.04: Scheme depicting the synthesis of titanium isopropoxide trans-1,4-DACH salen 
complexes {Ti2(16-18)(O
iPr)6}. 
 
 Initial attempts to synthesise trans-1,4-DACH salen complexes using 
(16-18)H2 ligands and Ti(O
i
Pr)4 yielded different products dependent upon the 
ortho-phenol substituents. Following prior titanium work with hindered salan ligands 
(Chapter 2), the (16-18)H2 ligands were reacted with two equivalents of Ti(O
i
Pr)4 to 
yield a bimetallic complex (Figure 5.04). The complexation of less sterically 
hindered ortho-phenol substituted ligands (R1 = Me, H) was attempted but these 
ligands resulted in insoluble titanium complexes. It was speculated the formation of 
polymeric material was occurring. Recrystallisation attempts from hexane or 
hexane/toluene mixes yielded crystals of Ti2(16-18)(O
i
Pr)6 suitable for X-ray 
crystallographic studies. Ti2(16-18)(O
i
Pr)6 were all obtained as pure products after 
recrystallisation and they were characterised by 
1
H/
13
C{
1
H} NMR spectroscopy and 
CHN analysis.  
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5.3.2 Solid-state characterisation by X-ray crystallography 
 Crystals suitable for X-ray diffraction were obtained for Ti2(16-18)(O
i
Pr)6, a 
solid-state structure is given for Ti2(16)(O
i
Pr)6 in figure 5.05. These 
Ti2(16-18)(O
i
Pr)6 structures contained an inversion centre hence both titanium metal 
centres are in equivalent crystallographic environments. The DACH backbone adopts 
the favourable chair configuration. The titanium metals are five coordinate with three 
isopropoxide groups, and a chelating amine/phenoxy ligand. The titanium centres 
adopt distorted trigonal bipyramidal geometries where the imine and a single 
isopropoxide moiety assume axial positions. 
 
Figure 5.05: Solid-state structure for Ti2(16)(O
iPr)6. Ellipsoids are shown at the 30 % probability 
level, hydrogen atoms and isopropoxide –CH3 moieties have been removed for clarity. 
 
 Selected bond lengths and angles for Ti2(16-18)(O
i
Pr)6 are given in 
table 5.01. The phenoxy-titanium (Ti1-O2) bond lengths are slightly longer 
{1.8932(17) - 1.901(2) Å} than previously reported Ti2(2-5,8,12,13)(O
i
Pr)6 
complexes {1.8622(17) - 1.8883(17) Å} (see section 2.4.2).
14
 The imine N1-Ti1 
bond {2.224(2) - 2.239(2) Å} presented shorter lengths than similar amine N1-Ti1 
bonds {2.3499(18) - 2.3567(18) Å}.
14
 The shorter bond lengths are indicative of the 
stronger coordination of the imine justifying the formation of polymeric complexes 
when the ortho position is less sterically hindered. The equatorial substituents are 
distorted towards the axial nitrogen {80.76(9) - 84.33(8) °}. The bulky trityl (-CPh3) 
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group in the ortho-phenoxy position causes the axial isopropoxide to converge 
towards 180 ° {179.48(8) °} in comparison to the same angle with 
t
Bu 
ortho-phenoxy groups {174.29(8) - 174.63(10) °}. The equatorial isopropoxide 
groups of trityl substituted complexes are further slightly distorted towards the axial 
nitrogen {81.43(8) - 81.74(8) °} in comparison to complexes containing 
t
Bu 
ortho-phenoxy groups {83.58(8) - 84.33(8) °}. 
 
 Ti2(16)(O
i
Pr)6 Ti2(17)(O
i
Pr)6 Ti2(18)(O
i
Pr)6 
Ti1-O1 1.787(2) 1.7915(19) 1.7815(18) 
Ti1-O2 1.901(2) 1.8985(17) 1.8932(17) 
Ti1-O3 1.811(2) 1.8059(19) 1.8394(18) 
Ti1-O4 1.814(2) 1.8264(19) 1.8149(18) 
Ti1-N1 2.225(3) 2.224(2) 2.239(2) 
N1-Ti1-O1 174.63(10) 174.29(8) 179.48(8) 
N1-Ti1-O2 80.76(9) 80.86(7) 80.79(7) 
N1-Ti1-O3 84.17(10) 84.33(8) 81.74(8) 
N1-Ti1-O4 83.88(10) 83.58(8) 81.43(8) 
 
Table 5.01: Selected bond lengths (Å) and angles (°) for LM2 titanium salen complexes 
{Ti2(16-18)(O
iPr)6}, as determined by X-ray crystallography. 
 
5.3.3 Solution characterisation by NMR spectroscopy 
 Ti2(16-18)(O
i
Pr)6 were characterised by 
1
H and 
13
C{
1
H} NMR spectroscopy 
the 
1
H NMR spectrum for Ti2(17)(O
i
Pr)6 is given in figure 5.06. This spectrum is 
consistent with the 
1
H NMR spectra obtained for Ti2(16,18)(O
i
Pr)6 and the solid-state 
structures. The fact that no uncoordinated ligand resonances were observed indicated 
full coordination of the ligands to titanium. The presence of six isopropoxide methine 
resonances (4.91 ppm) and corresponding CH3 isopropoxide resonances (1.27 ppm) 
confirms the coordination of two -Ti(O
i
Pr)3 groups to a single ligand, when 
integrated relative to one 17H2 ligand. The CH2 groups are in equivalent 
environments which is best demonstrated by a single resonance (32.5 ppm) in the 
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13
C{
1
H} NMR spectra. Axial and equatorial CH2 protons gave rise to two separate 
resonances (1.58, 2.25 ppm) indicating a locked chair configuration where ring 
flipping is significantly hindered. 
 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
1
.2
7
2
1
.4
7
9
1
.5
5
7
1
.5
8
8
1
.6
2
5
2
.2
3
8
2
.2
6
0
2
.3
1
8
4
.3
8
8
4
.8
7
0
4
.8
9
0
4
.9
1
1
4
.9
3
1
4
.9
5
1
7
.0
1
1
7
.0
1
6
7
.2
0
2
7
.2
0
9
8
.2
8
7
3
6
.0
2
1
8
.0
2
4
.0
0
4
.0
0
6
.0
0
2
.0
1
6
.0
4
1
.9
9
2
.0
0
2
.0
0
 
Figure 5.06: 1H NMR spectrum for Ti2(17)(O
iPr)6 in CDCl3 at 298 K. 
 
5.4 trans-1,4-DACH Aluminium Methyl Complexes 
5.4.1 Synthesis 
  
Figure 5.07: Scheme depicting the synthesis of aluminium methyl trans-1,4-DACH salen complexes 
{Al2(16-18)Me4}. 
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 Similarly trans-1,4-DACH salen ligands {(16-18)H2} were reacted with a 2M 
AlMe3 solution in a 2:1 ratio of metal to ligand (Figure 5.07). The product was 
isolated by recrystallisation to yield pure Al2(16-18)Me4 complexes. The isolated 
Al2(16-18)Me4 complexes contained two aluminium metal centres where each was 
coordinated to a single ligand phenoxy group. Similar synthetic attempts under 
varying conditions were conducted with ligands containing less steric bulk about the 
ortho-phenol position but attempts resulted in undeterminable compounds. These 
complexes with less sterically hindered ligands yielded insoluble materials, 
additionally in some cases temperature and time caused more insoluble material to be 
produced. It was speculated that the possible formation of polymeric conglomerates 
of complexes and ligands was occurring. The Al2(16-18)Me4 complexes were 
characterised by 
1
H/
13
C{
1
H} NMR spectroscopy and CHN analysis. Recrystallisation 
attempts resulted in crystals of Al2(16)Me4 and Al2(17)Me4 which were suitable for 
X-ray diffraction characterisation. 
 
5.4.2 Solid-state characterisation by X-ray crystallography 
 
 
Figure 5.08: Solid-state structure for Al2(16)Me4. Ellipsoids are shown at the 30 % probability level, 
hydrogen atoms have been removed for clarity. 
 
 Recrystallisation of the aluminium trans-1,4-DACH salen complexes resulted 
in suitable crystals of Al2(16,17)Me4 for X-ray diffraction studies. The structure for 
Al2(16)Me4 is given in figure 5.08. The aluminium metal centres are four coordinate 
and only bound to a single phenoxy and a single imine of the trans-1,4-DACH salen 
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ligand, the other two coordination sites are occupied by methyl groups. The carbon 
aluminium bonds are similar in length to each other and are also of similar lengths to 
prior aluminium carbon bonds (see section 4.3) (Table 5.02).
15-17
 Aluminium 
nitrogen imine bonds {Al1-N1 = 1.979(4) - 1.9783(12) Å} are shorter, as expected, 
than previously discussed aluminium nitrogen amine bonds {2.07(2) - 2.188(7) Å} 
(see 4.3).
15
 The aluminium metal centres adopt pseudo tetrahedral geometries. 
Interestingly the nitrogen-aluminium-carbon angles {N1-Al1-C1/C2} are 
inequivalent within each structure despite their presumed similarity. The N1-Al-C1 
and N1-Al-C2 angles are also significantly different between the crystal structures of 
Al2(16)Me4 and Al2(17)Me4. The N1-Al1-O1 chelate angle {94.39(5) - 94.69(14) °} 
significantly deviates from the ideal tetrahedral angle of 109 °.  
 
 Al2(16)Me4 Al2(17)Me4 
Al1-C1 1.946(5) 1.9497(17) 
Al1-C2 1.952(5) 1.9637(17) 
Al1-O1 1.763(3) 1.7684(11) 
Al1-N1 1.979(4) 1.9783(12) 
N1-Al1-C1 108.73(18) 109.05(7) 
N1-Al1-C2 115.00(18) 113.43(7) 
N1-Al1-O1 94.69(14) 94.39(5) 
 
Table 5.02: Selected bond lengths (Å) and angles (°) for LM2 aluminium salen complexes 
{Al2(16-17)Me4}, as determined by X-ray crystallography. 
 
5.4.3 Solution characterisation by NMR spectroscopy 
Al2(16-18)Me4 were characterised by 
1
H and 
13
C{
1
H} NMR spectroscopy. 
The 
1
H and 
13
C{
1
H} NMR spectra were consistent with the solid-state structures 
determined by X-ray diffraction. The 
1
H NMR spectrum for Al2(17)Me4 is given in 
figure 5.09, the NMR spectra were consistent throughout the Al2(16-18)Me4 
complexes. No ligand resonances were observed, confirming the full coordination of 
the (16-18)H2 ligands. Twelve shielded aluminium bound methyl resonances 
(-0.19 ppm) were present, relative to a single ligand (17H2), confirming four 
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aluminium bound methyl groups (Figure 5.09). The DACH ring CH2 protons were 
located in a slightly broad resonance region at ~1.6 ppm, this region coincided with 
the 
t
Bu-phenoxy substituent resonance at 1.65 ppm. The imine CH resonance and 
two phenoxy protons resonances also coincided at 7.40 ppm.  
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Figure 5.09: 1H NMR spectrum for {Al2(17)Me4} in d8-toluene at 298 K 
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5.5 Attempts to Coordinate trans-1,4-DACH Salen Ligands to 
Zirconium and Zinc. 
5.5.1 Synthesis 
 
Figure 5.10: Scheme depicting the synthesis of zinc methyl trans-1,4-DACH salen complex 
Zn2(17)Me2(THF)2. 
 
 The complexation of (16-18)H2 to diethyl zinc was attempted and 
coordination occurred and various stoichiometries were investigated. Partial success 
was achieved with the complexation of (16-18)H2 with a two equivalence of 
dimethyl zinc. The reaction of 17H2 with dimethyl zinc and purification by 
recrystallisation resulted in a mixture of zinc complexes. Exposure of the dimethyl 
zinc and 17H2 ligand products to THF prior to recrystallisation attempts from toluene 
and hexane yielded crystals of Zn2(17)Me2(THF)2 suitable for X-ray diffraction 
studies (Figure 5.10). Although isolated as individual crystals the 
1
H NMR spectrum 
revealed broad resonances at 298 K. 
1
H NMR spectroscopy was inconclusive and 
CHN elemental analysis significantly deviated from the calculated values. Further 
attempts to synthesise Zn2(16,18)Me4 complexes either resulted in the production of 
a plethora of species identified by 
1
H NMR spectroscopy or highly soluble products 
which could not be purified from common solvents. Attempts at the formation of 
zinc complexes using less sterically bulky ligands about the ortho-phenol position 
(R1 = Me, H) were troublesome, typically resulting in insoluble material.  
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 Attempts to synthesise LM2 type structures using Zr(O
i
Pr)4.HO
i
Pr and 
(16-18)H2 were unsuccessful. The resulting complexes were typically insoluble, a 
few cases of soluble complexes were isolated but the solubility of the complexes 
changed with time or heating. The zirconium products were indeterminate and any 
soluble product was presumed unstable in solution making analysis difficult. We 
speculated that formation of multiple products, where the increased size of the 
zirconium metal centre compared to titanium allows the coordination of more than 
one ligand. Furthermore zirconium complexes have been shown to bridge via 
phenoxy or isopropoxide groups (See section 3.2).  
 
5.5.2 Solid-state characterisation by X-ray crystallography 
 
 
Figure 5.11: Solid-state structure for Zn2(17)Me2(THF)2. Ellipsoids are shown at the 30 % probability 
level, hydrogen atoms have been removed for clarity. 
  
 Zn2(17)Me2(THF)2 was isolated as crystals and determined by X-ray 
diffraction (Figure 5.11), selected bond lengths (Å) and angles (°) are given in 
table 5.03. Similar zinc complexes containing one phenoxy and one imine have been 
characterised by X-ray crystallography.
18-20
 Comparison to the earliest reported 
imine phenoxy zinc complex showed similar Zn-C bonds {1.965(2) Å} and Zn-Nimine 
bonds {2.051(2) Å}.
20
 The zinc centres within Zn2(17)Me2(THF)2 are four 
coordinate; bound to an alkyl, phenoxy oxygen, imine nitrogen and a THF oxygen. 
As expected the THF Zn1-O2 bond {2.2029(15) Å} is significantly longer then the 
phenoxy Zn1-O1 bond {1.9312(13) Å}. The zinc centres adopt a pseudo tetrahedral 
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structure, where the degree of distortion is represented by the N1-Zn1-C1 angle 
{131.14(9) °}. 
 
Zn2(17)Me2.(THF)2 
Zn1-C1 1.961(2) O1-Zn1-O2 95.86(6) 
Zn1-O1 1.9312(13) N1-Zn1-C1 131.14(9) 
Zn1-O2 2.2029(15) N1-Zn1-O1 93.53(6) 
Zn1-N1 2.0356(16) N1-Zn1-O2 93.11(6) 
 
Table 5.03: Selected bond lengths (Å) and angles (°) for the zinc salen complex 
{Zn2(17)Me2.(THF)2}, as determined by X-ray crystallography. 
 
5.6 Ring-Opening-Polymerisation of Lactide  
Ti2(16-18)O
i
Pr6 and Al2(16-18)Me4 were trialled as initiators for the ROP of 
rac-lactide. The titanium initiators {Ti2(16-18)O
i
Pr6} were investigated for the ROP 
of rac-lactide in toluene and solvent free conditions. The aluminium initiators were 
investigated for the solvent ROP of rac-lactide, benzyl alcohol was added as a 
co-initiator and its effect at different ratios was studied. Conversions were calculated 
by 
1
H NMR spectroscopy by comparison of the monomer and polymer methine 
regions. Molecular weights (Mn) and PDI values were obtained from gel permeation 
chromatography (GPC). Stereoselectivity was calculated from homonuclear 
decoupled 
1
H NMR spectroscopy and the probability of racemic enchainment was 
calculated by Bernoullian statistics.
21
 
 
5.6.1 Titanium and aluminium initiators for the solution ROP of rac-lactide  
Titanium and aluminium 1,4-DACH salen complexes {Ti2(16-18)O
i
Pr6, 
Al2(16-18)Me4} were trialled for the ROP of rac-lactide. The ROP using 
Ti2(16-18)O
i
Pr6 complexes was investigated at 80 °C in toluene at 100:1 
[rac-lactide]:[initiator] ratio. The aluminium initiators utilised conditions of 80 °C in 
toluene, benzyl alcohol was added in-situ to promote the ROP reaction. The 
polymerisation data is given in table 5.04. 
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 Ratio
 a
 
Time 
(hours) 
Conv. 
(%)
b 
Mn
c
 
(theo) 
Mn
d 
PDI
d 
Pr
e 
Ti2(16)O
i
Pr6 100:1 24 91 6600 4850 1.50 0.53 
Ti2(17)O
i
Pr6 100:1 24 92 6700 5450 1.33 0.55 
Ti2(18)O
i
Pr6 100:1 24 94 6850 4800 1.32 0.44 
Al2(16)Me4 100:1:2 24 96 7000 9000 1.24 0.42 
Al2(16)Me4 100:1:4 24 99 3700 5400 1.24 0.42 
Al2(16)Me4 100:1:8 24 99 1900 2700 1.27 0.40 
Al2(17)Me4 100:1:2 24 96 7050 9250 1.22 0.35 
Al2(17)Me4 100:1:4 24 99 3700 5500 1.23 0.35 
Al2(17)Me4 100:1:8 24 96 1850 2650 1.22 0.38 
Al2(18)Me4 100:1:2 24 73 5350 6750 1.08 0.43 
 
Table 5.04: Solution ROP of rac-lactide for Ti2(16-18)(O
iPr)6 in 10 ml of toluene at 80 °. 
a ratio of 
[rac-lactide]:[initiator]:[benzyl alcohol]. b Conversion ascertained by 1H NMR spectroscopy. 
c Theoretical molecular weight calculated from conversion (Ti = Conv. × 100/2 × 144.13 + 60.10) 
(Al = Conv. × 100/[co-initiator ratio] × 144.13 + 108.14) (rounded to the nearest 50), d Molecular 
weight and PDI determined by GPC (THF) using polystyrene standards without applying a correction 
factor. e Pr as calculated from 
1H NMR homonuclear decoupled spectroscopy in CDCl3. 
 
 The titanium initiators Ti2(16-18)(O
i
Pr)6 resulted in high conversion after 
24 h. Slightly lower molecular weights than expected were obtained which was 
attributed to multiple initiating isopropoxide groups per metal centre. Moderate chain 
length distributions were observed (PDI = 1.32 -1.50), this was also attributed to the 
potential to initiate multiple PLA chains per metal centre.  
 High conversions were obtained after 24 h when the aluminium initiators 
{Al2(16-18)Me4} were utilised. Molecular weight distributions were typically low 
(PDI = 1.08 – 1.27) and the molecular weights were dependent upon the ratio of 
benzyl alcohol utilised, this observation is indicative of an immortal polymerisation 
system. All the aluminium initiators {Al2(16-18)Me4} resulted in isotacticly biased 
PLA (Pr = 0.35 – 0.43), a stronger degree of stereocontrol was found for Al2(17)Me4 
(Pr = 0.35) independent of the amount of benzyl alcohol co-initiator. MALDI-TOF 
mass spectrometry of PLA initiated by Al2(16)Me4 with eight equivalents of benzyl 
alcohol was performed (Figure 5.12). The unit spacing between peaks is ~72 g mol
-1
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indicating transesterification reactions. Benzyl alcohol was identified as the end 
group supporting a chain exchange mechanism.  
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Figure 5.12: MALDI- TOF mass spectra (ionised with Na+) of PLA produced using initiator 
Al2(16)Me4, at 80 C after 24 h at 100:1:8 [rac-lactide]:[initiator]:[benzyl alcohol] ratio. 
 
5.6.2 Titanium initiators for the solvent free ROP of rac-lactide  
 Ti2(16-18)O
i
Pr6 were trialled for the ROP of rac-lactide in solvent free 
conditions of 130 °C at a 300:1 [rac-lactide]:[Initiator] ratio. The aluminium 
analogues {Al2(16-18)Me4} were not investigated under these condition due to 
complexities involved with co-initiator addition. High conversion of rac-lactide to 
PLA was achieved for Ti2(16-18)O
i
Pr6 initiators before methanol quenching after 1 h 
(Table 5.05). The molecular weights (Mn) were lower than the theoretical derived 
molecular weights (Mn (theo)), higher PDI values (PDI = 1.34 - 1.74) than the 
analogous solvated polymerisations were obtained. The high PDI and low Mn values 
were credited to multiple initiating isopropoxide groups per metal centre. 
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Time 
(hours) 
Conv. 
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d 
Ti2(16)O
i
Pr6 1 95 20600 9,450 1.74 0.51 
Ti2(17)O
i
Pr6 1 96 20800 15,500 1.60 0.51 
Ti2(18)O
i
Pr6 1 94 20400 17,600 1.34 0.51 
 
Table 5.05: Solvent free ROP of rac-lactide for Ti2(16-18)(O
iPr)6 at 130 °C in a 300:1 
[rac-lactide]:[initiator] ratio. a Conversion ascertained by 1H NMR spectroscopy. b Theoretical 
molecular weight calculated from conversion (Conv. × 300/2 × 144.13 + 60.10) (rounded to the 
nearest 50), c Molecular weight and PDI determined by GPC (THF) using polystyrene standards 
without applying a correction factor. d Pr as calculated from 
1H NMR homonuclear decoupled 
spectroscopy in CDCl3. 
 
5.7 Kinetic Studies of the Ring-Opening-Polymerisation of Lactide  
 The apparent rate of propagation (kapp) was determined by NMR 
spectroscopy scale ROP of lactide experiments using Al2(16,17)Me4 initiators with 
two equivalence of benzyl alcohol as a co-initiator. Both rac-lactide and L-lactide 
were investigated to quantitatively indentify any rate enhancement and 
stereoselective preferences of these isotactic biased initiators. The ROP reactions 
were performed in an NMR tube using 50 mg of lactide in 0.6 ml of d8-toluene at 
80 °C, the initiators {Al2(16,17)Me4} were in a 100:1:2 ratio of 
[lactide]:[initiator]:[benzyl alcohol]. By plotting pseudo first order graphs of 
ln([LA]0/[LA]t) against time the slope of the graph is equal to the apparent first order 
rate constant (kapp) {Figure 5.13 = Al2(16)Me4, Figure 5.14 = Al2(17)Me4}. 
 
 Lactide 
kapp (x 10
-3
) 
(min
-1
)
 R
2
 
Al2(16)Me4 L 2.09(1) 0.9987 
Al2(16)Me4 Rac 1.96(1) 0.9994 
Al2(17)Me4 L 2.31(1) 0.9996 
Al2(17)Me4 Rac 1.37(1) 0.9996 
 
Table 5.06: kapp values and R
2 values for ROP of rac-lactide and L-lactide by Al2(16-17)Me4 initiators. 
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Figure 5.13 Pseudo first order plots for the ROP of rac-lactide (Red) and L-lactide (Blue) by 
Al2(16)Me4. For each case 50 mg of lactide was dissolved in 0.6 ml of d8-touene at 80 °C at 100:1:2 
[rac-lactide]:[initiator]:[benzyl alcohol] ratio. 
 
 The pseudo first order plots for the ROP of rac-lactide and L-lactide data 
were truncated as the rate did not equilibrate until ~200 mins (Figure 5.13, 
figure 5.14). Table 5.06 gives the kapp rates for rac-lactide and L-lactide using 
Al2(16,17)Me4 as the initiators. No significant difference between the kapp values for 
L-lactide and rac-lactide was observed using Al2(16)Me4 initiator. Al2(17)Me4 
revealed an approximate 70 % increase in apparent rate (kapp) towards L-lactide over 
rac-lactide. Al2(17)Me4 resulted in a much larger kapp difference between the ROP of 
L-lactide and rac-lactide than Al2(16)Me4 (Table 5.06). This is consistent with the 
greater stereoselectivity observed for Al2(17)Me4 (Pr = 0.35) over Al2(16)Me4 
(Pr = 0.42) (Table 5.04). The cause of the enhanced stereoselectivity upon 
substitution of the para-phenoxy subsistent is unresolved but the para-positioning is 
indicative of an electronic effect. It should be noted the N1-Al1-C1/C2 angles 
showed variance between the two structures Al2(16,17)Me4 indicating the likely 
lactide coordination sites upon the aluminium metal are not equivalent between the 
structures (Table 5.02). 
L-lactide 
rac-lactide l
n
{[
L
A
] 0
/L
A
] t
} 
Time (mins) 
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Figure 5.14: Pseudo first order plots for the ROP of rac-lactide (Red) and L-lactide (Blue) by 
Al2(17)Me4. For each case 50 mg of lactide was dissolved in 0.6 ml of d8-toluene at 80 °C at 100:1:2 
[rac-lactide]:[initiator]:[benzyl alcohol] ratio. 
 
5.8 Conclusion 
 The synthesis of novel trans-1,4-DACH salen complexes {Ti2(16-18)(O
i
Pr)6, 
Al2(16-18)Me4} is reported herein with supporting characterisation by 
1
H/
13
C{
1
H} 
NMR spectroscopy and CHN analysis. Ti2(16-18)(O
i
Pr)6 and Al2(16,17)Me4 were 
isolated as crystals and their structures determined by X-ray diffraction studies. Both 
metals were shown to coordinate to the ligands in a 2:1 metal-to-ligand ratio. The 
attempted synthesis of derivatives with ligands containing less sterically bulky 
groups (H, Me, or Cl) in the ortho position of the phenol rings resulted in highly 
insoluble complexes. The synthesis of various zirconium trans-1,4-DACH salen 
complexes was unsuccessful. The complexation of 17H2 to ZnMe2 resulted in the 
formation of Zn2(17)Me4(THF)2 as determined by X-ray crystallography, further 
analysis did not confirm this species as a pure bulk material. Attempts to synthesise 
further Zn(II) trans-1,4-DACH salen complexes with (16,18)H2 were unsuccessful.  
 The titanium complexes {Ti2(16-18)(O
i
Pr)6} were investigated for the ROP 
of rac-lactide under solvent free conditions at 130 °C in a 300:1 
[rac-lactide]:[initiator] ratio. Ti2(16-18)(O
i
Pr)6 and Al2(16,17)Me4 were trialled for 
the ROP of rac-lactide at 80 °C in toluene at a 100:1 [rac-lactide]:[initiator] ratio. 
L-lactide 
rac-lactide l
n
{[
L
A
] 0
/L
A
] t
} 
Time (mins) 
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Two equivalents of benzyl alcohol were added to initiate the ROP of rac-lactide 
using Al2(16-18)Me4. Both aluminium {Al2(16-18)Me4} and titanium 
{Ti2(16-18)(O
i
Pr)6} initiators attained high conversion after 24 h. Moderate chain 
length control is observed for these initiators with lower molecular weight PLA 
being obtained due to multiple initiation sites per titanium metal centre. The 
aluminium initiators Al2(16-18)Me4 display some isotactic stereoselectivity for the 
ROP of rac-lactide, where Al2(17)Me4 is the most selective (Pr = 0.35). Comparative 
apparent rate constants (kapp) for the ROP of rac-lactide and L-lactide are determined 
by 
1
H NMR spectroscopy and Al2(17)Me4 is 70 % more active towards L-lactide 
than rac-lactide, which is consistent with a chain-end control mechanism. The 
isotactic bias observed is dependent upon the ortho/para-phenoxy substituents. 
Altering the para subsistent to a 
t
Bu has a detrimental effect on the isotactic 
stereoselectivity observed, this was speculatively attributed to electronic variations. 
The addition of excess benzyl alcohol to the ROP of rac-lactide by Al2(16,17)Me4 
proportionally reduces the resulting PLA molecular weights without loss of 
stereoselectivity. This is indicative of an immortal polymerisation system where a 
chain-end exchange mechanism is in operation.
22
 
 
5.9 Future Work 
 Smaller ortho-phenol substituents upon the trans-1,4-DACH salen ligands 
resulted in insoluble material after complexation to titanium or aluminium. Further 
work could be conducted to ascertain the structure of these complexes through 
further synthetic attempts and solution trails, such as monitoring the reaction via 
NMR spectroscopy. Solid-state characterisation techniques could also be used to 
identify the compounds. Further-work preparing zinc complexes could be conducted 
in an attempt to isolate more complexes as pure material and investigate these for the 
ROP of cyclic esters. Attempts with other metals such as zirconium, hafnium and 
indium could be conducted to expand the library of this series of initiators.  
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Their Application for the ROP of rac-Lactide 
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6. Aluminium trans-1,2-DACH Salalen Complexes and 
Their Application for the ROP of rac-Lactide 
6.1 Introduction 
 As discussed in chapter 1.3.6 imine and amine linked bis(phenoxy) 
aluminium complexes have been widely investigated for the ROP of lactide.
1-3
 
Aluminium imine bis(phenoxy) complexes are some of the most selective initiators 
for isotactic PLA. The aluminium R-(+)-1,1’-binaphthyl-2,2’-diamine linked 
bis(phenoxy) complex was reported by Spassky et al. and is one of the earliest 
examples of an aluminium imine bis(phenoxy) complex which resulted in isotactic 
stereoselectivity for the ROP of rac-lactide.
4
 This was preceded by further 
aluminium salen bis(phenoxy) initiators, notably; alkane linked salen bis(phenoxy) 
complexes by Nomura et al.
5, 6
 and 1,2-diaminocyclohexane (1,2-DACH) linked 
salen bis(phenoxy) complexes by Fiejen et al.
7, 8
, which both result in isotactic PLA 
from rac-lactide. 
 Related amine bis(phenoxy) aluminium (aluminium salan) complexes were 
synthesised by Gibson et al.
9
 who showed the stereoselectivity of such complexes 
could be inverted by changing the phenoxy substituents, where Me substituents gave 
isotactic biased PLA and Cl substituents resulted in heterotactic PLA. DACH linked 
salan bisphenoxy aluminium complexes were also synthesised by Fiejen et al.
10
 and 
demonstrated high isotactic control. This has led to interest in salalen systems which 
contain both an imine phenol linked to an amine phenol.
11
 The most pertinent study 
of an aluminium system of this type utilised for the ROP of rac-lactide was reported 
by Jones et al.
11
 Only the imine phenol substituents were varied in the previous study 
and PLA stereoselectivity was predominately heterotactic biased. Investigation into 
varying the alkyl group on the nitrogen was conducted to reveal that the 
stereoselectivity bias could be inverted. Herein similar salalen aluminium complexes 
are reported using a trans-1,2-DACH linking group. The trans-1,2-DACH linked 
salen bis(phenoxy) complexes by Fiejen et al. produced highly isotactic PLA.
7, 8
 It 
was anticipated that the more ridged and chiral DACH would form strongly defined 
initiator structures and induce stereocontrol. Additionally, investigation into the 
effect of phenol substituents of both the imine phenol and amine phenol groups was 
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conducted with respect to steric bulk and electronic effects. Kol et. al. reported the 
use of salalen titanium complexes for the selective polymerization of 1-hexene and 
propylene.
12
 Prior aluminium DACH salalen complexes have been reported in the 
literature for the enantioselective hydrophosphonylation of aldehydes
13, 14
 and 
aldimines.
14
 Katsuki et al. was the first to report the enantioselective oxidation of 
sulphides by aluminium salalen complexes and has demonstrated high 
enantioselectivity in various systems.
15-17
 The same complexes were shown to be 
active for the oxidation of cyclic dithioacetals and afforded high enantioselectivity 
alongside high diastereoselectivity.
18
 Although their catalytic activity was studied in 
detail the aluminium salalen structural aspects and coordinated N-methyl chirality are 
discussed to a lesser degree by Katsuki and Saito.
14
  
 
6.2 Synthesis of trans-1,2-DACH Salalen Ligands 
The ligand synthesis shown in figure 6.01 is an adaptation of the procedures 
used by Katsuki et al.
19
 The ligands were synthesised from rac-1,2-trans-DACH 
which was first protected with a Boc group and the mono-boc-protected 
rac-1,2-trans-DACH was isolated by acid/base extractions. The 
mono-boc-1,2-trans-DACH was reacted with a selected salicylaldehyde by an imine 
condensation reaction, which was then reduced. The boc-protected half salans 
{(19-21)HBoc} were then synthesised by reductive methylation and the crude 
mixture was analysed by NMR spectroscopy. The compound was then deprotected 
with acid and reacted with a second substituted salicylaldehyde via an imine 
condensation to produce the pure trans-1,2-DACH salalen ligands {(22-30)H2}. All 
of the salalen ligands shown in figure 6.01 {(22-30)H2} were isolated and 
characterised by 
1
H/
13
C{
1
H} NMR spectroscopy, and high resolution ESI-TOF mass 
spectrometry. This method allows independent variation of the salan phenol 
substituents and the salen phenol substituents. Chirally resolved (R,R)-1,2-DACH 
was used for the synthesis of a chiral salalen ligand (R,R-22)H2, by the same 
methodology. The steric and electronic effects of the phenol substituents were upon 
the salan and salen sections were investigated and consequently their effect upon the 
ROP of rac-lactide can be probed in detail. 
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Figure 6.01: Reaction pathway detailing the synthesis of trans-1,2-DACH-salalen ligands. 
 
6.3 Aluminium trans-1,2-DACH Salalen  Complexes 
6.3.1 Synthesis of aluminium trans-1,2-DACH salalen complexes 
 The aluminium methyl 1,2-DACH-salalen complexes {Al(22-30)Me} were 
isolated by reacting the ligands (22-30)H2 with AlMe3 (2M in hexanes) in a 1:1 ratio 
in toluene. The crude product was recrystallised from toluene/hexane mixes. The 
aluminium complexes Al(22-25,28)Me were characterised by 
1
H/
13
C{
1
H} NMR 
spectrometry, and CHN analysis. While the Al(22-30)Me complexes can be isolated 
as solids Al(26-27)Me and Al(29-30)Me were insoluble in all suitable solvents for 
characterisation. As shown in previously discussed work (Chapter 4) Al(6-9,11)OBn 
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complexes can be isolated promoting solvent free and co-initiator free 
polymerisation studies. Aluminium complexes Al(22-30)Me were further reacted 
with 1.1 equivalence of benzyl alcohol (BnOH) in toluene (Figure 6.02), which were 
purified by recrystallisation in toluene/hexane mixes. The benzyl alcohol complexes 
Al(22-30)OBn are notably more soluble in organic solvents, and as such complexes  
Al(22-28)OBn and Al(30)OBn were characterised by 
1
H/
13
C{
1
H} NMR 
spectroscopy, and CHN analysis. After multiple attempts Al(29)OBn could not be 
isolated in acceptable purity although the analysis revealed the major product as the 
desired Al(29)OBn complex.   
 
 
Figure 6.02: Reaction scheme for the synthesis of aluminium methyl and benzyloxy 
1,2-DACH-salalen complexes. 
 
6.3.2 Solid-state characterisation of aluminium trans-1,2-DACH salalen 
complexes 
 Few structures of aluminium salalen complexes have been characterised by 
X-ray crystallography. A chloro-aluminium 1,2-DACH-salalen complex was 
reported by Saito and Katsuki, the aluminium coordinated tertiary amine was shown 
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to be exclusively in the S configuration.
13
 Jones et al. reported aluminium salalen 
structures which contained varying phenoxy substituents upon the salan and salen 
segments.
11
 Suitable crystals for X-ray diffraction were obtained for Al(22)Me 
(Figure 6.03), Al(R,R-22)Me (Figure 6.04), and Al(25)OBn (Figure 6.05).  
 
 
Figure 6.03: Solid-state structure for Al(22)Me. Ellipsoids are shown at the 30 % probability level, 
hydrogen atoms have been removed for clarity. 
 
Figure 6.04: Solid-state structure for Al(R,R-22)Me. Ellipsoids are shown at the 30 % probability 
level, hydrogen atoms have been removed for clarity. 
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Figure 6.05: Solid-state structure for Al(25)OBn. Ellipsoids are shown at the 30 % probability level, 
hydrogen atoms have been removed for clarity. 
  
 All the aluminium 1,2-DACH salalen crystal structures obtained adopt 
pseudo trigonal bipyramidal geometries (Figure 6.03, 6.04, and 6.05). The Namine and 
the O-Phimine adopt axial positions, which is consistent with prior literature Al salalen 
structures.
11, 13
 Within the Al(22)Me structure the Namine centre (N1) is illustrated in 
the R configuration, and the carbon centres of the 1,2-DACH in the S,S configuration. 
The crystal contains a centre of inversion which allows inversion of the structure to 
obtain the diastereomers configuration Al-(S)-Namine, (R,R)-1,2-DACH. Conversely, 
the literature solid-state structure for Al(R,R-22)Cl exclusively adopted the Al-(S)-
Namine, (R,R)-1,2-DACH diastereomer,
13
 due to chirality limitations within the 
synthetic procedure. Additionally the solid-state structure for the chirally resolved 
Al(R,R-22)Me was modelled as the exclusive Al-(R)-Namine, (R,R)-1,2-DACH 
diastereomers (Figure 6.04). The identification of multiple stereo-isomers is pertinent 
to further characterisation. A benzyloxy aluminium salalen complex {Al(25)OBn} 
was structurally determined by X-ray crystallography and identified as the Al-(R)-
Namine, (R,R)-1,2-DACH diastereomers (Figure 6.05), a centre of inversion allows the 
Al-(S)-Namine, (S,S)-1,2-DACH diastereomer. To our knowledge no solid-state 
structures of aluminium salalen complexes containing non-
t
Bu phenoxy substituents 
upon the salan segment, or aluminium bound alkoxy groups have been previously 
reported.  
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The solid-state structures for all the salalen complexes discussed in table 6.01 
show the same trends in bond lengths (Å) and angles (°). Al(22)Me and 
Al(R,R-22)Me show very similar bond lengths and angles. However, there is a clear 
twist of the amine phenoxy ring between the diastereomers, which is demonstrated 
through a torsion angle measured between C1-DACH-N1-Camine-Cphenoxy (Table 6.02). 
Similar torsion angles are observed between Al(22)Me and Al(R,R-22)Cl
13
 as they 
can both be the Al-(S)-Namine, (R,R)-1,2-DACH diastereomer. Therefore, Al(R,R-
22)Me and Al(25)OBn have comparable torsion angles as they can both be 
represented as the Al-(R)-Namine, (R,R)-1,2-DACH diastereomer. 
 
 Al(22)Me Al(R,R-
22)Me 
Al(25)OBn Al(R,R-
22)Cl
13
 
Al(Salen)
Et
20
 
Al(Salan)
Et
10
 
Al1-O1 1.768(4) 1.7665(15) 1.7714(11) 1.747(2) 1.802(4) 1.763(2) 
Al1-O2 1.831(4) 1.8339(13) 1.8065(10) 1.800(2) 1.821(4) 1.793(2) 
Al1-N1 2.179(5) 2.2083(16) 2.1192(12) 2.124(2) 2.046(5) 2.448(2) 
Al1-N2 1.978(6) 1.9801(17) 1.9652(12) 1.960(2) 2.011(6) 2.039(2) 
Al1-C1 1.966(7) 1.968(2) 1.7335(11)
a
 2.187(1)
b
 1.969(7) 1.972(3) 
N1-C 
(Amine) 
1.478(8) 1.492(3) 1.492(2) 1.500(3) --- 1.494(3) 
--- --- --- --- --- 1.520(3) 
N2=C 
(Imine) 
1.303(8) 1.306(2) 1.298(2) 1.292(3) 1.291(7) --- 
--- --- --- --- 1.292(8) --- 
O1-Al1-N1 88.8(2) 87.73(6) 88.71(5) 91.24(9) 86.5(2) 84.89(7) 
O2-Al1-N2 87.6(2) 88.62(6) 89.65(5) 88.66(9) 88.0(2) 91.53(8) 
C1-Al1-N1 95.1(3) 94.27(8) 90.11(5)
a
 91.84(7)
b
 101.9(3) 88.59(9) 
C1-Al1-N2 121.5(3) 121.87(9) 113.22(5)
 a
 120.57(7)
b
 106.7(3) 119.7(1) 
N1-Al1-N2 77.7 (2) 77.93(6) 80.49(5) 79.34(9) 77.6(2) 78.11(7) 
O1-Al1-O2 93.0(2) 94.43(6) 90.68(5) 94.81(9) 89.4(2) 95.81(8) 
 
Table 6.01: Selected bond lengths (Å) and angles (°) for aluminium salalen compounds and 
comparative literature complexes, Al(R,R-22)Cl13, Al(Salen)Et,20 Al(Salan)Et.10 a O3 was substituted 
for C(1), b Cl was substituted for C(1). 
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 Torsion angle 
C1-DACH-N1-Camine-Cphenoxy 
Al(22)Me 46.6(7) 
Al(R,R-22)Me 178.4(1) 
Al(25)OBn 177.9(1) 
Al(R,R-22)Cl
13
 45.8(3) 
 
Table 6.02: Selected torsion angles (°) for 1,2-DACH-Salalen structures. 
 
 
Figure 6.06: Depiction of Al(Salen)Et20 and Al(Salan)Et10 used for structural comparison (Table 6.01). 
 
As expected there is a clear difference in imine and amine bond lengths. 
Imine bond lengths (C=N) in these complexes {Al(22)Me, Al(R,R-22)Me, 
Al(25)OBn} are between 1.298(2) - 1.306(2) Å, which are consistent with the 
literature solid-state salen complex {Al(Salen)Et} (Figure 6.06).
20
  Moreover, 
amine-benzyl bond lengths {1.478(8) – 1.492(3) Å} are consistent with previously 
reported DACH salan complexes.
10
 The Al-N1amine bonds are longer 
{2.1192(12) - 2.2083(16) Å} than Al-N1imine bonds {1.9652(12) - 1.9801(17) Å}. 
Furthermore, the Al-Nimime bonds in aluminium salalen complexes are similar to 
equivalent bonds within 1,2-DACH salen species {Al(Salen)Et} (Figure 6.06). 
Within the Al(salan)Et structure the Al-Namine bonds are not equal indicating a bias to 
coordinate more strongly to one Namine over the other.
10
 The angles between 
equatorial and axial groups within the benzyloxy salalen complex Al(25)OBn 
converge towards 90 ° when compared to Al(22)Me or Al(R,R-22)Me. The reduced 
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steric demands of the amine phenoxy substituents possibly allow the ligands to 
orientate towards a less distorted trigonal bipyramidal structure.  
 
6.3.3 Solution characterisation of aluminium trans-1,2-DACH salalen complexes 
 
Figure 6.07: Depiction of the possible diastereomers and enantiomers that aluminium salalen 
complexes can adopt. 
 
 There are three chiral centres in the ligands when coordinated, with the 
trans-1,2-DACH ring locked in either R,R or S,S configurations, the amine becomes 
chiral once coordinated. The aluminium metal is also a chiral centre. There are four 
possible diastereomers configurations {Al-(R)-Namine, (S,S)-1,2-DACH}, {Al-(S)-
Namine, (S,S)-1,2-DACH}, {Al-(S)-Namine, (R,R)-1,2-DACH}, {Al-(R)-Namine, (R,R)-
1,2-DACH} (Figure 6.07). Due to the locked configurations (R,R, S,S) of the DACH 
ring the system can be considered as a diastereomer system. As discussed before two 
possible diastereomers are present in the solid-state structure for Al(22)Me, in this 
scenario the diastereomers are enantiomers. The solid-state structure was also 
supported by solution NMR spectroscopy.  
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Figure 6.08: Al(22)Me 1H NMR spectrum for the isolated enantiomers {Al-(S)-Namine, 
(R,R)-1,2-DACH} and {Al-(R)-Namine, (S,S)-1,2-DACH}. 
 
 A single pair of enantiomers, as opposed to diastereomers, is demonstrated by 
the 
1
H NMR spectrum (Figure 6.08) of the X-ray crystallographically determined 
compound Al(22)Me. The two enantiomers present in the solution state are not 
distinguishable by conventional 
1
H NMR spectroscopy. A single Al-Me resonance 
was identified at low chemical shift (-0.48 ppm), alongside a single Namine-Me 
resonance, indicating a single diastereomer. Doublets at 2.92 ppm and 4.07 ppm are 
identified as inequivalent Namine-C-H2 protons. Therefore, demonstrating structural 
rigidity around the Namine region and reinforcing the presence of a single pair of 
enantiomers. 
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Figure 6.09: Al(R,R-22)Me 1H NMR spectrum depicting the diastereomers {Al-(S)-Namine, 
(R,R)-1,2-DACH} and {Al-(R)-Namine, (R,R)-1,2-DACH}. 
 
 The 
1
H NMR spectrum for Al(R,R-22)Me suggests the presence of two 
diastereomers in solution (Figure 6.09). This observation is not consistent with a 
single diastereomers in the solid-state as characterised by X-ray crystallography. 
Two Al-Me resonances are present in the 
1
H NMR spectrum. The Al-Me resonance 
at -0.48 ppm is consistent with the previously discussed Al(22)Me structure and is 
attributed to the {Al-(S)-Namine, (R,R)-1,2-DACH} isomer exclusively, due to (R,R)-
1,2-DACH being used as the staring material disallowing its enantiomer {Al-(R)-
Namine, (S,S)-1,2-DACH}. Under the same principle the resonance at -0.42 ppm is 
attributed to the X-ray crystallography determined diastereomers {Al-(R)-Namine, 
(R,R)-1,2-DACH}. The N-Me resonances at 1.76 and 1.84 ppm were assigned to the 
{Al-(S)-Namine, (R,R)-1,2-DACH} and {Al-(R)-Namine, (R,R)-1,2-DACH} respectively. 
The Namine-C-H2 doublets at 2.94 ppm and 4.08 ppm confirm the presence of the 
{Al-(S)-Namine, (R,R)-1,2-DACH} diastereomer. Two doublets at 2.80 ppm and 3.72 
ppm were assigned to Namine-CH2 protons from the {Al-(R)-Namine, (R,R)-1,2-DACH}, 
the 4.08 ppm resonance is significantly shifted upfield from its analogous 3.72 ppm 
Namine-C-H2 resonance.  
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Figure 6.10: a) The 1H NMR spectrum of the crystallised product of Al(22)Me showing a bias 
towards the {Al-(S)-Namine, (R,R)-1,2-DACH} and {Al-(R)-Namine, (S,S)-1,2-DACH} enantiomer 
pairing. b) The 1H NMR spectrum for the further crystallised product from the same solution, 
resulting in a bias towards the {Al-(R)-Namine, (R,R)-1,2-DACH} and {Al-(S)-Namine, (S,S)-1,2-DACH} 
enantiomer pairing. 
 
 The exact diastereomers isolated is dependent upon the crystallisation 
conditions. A further attempt at synthesising Al(22)Me resulted in a mixture of 
diastereomers (Figure 6.10a), in this specific example the {Al-(R)-Namine, (R,R)-1,2-
DACH}/ {Al-(S)-Namine, (S,S)-1,2-DACH} enantiomer pairing was isolated in a 2:1 
majority. Further crystallisation of the resulting solution resulted in the opposite 
enantiomer pairing ({Al-(S)-Namine, (R,R)-1,2-DACH}/{Al-(R)-Namine, (S,S)-1,2-
DACH}) as the major product in a 2:1 ratio (Figure 6.10b). This dependence on 
crystallisation conditions is not a unique phenomenon and the other aluminium 
complexes discussed here have also been isolated as mixtures of diastereomers or 
specific enantiomer pairs. All of the aluminium methyl salalen complexes {Al(23-
25,28)Me} were isolated as the {Al-(R)-Namine, (R,R)-1,2-DACH}/{Al-(S)-Namine, 
(S,S)-1,2-DACH} enantiomer pairings with the exception of Al(22)Me (Figure 6.11).  
a) 
b) 
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Figure 6.11: Truncated 1H NMR spectrum showing aluminium methyl salalen complexes isolated 
enantiomer pairs. 
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Figure 6.12: 1H NMR spectrum for Al(25)OBn 
Al(28)Me 
Al(25)Me 
Al(24)Me 
Al(23)Me 
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The aluminium benzyloxy salalen complexes displayed similar characteristic 
to their aluminium methyl counterparts. The solid-state structure for the Al(25)OBn 
complex was identified as the {Al-(R)-Namine, (R,R)-1,2-DACH}/{Al-(S)-Namine, 
(S,S)-1,2-DACH} enantiomer pairing. Additionally one enantiomer pairing is 
observed in solution (Figure 6.12), the characteristic amine CH2 protons are 
represented as two doublets at 3.51 ppm and 2.67 ppm. In this case the doublet at 
2.67 ppm also coincides with a CH proton from the DACH ring. There is significant 
broadening of the CH2 protons about the OBn moieties representing a degree of 
fluxionality about the OBn group. 
2.53.03.54.04.55.05.5 ppm
Al(22)OBn
Al(23)OBn
Al(24)OBn
Al(27)OBn
 
Figure 6.13: 1H NMR spectra of Al(23-25,28)OBn salalen complexes isolated with an enantiomer 
pair as the major product. 
 
 Akin to the Al-Me salalen complexes the diastereomers isolated for the 
Al(22-30)OBn complexes is highly dependent upon crystallisation conditions. 
Al(24,25,28)OBn were obtained as the enantiomer pair {Al-(R)-Namine, 
(R,R)-1,2-DACH}/{Al-(S)-Namine, (S,S)-1,2-DACH} as the major product, as evident 
from the CH2 proton resonances of the 
1
H NMR spectra (Figure 6.13). Only 
Al(23)OBn formed the {Al-(S)-Namine, (R,R)-1,2-DACH}/{Al-(R)-Namine, 
(S,S)-1,2-DACH} enantiomer pair as the major product, indicated by the significant 
shift of the amine CH2 protons (Figure 6.13). The other aluminium benzyloxy 
{Al(22,26,27,29,30)OBn} complexes were isolated as a mixtures of diastereomers in 
approximate 1:1 ratios. 
Al(23)OBn 
Al(24)OBn 
Al(25)OBn 
Al(28)OBn 
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 Upon heating (80 °C, toluene) an aluminium salalen complex, which was 
isolated as a single enantiomer pairing, the alternate enantiomer pairing is formed. 
This observation is true for aluminium methyl salalen complexes and their benzyloxy 
derivatives. Significant inter-conversion occurs after exposure to elevated 
temperatures for 30 mins. This is clearly demonstrated by figure 6.14, Al(22)Me was 
heated (80 °C) for 4 hours and the resulting spectrum (figure 6.14) shows the 
presence of  two diastereomers. The stereomeric mixture equilibrates at a 1:1 ratio so 
there is presumably little difference in energy between the various diastereomers in 
solution. This is of significant importance, as rac-lactide ROP was conducted above 
80 °C. The complexes can be considered as mixtures of diastereomers within the 
polymerisations, irrelevant of the stereomeric form a specific aluminium salalen 
complex is isolated as. 
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Figure 6.14: a) 1H NMR spectrum of Al(22)Me at 20 °C. b) 1H NMR spectrum of Al(22)Me after 
heating (4h, 80 °C). 
 
6.4 Ring-Opening-Polymerisation of rac-Lactide  
 The aluminium salalen complexes were trialled as initiators for the ROP of 
rac-lactide in solution and solvent free conditions. The aluminium methyl salalen 
complexes require the addition of one equivalent of benzyl alcohol as a co-initiator to 
a) 
b) 
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form the presumed in-situ benzyloxy complex. The isolated aluminium benzyloxy 
complexes were utilised without the addition of a co-initiator. Only the aluminium 
salalen benzyloxy complexes were used for solvent free ROP reactions due to 
practical complications.   
 
6.4.1 Solution ROP of rac-lactide 
 Solution polymerisations were performed in 10 ml of toluene at 80 °C using 
1.0 g of rac-lactide in all cases. A 100:1 lactide to initiator ratio was utilised and one 
equivalent of benzyl alcohol was introduced as a co-initiator where required. 
Aluminium salen complexes are typically slow,
5, 6
 particularly in the case of salen 
complexes with a 1,2-DACH bridging group where 12 days was required to achieve 
appreciable conversion at 70 °C.
7
 Within this report a typical polymerisation required 
4 days to reach acceptable conversions, the data is given in table 6.03. 
Polymerisations of rac-lactide using Al(25)OBn and Al(28)OBn initiators yielded 
low conversion and as such were repeated and allowed 10 days reaction time.  
 The reactions reached appreciable conversion although the presence of a 
t
Bu 
group on the salen moiety significantly reduced conversion. This is presumably a 
steric effect although this is in conjunction with the orientation of the salen phenoxy, 
as the same effect is not observed to such a degree when considering the salan 
section. The effect of the salen phenoxy substituent upon rate is investigated later in 
this chapter (see figure 6.18). Molecular weight distributions are narrow with PDI 
values ranging between 1.06 - 1.67. The resulting tacticity of the PLA is defined by 
the phenoxy group substituents upon the Al salalen initiators. The initiators 
containing 
t
Bu-phenoxy substituents on the imine and amine sections {Al(22)Me, 
Al(R,R-22)Me, Al(22)OBn} were the least active initiators investigated in this series. 
The molecular weights (Mn) were much higher than anticipated for the low 
conversion polymers produced by Al(22)Me and Al(R,R-22)Me initiators. It was 
speculated that not all of the Al(22)Me and Al(R,R-22)Me initiators initiated a 
growing polymer chain. 
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Time 
(days) 
Conv.  
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d 
Al(22)Me 4  34 5000 8950
 
1.06 0.49 
Al(R,R-22)Me 4 30 4400 10100
 
1.06 0.55 
Al(22)OBn 4 26 3900 3750 1.08 0.54 
Al(23)Me 4  71 10300 12200 1.07 0.65 
Al(23)OBn 4 91 13200 19550 1.12 0.61 
Al(24)Me 4 97 14100 17150 1.35 0.60 
Al(24)OBn 4 99 14400 17000 1.18 0.69 
Al(25)Me 4  83 12100 7700 1.06 0.57 
Al(25)OBn 10 40 5900 6400 1.08 0.42 
Al(26)OBn 4  96 13900 24600 1.12 0.56 
Al(27)OBn 4 96 13900 19900 1.27 0.54 
Al(28)Me 4 61 8900 7100 1.07 0.54  
Al(28)OBn 10 49 7200 8300 1.06 0.31 
Al(29)OBn 4 96 13900 14600 1.67 0.54 
Al(30)OBn 4  99 14400 19350 1.15 0.73 
 
Table 6.03: Solution ROP of rac-lactide for Al(22-25,28)Me and Al(22-30)OBn initiators. 10 ml of 
toluene, 80 °C, 100:1:1 [rac-lactide]:[initiator]:[benzyl alcohol]*where required. a Conversion 
ascertained by 1H NMR spectroscopy. b Theoretical molecular weight calculated from conversion 
(Conv. × 100 × 144.13 + 108.14), c Molecular weight and PDI determined by GPC (THF) using 
polystyrene standards without applying a correction factor. d Pr as calculated from 
1H NMR 
homonuclear decoupling spectroscopy in CDCl3. 
 
 A slight heterotactic bias was typically obtained when the salan phenoxy 
contained 
t
Bu moieties Al(23,24)Me/OBn. Interestingly, the introduction of 
t
Bu 
group upon the salen phenoxy resulted in the production of PLA with a slight 
isotactic bias for Al(25,28)OBn initiators (Figure 6.15), this was not observed for 
Al(22)OBn or analogous Al(25,28)Me initiators. Moreover, the in-situ reactions 
using Al(22-25,28)Me initiators with BnOH co-initiator gave different yields and 
selectivity than their Al(22-25,28)OBn analogues. It was postulated that multiple 
initiating species were being produced during the in-situ reactions, whereas the 
isolated Al(22-25,28)OBn initiators were comparatively well defined.  
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Figure 6.15: 1H NMR homonuclear decoupled spectrum showing tetrad resonances for the ROP of 
rac-lactide by Al(28)OBn in toluene at 80 °C. 
 
 The introduction of chloro-substituents upon the salen phenoxy ring gave an 
increase in conversion all achieving > 96 % conversion after 4 days at 80 °C in 
toluene (See table 6.03; Al(24)Me, Al(24,27,30)OBn). Narrow molecular weight 
distributions were still obtained and the resulting PLA revealed some heterotactic 
selectivity (Pr = 0.54 – 0.73). The homonuclear decoupled 
1
H NMR spectrum for 
PLA produced by Al(30)OBn is given in figure 6.16, a clear enhancement of the [isi] 
and [sis] tetrads at 5.15 ppm and 5.22 ppm is observed. This switch to a heterotactic 
preference and enhanced activity is presumably an electronic effect, a direct result of 
the chloro-phenoxy substituents. The 1,2-DACH salalen aluminium initiators series 
show enhanced rates when compared to prior 1,2-DACH salen aluminium initiators, 
although the stereoselectivity was not maintained.
7,  8
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Figure 6.16: 1H NMR homonuclear decoupled spectrum showing tetrad resonances for the ROP of 
rac-lactide by Al(30)OBn in toluene at 80 °C. 
 
6.4.2 Solvent free ROP of rac-lactide 
Solvent free polymerisations were performed at 130 °C where 1.0 g of 
rac-lactide was melted in the presence of Al(22-30)OBn initiators, the reaction was 
allowed to proceed for the amount of time given in table 6.04. The isolated 
benzyloxy initiators {Al(22-30)OBn} allowed the solvent free ROP reactions to be 
conducted. When the aluminium salalen initiator contained chloro or hydrogen 
substituents on both the salan and salen phenoxy groups good conversion is obtained 
in 2 h. On the other hand the steric bulk associated with the 
t
Bu moieties of the 
initiator Al(22)OBn reduces activity, hence 48 hours is required for appreciable 
conversion to be obtained. It was speculated that isolated complex diastereomers 
interconvert at the higher temperatures in melt conditions, although direct analysis of 
the initiators under these condition is complicated.  
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 Time (h) 
Conv.  
(%)
a 
Mn
b
 
(theo) 
Mn
c 
PDI
c 
Pr
d 
Al(22)OBn 48 30 13100 7850 1.07 0.54 
Al(23)OBn 24 85 36900 57600 1.51 0.58 
Al(24)OBn 24 91 39500 48150 1.71 0.64 
Al(25)OBn 24 27 11800 9100 1.06 0.41 
Al(26)OBn 2 42 18300 28700 1.07 0.51 
Al(27)OBn 2 94 40800 33350 1.10 0.57 
Al(28)OBn 24 68 29500 14300 1.56 0.43 
Al(29)OBn 2 98 42500 46550 1.47 0.61 
Al(30)OBn 24 60 26100 23350 1.14 0.72 
 
Table 6.04: Solvent free ROP of rac-lactide for initiators Al(22-30)OBn at 130 °C, 300:1 
[rac-lactide]:[initiator] ratio. a Conversion ascertained by 1H NMR spectroscopy. b Theoretical 
molecular weight calculated from conversion (Conv. × 300 × 144.13 + 108.14), c Molecular weight 
and PDI determined by GPC (THF) using polystyrene standards without applying a correction factor. 
d Pr as calculated from 
1H NMR homonuclear decoupling spectroscopy in CDCl3. 
 
 The melt polymerisation data is shown in table 6.04, notably 
t
Bu moieties on 
either the salan or salen phenoxy groups gave lower conversions. At elevated 
temperature narrow molecular weight distributions could still be obtained for 
Al(22,25-27,30)OBn (PDI = 1.06 - 1.14). Parallel to the solution ROP of rac-lactide 
heterotacticly biased PLA was obtained when chloro substituents were present on the 
salen phenoxy (Pr = 0.57 – 0.72), no loss in stereoselectivity was observed at the 
elevated temperature. The homonuclear decoupled 
1
H NMR spectrum of PLA 
produced by Al(30)OBn used to determine PDI is given in figure 6.17, a significant 
enhancement of the [isi] and [sis] tetrads is shown. Analogous to the solution state 
polymerisations 
t
Bu groups on the salen segment results in a slight isotactic bias 
(Pr = 0.41 – 0.43), with the exception of the Al(22)OBn initiator. 
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Figure 6.17: 1H NMR homonuclear decoupled spectrum showing tetrad resonances for the ROP of 
rac-lactide by Al(30)OBn under solvent free conditions. 
 
6.4.3 Kinetic investigation for the solution ROP of rac-lactide 
 Kinetic experiments were performed to analyse the apparent rate of 
propagation of the ROP of rac-lactide by 1,2-DACH aluminium salalen complexes. 
The effect of the changing the substituents on the salen phenoxy was investigated. 
The kinetic experiments were performed on an NMR scale using 0.05 g of 
rac-lactide in a 100:1 ratio with an aluminium initiator {Al(25-27)OBn} at 80 °C in 
d8-toluene. The graph of ln([LA]0/[LA]t) versus time gave pseudo first order linear 
plots (Figure 6.18). The aluminium salalen complexes chosen for kinetic analysis 
contained hydrogen substituents on the salan phenoxy, 
t
Bu, H, and Cl substituents 
were investigated on the salen phenoxy. The apparent first order rate constant was 
determined from the graph given in figure 6.18. When 
t
Bu and H substituents are 
present upon the phenoxy ring long reaction times are required hence the spectra 
were recorded in greater than 24 h intervals. Contrastingly Cl substituents resulted in 
very high conversion after 24 h, hence a spectrum was recorded at 15 mins intervals. 
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Figure 6.18: Pseudo first order plots for the ROP of rac-lactide by Al(25-27)OBn. 50 mg of 
rac-lactide in 0.6 ml of d8-toluene at 80 °C at 100:1 [rac-lactide]:[initiator] ratio. 
 
 
kapp (min
-1
) 
(× 10
-5
)
 R
2
 
Al(25)OBn 2.00(7) 0.9946 
Al(26)OBn 24.0(7) 0.9972 
Al(27)OBn 153.7(1) 1.0000 
 
Table 6.05: kapp values and R
2 values for ROP of rac-lactide by Al(25-27)OBn initiators 
 
 It can be clearly seen that 
t
Bu salen phenoxy substituents hinder the ROP 
reaction rate, kapp = 2.00 × 10
-5
 min
-1
 (Table 6.05). A significant enhancement of 
around two orders of magnitude (152.71 × 10
-5
 min
-1
) is observed when Cl moieties 
are present on the salen phenoxy ring. Previous salalen aluminium initiators trialled 
for the ROP of rac-lactide within the Jones group gave first order kapp between 
13.80 × 10
-5
 - 33.53 × 10
-5
 min
-1
 for 
t
Bu, Me, and H salan ortho-phenoxy 
substituents.
11
 The 1,2-DACH salan complex synthesised by Feijen et al.
10
 analogous 
to Al(26)OBn, containing hydrogen phenoxy substituents, gave a 
kapp = 448 × 10
-5
 min
-1
. Feijen et al.
10
 also reported that Cl substituents on salan 
phenoxy groups gave a reduction in apparent rate, kapp = 93.7 × 10
-5
 min
-1
. 
Al(25)OBn 
ln
{[
L
A
] 0
/L
A
] t
} 
Time (h) 
Al(26)OBn 
Al(27)OBn 
 219 
Previously reported salen rac-1,2-DACH complexes for the ROP of rac-lactide by 
Feijen et al.
8
 gave kapp = 11.6 × 10
-5
 min
-1
 at 70 °C (62:1 rac-lactide to initiator ratio) 
this is comparable to the kapp reported for the ROP of rac-lactide by the salalen 
complex Al(25)OBn. 
 Kinetic investigations of the ROP of rac-lactide by Al(28)Me and Al(28)OBn 
was conducted. The experiments were performed at 80 °C in d8-toluene using 0.05 g 
of rac-lactide in a 20:1 ratio, one equivalent of BnOH was added to the Al(28)Me 
initiated polymerisation. Apparent rates of propagation (kapp) were obtained from the 
gradient of pseudo first order rate plots (Figure 6.19). The in-situ Al(28)Me + BnOH 
initiator system was more than two times faster (kapp = 20.82 × 10
-5
 min
-1
) than the 
less active Al(28)OBn initiator (kapp = 9.51 × 10
-5
 min
-1
) (Table 6.06). The expected 
initiating species from the in-situ reaction of Al(28)Me + BnOH is Al(28)OBn. This 
rate difference indicated the active species from the in-situ reaction of Al(28)Me + 
BnOH were not identical to the isolated Al(28)OBn initiator. This demonstrates the 
formation of a discrete metal co-initiator species cannot always be assumed within 
in-situ ROP reactions. 
 
Figure 6.19: Pseudo first order plots for the ROP of rac-lactide by Al(28)Me with one equivalent of 
benzyl alcohol and Al(28)OBn at 80 °C in d8-toluene. 50 mg of rac-lactide in 0.6 ml of d8-toluene at 
80 °C at 20:1 [rac-lactide]:[initiator] ratio, one equivalent of BnOH was added in-situ to the Al(28)Me 
initiator. 
Al(28)OBn 
Al(28)Me 
ln
{[
L
A
] 0
/L
A
] t
} 
Time (h) 
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kapp (min
-1
) 
(×10
-5
)
 R
2
 
Al(28)Me 20.8(6) 0.9971 
Al(28)OBn 9.51(5) 0.9983 
 
Table 6.06: kapp values and R
2 values for ROP of rac-lactide by Al(28)Me and Al(28)OBn initiators.  
 
6.5 Conclusion  
 Further salalen ligands with a 1,2-DACH backbone {(22-30)H2} were 
synthesised and characterised to expand the derivatives library for these ligands. 
Aluminium methyl complexes Al(22-30)Me were synthesised along with their 
benzyloxy derivatives Al(22-30)OBn. The majority of aluminium complexes 
{Al(22-25,28)Me, Al(22-30)OBn} were characterised by 
1
H, 
13
C{
1
H} NMR 
spectroscopy and CHN analysis. Solid-state structures for Al(22)Me, Al(R,R-22)Me, 
and Al(25)OBn were determined by X-ray diffraction. X-ray diffraction 
demonstrated; Al(22)Me existed as the {Al-(S)-Namine, (R,R)-1,2-DACH}/{Al-(R)-
Namine, (S,S)-1,2-DACH} diastereomers, Al(R,R-22)Me existed as the {Al-(R)-Namine, 
(R,R)-1,2-DACH} diastereomer, Al(25)OBn existed as the {Al-(R)-Namine, (R,R)-1,2-
DACH}/{Al-(R)-Namine, (R,R)-1,2-DACH} diastereomers. NMR spectroscopic 
investigations showed the isolation of isomers was possible with a dependence upon 
crystallisation conditions. However, in solution these isomers interconvert at high 
temperature (80 °C).  
 The ROP of rac-lactide was conducted using Al(22-25,28)Me, Al(R,R-22)Me, 
and Al(22-30)OBn initiators to investigate the effect of substituents (R = 
t
Bu, H, and 
Cl) upon the imine (salen) side and amine (salan) side. Al(22-25,28)Me and 
Al(R,R-22)Me were investigated for the polymerisation of rac-lactide with benzyl 
alcohol as a co-initiator. The solution (toluene) ROP of rac-lactide attained 
appreciable conversion for the majority of cases in 4-10 days (80 ºC, 100:1 
[rac-lactide]:[initiator] ratio). The solvent free ROP of rac-lactide resulted in 
appreciable conversion for Al(22-30)OBn initiators between 2-48 hours dependent 
upon the phenoxy substituents. Bulky 
t
Bu phenoxy groups had a negative impact 
upon polymerisation rate, where rate follows Cl > H > 
t
bu for Al(25-27)OBn 
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initiators. Selectivity ranged from moderately isotactic to moderately heterotactic 
(Pr = 0.31 - 0.73). Al(25,28)OBn initiators gave the strongest isotactic bias 
(Pr = 0.31 - 0.43) and Al(30)OBn revealed the strongest heterotactic bias 
(Pr = 0.72 - 0.73). A greater than two fold rate difference was observed between 
Al(28)Me + BnOH (kapp = 20.82 × 10
-5
 min
-1
) and isolated Al(28)OBn initiator 
(kapp = 9.51 × 10
-5
 min
-1
). This prompted speculation that the active species from 
Al(28)Me + BnOH contained other initiating complexes than just the Al(28)OBn 
species. 
 
6.6 Future Work  
 Further derivatives of 1,2-DACH salalen ligands could be synthesised, firstly 
the phenol substituents could be varied. The amine-methyl group could also be 
varied as previous work on salalen complexes has shown this substituent region can 
affect the initiator properties.
11
 Other metals can be trialled with this ligand set, e.g. 
group 4, indium, and lanthanides are possible candidates. The presence of one 
initiating benzyloxy group upon the aluminium metal makes these initiators 
candidates for initiating co-polymerisation reactions with other cyclic esters. Other 
salalen ligands could be synthesised with differing linking diamines, a notable 
candidate is based upon the salen ligands synthesised by Nomura et. al.,
6
 the possible 
salalen variant is given in figure 6.20. 
 
Figure 6.20: Potential aluminium salalen complex for the ROP of rac-lactide. 
 
6.7 Final concluding remarks  
The homo/piperazine based salan ligands gave 2:1 titanium to ligand 
complexes {Ti2(1-5,8-9,12-13)(O
i
Pr)6} with an interesting equilibrium based upon 
the steric demands of the ortho-phenoxy substituents. The bimetallic titanium 
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complexes were active for the ROP of lactide but lacked control over molecular 
weight and resulted in predominately atactic PLA. Homopiperaine salan group 4 
monometallic complexes were formed and the titanium complexes {Ti(6-11)(O
i
Pr)2} 
were poor initiators most likely due to hindrance about the titanium metal. The 
zirconium and hafnium homopiperazine salan complexes {Zr/Hf(6-9,10)(O
i
Pr)2} 
resulted in mostly atactic lactide but the hafnium initiators {Hf(6,7)(O
i
Pr)2} resulted 
in an isotactic biased PLA from rac-lactide in solvent and solvent free conditions. 
Aluminium benzyloxy and aluminium methyl homopiperazine salan complexes were 
synthesised as monometallic complexes. The aluminium benzyloxy homopiperazine 
salan complexes {Al(6-9,11)OBn} were shown to be active under solvent free 
conditions for the ROP of rac-lactide, ε-caprolactone, and δ-valerolactone. 
1,4-DACH salen titanium and aluminium bimetallic complexes {Ti2(16-18)(O
i
Pr)6, 
Al2(16-18)Me4} were isolated with bulky ortho-phenoxy substituents and proven to 
be active initiators for the ROP of lactide. The aluminium 1,4-DACH based salen 
complexes {Al2(16-18)Me4} were shown to polymerise lactide in an immortal 
manner and resulted in isotactic biased PLA. A systematic study of 1,2-DACH 
salalen complexes {Al(22-25,28)Me, Al(22-30)OBn} was conducted and the 
phenoxy substituents on the imine and amine side were systematically investigated. 
Imine phenoxy substituents were shown to have the most prominent effect upon 
activity and stereoselectivity. Additionally isolated aluminium benzyloxy 1,2-DACH 
salalen complexes and aluminium benzyloxy 1,2-DACH salalen complexes formed 
in-situ within a polymerisation were compared, where the initiators formed in-situ 
resulted in reduced selectivity. 
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7. Experimental 
7.1 General Experimental Considerations  
Metal complex preparations and characterisations were performed under dry 
inert gas atmosphere (N2 or Ar) using standard Schlenk line and glove box 
techniques. Dry solvents were collected from an MBraun solvent purification system 
(SPS) for the handling of and preparation of metal complexes. Laboratory reagent 
grade solvents were used for the preparation of ligands. All chemicals were 
purchased from Sigma-Aldrich and used without further purification unless stated. 
Ti(O
i
Pr)4 (97 %, Aldrich) was purified by vacuum distillation and stored under inert 
atmosphere within a young’s ampoule. Rac-lactide was crystallised from high purity 
toluene obtained from an MBraun SPS system and sequentially sublimed twice 
before glove-box storage under inert atmosphere. ε-caprolactone and 
δ-valereolactone were purified by vacuum distillation before storage under inert 
atmosphere.  
 
1
H and 
13
C{
1
H} NMR spectra were recorded with a Bruker 250, 300, 400 or 
500 MHz instrument and referenced to residual solvent peaks. NMR spectroscopy 
analysis was conducted in CDCl3, C6D5CD3, or C4D8O. CDCl3 was dried by 
distillation from calcium hydride, before use with metal complexes. C6D5CD3 and 
C4D8O were dried over molecular sieves before use. NMR tubes fitted with Young’s 
taps were utilised for analysis of metal complexes, high temperature, and kinetic 
experiments. Ligands dissolved in acetonitrile were analysed by high resolution mass 
spectrometry on a micrOTOFQ (ESI-TOF) spectrometer in the positive mode. CHN 
elemental analysis data was recorded by either Mr. A. Craver (at the University of 
Bath, on an Exeter Analytical CE440 Elemental Analyzer) or by Mr Stephen Boyer 
(London Metropolitan University). X-ray diffraction data was collected on a Nonius 
Kappa CCD diffractometer using Mo-Kα radiation (λ = 0.71073 Å) at 150 K. X-ray 
diffraction data for Ti2(1)2(O
i
Pr)4 was recorded at the diamond synchrotron facility 
using X-ray wavelength of λ = 0.6889 Å at 150 K by Dr Mary Mahon. All structures 
were solved by direct methods and refined on all F
2
 data using the SHELXL-97 suite 
of programs. All hydrogen atoms were included in idealised positions and refined 
using the riding model.  
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7.2 General Polymerisation Procedures  
 
1
H Homonuclear decoupled NMR spectroscopy was preformed on a Bruker 
400 MHz spectrometer for determination of Pr (Pr = the probability of heterotactic 
linkages) values of rac-lactide polymers. This was found through analysis of the 
decoupled methine region of the spectra by Bernoulli statistics discussed by Coates 
et al.
1
 Polymers were analysed by GPC on a Polymer Laboratories PL-GPC 50 
integrated system using a PLgel 5 μm MIXED-D 300 × 7.5 mm column at 35°C with 
a flow rate of 1 ml min
-1
. Samples were solubilised in THF and filtered through a 
PTFE 0.2 μm filter prior to auto-sampler injection. The polymers are analysed by 
refractive index which was referenced against 11 narrow molecular weight 
polystyrene polymer standards giving a calibrated range of Mw 615-568000 Da. The 
PDI is calculated from Mw/Mn (Mw = weight average molecular weight, Mn = number 
average molecular weight). MALDI-TOF mass spectrometry analysis of polymers 
was conducted by the EPSRC National Mass Spectrometry service Centre, Swansea, 
UK on the Applied Biosystems Voyager DE-STR instrument. The samples were 
dissolved in THF and analysed in positive-reflection mode using a dithranol matrix 
with a NaOAc additive to promote positive ionisation. 
 
7.3 Homo/Piperazine Salan Ligand Preparation for Chapters 2-4 
1H2. 2,4-di-methylphenol (8.50 g, 69.6 mmol), piperazine anhydrous (3.00 g, 34.8 
mmol), and formaldehyde (38% in H2O) (5.78 ml, 2.35 g, 78.1 mmol) were refluxed 
in MeOH (40 ml) for 24 h. During which time a white precipitate was observed this 
was filtered and washed with cold MeOH and dried to yield a white solid (5.64 g, 
15.9 mmol, 46 %). 
1
H NMR (CDCl3): δ 2.22 (6H, s, Me), 2.23 (6H, s, Me), 2.30 – 
3.20 (8H, br, ring-CH2), 3.67 (4H, s, N-CH2-Ar), 6.65 (2H, d, J = 1.5 Hz, ArH), 6.85 
(2H, d, J = 1.5 Hz, ArH), 10.54 (2H, br, OH). 
13
C{
1
H} NMR (CDCl3): δ 15.7 (CH3), 
20.5 (CH3), 52.4 (CH2), 61.4 (CH2), 119.9 (Ar), 124.7 (Ar), 126.9 (ArH), 127.9 (Ar), 
138.8 (ArH), 153.4 (ArO). Calc. m/z [C22H30N2O2 + H]
+
 355.2385. Found 355.2488. 
 
2H2. 2-methyl-4-tert-butylphenol (3.97 g, 22.4 mmol), piperazine anhydrous (1.00 g, 
11.6 mmol), and formaldehyde (38% in H2O) (1.92 ml, 0.78 g, 26.0 mmol) were 
refluxed in MeOH (25 ml) for 24 h. During which time a white precipitate was 
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observed this was filtered and washed with cold MeOH and dried to yield a white 
solid (1.20 g, 2.7 mmol, 24 %). 
1
H NMR (CDCl3): δ 1.28 (18H, s, 
t
Bu), 2.24 (6H, s, 
CH3), 2.30 – 3.20 (8H, br, ring-CH2), 3.71 (4H, s, N-CH2-Ar), 6.84 (2H, d, J = 2.0 
Hz, ArH), 7.08 (2H, d, J = 2.0 Hz, ArH), 10.67 (2H, br, OH). 
13
C{
1
H} NMR (CDCl3): 
δ 16.1 (CH3), 31.7 (CH3), 33.9 (C), 52.5 (CH2), 61.8 (CH2), 119.5 (Ar), 123.2 (ArH), 
124.2 (Ar), 127.1 (ArH), 141.6 (Ar), 153.4, (ArO). Calc. m/z [C28H42N2O2 + H]
+
 
439.3325. Found 439.3306. 
 
3H2. 2,4-di-tert-butylphenol (14.37 g, 69.7 mmol), piperazine anhydrous (3.00 g, 
34.8 mmol), and of formaldehyde (38% in H2O) (5.78 ml, 2.35 g, 78.14 mmol) were 
refluxed in MeOH (40 ml) for 24 h. During which time a white precipitate was 
observed this was filtered and washed with cold MeOH and dried to yield a white 
solid (13.31 g, 25.5 mmol, 73 %). 
1
H NMR (CDCl3): δ 1.28 (18H, s, 
t
Bu), 1.42 (18H, 
s, 
t
Bu), 2.10 – 3.20 (8H, br, ring-CH2), 3.72 (4H, s, N-CH2-Ar), 6.84 (2H, d, J = 2.5 
Hz , ArH), 7.23 (2H, d, J = 2.5 Hz, ArH), 10.68 (2H, br, OH). 
13
C{
1
H} NMR 
(CDCl3): δ 29.7 (CH3), 31.8 (CH3), 34.3 (C), 35.0 (C), 52.3 (CH2), 62.1 (CH2), 120.4 
(Ar), 123.2 (ArH), 123.7 (ArH), 135.7 (Ar), 140.9 (Ar), 154.2, (ArO). Calc. m/z 
[C22H30N2O2 + H]
+
 523.4263. Found 523.4366. 
 
4H2. 2-tert-butyl-4-methylphenol (7.63 g, 46.5 mmol), piperazine anhydrous (2.00 g, 
23.2 mmol), and formaldehyde (38% in H2O) (3.85 ml, 1.57 g, 52.1 mmol) were 
refluxed in MeOH (30 ml) for 24 h. During which time a white precipitate was 
observed this was filtered and washed with cold MeOH and dried to yield a white 
solid (5.66 g, 12.9 mmol, 56 %). 
1
H NMR (CDCl3): δ 1.41 (18H, s, 
t
Bu), 2.25 (6H, s, 
Me), 2.30 – 3.20 (8H, b, ring-CH2), 3.69 (4H, s, N-CH2-Ar), 6.68, (2H, s, ArH), 7.01 
(2H, s, ArH), 10.68 (2H, b, OH). 
13
C{
1
H} NMR (CDCl3): δ 20.9 (CH3), 29.6 (CH3), 
34.7 (C), 52.2 (CH2), 61.3 (CH2), 121.0 (Ar), 126.9, 127.5 (ArH), 127.1 (Ar), 136.4 
(Ar), 154.2 (ArO). Calc. m/z [C28H42N2O2 + H]
+
 439.3325. Found 439.3308. 
 
5H2. 2,4-di-tert-amylphenol (5.44 g, 23.2 mmol), piperazine anhydrous (1.00 g, 11.6 
mmol), and formaldehyde (38% in H2O) (1.92 ml, 0.78 g, 26.0 mmol) were refluxed 
in MeOH (25 ml) for 24 h. During which time a white precipitate was observed this 
was filtered and washed with cold MeOH and dried to yield a white solid (1.84 g, 3.2 
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mmol, 28 %). 
1
H NMR (CDCl3): δ 0.62 (6H, t, J = 7.5 Hz, CH3), 0.64 (6H, t, J = 7.5 
Hz, CH3), 1.24 (12H, s, CH3), 1.36 (12H, s, CH3), 1.57 (4H, q, J = 7.5 Hz, CH2), 1.88 
(4H, q, J = 7.5 Hz, CH2), 2.30 – 3.20 (8H, br, ring-CH2), 3.67 (4H, s, N-CH2-Ar), 
6.76 (2H, d, J = 2.0 Hz, ArH), 7.08 (2H, d, J = 2.0 Hz, ArH), 10.55 (2H, br, OH). 
13
C{
1
H} NMR (CDCl3): δ 9.3 (CH3), 9.7 (CH3), 27.7 (CH2), 28.7 (CH3), 33.1 (CH2), 
37.3 (C), 38.5 (C), 52.2 (CH2), 61.2 (CH2), 120.1 (Ar), 124.3 (ArH), 125.3 (ArH), 
133.9 (Ar), 139.0 (Ar), 153.9 (ArO). Calc. m/z [C38H63N2O2 + H]
+
 579.4890. Found 
579.4906. 
 
6H2. 2,4-di-methyl-butylphenol (2.44 g, 20.0 mmol), homo-piperazine (1.00 g, 10.0 
mmol), and formaldehyde (38% in H2O) (1.67 ml, 0.68 g, 22.6 mmol) were refluxed 
in MeOH (20 ml) for 24 h. During which time a white precipitate was observed this 
was filtered and washed with cold MeOH and dried to yield a white solid (1.84 g, 5.0 
mmol, 50 %). 
1
H NMR (CDCl3): δ 1.93 (2H, quin, J = 6.1 Hz, CH2), 2.22 (12H, s, 
Me), 2.78 (4H, s,
 
ring-CH2), 2.83 (4H, t, J = 6.2 Hz, ring-CH2), 3.74 (4H, s, N-CH2-
Ar), 6.62 (2H, s, ArH), 6.87 (2H, s, ArH), 10.82 (2H, br, OH). 
13
C{
1
H} NMR 
(CDCl3): δ 15.7 (CH3), 20.5 (CH3), 26.7 (CH2), 53.5 (CH2), 54.6 (CH2), 62.0 (CH2), 
120.1 (Ar), 124.7 (Ar), 126.7 (ArH), 127.7 (Ar), 130.7 (ArH), 153.7, (ArO). Calc. 
m/z [C23H32N2O2 + H]
+
 369.2542. Found 369.2530. 
 
7H2. 2-methyl-4-tert-butylphenol (3.28 g, 20.0 mmol), homo-piperazine (1.00 g, 10.0 
mmol), and formaldehyde (38% in H2O) (1.66 ml, 0.67 g, 22.5 mmol) were refluxed 
in MeOH (20 ml) for 24 h. During which time a white precipitate was observed this 
was filtered and washed with cold MeOH and dried to yield a white solid (1.68 g, 3.7 
mmol, 37 %). 
1
H NMR (CDCl3): δ 1.28 (18H, s, 
t
Bu), 1.95 (2H, quin, J = 6.0 Hz, 
CH2), 2.25 (6H, s,
 
CH3), 2.80 (4H, s, ring-CH2), 2.85 (4H, t, J = 6.0 Hz, ring-CH2), 
3.78 (4H, s, N-CH2-Ar), 6.81 (2H, d, J = 2.3 Hz, ArH), 7.08 (2H, d, J = 2.3 Hz, ArH), 
10.95 (2H, br, OH). 
13
C{
1
H} NMR (CDCl3): δ 16.1 (CH3), 26.8 (CH2), 31.8 (CH3), 
34.0 (C), 53.6 (CH2), 54.8 (CH2), 62.5 (CH2), 120.4 (Ar), 123.0 (ArH), 124.2 (Ar), 
127.1 (ArH), 141.4 (Ar), 153.7, (ArO). Calc. m/z [C29H44N2O2 + H]
+
 453.3481. 
Found 453.3497. 
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8H2. 2,4-di-tert-butylphenol (4.12 g, 20.0 mmol), homo-piperazine (1.00 g, 10.0 
mmol), and formaldehyde (38% in H2O) (1.66 ml, 0.67 g, 24.5 mmol) were refluxed 
in MeOH (20 ml) for 24 h. During which time a white precipitate was observed this 
was filtered and washed with cold MeOH and dried to yield a white solid (1.29 g, 2.4 
mmol, 24 %). 
1
H NMR (CDCl3): δ 1.28 (18H, s, 
t
Bu), 1.42 (18H, s, 
t
Bu), 1.91 (2H, 
quintet, J = 6.0 Hz, ring-CH2), 2.78 (4H, s, ring-CH2), 2.83 (4H, t, J = 6.0 Hz, ring-
CH2), 3.77 (4H, s, N-CH2), 6.84 (2H, d, J = 2.5 Hz, ArH), 7.23 (2H, d, J = 2.5 Hz, 
ArH), 10.68 (2H, br, OH). 
13
C{
1
H} NMR (CDCl3): δ 26.9 (CH2), 29.7 (CH3), 31.8 
(CH3), 34.2 (C), 35.0 (C), 52.2 (CH2), 54.6 (CH2), 62.6 (CH2), 121.4 (Ar), 123.1 
(ArH), 123.6 (ArH), 135.8 (Ar), 140.7 (Ar), 154.4, (ArO). Calc. m/z [C35H56N2O2 + 
H]
+
 537.4420. Found 537.4442. 
 
9H2. 2-tert-butyl-4-methylphenol (3.28 g, 20.0 mmol), homo-piperazine (1.00 g, 10.0 
mmol), and formaldehyde (38% in H2O) (1.66 ml, 0.67 g, 22.5 mmol) were refluxed 
in MeOH (20 ml) for 24 h. During which time a white precipitate was observed this 
was filtered and washed with cold MeOH and dried to yield a white solid (1.56 g, 3.5 
mmol, 35 %). 
1
H NMR (CDCl3): δ 1.42 (18H, s, 
t
Bu), 1.89 (2H, quin, J = 6.1 Hz, 
CH2), 2.24 (6H, s, CH3), 2.77 (4H, s, ring-CH2), 2.81 (4H, t, J = 6.0 Hz, ring-CH2), 
3.75 (4H, s, N-CH2-Ar), 6.66 (2H, d, J = 1.9 Hz, ArH), 7.01 (2H, d, J = 2.3 Hz, ArH), 
11.00 (2H, br, OH). 
13
C{
1
H} NMR (CDCl3): δ 20.9 (CH2), 26.9 (CH3), 29.6 (CH3), 
34.7 (C), 53.2 (CH2), 54.6 (CH2), 62.1 (CH2), 122.0 (Ar), 126.9 (ArH), 127.3 (Ar), 
127.4 (ArH), 136.6 (Ar), 154.6, (ArO). Calc. m/z [C29H44N2O2 + H]
+
 453.3481. 
Found 453.3494. 
 
10H2. 2,4-di-tert-amylphenol (4.68 g, 20.0 mmol), homo-piperazine (1.00 g, 10.0 
mmol), and formaldehyde (38% in H2O) (1.67 ml, 0.68 g, 22.5 mmol) were refluxed 
in MeOH (20 ml) for 24 h. During which time a white precipitate was observed this 
was filtered and washed with cold MeOH and dried to yield a white solid (1.85 g, 3.1 
mmol, 31 %). 
1
H NMR (CDCl3): δ 0.64 (12H, q, J = 7.6 Hz CH3), 1.23 (12H, s, CH3), 
1.37 (12H, s, CH3), 1.57 (4H, quart, J = 7.5 Hz, CH2), 1.90 (4H, quart, J = 7.3 Hz, 
CH2), 1.90 (2H, s, ring-CH2), 2.74 (4H, s, ring-CH2), 2.81 (4H, t, J = 5.8 Hz, ring-
CH2), 3.76 (4H, s, N-CH2-Ar), 6.74 (2H, d, J = 2.3 Hz, ArH), 7.07 (2H, d, J = 2.5 Hz, 
ArH), 10.87 (2H, br, OH). 
13
C{
1
H} NMR (CDCl3): δ 9.3 (CH3), 9.7 (CH3), 26.8 
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(CH2), 27.8 (CH3), 28.7 (CH3), 33.2 (C), 37.3 (C), 37.4 (CH2), 38.5 (CH2), 53.1 
(CH2), 54.6 (CH2), 62.6 (CH2), 121.1 (Ar), 124.2 (ArH), 125.2 (ArH), 134.0 (Ar), 
138.9 (Ar), 154.2 (ArO). Calc. m/z [C39H64N2O2 + H]
+
 593.5046. Found 593.4993. 
 
11H2. homopiperazine anhydrous (2.20 g, 25 mmol) and formaldehyde (38% in H2O) 
(5.30 ml, 75.4 mmol) were refluxed (2 h) in MeOH (40 ml). The solution was then 
cooled to room temperature and 4-tert-butylphenol (7.51 g, 50.0 mmol) in methanol 
(60 ml) was added slowly then refluxed (16 h) and then cooled to room temperature. 
The solid was filtered, washed in cold MeOH then dried under vacuum to yield a 
white powder (2.31 g, 5.5 mmol, 22%). 
1
H NMR (CDCl3): δ 1.27 (18H, s, CH3), 1.94 
(2H, quintet, J = 6.0 Hz, CH2), 2.79 (4H, s, CH2), 2.84 (4H, t, J = 6.0 Hz, CH2), 3.78 
(4H, s, CH2), 6.76 (2H, d, J = 8.50 Hz, ArH), 6.95 (2H, d, J = 2.5 Hz, ArH), 7.19 (2H, 
dd, J = 8.5 Hz, J = 2.5 Hz, ArH), 10.47 (2H, br, OH). 
13
C{
1
H} NMR (CDCl3): δ 26.8 
(CH2), 31.6 (CH3), 34.0 (C), 53.6 (CH2), 54.7 (CH2), 62.4 (CH2), 115.5 (ArH), 121.0 
(Ar), 125.4 (ArH), 125.6 (ArH), 141.9 (Ar), 155.4 (ArO). Calc. m/z [C27H40N2O2 + 
H]
+
425.3168. Found 425.3233. 
 
12H2. 2,4-di-tert-butylphenol (4.11 g, 19.9 mmol), 2-methylpiperazine (1.00 g, 10.0 
mmol), and formaldehyde (38 % in H2O) (1.62 ml, 0.66 g, 21.9 mmol) were refluxed 
in MeOH (20 ml ml) for 24 h. During which time a white precipitate was observed 
this was filtered and washed with cold MeOH and dried to yield a white solid (2.71 g, 
5.0 mmol, 51 %). 
1
H NMR (CDCl3): δ 1.23 (3H, d J = 6.5 Hz), 1.28 (9H, s, 
t
Bu), 
1.29 (9H, s, 
t
Bu), 1.41 (18H, s, 
t
Bu), 2.10 – 3.20 (7H, br, ring-CH2/CH), 3.69 (4H, m, 
N-CH2-Ar), 6.82, (2H, br ArH), 7.21 (1H, d, J = 2.5 Hz, ArH), 7.23 (1H, d, J = 2.5 
Hz, ArH), 10.71 (1H, br, OH), 10.82 (1H, br, OH). 
13
C{
1
H} NMR (CDCl3): δ 25.7 
(CH3), 29.7 (CH3), 31.8 (CH3), 34.2 (C), 35.0 (C), 52.5 (CH2), 62.1 (CH2), 120.8 
(Ar), 122.9 (ArH), 123.0 (ArH), 123.5 (ArH), 123.6 (ArH), 135.6 (Ar), 135.7 (Ar), 
140.9 (Ar), 140.9 (Ar), 154.1, (ArO). Calc. m/z [C35H56N2O2 + H]+ 537.4420. Found 
537.4413. 
 
13H2. 2-tert-butyl-4-methylphenol (3.38 g, 20.5 mmol), 2-methylpiperazine (1.00 g, 
10.0 mmol), and formaldehyde (38% in H2O) (1.66 ml, 0.67 g, 22.5 mmol) were 
refluxed in MeOH (20 ml) for 24 h. During which time a white precipitate was 
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observed this was filtered and washed with cold MeOH and dried to yield a white 
solid (1.29 g, 2.8 mmol, 29 %). 
1
H NMR (CDCl3): δ 1.21 (3H, d J = 6.5 Hz, ring-
CH3), 1.42 (18H, s, 
t
Bu), 2.26 (6H, s, Me), 2.30 – 3.20 (7H, br, ring-CH2/CH), 3.30 
(1H, br, N-CH2), 3.65 (2H, m, N-CH2), 4.27 (1H, br, N-CH2), 6.68 (1H, s, ArH), 6.68 
(1H, s, ArH), 7.01 (1H, d, J = 2.0 Hz, ArH), 7.02 (1H, d, J = 2.0 Hz, ArH), 10.67 (2H, 
br, OH). 
13
C{
1
H} NMR (CDCl3): δ 20.9 (CH3), 24.1 (CH3), 29.5 (CH3), 29.5 (CH3), 
34.6 (C), 34.6 (C), 52.6 (CH2), 57.4 (CH2), 61.7 (CH2), 121.1 (Ar), 126.7 (ArH), 
127.0 (ArH), 127.4 (ArH), 127.4 (Ar), 127.5 (ArH), 136.4 (Ar), 134.4 (Ar), 154.3 
(ArO). Calc. m/z [C29H44N2O2 + H]
+
 453.3481. Found 453.3462. 
 
14H2. 2,4-di-tert-amylphenol (9.36 g, 40.0 mmol), 2-methylpiperazine (2.00 g, 20.0 
mmol), and formaldehyde (38 % in H2O) (3.31 ml, 1.35 g, 44.5 mmol) were refluxed 
in MeOH (30 ml) for 24 h. During which time a white precipitate was observed this 
was filtered and washed with cold MeOH and dried to yield a white solid (5.96 g, 
10.3 mmol, 52 %). 
1
H NMR (CDCl3): δ 0.66 (12H, m, CH3), 1.21 (3H, d, Me, J = 6.3 
Hz), 1.25 (12H, s, CH3), 1.36 (12H, s, CH3), 1.56 (4H, q, CH2), 1.89 (4H, m, CH2), 
2.10 – 3.20 (7H, b, ring-CH2), 3.30 (1H, b, N-CH2-Ar), 3.65 (2H, m, N-CH2-Ar), 
4.25 (1H, b, N-CH2-Ar), 6.75 (2H, s, ArH), 7.07 (2H, m, ArH), 10.58 (2H, b, OH). 
13
C{
1
H} NMR (CDCl3): δ 9.3 (CH3), 9.7 (CH3), 28.7 (CH3), 33.1 (CH2), 37.3 (C), 
38.5 (C), 52.5 (ring-CH2), 57.8 (ring-CH2), 62.1 (N-CH2), 120.1 (ArC), 120.2 (ArC), 
124.2 (ArH), 124.3 (ArH), 125.1 (ArH), 125.3 (ArH), 133.9(Ar), 138.8 (Ar), 138.8 
(Ar), 153.9 (ArO). Calc. m/z [C39H64N2O2 + H]
+
 593.5046. Found 593.5063. 
 
15H2. 2-methyl-4-tert-butylphenol (3.38 g, 20.5 mmol), 2-methylpiperazine (1.00 g, 
10.0 mmol), and formaldehyde (38 % in H2O) (1.66 ml, 0.67 g, 22.5 mmol) were 
refluxed in MeOH (20 ml, 65 °C) to yield a white solid (1.20 g, 2.7 mmol, 27 %). 
1
H 
NMR (CDCl3): δ 1.23 (3H, d, Me, J = 6.5 Hz), 1.31 (18H, s, 
t
Bu), 2.25 (6H, s, Me), 
2.30 – 3.20 (7H, b, ring-CH2), 3.28 (1H, b, N-CH2-Ar), 3.68 (2H, m, N-CH2-Ar), 
4.36 (1H, b, N-CH2-Ar), 6.84 (4H, s, ArH), 7.08 (4H, s, ArH), 10.66 (2H, b, OH). 
13
C{
1
H} NMR (CDCl3): δ 16.1 (CH3), 31.7 (CH3), 34.0 (C), 52.7 (CH2), 61.7 (CH2), 
119.5 (Ar), 119.9 (Ar), 123.1 (ArH), 123.2 (ArH), 126.9 (ArH), 127.1 (ArH), 124.1 
(Ar), 141.6 (Ar), 141.7 (Ar), 141.6 (Ar), 153.4, (ArO). Calc. m/z [C29H44N2O2 + H]
+
 
453.3481. Found 453.3475. 
 232 
7.4 Preparation of Complexes for Chapter 2 
7.4.1 Preparation of titanium bimetallic homo/piperazine salan complexes 
Ti2(1)(O
i
Pr)6. 1H2 (0.50 g, 1.41 mmol) and Ti(O
i
Pr)4 (0.85 ml, 2.87 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (40 ml) to yield pale yellow crystals (0.51 g, 0.64 
mmol, 45 %). The NMR was a mixture of Ti2(1)(O
i
Pr)6 and Ti2(1)2(O
i
Pr)4 and 
Ti(O
i
Pr)4 in a 4:1:2 ratio as discussed in the text. The NMR spectrum for the 
individual components follows: Ti2(1)(O
i
Pr)6 
1
H NMR (CDCl3) (233 K): δ 1.26 (36H, 
d, J = 6.0 Hz, CH3), 2.13 (6H, s, CH3), 2.15 (3H, s, CH3), 2.16 (3H, s, CH3), 2.30 – 
3.90 (8H, br, ring-CH2), 4.09 (4H, m, N-CH2-Ar), 4.89 (6H, br, CH), 6.69 (2H, s 
ArH), 6.83 (2H, s, ArH). Ti2(1)2(O
i
Pr)4 
1
H NMR (233 K): δ 0.94 (3H, d, J = 6.0 Hz, 
Me), 0.97 (3H, d, J = 6.0 Hz, Me), 1.16 (6H, d, J = 6.0 Hz, Me), 1.20 – 1.40 (12H, br, 
CH3), 2.08 (3H, s, Me), 2.10 – 2.25 (18H, br, Me), 2.28 (3H, s, Me), 2.30 – 3.90 
(16H, br, ring-CH2), 4.09 (8H, m, N-CH2-Ar), 4.89 (4H, b, CH), 6.57 (2H, ArH), 
6.76 (2H, ArH), 6.84 (2H, ArH), 6.92 (2H, ArH). Ti(O
i
Pr)4 
1
H NMR (CDCl3) 
(233 K): δ 1.26 (24H, d, J = 6.0 Hz, CH3), 4.47 (4H, sept, J = 6.0 Hz, CH). 
13
C{
1
H} 
NMR (CDCl3): δ 16.8 (CH3), 20.5 (CH3), 26.7 (CH3), 43.3 (CH2), 52.0 (CH2), 77.8 
(CH), 122.7 (Ar), 124.8 (Ar), 127.0 (Ar), 127.7 (ArH), 130.8 (ArH), 158.2 (ArO). 
Calc. (%) for C40H70N2O8Ti2: C 59.85, H 8.79, N 3.49. Found (%), C 59.3, H 8.80, N 
3.72. 
 
Ti2(2)(O
i
Pr)6. 2H2 (0.22g, 0.50 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (20 ml) to yield a pale yellow crystals (0.19 g, 
0.20 mmol, 41 %). The NMR was a mixture of Ti2(2)(O
i
Pr)6 and Ti2(2)2(O
i
Pr)4 and 
Ti(O
i
Pr)4 in a 4:1:2 ratio as discussed in the text. The NMRs for the individual 
components are: Ti2(2)(O
i
Pr)6 
1
H NMR (CDCl3) (233 K): δ 1.23 (18H, s, CH3), 1.26 
(36H, d,
 
J = 6.0 Hz, CH3), 2.18 (6H, br, CH3), 2.30 – 4.00 (8H, br, ring-CH2), 4.15 
(4H, br, N-CH2-Ar), 4.90 (6H, br, CH), 6.89 (2H, br, ArH), 7.10 (2H, br ArH), 
Ti2(2)2(O
i
Pr)4 
1
H NMR (CDCl3) (233 K): δ 0.85 (3H, d,
 
J = 6.0 Hz, CH3), 0.87 (3H, 
d,
 
J = 6.0 Hz, CH3), 0.97 (3H, d,
 
J = 6.0 Hz, CH3), δ 1.14 (18H, s, CH3), 1.10 – 1.50 
(15H, br, CH3), 1.34 (18H, s, CH3), 2.13 (3H, s CH3), 2.20 (6H, s, CH3), 2.26 (3H, s, 
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CH3), 2.30 – 4.00 (16H, br, ring-CH2), 4.15 (8H, m, N-CH2-Ar), 4.90 (4H, br, CH), 
6.70 (2H, s, ArH), 6.94 (2H, s, ArH), 7.05 (2H, s, ArH), 7.17 (2H, s, ArH). Ti(O
i
Pr)4 
1
H NMR (CDCl3) (233 K): δ 1.26 (24H, d, J = 6.0 Hz, CH3), 4.47 (4H, sept, J = 6.0 
Hz, CH). 
13
C{
1
H} NMR (CDCl3): δ 17.2 (CH3), 26.7 (CH3), 31.8 (C), 43.3 (CH2), 
52.3 (CH2), 77.8 (CH), 122.3 (Ar), 124.0 (ArH), 124.1 (Ar), 127.2 (ArH), 140.7 (Ar), 
158.3 (ArO). Calc. (%) for C46H82N2O8Ti2: C 62.30, H 9.32, N 3.16. Found (%), C 
61.7, H 9.33, N 3.21. 
 
Ti2(3)(O
i
Pr)6. 3H2 (0.49g, 0.94 mmol) and Ti(O
i
Pr)4 (0.70 ml, 2.36 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (30 ml) to yield yellow crystals (0.37 g, 0.38 
mmol, 41 %). 
1
H NMR (CDCl3): δ 1.27 (18H, s, 
t
Bu), 1.30 (36H, d J = 6.0 Hz, CH3), 
1.43 (18H, s, CH3), 2.10 – 3.80 (8H, br, ring-CH2), 4.16 (4H, s, N-CH2-Ar), 4.92 (6H, 
sept, J = 6.0 Hz, CH), 6.97 (2H, d = 2.3 Hz, ArH), 7.20 (2H, d = 2.3 Hz, ArH).
 
13
C{
1
H} NMR (CDCl3): δ 27.0 (CH3), 29.7 (CH3), 31.9 (CH3), 34.3 (C), 35.1 (C), 
52.2 (CH2), 77.4 (CH), 123.2 (ArH), 123.7 (ArH), 124.5 (Ar), 135.5 (Ar), 140.1 (Ar), 
154.7 (ArO). Calc. (%) for C52H94N2O8Ti2: C 64.32, H 9.76, N 2.88. Found (%), C 
63.8, H 9.76, N 2.78. 
 
Ti2(4)(O
i
Pr)6. 4H2 (0.22g, 0.50 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (20 ml) to yield pale yellow crystals (0.23 g, 0.26 
mmol, 52 %). 
1
H NMR (CDCl3): δ 1.31 (36H, d, J = 6.0 Hz, CH3), 1.41 (18H, s, 
CH3), 2.21 (6H, s, Me), 2.30 – 3.80 (8H, br, ring-CH2), 4.12 (4H, s, N-CH2-Ar), 4.93 
(6H, sept, J = 6.0 Hz, CH), 6.78 (2H, d, J = 2.0 Hz, ArH), 6.97 (2H, d, J = 2.0 Hz, 
ArH). 
13
C{
1
H} NMR (CDCl3): δ 20.9 (CH3), 27.0 (CH3), 29.6 (CH3), 34.8 (C), 51.9 
(N-CH2), 77.6 (CH), 124.3 (Ar), 126.7 (Ar), 126.9 (ArH), 128.3 (ArH), 136.2 (Ar), 
158.9 (ArO). Calc. (%) for C46H82N2O8Ti2: C 62.30, H 9.32, N 3.16. Found (%), C 
61.9, H 9.28, N 3.61. 
 
Ti2(5)(O
i
Pr)6. 5H2 (0.50 g, 0.86 mmol) and Ti(O
i
Pr)4 (0.80 ml, 2.70 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (40 ml) to yield yellow crystals (0.18 g, 0.18 
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mmol, 20 %). 
1
H NMR (CDCl3): δ 0.61 (12H, m, CH3), 1.20 – 1.25 (12H, m, CH3), 
1.28 (36H, d, J = 6.0 Hz, CH3), 1.35 (12H, s, CH3), 1.54 (4H, m, CH2), 1.96 (4H, m, 
CH2), 2.20 – 2.80 (4H, br, ring-CH2), 3.30 – 3.80 (4H, br, ring-CH2), 4.10 (4H, s, N-
CH2-Ar), 4.90 (6H, sept, J = 6.0 Hz, CH), 6.88 (2H, d, J = 2.0 Hz, ArH), 7.04 (2H, d, 
J = 2.0 Hz, ArH). 
13
C{
1
H} NMR (CDCl3): δ 9.28 (CH3), 9.81 (CH3), 26.7 (CH3), 
26.8 (CH3), 27.0 (CH3), 27.8 (CH2) 28.8 (CH3) 32.8 (CH2), 37.3 (C), 38.6 (C), 43.7 
(CH2), 77.5 (CH), 123.4 (Ar), 125.2 (ArH), 125.3 (ArH), 133.7 (Ar), 138.1 (Ar), 
158.9 (ArO). Calc. (%) for C56H102N2O8Ti2: (%), C 65.48, H 10.01, N 2.73. Found 
CHN (%), C 64.2, H 9.98, N 3.02. 
 
Ti2(8)(O
i
Pr)6. 8H2 (0.48g, 0.89 mmol) and Ti(O
i
Pr)4 (0.80 ml, 2.70 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (30 ml) to yield pale yellow crystals (0.68 g, 0.69 
mmol, 77 %). 
1
H NMR (CDCl3): δ 1.27 (36H, br, CH3), 1.29 (18H, s, CH3), 1.45 
(18H, s, CH3), 2.00 (2H, br, ring-CH2), 2.98 (4H, br, ring-CH2), 3.14 (4H, br, ring-
CH2), 3.92 (4H, s, N-CH2-Ar), 4.90 (6H, sept, J = 6.0 Hz, CH), 6.86 (2H, d, J = 2.5 
Hz, ArH), 7.19 (2H, d J = 2.5 Hz, ArH).
 13
C{
1
H} NMR (CDCl3): δ 26.9 (CH3), 31.8 
(CH3), 34.3 (C), 35.1 (C), 55.2 (CH2), 64.3 (CH2), 77.6 (CH), 123.2 (ArH), 124.1 
(Ar), 124.6 (ArH), 135.5 (Ar), 140.0 (Ar), 159.9 (ArO). Calc. (%) for C53H96N2O8Ti2, 
C 64.62, H 9.82, N 2.84. Found (%), C 64.4, H 9.61, N 2.95 
 
Ti2(9)(O
i
Pr)6. 9H2 (0.51g, 1.13 mmol) and Ti(O
i
Pr)4 (1.00 ml, 3.38 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hexane (10 ml) to yield yellow crystals (0.37 g, 0.24 mmol, 
36 %). 
1
H NMR (CDCl3) (233 K): δ 1.26 (36H, b, CH3-
i
Pr), 1.42 (18H, d, 
t
Bu), 2.24 
(6H, m, Me), 2.41 (1H, b, ring-CH2), 2.59 (1H, b, ring-CH2), 2.80 (1H, b, ring-CH2), 
2.99 (1H, b, ring-CH2), 3.20 (2H, b, ring-CH2), 3.43 (2H, b, ring-CH2), 3.62 (2H, b, 
ring-CH2), 3.80-4.20 (4H, m, N-CH2-Ar), 4.90 (6H, b, CH), 6.64 (1H, s, ArH), 6.72 
(1H, s, ArH), 6.95 (1H, s, ArH), 7.04 (1H, s, ArH). 
13
C{
1
H} NMR (CDCl3): δ 21.0 
(CH3), 26.9 (CH3), 34.8 (C), 27.0 (CH3), 21.2 (CH2), 29.7 (CH2), 30.0 (CH2), 30.2 
(CH2), 30.6 (CH2), 56.8 (N-CH2), 77.6 (CH), 122.9 (Ar), 124.0 (Ar), 123.5 (ArH), 
127.9 (ArH), 139.4 (Ar), 163.1 (ArO). Calc. (%) for C47H84N2O8Ti2, C 62.66, H 9.40, 
N 3.11. Found (%), C 60.1, H 9.01, N 3.10. 
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Ti2(12)(O
i
Pr)6. 12H2 (0.60g, 1.11 mmol) and Ti(O
i
Pr)4 (1.00 ml, 3.38 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hexane (2 ml) to yield yellow crystals (0.72 g, 0.73 mmol, 
65 %). 
1
H NMR (CDCl3) (233 K): δ 0.97 (3H, d, J = 6.0 CH3), 1.25 (9H, br, CH3), 
1.28 (36H, d J = 6.0 Hz, CH3), 1.31 (9H, br, CH3), 1.41 (9H, s, CH3), 1.42 (9H, s, 
CH3), 2.40 – 3.70 (7H, br, ring-CH2), 3.95 (2H, br, N-CH2-Ar), 4.12 (2H, m, N-CH2-
Ar), 4.80 (3H, sept, J = 6.0 Hz, CH), 4.89 (3H, sept, J = 6.0 Hz, CH), 6.90 (1H, d, J = 
2.5 Hz, ArH), 7.14 (1H, d, J = 2.5 Hz, ArH), 7.18 (2H, br, ArH).
 13
C{
1
H} NMR 
(CDCl3): δ 26.7 (CH3), 26.8 (CH3), 26.8 (CH3), 26.9 (CH3), 26.9 (CH3), 29.7 (C), 
29.8 (C), 31.8 (CH3), 34.3 (C), 34.4 (C), 35.1 (CH2), 76.5 (CH), 77.4 (CH), 77.8 
(CH), 122.0 (ArH), 123.1 (ArH), 123.6 (ArH), 123.9 (Ar), 124.4 (ArH), 135.5 (Ar), 
135.7 (Ar), 140.0 (Ar), 141.0 (Ar), 158.9 (ArO). Calc. (%) for C53H96N2O8Ti2, C 
64.62, H 9.82, N 2.84. Found (%), C 63.0, H 9.48, N 3.04 
 
Ti2(13)(O
i
Pr)6. 13H2 (0.51g, 1.13 mmol) and Ti(O
i
Pr)4 (1.00 ml, 3.38 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hexane (5 ml) to yield yellow crystals (0.59 g, 0.65 mmol, 
58 %). 
1
H NMR (CDCl3): δ 1.07 (3H, d, J = 6.5, CH3), 1.31 (18H, d, J = 6.0 Hz, 
CH3), 1.33 (18H, d, J = 6.0 Hz, CH3), 1.44 (9H, s, CH3), 1.45 (9H, s, CH3), 2.23 (3H, 
s, CH3), 2.25 (3H, s, CH3), 2.48 (1H, br, CH2), 2.52 (1H, br, CH2), 2.66, (1H, br, 
CH2), 3.04 (1H, m, CH2), 3.34 (1H, m, CH2), 3.38 (1H, m, CH2), 3.55 (1H, br, CH2) 
3.94 (2H, s, CH2), 4.09 (2H, m, CH2), 4.83 (3H, sept, J = 6.0 Hz, CH), 4.92 (3H, sept, 
J = 6.0 Hz, CH), 6.72 (1H, s, ArH), 6.95 (1H, s, ArH), 6.98 (1H, s, ArH), 7.01 (1H, s, 
ArH). 
13
C{
1
H} NMR (CDCl3): δ 17.9 (CH3), 21.0 (CH3), 21.1 (CH3), 26.8 (CH3), 
26.9 (CH3), 29.7 (C), 30.0 (C), 34.8 (CH2), 44.9 (CH2), 49.5 (CH1), 50.2 (CH2), 53.4 
(CH2), 77.5 (CH), 77.9 (CH), 124.4 (Ar), 125.7 (ArH), 126.5 (Ar), 126.7 (ArH), 
127.6 (ArH), 127.6 (Ar), 128.2 (ArH), 136.2 (Ar), 136.5 (Ar), 159.1 (ArO), 159.7 
(ArO). Calc. (%) for C47H84N2O8Ti2, C 62.66, H 9.40, N 3.11. Found (%), C 61.0, H 
9.00, N 3.03 
 
Ti2(1)2(O
i
Pr)4. 1H2 (0.60 g, 1.69 mmol) and Ti(O
i
Pr)4 (0.50 ml, 1.69 mmol) were 
dissolved in Tol. (30 ml) then heated (80 °C) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from hexane to yield pale yellow crystals (0.27 
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g, 0.52 mmol, 31 %). 
1
H NMR (CDCl3) (233 K): δ 0.92 (6H, d, J = 6.0 Hz, CH3), 
0.95 (6H, d, J = 6.0 Hz, CH3), 1.15 (6H, d, J = 6.0 Hz, CH3), 1.29 (6H, d, J = 6.0 Hz, 
CH3), 1.86 (2H, t, J = 12.5 Hz, CH2), 2.06 (6H, s, CH3), 2.10 (6H, s, CH3), 2.13 (6H, 
s, CH3), 2.19 (4H, d, J = 7.5 Hz, CH2), 2.27 (6H, s, CH3), 2.61 (2H, d, J = 11.5 Hz, 
CH2), 2.69 (2H, d, J = 11.0 Hz, CH2), 2.82 (2H, t, J = 11.5 Hz, CH2), 3.19 (2H, t, J = 
12.0 Hz, CH2), 3.32 (2H, d, J = 12.0 Hz, CH2), 3.85 (2H, t, J = 11.5 Hz, CH2), 4.03 
(4H, m, CH2), 4.19 (2H, d, J = 13.5 Hz, CH2), 4.47 (2H, septet, J = 12.0 Hz, CH), 
4.92 (2H, septet, J = 12.0 Hz, CH), 6.56 (2H, s, ArH), 6.74 (2H, s, ArH), 6.82 (2H, s, 
ArH ), 6.91 (2H, s, ArH). 
13
C{
1
H} NMR (CDCl3): δ 16.5 (CH3), 16.7 (CH3), 17.4 
(CH3), 20.6 (CH3), 25.8 (CH3), 26.5 (CH3), 26.7 (CH3), 27.0 (CH3), 44.9 (CH2), 47.5 
(CH2), 48.8 (CH2), 51.4 (br, CH2), 52.8 (br, CH2), 59.3 (CH2), 78.5 (CH), 79.3 (CH), 
123.3 (ArH), 123.7 (ArH), 124.7 (ArH), 126.0 (ArH), 126.9 (ArH), 127.6 (ArH), 
127.9 (Ar), 129.6 (Ar), 130.5 (Ar), 130.9 (Ar), 158.5 (ArO), 163.2 (ArO). Calc. (%) 
for C28H42N2O4Ti: C 64.86, H 8.16, N 5.40. Found (%), C 64.67, H 8.16, N 5.56.  
 
7.4.2 Preparation of titanium monometallic homopiperazine salan complexes 
Ti(6)(O
i
Pr)2. 6H2 (0.37 g, 1.00 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) were 
dissolved in toluene (30 ml) then heated (80 °C) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from hexane to yield pale yellow crystals (0.14 
g, 0.26 mmol, 26 %). 2 species identified in the solution state NMR spectra. 
1
H NMR 
(CDCl3): δ 0.40 (3H, d, J = 5.5 Hz, CH3), 1.14 (6H, br, CH3), 1.19 (3H, d, J = 5.5 Hz, 
CH3), 1.68 (1H, m, CH2), 1.88 (1H, m, CH2), 2.21 (9H, s, CH3), 2.29 (3H, s, CH3), 
2.42 (2H, br, CH2), 2.79 (1H, d, J = 6.0 Hz, CH2), 3.11 (1H, d, J = 11.5 Hz, CH2), 
3.31 (2H, s, CH2), 3.60 (1H, d, J = 6.5 Hz, CH2), 3.72 (1H, m, CH2), 3.95 (1H, m, 
CH2), 4.20 (2H, d, J = 11.0 Hz, CH2), 4.46 (1H, m, CH2), 4.85 (1H, m, CH2), 4.93 
(1H, m, CH2), 6.68 (2H, s, ArH), 6.91 (1H, s, ArH).
 
2
nd
 species 
1
H NMR (CDCl3): δ 
0.45 – 1.45 (12H, br, CH3), 2.00 – 2.50 (12H, br, CH3), 2.00 – 2.50 (4H, br, CH2), 
3.00 – 5.00 (10H, br, CH2), 3.00 – 5.00 (2H, br, CH), 6.58 (2H, s, ArH ), 6.87 (2H, s, 
ArH).
 13
C{
1
H} NMR (CDCl3): δ 16.5 (CH3), 16.9 (CH3), 20.8 (CH3), 23.0 (CH2), 
23.7 (CH2), 25.9 (CH3), 26.1 (CH3), 26.3 (CH3), 50.8 (br, CH2), 55.6 (CH2), 58.0 
(CH2), 59.2 (br, CH2), 62.7 (br, CH2), 64.1 (CH2), 72.1 (CH), 73.2 (CH), 75.7 (CH), 
75.9 (CH), 123.4 (ArH), 124.6 (ArH), 125.4 (ArH), 127.4 (Ar), 122.0 – 132.0 (Ar), 
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131.5 (Ar), 163.0 (ArO). Calc. (%) for C29H44N2O4Ti: C 65.41, H 8.33, N 5.26. 
Found (%), C 65.29, H 8.27, N 5.37 
 
Ti(7)(O
i
Pr)2. 7H2 (0.46 g, 1.02 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) were 
dissolved in toluene (30 ml) then heated (80 °C) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from hexane to yield pale yellow crystals (0.48 
g, 0.78 mmol, 77 %). 2 species identified in the solution state NMR spectra.
 1
H NMR 
(CDCl3): δ 0.32 (3H, d, J = 6.0 Hz, CH3), 0.87 (6H, br, CH3), 1.65 (9H, d, J = 6.0 Hz, 
CH3), 1.26 (36H, s, CH3), 1.71 (1H, m, CH2), 1.90 (2H, m, CH2), 2.16 (4H, br, CH2), 
2.28 (12H, s, CH3), 2.24 (2H, br, CH2), 2.80 (1H, d, J = 6.5 Hz, CH2), 3.16 (1H, d, J 
= 11.5 Hz, CH2), 3.30 (4H, br, CH2), 3.61 (1H, d, J = 6.5 Hz, CH2), 3.71 (2H, m, 
CH2), 3.97 (1H, m, CH), 4.20 (2H, d, J = 11.5 Hz, CH2), 4.22 (1H, br, CH2), 4.45 
(1H, m, CH), 4.80 (1H, m, CH), 4.92 (1H, m, CH), 6.74 (2H, br, ArH), 6.86 (2H, s, 
ArH), 7.05 (2H, br, ArH), 7.11 (2H, s, ArH).
 13
C{
1
H} NMR (CDCl3): δ 16.5 (CH3), 
16.9 (CH3), 20.7 (CH3), 23.0 (C), 23.7 (C), 25.8 (CH3), 26.1 (CH3), 26.3 (CH3), 55.6 
(CH2), 58.0 (CH2), 59.2 (br, CH2), 62.7 (br, CH2), 64.1 (CH2), 72.1 (CH), 73.1 (CH), 
75.7 (CH), 75.9 (CH), 122.9 (Ar), 123.4 (ArH), 124.0 (Ar), 126.7 (br, Ar), 127.9 
(ArH), 139.1 (Ar), 163.0 (ArO). Calc. (%) for C35H56N2O4Ti: C 68.17, H 9.15, N 
4.54. Found (%), C 68.29, H 9.28, N 4.57 
 
Ti(8)(O
i
Pr)2. 8H2 (0.54 g, 1.01 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) were 
dissolved in toluene (30 ml) then heated (80 °C) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from hexane to yield pale yellow crystals (0.24 
g, 0.34 mmol, 34 %). 2 species identified in the solution state NMR spectra in a 
approximate 50:50 ratio, a third species is present in a negligible ratio. 
1
H NMR 
(CDCl3): δ 0.39 (3H, d, J = 6.0 Hz, CH3), 0.55 (3H, d, J = 6.0 Hz, CH3), 0.72 (3H, d, 
J = 6.0 Hz, CH3), 0.94 (3H, d, J = 6.0 Hz, CH3), 0.97 (3H, d, J = 6.0 Hz, CH3), 0.98 
(3H, d, J = 6.0 Hz, CH3), 1.01 (6H, d, J = 6.0 Hz, CH3), 1.26 (18H, s, 
t
Bu), 1.28 (18H, 
s, 
t
Bu), 1.46 (9H, s, 
t
Bu), 1.47 (9H, s, 
t
Bu), 1.48 (18H, s, 
t
Bu), 1.82 (2H, m, CH2), 
2.23 (3H, m, CH2), 2.38 (3H, m, CH2), 2.45 (1H, m, CH2), 2.72 (2H, m, CH2), 3.05 
(1H, d, J = 11.5 Hz, CH2), 3.23 (2H, d, J = 11.5 Hz, CH2), 3.44 (1H, d, J = 14.5 Hz, 
CH2), 3.55 (2H, m, CH2), 3.61 (2H, d, J = 6.5 Hz, CH2), 3.88 (2H, m, CH2), 3.97 (1H, 
br, CH2), 4.01 (2H, d, J = 11.5 Hz, CH2), 4.13 (1H, d, J = 11.5 Hz, CH2), 4.17 (1H, m, 
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CH2), 4.23 (1H, m, CH), 4.28 (1H, m, CH), 4.51 (1H, d, J = 11.5 Hz, CH2), 4.55 (2H, 
m, CH), 6.74 (1H, d, J = 2.0 Hz, ArH), 6.88 (2H, d, J = 2.5 Hz, ArH), 6.90 (1H, d, J 
= 2.5 Hz, ArH), 7.16 (1H, d, J = 2.5 Hz, ArH), 7.25 (2H, d, J = 2.5 Hz, ArH), 7.27 
(1H, br, ArH). 
13
C{
1
H} NMR (CDCl3): δ 22.9 (CH2), 23.3 (CH2), 25.4 (CH3), 25.5 
(CH3), 25.9 (CH3), 26.1 (CH3), 26.2 (CH3), 26.7 (CH3), 30.0 (CH3), 30.3 (CH3), 30.6 
(CH3), 32.0 (CH3), 34.1 (C), 34.2 (C), 35.1 (C), 35.3 (C), 35.5 (C), 35.6 (C), 51.3 
(CH2), 52.6 (CH2), 55.2 (CH2), 55.3 (CH2), 55.6 (CH2), 57.7 (CH2), 58.4 (CH2), 59.0 
(CH2), 63.2 (CH2), 64.4 (CH2), 64.6 (CH2), 72.7 (CH), 72.9 (CH), 74.9 (CH), 76.0 
(CH), 121.5 (ArH), 122.2 (Ar), 122.9 (Ar), 123.5 (Ar), 123.7 (ArH), 123.8 (ArH), 
123.9 (ArH), 123.9 (ArH), 124.0 (ArH), 124.4 (ArH), 124.6 (Ar), 134.1 (Ar), 134.3 
(Ar), 136.7 (Ar), 136.8 (Ar), 138.3 (Ar), 138.5 (Ar), 139.4 (Ar), 139.5 (Ar), 159.1 
(ArO), 160.0 (ArO), 163.5 (ArO), 164.3 (ArO). Calc. (%) for C41H68N2O4Ti: C 70.26, 
H 9.78, N 4.00. Found (%), C 70.19, H 9.69, N 4.12. 
 
Ti(9)(O
i
Pr)2. 9H2 (0.46 g, 1.02 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) were 
dissolved in toluene (30 ml) then heated (80 °C) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from hexane to yield pale yellow crystals (0.16 
g, 0.26 mmol, 26 %). 2 species identified in the solution state NMR spectra in a 
approximate 50:50 ratio. 
1
H NMR (CDCl3): δ 0.41 (3H, br, CH3), 0.55 (3H, d, J = 6.0 
Hz, CH3), 0.72 (3H, d, J = 6.0 Hz, CH3), 0.98 (3H, d, J = 6.0 Hz, CH3), 1.02 (3H, d, J 
= 6.0 Hz, CH3), 1.00 (3H, s, CH3), 0.98 (6H, br, CH3), 1.43 (54H, s, 
t
Bu), 1.81 (3H, 
m, CH2), 2.15 – 2.30 (7H, br, CH2), 2.22 (6H, s, CH3), 2.24 (6H, s, CH3), 2.25 (6H, s, 
CH3), 2.30-2.45 (6H, m, CH2), 2.54 (1H, m, CH2), 2.66 (2H, m, CH2), 2.78 (1H, br, 
CH2), 3.05 (2H, d, J = 12.0 Hz, CH2), 3.22 (2H, d, J = 11.5 Hz, CH2), 3.41 (2H, t, J = 
13.0 Hz, CH2), 3.43 (2H, br, CH2), 3.54 (2H, br, CH2), 3.68 (2H, d, J= 3.5 Hz, CH2), 
3.82 (2H, br, CH), 3.98 (3H, br, CH2), 4.05 (2H, d, J = 12.0 Hz, CH2), 4.12 (2H, m, 
CH2), 4.24 (2H, m, CH), 4.51 (2H, d, J = 14.0 Hz, CH2), 4.61 (2H, m, CH), 5.31 (1H, 
d, J = 13.0 Hz, CH2), 6.61 (1H, s, ArH), 6.75 (2H, s, ArH), 6.77 (2H, s, ArH ), 6.81 
(1H, s, ArH), 6.97 (1H, s, ArH), 7.01 (4H, s, ArH), 7.09 (1H, s, ArH). 
13
C{
1
H} NMR 
(CDCl3): δ 20.9 (CH3), 21.0 (CH3), 21.1 (CH3), 22.9 (CH3), 23.4 (CH3), 25.8 (CH3), 
25.9 (CH3), 26.0 (CH3), 26.3 (CH3), 26.4 (CH3), 26.9 (CH3), 29.9 (CH3), 30.2 (CH3), 
30.6 (CH3), 34.8 (C), 35.0 (C), 35.2 (C), 35.3 (C), 50.9 (CH2), 52.6 (CH2), 55.2 
(CH2), 55.5 (CH2), 55.7 (CH2), 57.8 (CH2), 58.4 (CH2), 59.1 (CH2), 62.9 (CH2), 64.3 
 239 
(CH2), 64.4 (CH2), 64.7 (CH2), 72.7 (CH), 73.0 (CH), 75.1 (CH), 75.9 (CH), 121.8 
(Ar), 122.9 (Ar), 124.2 (Ar), 124.6 (Ar), 124.9 (Ar), 125.3 (Ar), 125.7 (ArH), 125.9 
(Ar), 126.0 (Ar), 126.9 (ArH), 127.4 (ArH), 127.7 (ArH), 127.8 (ArH), 128.0 (ArH), 
128.2 (ArH), 134.8 (Ar), 135.0 (Ar), 137.5 (Ar), 137.6 (Ar), 134.8 (Ar), 159.1 (ArO), 
159.9 (ArO), 163.5 (ArO), 164.3 (ArO). Calc. (%) for C35H56N2O4Ti: C 68.17, H 
9.15, N 4.54. Found (%), C 66.45, H 8.85, N 4.58.  
 
Ti(10)(O
i
Pr)2. 10H2 (0.60 g, 1.01 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) were 
dissolved in toluene (30 ml) then heated (80 °C) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from hexane to yield pale yellow crystals (0.13 
g, 0.17 mmol, 17 %). 2 species identified in the solution state NMR spectra in a 
approximate 50:50 ratio. 
1
H NMR (CDCl3): δ 0.33 (3H, d, J = 6.0 Hz, CH3), 0.55 
(3H, d, J = 6.0 Hz, CH3), 0.67 (15H, m, CH3), 0.76 (12H, m, CH3), 0.99 (3H, d, J = 
6.0 Hz, CH3), 1.01 (3H, d, J = 6.0 Hz, CH3), 1.12 (6H, d, J = 6.0 Hz, CH3), 1.23 (6H, 
s, CH3), 1.26 (12H, s, CH3), 1.29 (6H, s, CH3), 1.39 (3H, s, CH3), 1.41 (3H, s, CH3), 
1.45 (9H, s, CH3), 1.47 (9H, s, CH3), 1.60 (8H, m, CH2), 1.60 (8H, m, CH2), 1.75 – 
1.95 (6H, m, CH2), 2.07 (3H, m, CH2), 2.22 (4H, m, CH2), 2.30 – 2.50 (4H, m, CH2), 
2.66 (1H, m, CH2), 2.78 (2H, m, CH2), 3.06 (1H, d, J = 11.5 Hz, CH2), 3.20 (2H, d, J 
= 11.5 Hz, CH2), 3.44 (1H, d, J = 14.5 Hz, CH2), 3.53 (2H, d, J = 7.5 Hz, CH2), 3.62 
(2H, d, J = 6.5 Hz, CH2), 3.90 (2H, m, CH2), 4.00 (1H, br, CH2), 4.10 (3H, d, J = 
11.5 Hz, CH2), 4.22 (1H, m, CH2), 4.25 (1H, m, CH), 4.34 (1H, m, CH), 4.54 (1H, d, 
J = 13.5 Hz, CH2), 4.59 (1H, m, CH), 4.68 (1H, m, CH), 6.68 (1H, d, J = 2.0 Hz, 
ArH), 6.83 (2H, d, J = 2.5 Hz, ArH), 6.85 (1H, d, J = 2.0 Hz, ArH), 7.05 (1H, d, J = 
2.0 Hz, ArH), 7. 14 (2H, d, J = 2.5 Hz, ArH), 7.16 (1H, br, ArH). 
13
C{
1
H} NMR 
(CDCl3): δ 9.3 (CH3), 9.4 (CH3), 9.7 (CH3), 9.9 (CH3), 22.9 (CH2), 23.4 (CH2), 25.7 
(CH3), 25.8 (CH3), 26.2 (CH3), 26.3 (CH3), 26.4 (CH3), 27.0 (CH3), 27.4 (CH3), 27.8 
(CH3), 27.8 (CH3), 28.0 (CH3), 28.1 (CH3), 28.2 (CH3), 28.3 (CH3), 28.7 (CH3), 28.7 
(CH3), 28.9 (CH3), 29.0 (CH3), 29.1 (CH3), 29.2 (CH3), 29.3 (CH3), 32.9 (C), 33.3 
(C), 33.8 (C), 37.2 (CH2), 37.2 (CH2), 37.3 (CH2), 37.4 (CH2), 37.6 (C), 38.3 (C), 
38.5 (C), 38.9 (C), 38.9 (C), 51.1 (CH2), 52.5 (CH2), 55.4 (CH2), 55.6 (CH2), 57.6 
(CH2), 58.2 (CH2), 59.0 (CH2), 63.2 (CH2), 64.7 (CH2), 64.8 (CH2), 65.2 (CH2), 72.7 
(CH), 73.0 (CH), 74.8 (CH), 75.9 (CH), 120.9 (Ar), 121.9 (Ar), 123.3 (Ar), 123.4 
(ArH), 123.8 (ArH), 124.5 (ArH), 124.6 (ArH), 125.3 (ArH), 125.9 (ArH), 126.5 
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(ArH), 132.9 (Ar), 133.0 (Ar), 134.9 (Ar), 135.1 (Ar), 136.1 (Ar), 136.2 (Ar), 137.2 
(Ar), 137.4 (Ar), 158.8 (ArO), 159.7 (ArO), 163.5 (ArO), 164.1 (ArO). CHN Calc. 
(%) for C45H76N2O4Ti: C 71.40, H 10.12, N 3.70. Found (%), C 71.38, H 9.97, N 
3.78. 
 
Ti(11)(O
i
Pr)2. 11H2 (0.43 g, 1.01 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) were 
dissolved in toluene (30 ml) then heated (80 °C) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from hexane to yield pale yellow crystals (0.39 
g, 0.66 mmol, 65 %). 
1
H NMR (CDCl3): δ 0.63 (6H, d, J = 6.0 Hz, CH3), 1.61 (6H, d, 
J = 6.0 Hz, CH3), 1.28 (18H, s, 
t
Bu), 1.72 (1H, m, CH2), 1.72 (1H, m, CH2), 2.19 (1H, 
m, CH2), 2.28 (2H, m, CH2), 2.81 (2H, d, J = 6.5 Hz, CH2), 3.20 (2H, d, J = 11.5 Hz, 
CH2), 3.61 (2H, d, J = 6.0 Hz, CH2), 3.61 (2H, br, CH2), 3.84 (1H, m, CH), 4.22 (2H, 
d, J = 11.5 Hz, CH2), 4.82 (1H, m, CH), 6.79 (1H, s, ArH), 6.82 (1H, s, ArH), 7.02 
(2H, d, J = 2.0 Hz, ArH), 7.18 (1H, s, ArH), 7.27 (1H, s, ArH). 
13
C{
1
H} NMR 
(CDCl3): δ 23.0 (CH2), 26.1 (CH3), 26.2 (CH3), 31.9 (CH3), 34.0 (C), 55.3 (CH2), 
58.0 (CH2), 64.1 (CH2), 72.0 (CH), 73.0 (CH), 116.6 (ArH), 123.6 (Ar), 125.9 (ArH), 
126.5 (ArH), 139.7 (Ar), 164.1 (ArO). CHN Calc. (%) for C33H52N2O4Ti: C 67.33, H 
8.90, N 4.76. Found (%), C 67.42, H 8.89, N 4.70. 
 
7.4.3 Preparation of titanium catechol homo/piperazine salan complexes 
Ti(1)Catechol. 1H2 (0.60 g, 1.69 mmol) and Ti(O
i
Pr)4 (0.50 ml, 1.69 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (1 h). Catechol (0.185 g, 1.68 mmol) was 
added to the yellow solution and the resulting dark red solution was stirred (16 h) 
before the solvent was removed in-vacuo and recrystallised from hot toluene (30 ml) 
to yield orange crystals (0.71 g, 1.39 mmol, 83 %). 
1
H NMR (CDCl3): δ 2.18 (2H, d, 
J = 6.5 Hz, CH2), 2.25 (6H, s, CH3), 2.26 (6H, s, CH3), 2.63 (2H, d, J = 5.5 Hz, CH2), 
3.23 (2H, d, J = 6.5 Hz, CH2), 3.38 (2H, d, J = 14.0 Hz, CH2), 3.80 (2H, d, J = 5.5 Hz, 
CH2), 4.51 (2H, d, J = 13.5 Hz, CH2), 6.40 (1H, d, J = 3.5 Hz, ArH), 6.42 (1H, d, J = 
3.5 Hz, ArH), 6.62 (1H, d, J = 3.5 Hz, ArH), 6.64 (1H, d, J = 3.5 Hz, ArH), 6.65 (2H, 
s, ArH), 6.96 (2H, s, ArH). 
13
C{
1
H} NMR (CDCl3): δ 16.7 (CH3), 20.7 (CH3), 49.7 
(CH2), 50.1 (CH2), 58.5 (CH2), 111.2 (ArH), 119.1 (ArH), 121.9 (Ar), 126.1 (Ar), 
126.8 (ArH), 129.0, (Ar), 131.4, (ArH), 157.3, (ArO), 158.7, (ArO). Calc. (%) for 
C28H32N2O4Ti: C 66.14, H 6.34, N 5.51. Found (%), C 66.28, H 6.20, N 5.55. 
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Ti(1)-3,5-Di-tert-butylcatechol. 1H2 (0.36 g, 1.02 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 
mmol) were dissolved in CH2Cl2 (30 ml) and stirred (1 h). 3,5-Di-tert-butylcatechol 
(0.225 g, 1.01 mmol) was added to the yellow solution and the resulting dark red 
solution was stirred (16 h) before the solvent was removed in-vacuo and 
recrystallised from hot toluene (30 ml) to yield orange crystals (0.42 g, 0.68 mmol, 
67 %). 
1
H NMR (CDCl3): δ 1.12 (9H, s, 
t
Bu), 1.26 (9H, s, 
t
Bu), 2.19 (2H, d, J = 6.0 
Hz, CH2), 2.24 (6H, s, CH3), 2.27 (6H, s, CH3), 2.65 (2H, d, J = 5.5 Hz, CH2), 3.24 
(2H, d, J = 6.0 Hz, CH2), 3.40 (2H, d, J = 13.5 Hz, CH2), 3.91 (2H, d, J = 5.5 Hz, 
CH2), 4.51 (2H, d, J = 13.5 Hz, CH2), 6.34 (1H, d, J = 2.5 Hz, ArH), 6.62 (1H, d, J = 
4.5 Hz, ArH), 6.61 (2H, s, ArH), 6.96 (2H, s, ArH). 
13
C{
1
H} NMR (CDCl3): δ 16.5 
(CH3), 20.7 (CH3), 29.6 (CH3), 32.1 (CH3), 34.3 (C), 34.5 (C), 49.8 (CH2), 55.1 
(CH2), 58.6 (CH2), 106.9 (ArH), 112.9 (ArH), 121.7 (Ar), 126.2 (Ar), 126.6 (ArH), 
128.5 (Ar), 131.1 (ArH), 131.3 (Ar), 141.1 (Ar), 154.8, (ArO), 157.6, (ArO), 158.8, 
(ArO). Calc. (%) for C36H48N2O4Ti: C 69.67, H 7.80, N 4.51. Found (%), C 64.47, H 
7.25, N 4.23. 
 
Ti(1)-3-Methoxycatechol. 1H2 (0.36 g, 1.02 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 
mmol) were dissolved in CH2Cl2 (30 ml) and stirred (1 h). 3-Methoxycatechol (0.142 
g, 1.01 mmol) was added to the yellow solution and the resulting dark red solution 
was stirred (16 h) before the solvent was removed in-vacuo and recrystallised from 
hot toluene (30 ml) to yield orange crystals (0.25 g, 0.46 mmol, 46 %). 
1
H NMR 
(CDCl3): δ 2.19 (2H, d, J = 6.5 Hz, CH2), 2.23 (6H, s, CH3), 2.25 (6H, s, CH3), 2.63 
(2H, d, J = 5.5 Hz, CH2), 3.22 (2H, d, J = 6.0 Hz, CH2), 3.38 (2H, d, J = 13.5 Hz, 
CH2), 3.69 (3H, s, CH3), 3.83 (2H, d, J = 5.5 Hz, CH2), 4.53 (2H, d, J = 13.5 Hz, 
CH2), 6.12 (1H, dd, J = 8.0 Hz, J = 1.0 Hz, ArH), 6.33 (1H, dd, J = 8.5 Hz, J = 1.5 
Hz, ArH), 6.54 (1H, t, J = 8.0 Hz, ArH), 6.64 (2H, s, ArH), 6.94 (2H, s, ArH).
13
C{
1
H} 
NMR (CDCl3): δ 16.6 (CH3), 20.7 (CH3), 49.7 (CH2), 55.2 (CH2), 56.9 (CH3), 58.6 
(CH2), 115.7 (ArH), 115.9 (ArH), 118.3 (ArH), 122.0 (Ar), 126.1 (Ar), 126.7 (ArH), 
128.9 (Ar), 131.3 (ArH), 144.1 (Ar), 146.7 (ArO), 157.4 (ArO), 160.0 (ArO). Calc. 
(%) for C29H34N2O5Ti: C 64.69, H 6.36, N 5.20. Found (%), C 64.74, H 6.29, N 5.39. 
 
Ti(1)-4-Nitrocatechol. 1H2 (0.36 g, 1.02 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) 
were dissolved in CH2Cl2 (30 ml) and stirred (1 h). 4-Nitrocatechol (0.16 g, 1.03 
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mmol) was added to the yellow solution and the resulting dark red solution was 
stirred (16 h) before the solvent was removed in-vacuo and recrystallised from hot 
toluene (30 ml) to yield orange crystals (0.44 g, 0.80 mmol, 78 %). 
1
H NMR (CDCl3): 
δ 2.25 (6H, s, CH3), 2.27 (6H, s, CH3), 2.31 (2H, d, J = 7.0 Hz, CH2), 2.75 (2H, d, J 
= 5.5 Hz, CH2), 3.32 (2H, d, J = 6.0 Hz, CH2), 3.47 (2H, d, J = 14.0 Hz, CH2), 3.79 
(2H, d, J = 6.0 Hz, CH2), 4.48 (2H, d, J = 14.0 Hz, CH2), 6.38 (1H, d, J = 8.5 Hz, 
ArH), 6.70 (2H, s, ArH), 6.98 (2H, s, ArH), 7.25 (1H, s, ArH), 7.70 (1H, dd, J = 8.5 
Hz, J = 2.5 Hz, ArH).
 13
C{
1
H} NMR (CDCl3): δ 16.5 (CH3), 20.8 (CH3), 49.8 (CH2), 
55.2 (CH2), 58.5 (CH2), 106.2 (ArH), 110.0 (ArH), 117.5 (ArH), 121.7 (Ar), 125.9 
(Ar), 126.8 (ArH), 130.1 (Ar), 131.7 (ArH), 144.5 (Ar), 157.1 (ArO), 158.2 (ArO), 
166.3 (ArO). Calc. (%) for C28H31N3O6Ti: C 60.77, H 5.65, N 7.59. Found (%), C 
60.81, H 5.79, N 7.49. 
 
Ti(2)Catechol. 2H2 (0.74 g, 1.69 mmol) and Ti(O
i
Pr)4 (0.50 ml, 1.69 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (1 h). Catechol (0.186 g, 1.69 mmol) was 
added to the yellow solution and the resulting dark red solution was stirred (16 h) 
before the solvent was removed in-vacuo and recrystallised from hot toluene (30 ml) 
to yield orange crystals (0.72 g, 1.22 mmol, 72 %). 
1
H NMR (CDCl3): δ 1.29 (18H, s, 
t
Bu), 2.17 (2H, d, J = 6.5 Hz, CH2), 2.29 (6H, s, CH3), 2.23 (6H, s, CH3), 2.64 (2H, d, 
J = 5.5 Hz, CH2), 3.22 (2H, d, J = 6.5 Hz, CH2), 3.40 (2H, d, J = 13.5 Hz, CH2), 3.79 
(2H, d, J = 5.5 Hz, CH2), 4.53 (2H, d, J = 13.5 Hz, CH2), 6.39 (1H, d, J = 3.5 Hz, 
ArH), 6.41 (1H, d, J = 4.0 Hz, ArH), 6.61 (1H, d, J = 4.0 Hz, ArH), 6.63 (1H, d, J = 
3.5 Hz, ArH), 6.83 (2H, d, J = 2.5, ArH), 7.14 (2H, d, J = 2.5, ArH). 
13
C{
1
H} NMR 
(CDCl3): δ 17.0 (CH3), 31.8 (CH3), 34.1 (C), 49.6 (CH2), 55.1 (CH2), 58.8 (CH2), 
111.1 (ArH), 119.0 (ArH), 121.5 (Ar), 123.0 (ArH), 125.3 (Ar), 127.7 (ArH), 142.4 
(Ar), 144.5 (Ar), 157.2 (ArO), 158.9 (ArO). Calc. (%) for C34H44N2O4Ti: C 68.91, H 
7.48, N 4.73. Found (%), C 68.87, H 7.57, N 4.71. 
 
Ti(6)Catechol. 6H2 (0.37 g, 1.00 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (1 h). Catechol (0.11 g, 1.00 mmol) was 
added to the yellow solution and the resulting dark red solution was stirred (16 h) 
before the solvent was removed in-vacuo and recrystallised from hot toluene (30 ml) 
to yield orange crystals (0.33 g, 0.63 mmol, 62 %). 
1
H NMR (CDCl3): δ 2.00 (2H, m, 
 243 
CH2), 2.12 (6H, s, CH3), 2.23 (6H, s, CH3), 2.41 (2H, d, J = 7.5 Hz, CH2), 2.54 (1H, 
d, J = 7.0 Hz, CH2), 2.58 (1H, d, J = 6.5 Hz, CH2), 3.16 (2H, d, J = 7.0 Hz, CH2), 
3.22 (2H, d, J = 13.5 Hz, CH2), 4.14 (2H, br, CH2), 4.39 (2H, d, J = 13.0 Hz, CH2), 
6.40 (1H, d, J = 3.5 Hz, ArH), 6.42 (1H, d, J = 3.5 Hz, ArH), 6.62 (1H, d, J = 3.5 Hz, 
ArH), 6.64 (1H, d, J = 3.5 Hz, ArH), 6.65 (2H, s, ArH), 6.96 (2H, s, ArH). 
13
C{
1
H} 
NMR (CDCl3): δ 16.5 (CH3), 20.8 (CH3), 23.2 (CH2), 49.3 (CH2), 58.7 (CH2), 63.1 
(CH2), 111.6 (ArH), 119.5 (ArH), 123.1 (ArH), 125.5 (Ar), 127.0 (ArH), 129.1 (Ar), 
131.5 (ArH), 158.2 (br, ArO), 158.8 (br, ArO). Calc. (%) for C29H34N2O4Ti: C 66.67, 
H 6.56, N 5.36. Found (%), C 66.28, H 6.20, N 5.55. 
 
Ti(6)-3-Methoxycatechol. 6H2 (0.37 g, 1.00 mmol) and Ti(O
i
Pr)4 (0.30 ml, 1.01 
mmol) were dissolved in CH2Cl2 (30 ml) and stirred (1 h). 3-Methoxycatechol (0.142 
g, 1.01 mmol) was added to the yellow solution and the resulting dark red solution 
was stirred (16 h) before the solvent was removed in-vacuo and recrystallised from 
hot toluene (30 ml) to yield orange crystals (0.50 g, 0.91 mmol, 89 %). 
1
H NMR 
(CDCl3): δ 2.01 (2H, d, J = 6.5 Hz, CH2), 2.12 (6H, br, CH3), 2.36 (6H, s, CH3), 2.40 
(2H, d, J = 7.5 Hz, CH2), 2.56 (2H, m, CH2), 3.15 (2H, d, J = 7.0 Hz, CH2), 3.22 (2H, 
d, J = 13.5 Hz, CH2), 3.75 (3H, s, CH3), 3.80 – 4.40 (2H, br, CH2) 4.41 (2H, d, J = 
13.5 Hz, CH2), 6.14 (1H, dd, J = 8.0 Hz, J = 1.5 Hz, ArH), 6.37 (1H, dd, J = 8.0 Hz, J 
= 1.5 Hz, ArH), 6.58 (1H, t, J = 8.0 Hz, ArH), 6.65 (1H, br, ArH), 6.92 (1H, br, ArH). 
13
C{
1
H} NMR (CDCl3) (328 K): δ 16.4 (CH3), 20.7 (CH3), 23.5 (CH2), 49.6 (CH2), 
57.2 (CH3), 58.9 (CH2), 63.3 (CH2), 106.3 (ArH), 106.7 (ArH), 118.9 (ArH), 123.2 
(Ar), 125.6 (Ar), 126.9 (ArH), 129.1 (Ar), 131.6 (ArH), 144.5 (Ar), 158.4, (ArO), 
160.4, (ArO), 177.6, (ArO). Calc. (%) for C30H36N2O5Ti: C 65.22, H 6.57, N 5.07. 
Found (%), C 65.18, H 6.65, N 5.16. 
 
Ti(6)-4-Nitrocatechol. 6H2 (0.50 g, 1.36 mmol) and Ti(O
i
Pr)4 (0.40 ml, 1.35 mmol) 
were dissolved in CH2Cl2 (30 ml) and stirred (1 h). 4-Nitrocatechol (0.21 g, 1.35 
mmol) was added to the yellow solution and the resulting dark red solution was 
stirred (16 h) before the solvent was removed in-vacuo and recrystallised from hot 
toluene (30 ml) to yield orange crystals (0.34 g, 0.60 mmol, 44 %). 
1
H NMR (CDCl3): 
δ 2.06 (2H, m, CH2), 2.15 (6H, s, CH3), 2.27 (6H, s, CH3), 2.32 (2H, m, CH2), 2.37 
(Toluene-CH3), 2.53 (2H, d, J = 7.5 Hz, CH2), 2.63 (2H, m, CH2), 3.26 (2H, d, J = 
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7.0 Hz, CH2), 3.37 (2H, d, J = 14.0 Hz, CH2), 4.30 (2H, d, J = 13.5 Hz, CH2), 6.41 
(1H, d, J = 9.0 Hz, ArH), 6.72 (2H, s, ArH), 6.98 (2H, s, ArH), 7.15-7.30 (m, 
Toluene-ArH) 7.27 (1H, s, ArH), 7.74 (1H, dd, J = 8.5 Hz, J = 2.5 Hz, ArH).
 13
C{
1
H} 
NMR (CDCl3): δ 16.4 (CH3), 20.8 (CH3), 23.1 (CH2), 58.6 (CH2), 58.9 (CH2), 63.3 
(CH2), 106.6 (ArH), 110.4 (ArH), 117.7 (ArH), 122.5 (Ar), 125.1 (Ar), 127.1 (ArH), 
130.2 (Ar), 131.8 (ArH) 140.8, (ArO), 157.5 (ArO), 166.8 (ArO). Calc. (%) for 
C29H33N2O6Ti: C 61.38, H 5.86, N 7.40. Found (%), C 61.47, H 6.00, N 7.11. 
 
7.5 Preparation of Complexes for Chapter 3 
7.5.1 Preparation of zirconium homopiperazine salan complexes 
Zr(6)(O
i
Pr)2. 6H2 (0.48 g, 1.29 mmol) and Zr(O
i
Pr)4.
i
PrOH (0.5 g, 1.29 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.34 g, 0.59 
mmol, 46 %). 
1
H NMR (CDCl3) (233 K): δ 0.27 (6H, d, J = 6.8 Hz, Me), 1.24 (6H, d, 
J = 6.8 Hz, Me), 1.41 (1H, d, J = 5.8 Hz, CH2), 1.68 (1H, br, CH2), 2.17 (6H, s, Me), 
2.19 (6H, s, Me), 2.24 (2H, m, CH2), 2.88 (2H, d, J = 6.8 Hz, CH2), 3.07 (2H, d, J = 
11.6 Hz, CH2), 3.30 (1H, br, CH2), 3.30 (2H, br CH2), 3.55 (2H, d, J = 6.8 Hz, CH2), 
4.37 (2H, d, J = 11.6 Hz, N-CH2-Ar), 4.50 (1H, m, CH), 6.67 (2H, s, ArH), 6.90 (2H, 
s, ArH) 
13
C{
1
H} NMR (CDCl3) (253 K): δ 17.1 (CH3), 20.6 (CH3), 22.5 (CH2), 26.4 
(CH3), 27.2 (CH3), 54.2 (CH2), 56.0 (CH2), 63.2 (CH2), 67.5 (CH), 69.2 (CH), 122.4 
(Ar), 124.8 (Ar), 126.3 (Ar), 127.8 (ArH) 131.9 (ArH) 159.8 (ArO). Calc. (%) for 
C29H44N2O4Zr: C 60.48, H 7.70, N 4.86. Found (%), C 60.54, H 7.66, N 4.71. 
 
Zr(7)(O
i
Pr)2. 7H2 (0.58 g, 1.29 mmol) and Zr(O
i
Pr)4.
i
PrOH (0.5 g, 1.29 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.49 g, 0.74 
mmol, 58 %). 
1
H NMR (CDCl3) (233 K): δ 0.15 (6H, d , J = 5.8 Hz, Me), 1.21 (18H, 
s, 
t
Bu), 1.23 (6H, s, Me), 1.73 (1H, br, CH2), 2.15 (1H, br, CH2), 2.20 (6H, s, Me), 
2.26 (2H, br, CH2), 2.89 (2H, d, J = 6.6 Hz, CH2), 3.12 (2H, d, J = 11.6 Hz, CH2), 
3.27 (2H, m, CH2), 3.27 (1H, m, CH), 3.53 (2H, d, J = 6.8 Hz, N-CH2-Ar), 4.38 (2H, 
d, J = 11.4 CH), 4.43 (1H, s, J = 6.1 Hz, CH), 6.83 (2H, s, ArH), 7.09 (2H, s, ArH) 
13
C{
1
H} NMR (CDCl3) (233 K): δ 17.4 (CH3), 22.5 (CH2), 26.0 (CH3), 27.1 (CH3), 
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31.7 (CH3), 33.7 (C), 54.2 (CH2), 55.8 (CH2), 63.4 (CH2), 67.6 (CH), 69.9 (CH), 
121.7 (Ar), 123.8 (ArH), 125.7 (Ar), 128.4 (ArH), 138.4 (Ar), 159.8, (ArO). Calc. (%) 
for C35H56N2O4Zr: C 63.69, H 8.55, N 4.24. Found (%), C 62.7, H 8.55, N 4.65. 
 
Zr(8)(O
i
Pr)2. 8H2 (0.67 g, 1.25 mmol) and Zr(O
i
Pr)4.
i
PrOH (0.5 g, 1.29 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.31 g, 0.42 
mmol, 33 %). 
1
H NMR (CDCl3) (253 K): δ 0.01 (6H, s, CH3), 1.23 (18H, s, 
t
Bu), 
1.23 (6H, br, CH3), 1.42 (18H, s, 
t
Bu), 1.80 (1H, br, CH2), 2.21 (1H, br, CH2), 2.35 
(2H, br, CH2), 2.88 (2H, d, J = 6.3 Hz, CH2), 3.14 (2H, d, J = 10.4 Hz, CH2), 3.53 
(2H, d, J = 7.1 Hz, CH2), 3.60 (2H, br, N-CH2-Ar), 3.60 (1H, br, CH), 4.30 (2H, br, 
N-CH2-Ar), 4.32 (1H, br, CH), 6.88 (2H, s, ArH), 7.24 (2H, s, ArH) 
13
C{
1
H} NMR 
(CDCl3): δ 23.1 (CH2) 26.0 (CH3), 27.1 (CH3), 30.2 (CH3), 31.9 (CH3), 34.1 (C), 
35.3 (C), 56.5 (CH2), 63.9 (CH2), 68.6 (CH), 69.6 (CH), 122.8 (Ar), 124.4 (Ar), 
136.3 (Ar), 138.0 (Ar). due to poor solubility 2 Ar resonances were not detected. 
Calc. (%) for C41H68N2O4Zr: C 66.17, H 9.21, N 3.76. Found (%), C 66.1, H 9.30, N 
4.16.  
 
Zr(9)(O
i
Pr)2. 9H2 (0.58 g, 1.29 mmol) and Zr(O
i
Pr)4.
i
PrOH (0.5 g, 1.29 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.19 g, 0.29 
mmol, 22 %). 
1
H NMR (CDCl3) (233 K): δ 0.07 (6H, d, J = 5.1 Hz, Me), 1.21 (6H, d, 
J = 5.8 Hz, Me), 1.39 (18H, s, 
t
Bu), 1.42 (1H, br, CH2), 1.74 (1H, br, CH2), 2.19 (6H, 
s, CH3), 2.32 (2H, m, CH2), 2.89 (2H, d, J = 6.3 Hz, CH2), 3.10 (2H, d, J = 11.6 Hz, 
CH2), 3.50 (2H, d, J = 6.6 Hz, CH2), 3.59 (2H, br, N-CH2-Ar), 3.59 (1H, br, CH), 
4.27 (2H, br, N-CH2-Ar), 4.27 (1H, br, CH), 6.72 (2H, s, ArH), 7.00 (2H, s, ArH) 
13
C{
1
H} NMR (CDCl3) (233 K): δ 20.9 (CH3), 22.5 (CH2), 26.0 (CH3), 27.2 (CH3), 
29.8 (CH3), 34.9 (C), 54.3 (CH2), 56.0 (CH2), 63.5 (CH2), 67.9 (CH), 69.1 (CH), 
123.4 (Ar), 123.8 (ArH), 128.0 (Ar), 128.7 (ArH), 136.1 (Ar), 161.3, (ArO). Calc. (%) 
C35H56N2O4Zr: C 63.69, H 8.55, N 4.24. Found (%), C 63.68, H 8.66, N 4.24. 
 
Zr(10)(O
i
Pr)2. 10H2 (0.61 g, 1.03 mmol) and Zr(O
i
Pr)4.
i
PrOH (0.4 g, 1.03 mmol) 
were dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-
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vacuo and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.37 g, 
0.46 mmol, 45 %). 
1
H NMR (CDCl3) (233 K): δ 0.02 (6H, br, CH3), 0.52 (6H, t, J = 
7.2 Hz, CH3), 0.72 (6H, t, J = 7.2 Hz, CH3), 1.16 (6H, br, CH3), 1.19 (12H, s, CH3), 
1.34 (6H, s, CH3), 1.36 (6H, s, CH3), 1.50 (4H, m, CH2), 1.65 (2H, m, CH2), 1.79 
(1H, br, CH2), 2.11 (2H, m, CH2), 2.19 (1H, br, CH2), 2.33 (2H, m, CH2), 2.88 (2H, d, 
J = 6.6 Hz, CH2), 3.13 (2H, d, J = 11.4 Hz, CH2), 3.49 (2H, d, J = 7.1 Hz, CH2), 3.66 
(1H, br, CH), 3.66 (2H, br, N-CH2-Ar), 4.24 (1H, br, CH), 4.28 (2H, d, J = 11.6 Hz, 
CH2), 6.80 (2H, s, ArH), 7.10 (2H, s, ArH) 
13
C{
1
H} NMR (CDCl3) (253 K): δ 9.2 
(CH3), 9.8 (CH3), 22.7 (CH2), 26.0 (CH3), 27.0 (CH3), 27.2 (CH3), 27.7 (CH3), 28.6 
(CH3), 29.4 (CH3), 33.1 (C), 37.0 (C), 37.1 (CH2), 38.3 (CH2), 54.4 (CH2), 56.1 
(CH2), 64.0 (CH2), 68.2 (CH), 69.1 (CH), 123.5 (Ar), 125.4 (ArH), 126.2 (ArH), 
134.7 (Ar), 135.2 (Ar), 161.4 (ArO). Calc. (%) for C45H76N2O4Zr: C 67.53, H 9.57, 
N 3.50. Found (%), C 64.38, H 9.22, N 3.11. 
 
7.5.2 Preparation of hafnium homopiperazine salan complexes 
Hf(6)(O
i
Pr)2. 6H2 (0.39 g, 1.05 mmol) and Hf(O
i
Pr)4.
i
PrOH (0.5 g, 1.05 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.30 g, 0.45 
mmol, 43 %). 
1
H NMR (CDCl3) (233 K): δ 0.25 (6H, d, J = 5.8 Hz, Me), 1.23, (6H, d, 
J = 5.8 Hz, Me), 1.68 (1H, br, CH2), 2.15 (1H, br, CH2), 2.17 (6H, s, Me), 2.20 (6H, s, 
Me), 2.34 (2H, m, CH2), 2.95 (2H, d, J = 6.3 Hz, CH2), 3.12 (2H, d, J = 11.6 Hz, 
CH2), 3.37 (1H, br, CH2), 3.37 (2H, br CH2), 3.56 (2H, d, J = 6.8 Hz, CH2), 4.31 (2H, 
d, J = 11.6 Hz, N-CH2-Ar), 4.57 (1H, sept, J = 5.8 Hz, CH), 6.66 (2H, s, ArH), 6.92 
(2H, s, ArH) 
13
C{
1
H} NMR (CDCl3) (233 K): δ 17.1 (CH3), 20.6 (CH3), 22.5 (CH2), 
26.6 (CH3), 27.4 (CH3), 54.3 (CH2), 56.3 (CH2), 63.1 (CH2), 67.3 (CH), 69.0 (CH), 
122.4 (Ar), 124.9 (Ar), 126.9 (Ar), 127.8 (ArH) 131.9 (ArH) 159.6 (ArO). Calc. (%) 
for C29H44N2O4Hf: C 52.52, H 6.69, N 4.22. Found (%), C 52.4, H 6.71, N 4.28. 
 
Hf(7)(O
i
Pr)2. 7H2 (0.48 g, 1.05 mmol) and Hf(O
i
Pr)4.
i
PrOH (0.5 g, 1.05 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.42 g, 0.56 
mmol, 54 %). 
1
H NMR (CDCl3) (233 K): δ 0.13 (6H, d, J = 6.1 Hz, Me), 1.21 (18H, 
s, 
t
Bu), 1.22 (6H, s, 
t
Bu), 1.73 (1H, br, CH2), 2.16 (1H, br, CH2), 2.23 (6H, s, Me), 
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2.35 (2H, m, CH2), 2.95 (2H, d, J = 6.6 Hz, CH2), 3.16 (2H, d, J = 11.6 Hz, CH2), 
3.36 (2H, br, CH2), 3.36 (1H, br, CH), 3.55 (2H, d, J = 6.8 Hz, N-CH2-Ar), 4.42 (2H, 
d, J = 11.4 Hz, N-CH2-Ar), 4.51 (1H, sept, J = 6.0 Hz, CH), 6.83 (2H, d, J = 2.3 Hz, 
ArH), 7.11 (2H, d, J = 2.0 Hz, ArH) 
13
C{
1
H} NMR (CDCl3) (233 K): δ 17.4 (CH3), 
22.5 (CH2), 26.2 (CH3), 27.3 (CH3), 31.7 (CH3), 33.7 (C), 54.3 (CH2), 56.1 (CH2), 
63.4 (CH2), 67.4 (CH), 69.0 (CH), 121.7 (Ar), 123.7 (ArH), 126.3 (Ar), 128.4 (ArH), 
138.5 (Ar), 159.7 (ArO). Calc. (%) C35H56N2O4Hf: C 56.25, H 7.55, N 3.75. Found 
(%), C 56.24, H 7.48, N 3.63. 
 
Hf(8)(O
i
Pr)2. 8H2 (0.53 g, 0.99 mmol) and Hf(O
i
Pr)4.
i
PrOH (0.47 g, 0.99 mmol) 
were dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-
vacuo and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.14 g, 
0.17 mmol, 17 %). 
1
H NMR (CDCl3) (233 K): δ -0.02 (6H, d, J = 4.5 Hz, Me), 1.18 
(6H, d, J = 5.7 Hz, 
t
Bu), 1.20 (18H, s, 
t
Bu), 1.40 (18H, s, 
t
Bu), 1.79 (1H, br, CH2), 
2.19 (1H, br, CH2), 2.44 (2H, br, CH2), 2.95 (2H, d, J = 6.1 Hz, CH2), 3.17 (2H, d, J 
= 11.6 Hz, CH2), 3.52 (2H, d, J = 6.8 Hz, CH2), 3.63 (2H, br, N-CH2-Ar), 3.63 (1H, 
br, CH), 4.32 (2H, d, J = 11.6 Hz, N-CH2-Ar), 4.32 (1H, br, CH), 6.86 (2H, s, ArH), 
7.24 (2H, s, ArH) 
13
C{
1
H} NMR (CDCl3) (258 K): δ 22.6 (CH2), 25.8 (CH3), 27.5 
(CH3), 30.0 (CH3), 31.8 (CH3), 34.0 (C), 35.1 (C), 54.5 (CH2), 56.3 (CH2), 63.7 
(CH2), 68.0 (CH), 69.0 (CH), 122.6 (Ar), 124.5 (ArH), 124.6 (ArH), 136.3 (Ar), 
136.3 (Ar), 137.6 (Ar), 161.3 (ArO). Calc. (%) for C41H68N2O4Hf: C 59.22, H 8.24, 
N 3.37. Found (%), C 59.8, H 8.26, N 3.68. 
 
Hf(9)(O
i
Pr)2. 9H2 (0.48 g, 1.05 mmol) and Hf(O
i
Pr)4.
i
PrOH (0.5 g, 1.05 mmol) were 
dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-vacuo 
and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.50 g, 0.67 
mmol, 64 %). 
1
H NMR (CDCl3) (233 K): δ 0.07 (6H, s, Me), 1.20 (6H, d, J = 5.3 Hz, 
Me), 1.40 (18H, s, 
t
Bu), 1.41 (1H, br, CH2), 1.74 (1H, br, CH2), 2.20 (6H, s, CH3), 
2.42 (2H, m, CH2), 2.95 (2H, d, J = 6.8 Hz, CH2), 3.13 (2H, d, J = 11.6 Hz, CH2), 
3.52 (2H, d, J = 7.1 Hz, CH2), 3.65 (2H, br, N-CH2-Ar), 3.67 (1H, br, CH), 4.31 (2H, 
d, J = 11.6 Hz, N-CH2-Ar), 4.38 (1H, br, CH), 6.72 (2H, s, ArH), 7.03 (2H, s, ArH). 
13
C{
1
H} NMR (CDCl3) (233 K): δ 20.8 (CH3), 22.5 (CH2), 26.3 (CH3), 27.5 (CH3), 
29.9 (CH3), 34.8 (C), 54.5 (CH2), 56.2 (CH2), 63.4 (CH2), 67.7 (CH), 68.9 (CH), 
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123.4 (Ar), 123.9 (ArH), 128.0 (Ar), 128.6 (ArH), 136.6 (Ar), 161.2 (ArO). Calc. (%) 
for C35H56N2O4Hf: C 56.25, H 7.55, N 3.75. Found (%), C 56.35, H 7.43, N 3.64. 
 
Hf(10)(O
i
Pr)2. 10H2 (0.62 g, 1.05 mmol) and Hf(O
i
Pr)4.
i
PrOH (0.5 g, 1.05 mmol) 
were dissolved in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-
vacuo and recrystallised from hot hexane (40 ml) to yield colourless crystals (0.30 g, 
0.34 mmol, 32 %). 
1
H NMR (CDCl3) (233 K): δ 0.03 (6H, s, CH3), 0.52 (6H, t, J = 
7.3 Hz, CH3), 0.72 (6H, t, J = 7.3 Hz, CH3), 1.16 (12H, s, CH3), 1.20 (6H, s, CH3), 
1.35 (6H, s, CH3), 1.37 (6H, s, CH3), 1.50 (4H, m, CH2), 1.69 (2H, m, CH2), 1.78 
(1H, br, CH2), 2.09 (2H, m, CH2), 2.20 (1H, br, CH2), 2.43 (2H, m, CH2), 2.95 (2H, d, 
J = 6.3 Hz, CH2), 3.16 (2H, d, J = 11.4 Hz, CH2), 3.51 (2H, d, J = 7.3 Hz, CH2), 3.74 
(2H, br, N-CH2-Ar), 3.74 (1H, br, CH), 4.32 (2H, d, J = 11.4 Hz, N-CH2-Ar), 4.33 
(1H, br, CH), 6.80 (2H, s, ArH), 7.12 (2H, s, ArH).
 13
C{
1
H} NMR (233 K): δ 9.2 
(CH3), 9.8 (CH3), 22.9 (CH2), 26.3 (CH3), 27.1 (CH3), 27.6 (CH3), 27.7 (CH3), 28.4 
(CH3), 29.8 (CH3), 33.0 (C), 37.1 (C), 37.2 (CH2), 38.2 (CH2), 54.6 (CH2), 56.4 
(CH2), 63.8 (CH2), 68.0 (CH2), 68.9 (CH2), 122.5 (Ar), 125.4 (ArH), 126.3 (ArH), 
135.1 (Ar), 135.1 (Ar), 161.2 (ArO). Calc. (%) for C45H76N2O4Hf: C 60.89, H 8.63, 
N 3.16. Found (%), C 51.99, H 7.82, N 2.50. 
 
7.6 Preparation of Complexes for Chapter 4 
7.6.1 Preparation of methyl aluminium homopiperazine salan complexes 
Al(6)Me. A solution of 6H2 (0.69 g, 1.87 mmol) in toluene (30 ml) was heated to 
50°C and 2M AlMe3 (0.93 ml, 1.86 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). The crude 
mixture was recrystallised from a toluene:hexane mix to yield a white powder (0.45 
g, 1.1 mmol, 59 %). 
1
H NMR (298 K) (C6D5CD3): δ −0.59 (1.5H, s, Al-Me), −0.43 
(1.5H, s, Al-Me), 0.50 (0.5H, d, J = 15.5 Hz, CH2), 0.89 (1H, m, CH2), 1.04 (0.5H, br, 
CH2), 1.22 (1H, m, CH2), 1.35 (2H, m, CH2), 1.51 (1H, m, CH2), 1.68 (1H, m, CH2), 
2.28 (3H, s, CH3), 2.30 (3H, s, CH3), 2.43 (3H, s, CH3), 2.58 (2H, m, CH2), 2.62 (3H, 
s, CH3), 2.66 (2H, m, CH2), 2.92 (1H, m, CH2), 3.68 (1H, d, J = 13.0 Hz, CH2), 4.04 
(1H, d, J = 13.0 Hz, CH2), 6.45 (2H, d, J = 4.5 Hz, ArH), 6.95 (2H, s, ArH). 
13
C{
1
H} 
NMR (C6D5CD3): δ 16.7 (CH3), 17.0 (CH3), 20.8 (CH3), 22.0 (CH2), 22.4 (CH2), 
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46.2 (CH2), 49.5 (CH2), 51.1 (CH2), 55.5 (CH2), 61.7 (CH2), 62.8 (CH2), 119.0 (Ar), 
120.5 (Ar), 123.6 (Ar), 124.3 (Ar), 126.5 (ArH), 126.7 (ArH), 128.0 (Ar), 128.9 (Ar), 
131.7 (ArH), 131.9 (ArH), 157.7 (ArO), 157.9 (ArO). Calc. (%) for C24H33N2O2Al, 
C 70.56, H 8.14, N 6.86. Found (%), C 70.68, H 8.08, N 6.69. 
 
Al(7)Me. A solution of 7H2 (0.91 g, 2.01 mmol) in toluene (40 ml) was heated to 
50°C and 2M AlMe3 (1.0 ml, 1.00 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). The crude 
mixture was recrystallised from a toluene:hexane mix to yield a white powder (0.25 
g, 0.51 mmol, 25 %). 
1
H NMR (233 K) (C6D5CD3): δ −0.45 (3H, s, Al-Me), 0.18 (1H, 
br, CH2), 0.73 (1H, br, CH2), 1.12 (2H, d, J = 7.5 Hz, CH2), 1.39 (2H, d, J = 7.0 Hz, 
CH2), 1.51 (18H, s, CH3), 2.06 (1H, m, CH2), 2.45 (2H, d, J = 13.0 Hz, CH2), 2.54 
(2H, br, CH2), 2.64 (1H, br, CH2), 2.82 (6H, s, CH3), 3.97 (2H, d, J = 13.0 Hz, CH2), 
6.80 (2H, d, J= 2.0 Hz, ArH), 7.40 (2H, d, J = 2.0 Hz, ArH). 
13
C{
1
H} NMR 
(C6D5CD3): δ 17.3 (CH3), 21.9 (C), 32.2 (CH3), 40.0 (CH2), 49.4 (CH2), 52.1 (CH2), 
63.2 (CH2), 118.5 (Ar), 122.3 (ArH), 127.8 (Ar), 127.9 (ArH), 137.5 (Ar), 157.6 
(ArO). Calc. (%) for C30H45N2O2Al, C 73.14, H 9.21, N 5.69. Found (%), C 72.99, H 
9.09, N 5.78. 
 
Al(8)Me. A solution of 8H2 (0.54 g, 1.01 mmol) in toluene (30 ml) was heated to 
50°C and 2M AlMe3 (0.5 ml, 1.00 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). The crude 
mixture was recrystallised from a toluene:hexane mix to yield clear crystals suitable 
for X-ray diffraction (0.25 g, 0.43 mmol, 43 %). 
1
H NMR (233 K) (C4D8O): δ −0.87 
(3H, s, Al-Me), 1.26 (18H, s, CH3), 1.44 (9H, s, CH3), 1.50 (9H, s, CH3), 1.86 (1H, 
br, CH2), 2.33 (2H, br, CH2), 2.41 (1H, br, CH2), 2.62 (1H, br, CH2), 3.15 (2H, br, 
CH2), 3.23 (2H, m, CH2), 3.32 (2H, m, CH2), 3.41 (1H, br, CH2), 4.06 (1H, d, J = 
11.5 Hz, CH2), 4.27 (1H, d, J = 14.0 Hz, CH2), 6.79 (1H, s, ArH), 6.86 (1H, s, ArH), 
7.16 (1H, s, ArH), 7.20 (1H, s, ArH). 
13
C{
1
H} NMR (233 K) (C4D8O): δ 21.9 (CH2), 
29.8 (CH3), 29.1 (CH3), 31.3 (CH3), 31.4 (CH3), 33.7 (C), 33.8 (C), 34.8 (C), 35.1 
(C), 43.9 (CH2), 51.9 (CH2), 54.2 (CH2), 55.6 (CH2), 59.4 (CH2), 65.0 (CH2), 120.5 
(Ar), 121.8 (Ar), 122.4 (Ar), 122.7 (Ar), 123.2 (Ar), 123.5 (Ar), 135.8 (Ar), 136.4 
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(Ar), 137.3 (Ar), 137.8 (Ar), 155.7 (ArO), 159.7 (ArO). Calc. (%) for C36H57N2O2Al, 
C 74.96, H 9.96, N 4.86. Found (%), C 74.96, H 9.90, N 4.81. 
 
Al(9)Me. A solution of 9H2 (0.45 g, 1.00 mmol) in toluene (30 ml) was heated to 
50°C and 2M AlMe3 (0.5 ml, 1.00 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). The crude 
mixture was recrystallised from a toluene:hexane mix to yield a white powder (0.21 
g, 0.43 mmol, 43 %). 
1
H NMR (233 K) (C6D5CD3): δ −0.59 (3H, s, Al-Me), 0.54 (1H, 
d, J = 13.5 Hz, CH2), 0.92 (1H, br, CH2), 1.08 (1H, br, CH2), 1.16 (2H, br, CH2), 
1.30 (1H, d, J = 7.5 Hz, CH2), 1.55 (1H, br, CH2), 1.92 (9H, s, CH3), 1.95 (9H, s, 
CH3), 2.27 (1H, d, J = 11.5 Hz, CH2), 2.40 (1H, d, J = 14.5 Hz, CH2), 2.43 (1H, br, 
CH2), 2.43 (3H, s, 2.76), 2.48 (3H, s, 2.76), 2.57 (1H, br, CH2), 2.87 (1H, br, CH2), 
3.63 (1H, d, J = 11.5 Hz, CH2), 3.81 (1H, d, J = 14.0 Hz, CH2), 6.54 (1H, s, ArH), 
6.60 (1H, s, ArH), 7.36 (1H, s, ArH), 7.41 (1H, s, ArH). 
13
C{
1
H} NMR (233 K) 
(C4D8O): δ 21.3 (CH3), 21.4 (CH3), 22.9 (CH2), 30.2 (CH3), 30.9 (CH3), 35.6 (C), 
35.9 (C), 44.8 (CH2), 52.7 (CH2), 55.3 (CH2), 56.8 (CH2), 60.2 (CH2), 65.6 (CH2), 
122.1 (Ar), 123.3 (Ar), 123.4 (Ar), 124.8 (Ar), 127.4 (Ar), 127.5 (Ar), 128.1 (Ar), 
128.5 (Ar), 138.2 (Ar), 139.4 (Ar), 156.8 (ArO), 161.0 (ArO). Calc. (%) for 
C30H45N2O2Al, C 73.14, H 9.21, N 5.69. Found (%), C 73.02, H 9.25, N 5.73. 
 
Al(11)Me. A solution of 11H2 (0.85 g, 2.00 mmol) in toluene (40 ml) was heated to 
50°C and 2M AlMe3 (1.0 ml, 2.00 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). The crude 
mixture was recrystallised from a toluene:hexane mix to yield a white powder (0.55 
g, 1.18 mmol, 59 %). 
1
H NMR (233 K) (C4D8O): δ −0.53 (3H, s, Al-Me), 1.23 (18H, 
s, CH3), 1.23 (2H, br, CH2), 2.30 (2H, m, CH2), 2.94 (2H, br, CH2), 3.04 (2H, br, 
CH2), 3.13 (2H, br, CH2), 3.40 (2H, d, J = 13.5 Hz, CH2), 4.30 (2H, d, J = 13.0 Hz, 
CH2), 6.58 (2H, d, J = 8.5 Hz, ArH), 6.87 (2H, d, J = 2.0 Hz, ArH), 7.07 (2H, dd, J = 
8.5 Hz, J = 2.0 Hz, ArH). 
13
C{
1
H} NMR (C4D8O): δ 22.5 (CH2), 31.6 (CH3), 33.7 
(C), 50.2 (CH2), 52.7 (CH2), 63.1 (CH2), 119.3 (ArH), 119.7 (Ar), 124.6 (ArH), 
126.0 (ArH), 137.5 (Ar), 159.4 (ArO). Calc. (%) for C28H41N2O2Al, C 72.38, H 8.89, 
N 6.03. Found (%), C 72.35, H 8.88, N 6.17. 
7.6.2 Preparation of benzoxy aluminium homopiperazine salan complexes 
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Al(6)OBn. A solution of 6H2 (0.37 g, 1.00 mmol) in toluene (30 ml) was heated to 
50°C and 2M AlMe3 (0.5 ml, 1.00 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). Excess 
benzyl alcohol (0.52 ml, 5.02 mmol) was carefully added to the hot solution and 
allowed to stir (3 h, 80 °C) the reaction was then cooled and the solvent removed 
under vacuum. The crude mixture was recrystallised from a toluene:hexane mix to 
yield a white powder (0.22 g, 0.44 mmol, 44 %). 
1
H NMR (233 K) (C6D5CD3): δ 
0.22 (1H, d, J = 13.5 Hz, CH2), 0.75 (1H, br, CH2), 1.10 (2H, br, CH2), 1.45 (2H, br, 
CH2), 2.40 (6H, s, CH3), 2.45 (4H, m, CH2), 2.71 (2H, br, CH2), 2.81 (6H, s, CH3), 
4.30 (2H, d, J = 12.5 Hz, CH2), 5.25 (2H, s, CH2), 6.51 (2H, s, ArH), 7.15 (1H, br, 
ArH), 7.15 (2H, br, ArH), 7.23 (2H, m, ArH), 7.41 (2H, d, J = 7.5 Hz, ArH). 
13
C{
1
H} 
NMR (C6D5CD3): δ 16.8 (CH3), 20.8 (CH3), 21.9 (C), 22.4 (C), 45.6 (CH2), 50.0 
(CH2), 52.5 (CH2), 55.7 (CH2), 61.9 (CH2), 62.4 (CH2), 64.9 (CH2), 66.4 (CH2), 
119.6 (Ar), 120.5 (Ar), 124.3 (Ar), 124.7 (Ar), 126.1 (ArH), 126.5 (ArH), 126.6 
(ArH), 127.3 (ArH), 126.8 (ArH), 128.1 (Ar), 128.1 (ArH), 128.3 (ArH), 128.8 (Ar), 
131.8 (ArH), 132.0 (ArH), 157.4 (ArO), 157.3 (ArO). Calc. (%) for C30H37N2O3Al, 
C 71.98, H 7.45, N 5.60. Found (%), C 72.12, H 7.50, N 5.52. 
 
Al(7)OBn. A solution of 7H2 (0.45 g, 0.99 mmol) in toluene (30 ml) was heated to 
50°C and 2M AlMe3 (0.5 ml, 1.00 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). Excess 
benzyl alcohol (0.52 ml, 5.02 mmol) was carefully added to the hot solution and 
allowed to stir (3 h, 80°C) the reaction was then cooled and the solvent removed 
under vacuum. The crude mixture was recrystallised from a toluene:hexane mix to 
yield a white powder (0.47 g, 0.81 mmol, 81 %).
 1
H NMR (233 K) (C6D5CD3): δ 
0.11 (1H, d, J = 12.0 Hz, CH2), 0.70 (1H, br, CH2), 1.10 (2H, d, J= 8.0 Hz, CH2), 
1.47 (2H, br, CH2), 1.50 (18H, s, CH3), 2.43 (4H, m, CH2), 2.71 (2H, d, J = 6.5 Hz, 
CH2), 2.85 (6H, s, CH3), 4.31 (2H, d, J = 12.5 Hz, CH2), 5.29 (2H, s, CH2), 6.79 (2H, 
s, ArH), 7.15 (1H, br, ArH), 7.24 (2H, t, J = 7.5 Hz, ArH), 7.40 (4H, m, ArH). 
13
C 
NMR (C6D5CD3): δ 17.6 (CH3), 22.3 (CH2), 32.5 (C), 32.6 (CH3), 34.5 (CH2), 50.4 
(CH2), 52.9 (CH2), 63.2 (CH2), 66.7 (CH2), 119.5 (Ar), 122.7 (ArH), 126.5 (ArH), 
127.2 (ArH), 128.1 (Ar), 128.4 (ArH), 128.5 (ArH), 138.4 (Ar), 147.3 (Ar), 157.7 
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(ArO). Calc. (%) for C36H49N2O3Al, C 73.94, H 8.45, N 4.79. Found (%), C 73.91, H 
8.50, N 4.72. 
 
Al(8)OBn. A solution of 8H2 (0.54 g, 1.00 mmol) in toluene (40 ml) was heated to 
50°C and 2M AlMe3 (0.5 ml, 1.00 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). Excess 
benzyl alcohol (0.31 ml, 3.0 mmol) was carefully added to the hot solution and 
allowed to stir (3 h, 80°C) the reaction was then cooled and the solvent removed 
under vacuum. The crude mixture was recrystallised from a toluene:hexane mix to 
yield a white powder (0.24 g, 0.36 mmol, 36 %).
 1
H NMR (233 K) (C6D5CD3): δ 
0.29 (1H, br, CH2), 0.76 (1H, br, CH2), 1.48 (4H, br, CH2), 1.51 (18H, s, CH3), 2.00 
(18H, s, CH3), 2.56 (4H, m, CH2), 2.64 (2H, m, CH2), 4.32 (2H, d, J = 13.5 Hz, CH2), 
5.26 (2H, s, CH2), 6.77 (2H, s, ArH), 7.15 (1H, s, ArH), 7.21 (2H, t, J = 7.5 Hz, ArH), 
7.36 (2H, d, J = 7.5 Hz, ArH), 7.66 (2H, s, ArH). 
13
C{
1
H} NMR (C6D5CD3): δ 22.1 
(CH2), 30.1 (CH3), 32.1 (CH3), 34.2 (C), 36.1 (C), 50.7 (CH2), 52.3 (CH2), 63.7 
(CH2), 65.9 (CH2), 119.8 (Ar), 122.8 (ArH), 124.0 (ArH), 126.1 (ArH), 126.7 (ArH), 
128.1 (ArH), 137.9 (Ar), 139.0 (Ar), 147.0 (Ar), 157.6 (ArO). Calc. (%) for 
C42H61N2O3Al, C 75.41, H 9.19, N 4.19. Found (%), C 75.37, H 9.04, N 4.12. 
 
Al(9)OBn. A solution of 9H2 (0.45 g, 0.99 mmol) in toluene (30 ml) was heated to 
50°C and 2M AlMe3 (0.5 ml, 1.00 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). Excess 
benzyl alcohol (0.52 ml, 5.02 mmol) was carefully added to the hot solution and 
allowed to stir (5 h, 80°C) the reaction was then cooled and the solvent removed 
under vacuum. The crude mixture was recrystallised from a toluene:hexane mix to 
yield a white powder (0.20 g, 0.34 mmol, 34 %).
 1
H NMR (233 K) (C6D5CD3): δ 
0.40 (1H, d, J = 13.5 Hz, CH2), 0.76 (1H, br, CH2), 1.20 (2H, d, J = 9.0 Hz, CH2), 
1.40 (2H, br, CH2), 1.96 (18H, s, CH3), 2.43 (6H, s, CH3), 2.51 (4H, m, CH2), 2.66 
(2H, m, CH2), 4.27 (2H, d, J = 13.0 Hz, CH2), 5.25 (2H, s, CH2), 6.48 (2H, s, ArH), 
7.14 (1H, s, ArH), 7.21 (2H, t, J = 7.5 Hz, ArH), 7.40 (4H, m, ArH). 
13
C{
1
H} NMR 
(C6D5CD3): δ 21.0 (CH3), 22.1 (CH2), 30.9 (CH3), 35.7 (C), 50.6 (CH2), 52.2 (CH2), 
63.2 (CH2), 65.9 (CH2), 120.3 (Ar), 124.3 (Ar), 126.1 (ArH), 126.7 (ArH), 126.9 
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(ArH), 127.8 (ArH), 128.1 (ArH), 139.4 (Ar), 146.7 (Ar), 157.6 (ArO). Calc. (%) for 
C36H49N2O3Al, C 73.94, H 8.45, N 4.79. Found (%), C 73.86, H 8.51, N 4.75. 
 
Al(11)OBn. A solution of 11H2 (0.43 g, 1.01 mmol) in toluene (30 ml) was heated to 
50°C and 2M AlMe3 (0.5 ml, 1.00 mmol) was added slowly while stirring (30 mins, 
50°C), after which the solution was further heated and stirred (3 h, 80°C). Excess 
benzyl alcohol (0.31 ml, 3.00 mmol) was carefully added to the hot solution and 
allowed to stir (16 h, 70°C) the reaction was then cooled and the solvent removed 
under vacuum. The crude mixture was recrystallised from a toluene:hexane mix to 
yield a white powder (0.41 g, 0.74 mmol, 74 %). 
1
H NMR (C6D5CD3): δ 0.80 (1H, m, 
CH2), 1.14 (1H, m, CH2), 1.35 (18H, s, CH3), 1.50 (4H, m, CH2), 2.59 (2H, d, J = 7.5 
Hz, CH2), 3.22 (2H, d, J = 12.5 Hz, CH2), 3.36 (2H, m, CH2), 3.58 (2H, m, CH2), 
5.16 (2H, s, CH2), 6.85 (2H, d, J = 2.5 Hz, ArH), 7.04 (1H, m, ArH), 7.12 (2H, m, 
ArH), 7.14 (1H, s, ArH), 7.14 (1H, br, ArH), 7.22 (1H, d, J = 2.5 Hz, ArH), 7.25 (1H, 
d, J = 2.5 Hz, ArH), 7.29 (1H, m, ArH), 7.32 (1H, br, ArH). 
13
C{
1
H} NMR 
(C6D5CD3): δ 22.1 (CH2), 32.0 (CH3), 34.0 (C), 46.8 (CH2), 50.1 (CH2), 52.4 (CH2), 
55.2 (CH2), 62.6 (CH2), 66.3 (CH2), 120.9 (ArH), 121.4 (Ar), 125.3 (ArH), 126.3 
(ArH), 127.6 (ArH), 127.7 (ArH), 128.4 (ArH), 139.3 (Ar), 147.3 (Ar), 159.6 (ArO). 
Calc. (%) for C34H45N2O3Al, C 73.35, H 8.15, N 5.03. Found (%), C 73.45, H 8.14, 
N 4.89. 
 
7.7 Preparation of Ligands and Complexes for Chapter 5 
7.7.1 Preparation of trans-1,4-DACH salen ligands 
3-(tert-butyl)-2-hydroxy-5-methylbenzaldehyde. 2-(tert-butyl)-4-methylphenol (15 
g, 91.3 mmol) was dissolved in dry acetonitrile (150 ml) in an argon charged vessel. 
Then triethylamine (36.96 g, 365.3 mmol) and MgCl2 (17.39 g, 182.6 mmol) were 
added and allowed to stir (15 mins). At which point paraformaldehyde (19.20 g, 
639.4 mmol) was added and the mixture was stirred (15 mins) before refluxing (4 h) 
in an inert atmosphere. The solution was allowed to cool to room temperature before 
addition of 5% HCl (100ml). The product was extracted into diethyl ether (50 ml x 6), 
the organic layers were washed with saturated brine (20 ml x 3) and dried with 
MgSO4. The MgSO4 was removed by filtration and the solvent removed in-vacuo, 
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the solid was dissolved in hexane (10 ml) and run through a silica plug before 
crystallisation yielding beige solid (5.61 g, 29.2 mmol, 32 %). 
1
H NMR (CDCl3): δ 
1.32 (9H, s, CH3), 2.23 (3H, s, CH3), 7.06 (1H, s, ArH), 7.24 (1H, s, ArH), 9.73 (1H, 
s, CH), 11.51 (1H, s, OH). 
 
4-methyl-2-tritylphenol. p-Cresol (39.00 g, 360.6 mmol) was melted (100 °C) under 
an inert atmosphere and sodium metal (2.14 g, 93.1 mmol) was slowly added while 
vigorously stirring (1 h). Trityl chloride (20 g, 71.7 mmol) was added and the 
reaction was further heated (140 °C) and stirred (5 h). The reaction was cooled 
(~25 °C) then NaOH solution (1 M, 100 ml) and diethyl ether (100 ml) was added, 
the organic layer was isolated and washed with NaOH solution (1 M, 50 ml x 5). The 
organic phase was washed with water (50 ml x 2) then saturated brine (50 ml) before 
drying with MgSO4. MgSO4 was filtered and the solvent removed in-vacuo, the 
product was recrystallised from ethanol to yield a solid (16.45 g, 46.9 mmol, 65 %). 
1
H NMR (CDCl3): δ 2.16 (3H, s, CH3), 2.80 (1H, s, OH), 6.71 (1H, d, J =8 Hz, ArH), 
6.84 (1H, s, ArH), 7.01 (1H, d, J = 6.6 Hz, ArH), 7.15 – 7.30 (15H, m, ArH). 
 
2-hydroxy-5-methyl-3-tritylbenzaldehyde. 4-methyl-2-tritylphenol (12.0 g, 34.2 
mmol), hexamethylenetetramine (9.60 g, 68.5 mmol), and trifluoroacetic acid (35 ml) 
were added to a vessel and heated while stirring (120 °C, 4 h). The reaction was 
cooled (~75 °C) before addition of H2SO4 (33 % aq, 50 ml), the mixture was heated 
(125 °C) and further stirred (2 h). The reaction was then cooled to ambient 
conditions then water (50 ml) and ethyl acetate (50 ml) was added. The organic 
phase was isolated and the aqueous phase was further extracted with ethyl acetate (30 
ml x 3) at which point the organic layers were combined and washed with water (50 
ml) and brine (20 ml). The organic layer was dried with MgSO4 then filtered, the 
solvent was removed in-vacuo and recrystallised from ethanol to yield a white solid 
(9.04 g, 23.9 mmol, 70 %). 
1
H NMR (CDCl3): δ 2.20 (3H, s, CH3), 7.05 – 7.35 (17H, 
m, ArH), 9.72 (1H, s, CH), 11.10 (1H, s, OH). 
 
16H2 3,5-di-tert-butyl-2-hydroxybenzaldehyde (1.03 g, 4.4 mmol) and trans-1,4-
diaminocyclohexane (0.25 g, 2.2 mmol) were stirred in MeOH (40 ml) for 4 h. The 
resulting yellow precipitate was filtered and washed with cold MeOH and dried in 
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vacuo to yield a white solid (1.16 g, 2.1 mmol, 97 %). 
1
H NMR (CDCl3): δ 1.32 
(18H, s, 
t
Bu), 1.47 (18H, s, 
t
Bu), 1.74 (4H, m, ring-CH2), 1.98 (4H, m, ring-CH2), 
3.28 (2H, br, ring-CH), 7.12 (2H, d, J = 2.0 Hz, ArH), 7.40 (2H, d, J = 2.0 Hz, ArH), 
8.45 (2H, s, N=CH) 13.88 (2H, br, OH). 
13
C{
1
H} NMR (C6D5CD3): δ 29.6 (CH3), 
31.7 (CH3), 32.7 (CH2), 34.3 (C), 35.2 (C), 67.2 (CH), 118.0 (Ar), 129.6 (ArH), 
126.9 (ArH), 136.7 (Ar), 140.1 (Ar), 158.2 (ArO), 164.3 (N=CH). Calc. m/z 
[C36H54N2O2 + H]
+
 547.4258. Found 547.4320. 
 
17H2 3-(tert-butyl)-2-hydroxy-5-methylbenzaldehyde (1.88 g, 9.8 mmol) and trans-
1,4-diaminocyclohexane (0.56 g, 4.9 mmol) were stirred in MeOH (40 ml) for 4 h. 
The resulting yellow precipitate was filtered and washed with cold MeOH and dried 
in vacuo to yield a white solid (2.17 g, 4.7 mmol, 96 %). 
1
H NMR (CDCl3): δ 1.45 
(18H, s, 
t
Bu), 1.74 (4H, m, ring-CH2), 1.98 (4H, m, ring-CH2), 2.30 (6H, s, CH3), 
3.27 (2H, br, ring-CH), 6.94 (2H, br, ArH), 7.14 (2H, d, J = 2.0 Hz, ArH), 8.39 (2H, 
s, N=CH) 13.80 (2H, br, OH). 
13
C{
1
H} NMR (C6D5CD3): δ 20.8 (CH3), 29.5 (CH3), 
32.6 (CH2), 34.9 (C), 67.1 (CH), 118.5 (Ar), 126.8 (Ar), 129.5 (ArH), 130.6 (ArH), 
137.3 (Ar), 158.2 (ArO), 164.0 (N=CH). Calc. m/z [C30H42N2O2 + H]
+
 463.3319. 
Found 463.3362. 
 
18H2 2-hydroxy-5-methyl-3-tritylbenzaldehyde (3.0 g, 7.9 mmol) and trans-1,4-
diaminocyclohexane (0.45 g, 3.9 mmol) were stirred in MeOH (40 ml) for 4 h. The 
resulting yellow precipitate was filtered and washed with cold MeOH and dried in 
vacuo to yield a white solid (2.64 g, 3.2 mmol, 80 %) 
1
H NMR (CDCl3): δ 1.54 (4H, 
br, ring-CH2), 1.76 (4H, br, ring-CH2), 2.22 (6H, s, CH3), 3.08 (2H, br, ring-CH), 
7.09 (2H, s, ArH), 7.22 (32H, br, ArH), 8.30 (2H, s, N=CH) 13.34 (2H, br, OH). 
13
C{
1
H} NMR (CDCl3) (333 K): δ 20.9 (CH2), 30.9 (CH2), 32.6 (CH3), 63.6 (CH), 
67.1 (C), 119.1 (Ar), 125.6 (ArH), 127.3 (ArH), 127.5 (Ar), 130.9 (ArH), 131.2 (Ar), 
131.3 (ArH), 134.5 (ArH), 134.7 (Ar), 146.0 (Ar), 158.2 (ArO), 163.3 (N=CH). Calc. 
m/z [C60H54N2O2 + H]
+
 835.4264. Found 835.4267. 
 
7.7.2 Preparation of titanium trans-1,4-DACH salen complexes 
Ti2(16)(O
i
Pr)6. Ti(O
i
Pr)4 (0.31 ml, 1.03 mmol) was added to a solution of 16H2 (0.28 
g, 0.51 mmol) in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-
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vacuo and recrystallised from hexane to yield yellow crystals (0.22 g, 0.22 mmol, 
43 %). 
1
H NMR (CDCl3): δ 1.26 (36H, d, J = 6.0 Hz, 
t
Bu), 1.36 (18H, s, 
t
Bu), 1.49 
(18H, s, 
t
Bu), 1.61 (4H, m, ring-CH2), 2.26 (4H, d, J = 7.0 Hz, ring-CH2), 4.39 (2H, 
br, ring-CH), 4.91 (6H, Sept, J = 6.0 Hz, CH), 7.17 (2H, d, J = 2.5 Hz, ArH), 7.47 
(2H, d, J = 2.5 Hz, ArH), 8.32 (2H, s, N=CH). 
13
C{
1
H} NMR (CDCl3): δ 26.8 (CH3), 
29.6 (CH3), 31.7 (CH3), 32.6 (CH2), 34.3 (C), 35.4 (C), 62.6 (CH), 77.3 (CH), 121.5 
(Ar), 127.6 (ArH), 128.5 (ArH), 138.0 (Ar), 140.0 (Ar), 159.7 (ArO), 162.7 (N=CH). 
Calc. (%) for C54H94Ti2N2O8, C 65.18, H 9.52, N 2.82. Found (%), C 63.5, H 9.37, N 
2.78. 
 
Ti2(17)(O
i
Pr)6. Ti(O
i
Pr)4 (0.0.5 ml, 1.69 mmol) was added to a solution of 
17H2 (0.39 g, 0.84 mmol) in CH2Cl2 (30 ml) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from hexane to yield yellow crystals (0.19 g, 
0.21 mmol, 25 %). 
1
H NMR (CDCl3): δ 1.26 (36H, d, J = 6.0 Hz, CH3), 1.48 (18H, s, 
t
Bu), 1.59 (4H, m, ring-CH2), 2.25 (4H, d, J = 8.0 Hz ring-CH2), 2.32 (6H, s, Me), 
4.39 (2H, br, ring-CH), 4.91 (6H, Sept, J = 6.0 Hz, CH), 7.02 (2H, d, J = 1.5 Hz, 
ArH), 7.20 (2H, d, J = 2.0 Hz, ArH), 8.29 (2H, s, N=CH). 
13
C{
1
H} NMR (CDCl3): δ 
20.8 (CH3), 26.8 (CH3), 29.6 (CH3), 32.5 (CH2), 35.1 (C), 62.5 (CH), 77.3 (CH), 
122.0 (Ar), 126.6 (Ar), 131.3 (ArH), 132.2 (ArH), 138.4 (Ar), 159.8 (ArO), 162.3 
(N=CH). Calc. (%) for C48H82N2O8Ti2, C 63.29, H 9.07, N 3.08. Found (%), C 63.15, 
H 8.94, N 3.23. 
 
Ti2(18)(O
i
Pr)6. Ti(O
i
Pr)4 (0.30 ml, 1.01 mmol) was added to a solution of 18H2 (0.42 
g, 0.50 mmol) in CH2Cl2 (30 ml) and stirred (16 h). The solvent was removed in-
vacuo and recrystallised from hexane to yield yellow crystals (0.31 g, 0.24 mmol, 
48 %). 
1
H NMR (CDCl3) (328 K): δ 0.98 (36H, d, J = 5.5 Hz, 
t
Bu), 1.47 (4H, br, 
ring-CH2), 2.13 (4H, br, ring-CH2), 2.19 (2H, s, CH3), 4.22 (2H, br, ring-CH), 4.42 
(6H, br, CH), 7.00 – 7.30 (34H, br, ArH), 8.17 (2H, s, N=CH). 13C{1H} NMR 
(CDCl3) (328 K): δ 20.8 (CH3), 26.6 (CH3), 32.8 (CH2), 62.4 (CH), 63.9 (C), 77.1 
(CH), 122.9 (Ar), 125.5 (ArH), 126.2 (Ar), 127.2 (ArH), 131.5 (ArH), 133.0 (ArH), 
136.2 (ArH), 136.3 (ArH), 159.7 (ArO), 161.7 (N=CH). Calc. (%) for C78H94N2O8Ti2, 
C 73.00, H 7.38, N 2.18. Found (%), C 72.85, H 7.25, N 2.20.  
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7.7.3 Preparation of aluminium trans-1,4-DACH salen complexes 
Al2(16)Me4. 2M AlMe3 (0.84 ml, 1.68 mmol) in heptane was added to a solution of 
16H2 (0.46 g, 0.84 mmol) in toluene (40 ml) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from hexane to yield yellow crystals (0.19 g, 
0.29 mmol, 34 %). 
1
H NMR (D8-Tol): δ -0.27 (12H, s, Al-Me ) 1.37 (18H, s, 
t
Bu), 
1.57 (18H, s, 
t
Bu), 1.45 – 1.70 (8H, m, ring-CH2), 2.60 (2H, br, ring-CH), 6.94 (2H, 
d, J = 2.5 Hz, ArH), 7.40 (2H, s, N=CH), 7.69 (2H, d, J = 2.5 Hz, ArH). 
13
C{
1
H} 
NMR (D8-Tol): δ -5.7 (Al-Me), 30.6 (CH3), 32.6 (CH3), 33.4 (CH2), 35.3 (C), 36.3 
(CH2), 69.5 (CH), 119.8 (Ar), 130.1 (ArH), 133.2 (ArH), 138.5 (Ar), 140.1 (Ar), 
163.3 (ArO), 172.7 (N=CH). Calc. (%) for C40H64Al2N2O2, C 72.91, H 9.79, N 4.25. 
Found (%), C 73.03, H 9.66, N 4.19. 
 
Al2(17)Me4. 2M AlMe3 (0.60 ml, 1.20 mmol) in heptane was added to a solution of 
17H2 (0.28 g, 0.61 mmol) in toluene (40 ml) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from a hexane:toluene mixture to yield yellow 
crystals (0.13 g, 0.23 mmol, 37 %). 
1
H NMR (D8-Tol): δ -0.28 (12H, s, Al-Me ) 1.55 
(18H, s, 
t
Bu), 1.45 – 1.70 (8H, m, ring-CH2), 2.22 (6H, s, CH3), 2.59 (2H, br, ring-
CH), 6.59 (2H, d, J = 1.5 Hz, ArH), 7.29 (2H, s, N=CH), 7.39 (2H, d, J = 2.5 Hz, 
ArH). 
13
C{
1
H} NMR (D8-Tol): δ -7.0 (Al-Me), 20.6 (CH3), 29.5 (CH3), 32.6 (CH2), 
32.3 (C), 35.2 (CH2), 68.5 (CH), 119.2 (Ar), 125.5 (Ar), 132.7 (ArH), 135.7 (ArH), 
141.2 (Ar), 162.3 (ArO), 171.2 (N=CH). Calc. (%) for C34H52Al2N2O2, C 71.05, H 
9.12, N 4.87. Found (%), C 70.95, H 9.13, N 5.09. 
 
Al2(18)Me4. 2M AlMe3 (0.50 ml, 1.00 mmol) in heptane was added to a solution of 
18H2 (0.42 g, 0.50 mmol) in toluene (40 ml) and stirred (16 h). The solvent was 
removed in-vacuo and recrystallised from a hexane:toluene mixture to yield yellow 
crystals (0.22 g, 0.17 mmol, 34 %). 
1
H NMR (D8-Tol): δ -0.70 (12H, s, Al-Me ) 1.39 
(8H, br, ring-CH2), 2.10 (6H, s, CH3), 2.46 (2H, br, ring-CH), 6.61 (2H, d, J = 2.0 Hz, 
ArH), 6.95 – 7.15 (18H, m, ArH), 7.12 (2H, s, N=CH), 7.40 (6H, s, ArH), 7.43 (6H, 
s, ArH), 7.58 (2H, d, J = 2.5 Hz, ArH). 
13
C{
1
H} NMR (D8-Tol): δ -6.9 (Al-Me), 20.6 
(CH3), 32.3 (CH2), 63.9 (C), 68.1 (CH), 119.4 (Ar), 125.8 (ArH), 127.5 (ArH), 131.6 
(ArH), 139.3 (Ar), 139.4 (ArH), 146.1 (Ar), 161.8 (ArO), 170.6 (N=CH). Calc. (%) 
for C64H64Al2N2O2, C 81.16, H 6.81, N 2.96. Found (%), C 81.01, H 6.78, N 3.04. 
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7.8 Preparation of Ligands and Complexes for Chapter 6 
7.8.1 Preparation of trans-1,2-DACH salalen ligands 
tert-Butyl (2-aminocyclohexyl)carbamate. A solution of di-tert-butyl dicarbonate 
(9.61 g, 44.04 mmol) in CH2Cl2 (50 ml) was added dropwise to a cooled (0 °C) 
solution of trans-1,2-diaminecyclohexane (15.08 g, 70.47 mmol) in CH2Cl2 (50 ml) 
over a period of 30 mins while stirring. The solution was allowed to warm to room 
temperature and stirred overnight. CH2Cl2 (50 ml) and water (50 ml) were added to 
the resulting suspension to dissolve the precipitate and the organic phase was 
separated then the solvent was removed in-vacuo. The residue was dissolved in ethyl 
ether (50 ml) and water (50 ml) and the solution was acidified to pH 5 with 4M HCl, 
the mixture was separated and the aqueous layer was washed with ethyl ether (3 x 50 
ml). 2M NaOH was added to the aqueous layer until pH 10.5 was reached, at which 
point the product was extracted with AcOEt (3 x 50 ml). The organic phase was 
washed with saturated brine (20 ml) and dried with anhydrous MgSO4. After 
filtration the solvent was removed in-vacuo to yield a pale beige solid (7.17 g, 33.46 
mmol, 47 %). 
1
H NMR (CDCl3): δ 1.00 – 1.30 (4H, m, CH2), 1.38 (2H, s, NH2), 1.41 
(9H, s, 
t
Bu), 1.65 (2H, m, CH2), 1.95 (2H, m, CH2), 2.29 (1H, td, J = 10 Hz, J = 4.0 
Hz, CH), 3.08 (1H, br, CH), 4.52 (1H, br, NH). 
 
19HBoc. tert-Butyl (2-aminocyclohexyl)carbamate (2.00 g, 9.33 mmol) was added to 
a solution of 3,5-di-tert-butyl-2-hydroxybenzaldehyde (2.18 g, 9.30 mmol) in MeOH 
(30 ml) / THF (30 ml) and stirred for 1 h. Sodium borohydride (2.12 g, 56.03 mmol) 
was added slowly to the yellow solution and then stirred for 5 h until the solution 
became colourless. The reaction was quenched with water (10 ml) and the solvent 
partially removed in-vacuo. Water (50 ml) was then used to precipitate a white solid, 
which was then filtered and washed with water (3 x 50 ml). The resulting solid was 
dissolved in MeOH (30 ml) and formaldehyde solution (37 % in H2O, 2.12 ml, 26.74 
mmol) was slowly added and allowed to stir for 1 h. The solvent was removed in-
vacuo and the residue was dissolved in MeOH (30 ml) / THF (30 ml) and cooled 
(0 °C), then sodium borohydride (2.12 g, 56.03 mmol) was slowly added and the 
solution was stirred for 2 h. The reaction was quenched with water (10 ml) and the 
solvent partially removed in-vacuo. Water (50 ml) was then used to precipitate a 
 259 
white solid, which was then filtered and washed with water (3 x 50 ml) and dried to 
yield a white solid (3.40 g, 7.61 mmol, 82 %). 
1
H NMR (CDCl3): δ 1.00 – 1.20 (2H, 
m, CH2), 1.28 (9H, s, 
t
Bu), 1.43 (9H, s, 
t
Bu), 1.48 (9H, s, 
t
Bu), 1.60 – 2.10 (6H, m, 
CH2), 2.29 (3H, s, CH3), 2.36 (1H, m, CH), 3.62 (1H, m, CH), 3.75 (1H, m, NH), 
3.79 (1H, d, J = 4.5 Hz, CH2), 4.55 (1H, d, J = 10.0 Hz, CH2), 6.81 (1H, d, J = 2.5 Hz, 
ArH), 7.21 (1H, d, J = 2.5 Hz, ArH), 11.10 (1H, br, ArOH). 
 
19H3. 19HBoc (2.40 g, 5.37 mmol) was dissolved in methanol (30 ml) and 3M HCl 
(30 ml) then heated to 60 °C and allowed to stir (16 h). The mixture was neutralised 
with 3M NaOH and the white precipitate was extracted with AcOEt (20 ml x 4). The 
organic phase was washed with saturated brine (20 ml) then dried with MgSO4, the 
solid was removed by filtration and the solvent removed in-vacuo to yield an oily 
residue which was used without further purification (1.80 g, 5.19 mmol, 97 %) 
1
H 
NMR (CDCl3): δ 1.10 – 1.30 (4H, m, CH2), 1.28 (9H, s, 
t
Bu), 1.48 (9H, s, 
t
Bu), 1.65 
- 2.05 (4H, m, CH2), 2.25 (3H, s, CH3), 2.35 (1H, m, CH), 2.79 (1H, m, CH), 3.72 
(1H, d, J = 13.5 Hz, CH2), 3.86 (1H, d, J = 13.5 Hz, CH2), 4.12 (1H, q, J = 7.5 Hz, 
NH) 3.50 – 4.00 (3H, br, NH2, ArOH), 6.83 (1H, d, J = 2.5 Hz, ArH), 7.21 (1H, d, J 
= 2.5 Hz, ArH). 
 
20HBoc. tert-Butyl (2-aminocyclohexyl)carbamate (2.43 g, 11.34 mmol) was added 
to a solution of 2-hydroxybenzaldehyde (1.39 g, 11.38 mmol) in MeOH (30 ml) / 
THF (30 ml) and stirred for 1 h. Sodium borohydride (1.29 g, 34.10 mmol) was 
added slowly to the yellow solution and then stirred for 5 h until the solution became 
colourless. The reaction was quenched with water (10 ml) and the solvent partially 
removed in-vacuo. Water (50 ml) was then used to precipitate a white solid, which 
was then filtered and washed with water (3 x 50 ml). The resulting solid was 
dissolved in MeOH (30 ml) and formaldehyde solution (37 % in H2O, 2.58 ml, 31.79 
mmol) was slowly added and allowed to stir for 1 h. The solvent was removed in-
vacuo and the residue was dissolved in MeOH (30 ml) / THF (30 ml) and cooled 
(0 °C), then sodium borohydride (2.00 g, 52.87 mmol) was slowly added and the 
solution was stirred for 2 h. The reaction was quenched with water (10 ml) and the 
solvent partially removed in-vacuo. Water (50 ml) was then used to precipitate a 
white solid, which was then filtered and washed with water (3 x 50 ml) and dried to 
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yield a white solid (3.33 g, 9.96 mmol, 81 %). 
1
H NMR (CDCl3): δ 1.00 – 1.30 (4H, 
m, CH2), 1.41 (9H, s, 
t
Bu), 1.60 – 2.05 (4H, m, CH2), 2.21 (3H, s, CH3), 2.34 (1H, td, 
J = 11.0 Hz, J = 3.5 Hz, CH), 3.60 (1H, m, CH), 3.75 (1H, q, J = 14.0 Hz, CH2), 4.40 
(1H, br, NH), 6.71 (2H, m, ArH), 6.88 (1H, dd, J = 7.5 Hz, J = 1.5 Hz, ArH), 7.08 
(1H, td, J = 7.5 Hz, J = 1.5 Hz, ArH), 10.88 (1H, br, ArOH). 
 
20H3. 20HBoc (3.25g, 9.72 mmol) was dissolved in methanol (30 ml) and 3M HCl 
(30 ml) then heated to 60 °C and allowed to stir (16 h). The mixture was neutralised 
with 3M NaOH and the white precipitate was extracted with AcOEt (30 ml x 4). The 
organic phase was washed with saturated brine (20 ml) then dried with MgSO4, the 
solid was removed by filtration and the solvent removed in-vacuo to yield a white 
solid (1.85, 7.89 mmol, 81 %). 
1
H NMR (CDCl3): δ 1.10 – 1.35 (4H, m, CH2), 1.65 – 
2.05 (4H, m, CH2), 2.22 (3H, s, CH3), 2.34 (1H, td, J = 10.0 Hz, J = 3.5 Hz, CH), 
2.78 (1H, td, J = 10.0 Hz, J = 4.5 Hz, CH), 3.61 (1H, d, J = 13.5 Hz, CH2), 3.89 (1H, 
d, J = 13.5 Hz, CH2), 4.39 (3H, br, NH2, ArOH), 6.76 (1H, td, J = 7.5 Hz, J = 1.0 Hz, 
ArH), 6.82 (1H, dd, J = 8.0 Hz, J = 1.0 Hz, ArH), 6.97 (1H, dd, J = 7.5 Hz, J = 1.5 
Hz, ArH), 7.15 (1H, td, J = 7.5 Hz, J = 1.5 Hz, ArH). 
 
21HBoc. tert-Butyl (2-aminocyclohexyl)carbamate (3.00 g, 14.00 mmol) was added 
to a solution of 3,5-dichloro-2-hydroxybenzaldehyde (2.67 g, 13.98 mmol) in MeOH 
(30 ml) / THF (30 ml) and stirred for 1 h. Sodium borohydride (1.60 g, 42.29 mmol) 
was added slowly to the yellow solution and then stirred for 16 h until the solution 
became colourless. The reaction was quenched with water (10 ml) and the solvent 
partially removed in-vacuo. Water (50 ml) was then used to precipitate a white solid, 
which was then filtered and washed with water (3 x 50 ml). The resulting solid was 
dissolved in MeOH (30 ml) and formaldehyde solution (37 % in H2O, 3.18 ml, 39.18 
mmol) was slowly added and allowed to stir for 1 h. The solvent was removed in-
vacuo and the residue was dissolved in MeOH (30 ml) / THF (30 ml) and cooled 
(0 °C), then sodium borohydride (2.50 g, 66.09 mmol) was slowly added and the 
solution was stirred for 2 h. The reaction was quenched with water (10 ml) and the 
solvent partially removed in-vacuo. Water (50 ml) was then used to precipitate a 
white solid, which was then filtered and washed with water (3 x 50 ml) and dried to 
yield a white solid (4.30 g, 10.66 mmol, 76 %). 
1
H NMR (CDCl3): δ 1.10 – 1.35 (4H, 
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m, CH2), 1.48 (9H, s, 
t
Bu), 1.70 – 2.10 (4H, m, CH2), 2.27 (3H, s, CH3), 2.40 (1H, td, 
J = 11.0 Hz, J = 3.5 Hz, CH), 3.69 (1H, m, CH), 3.71 (1H, d, J = 14.0 Hz, CH2), 3.87 
(1H, d, J = 14.0 Hz, CH2), 4.48 (1H, d, J = 10.0 Hz, NH), 6.82 (1H, d, J = 2.5 Hz, 
ArH), 7.22 (1H, d, J = 2.5 Hz, ArH), 9.87 (1H, br, ArOH). 
 
21H3. 21HBoc (4.20 g, 10.41 mmol) was dissolved in methanol (30 ml) and 3M HCl 
(30 ml) then heated to 60 °C and allowed to stir (16 h). The mixture was neutralised 
with 3M NaOH and the white precipitate was extracted with AcOEt (30 ml x 4). The 
organic phase was washed with saturated brine (20 ml) then dried with MgSO4, the 
solid was removed by filtration and the solvent removed in-vacuo to yield a white 
solid (2.66, 8.77 mmol, 84 %). 
1
H NMR (CDCl3): δ 1.00 – 1.25 (4H, m, CH2), 1.61 
(1H, br, CH2), 1.71 (1H, br, CH2), 1.85 (2H, br, CH2), 2.21 (3H, s, CH3), 2.25 (1H, br, 
CH), 2.84 (1H, br, CH), 3.08 (1H, d, J = 12.0 Hz, CH2), 3.79 (1H, d, J = 12.5 Hz, 
CH2), 4.92 (3H, br, NH2, ArOH), 6.80 (1H, d, J = 2.5 Hz, ArH), 7.14 (1H, d, J = 2.5 
Hz, ArH).  
 
22H2. 19HBoc (1.00 g, 2.24 mmol) was dissolved in methanol (20 ml) and 3M HCl 
(20 ml) then heated to 60 °C and allowed to stir (16 h). The mixture was neutralised 
with 3M NaOH and the white precipitate was extracted with AcOEt (15 ml x 4). The 
organic phase was washed with saturated brine (10 ml) then dried with MgSO4, the 
solid was removed by filtration and the solvent removed in-vacuo. The oily residue 
was dissolved in MeOH (30 ml) and 3,5-di-tert-butyl-2-hydroxybenzaldehyde (0.52 
g, 2.24 mmol) was added. The solution was stirred for 2 h then the solid was filtered 
and further dried in-vacuo to yield a yellow solid (0.50 g, 0.89 mmol, 40 %). 
1
H 
NMR (CDCl3): δ 1.15 (9H, s, 
t
Bu), 1.28 (9H, s, 
t
Bu), 1.32 (9H, s, 
t
Bu), 1.35 – 1.45 
(3H, m, ring-CH2), 1.51 (9H, s, 
t
Bu), 1.63 – 2.07 (5H, m, ring-CH2), 2.26 (3H, s, 
CH3), 3.00 (1H, m, ring-CH), 3.33 (1H, m, ring-CH), 3.75 (1H, d, J = 13.0 Hz, CH2), 
3.91 (1H, d, J = 13.0 Hz, CH2), 6.83 (1H, d, J = 2.5 Hz, ArH), 7.06 (1H, d, J = 2.5 Hz, 
ArH), 7.14 (1H, d, J = 2.5 Hz, ArH), 7.41 (1H, d, J = 2.5 Hz, ArH), 8.40 (1H, s, CH), 
10.61 (1H, br, OH), 13.59 (1H, s, OH). 
13
C{
1
H} NMR (CDCl3): δ 24.8 (CH2), 25.3 
(CH2), 29.5 (CH3), 29.8 (CH3), 31.7 (CH3), 31.9 (CH3), 34.2 (C), 34.9 (C), 35.2 
(CH2), 35.4 (CH2), 66.6 (CH), 70.3 (CH), 118.1 (Ar), 121.0 (Ar), 122.5 (ArH), 123.3 
(ArH), 125.8 (ArH), 126.9(ArH), 135.4 (Ar), 136.6 (Ar), 139.8 (Ar), 139.8 (Ar), 
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154.7 (Ar), 158.2 (Ar), 165.8 (CH). Calc. m/z [C37H58N2O2 + Na]
+
 585.4396. Found 
585.4398 
 
(R,R-22)H2. tert-butyl (1S,2S)-2-aminocyclohexyl)carbamate (0.375 g, 1.75 mmol) 
was added to a solution of 3,5-di-tert-butyl-2-hydroxybenzaldehyde (0.41 g, 1.75 
mmol) in MeOH (15 ml) / THF (15 ml) and stirred for 1 h. Sodium borohydride 
(0.30 g, 9.99 mmol) was added slowly to the yellow solution and then stirred for 5 h 
until the solution became colourless. The reaction was quenched with water (10 ml) 
and the solvent partially removed in-vacuo. Water (30 ml) was then used to 
precipitate a white solid, which was then filtered and washed with water (3 x 30 ml). 
The resulting solid was dissolved in MeOH (30 ml) and formaldehyde solution (37 % 
in H2O, 0.40 ml, 4.93 mmol) was slowly added and allowed to stir for 1 h. The 
solvent was removed in-vacuo and the residue was dissolved in MeOH (15 ml) / 
THF (15 ml) and cooled (0 °C), then sodium borohydride (0.30 g, 9.99 mmol) was 
slowly added and the solution was stirred for 16 h. The reaction was quenched with 
water (10 ml) and the solvent partially removed in-vacuo. Water (30 ml) was then 
used to precipitate a white solid, which was then filtered and washed with water (3 x 
30 ml) and dried to yield a white solid. The white solid was dissolved in methanol 
(20 ml) and 3M HCl (20 ml) then heated to 60 °C and allowed to stir (16 h). The 
mixture was neutralised with 3M NaOH and the white precipitate was extracted with 
AcOEt (10 ml × 4). The organic phase was washed with saturated brine (10 ml) then 
dried with MgSO4, the solid was removed by filtration and the solvent removed in-
vacuo. The residue was dissolved in MeOH (20 ml) and 3,5-di-tert-butyl-2-
hydroxybenzaldehyde (0.41 g, 1.75 mmol) was added. The solution was stirred for 
16 h then the solid was filtered and further dried in-vacuo to yield a pale yellow solid 
(0.49 g, 0.87 mmol, 50 %). 
1
H NMR (CDCl3): δ 1.12 (9H, s, 
t
Bu), 1.25 (9H, s, 
t
Bu), 
1.29 (9H, s, 
t
Bu), 1.35 – 1.45 (3H, m, ring-CH2), 1.48 (9H, s, 
t
Bu), 1.63 – 2.07 (5H, 
m, ring-CH2), 2.23 (3H, s, CH3), 2.98 (1H, m, ring-CH), 3.31 (1H, m, ring-CH), 3.72 
(1H, d, J = 12.0 Hz, CH2), 3.88 (1H, d, J = 12.0 Hz, CH2), 6.80 (1H, d, J = 2.5 Hz, 
ArH), 7.03 (1H, d, J = 2.5 Hz, ArH), 7.11 (1H, d, J = 2.5 Hz, ArH), 7.38 (1H, d, J = 
2.5 Hz, ArH), 8.38 (1H, s, CH), 10.61 (1H, br, OH), 13.58 (1H, s, OH). 
13
C{
1
H} 
NMR (CDCl3): δ 24.8 (CH2), 25.3 (CH2), 29.5 (CH3), 29.7 (CH3), 31.6 (CH3), 31.9 
(CH3), 34.2 (C), 34.8 (C), 35.2 (CH2), 35.5 (CH2), 66.7 (CH), 70.4 (CH), 118.2 (Ar), 
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121.0 (Ar), 122.6 (ArH), 123.4 (ArH), 125.9 (ArH), 126.9 (ArH), 135.5 (Ar), 136.6 
(Ar), 139.9 (Ar), 154.8 (Ar), 158.2 (Ar), 165.8 (CH). Calc. m/z [C37H57N2O2]
-
 
561.4410. Found 561.4415 
 
23H2. 19H3 (1.00 g, 2.89 mmol) was dissolved in MeOH (30 ml) and 2-
hydroxybenzaldehyde (0.31 ml, 2.91 mmol) was added. The solution was stirred for 
2 h then the solid was filtered and further dried in-vacuo to yield a yellow solid (0.98 
g, 2.17 mmol, 75 %). 
1
H NMR (CDCl3): δ 1.11 (9H, s, 
t
Bu), 1.25 (9H, s, 
t
Bu), 1.31 – 
1.53 (3H, m, ring-CH2), 1.63 – 2.08 (5H, m, ring-CH2), 2.20 (3H, s, CH3), 2.97 (1H, 
m, ring-CH), 3.36 (1H, m, ring-CH), 3.70 (1H, br, CH2), 3.80 (1H, d, J = 13.0 Hz, 
CH2), 6.77 (1H, d, J = 2.0 Hz, ArH), 6.86 (1H, t, J = 7.5 Hz, ArH), 6.99 (1H, d, J = 
8.0 Hz, ArH), 7.11 (1H, br, ArH), 7.23 (1H, d, J = 7.5 Hz, ArH), 7.42(1H, t of d, J = 
8.0 Hz, , J = 2.0 Hz, ArH), 8.38 (1H, s, CH), 10.62 (1H, br, OH), 13.15 (1H, s, OH). 
13
C{
1
H} NMR (CDCl3): δ 23.1 (CH2), 24.6 (CH2), 25.1 (CH2), 29.3 (CH3), 31.7 
(CH3), 34.1 (C), 34.6 (C), 34.9 (CH2), 58.5 (CH2), 67.2 (CH), 70.1 (CH), 117.0 
(ArH), 118.4 (ArH), 119.1 (Ar), 120.7 (Ar), 122.5 (ArH), 123.1 (ArH), 131.3 (ArH), 
132.1 (ArH), 135.4 (Ar), 139.8 (Ar), 154.6 (ArO), 161.2 (ArO), 164.7 (CH). Calc. 
m/z [C29H42N2O2 + Na]
+
 473.3144. Found 473.3166 
 
24H2. 19H3 (0.80 g, 2.31 mmol) was dissolved in MeOH (30 ml) and 2-
hydroxybenzaldehyde (0.44 ml, 2.30 mmol) was added. The solution was stirred for 
2 h then the solid was filtered and further dried in-vacuo to yield a yellow solid (0.77 
g, 1.48 mmol, 64 %). 
1
H NMR (CDCl3): δ 1.10 (9H, s, 
t
Bu), 1.25 (9H, s, 
t
Bu), 1.28 – 
1.50 (3H, m, ring-CH2), 1.64 – 2.08 (5H, m, ring-CH2), 2.18 (3H, s, CH3), 2.94 (1H, 
m, ring-CH), 3.36 (1H, m, ring-CH), 3.70 (1H, d, J = 13.0 Hz, CH2), 3.81 (1H, d, J = 
13.0 Hz, CH2), 6.76(1H, d, J = 2.0 Hz, ArH), 7.10 (1H, br, ArH), 7.14 (1H, d, J = 2.0 
Hz, ArH), 7.42 (1H, d, J = 2.5 Hz, ArH), 8.29 (1H, s, CH), 10.50 (1H, br, OH), 14.20 
(1H, s, OH). 
13
C{
1
H} NMR (CDCl3): δ 22.5 (CH2), 24.5 (CH2), 25.1 (CH2), 29.3 
(CH3), 31.8 (CH3), 34.2 (C), 34.6 (C), 34.7 (CH3), 67.8 (CH), 69.5 (CH), 120.2 (Ar), 
120.4 (Ar), 122.7 (Ar), 122.8 (Ar), 122.8 (ArH), 123.2 (ArH), 129.2 (ArH), 132.0 
(ArH), 135.5 (Ar), 140.2 (Ar), 154.5 (ArO), 156.6 (ArO), 163.2 (CH). Calc. m/z 
[C29H40Cl2N2O2 + H]
+
 519.2545. Found 519.2564 
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25H2. 20H3 (0.60 g, 2.56 mmol) was dissolved in MeOH (30 ml) and 3,5-di-tert-
butyl-2-hydroxybenzaldehyde (0.60 g, 2.56 mmol) was added. The solution was 
stirred for 2 h then the solid was filtered and further dried in-vacuo to yield a yellow 
solid (0.92 g, 2.04 mmol, 80 %). 
1
H NMR (CDCl3): δ 1.20 – 1.44 (3H, m, ring-CH2), 
δ 1.33 (9H, s, tBu), 1.49 (9H, s, tBu), 1.60 – 2.06 (5H, m, ring-CH2), 2.30 (3H, s, 
CH3), 3.03 (1H, m, ring-CH), 3.36 (1H, td, J = 10.5 Hz, J = 4.5, Hz, ring-CH), 3.92 
(2H, m, CH2), 6.69 – 6.77 (2H, m, ArH), 6.94 (1H, m, ArH), 7.09 (1H, d, J = 2.5 Hz, 
ArH), 7.13 (1H, m, ArH), 7.41 (1H, d, J = 2.5 Hz, ArH), 8.42 (1H, s, CH), 9.6 – 11.8 
(1H, br, OH), 12.1 – 14.2 (1H, br, OH). 13C{1H} NMR (CDCl3): δ 24.7 (CH2), 25.3 
(CH2), 25.5 (CH2), 29.6 (CH3), 31.7 (CH3), 34.3 (C), 35.2 (C), 35.6 (CH3), 35.7 
(CH2), 58.7 (CH2), 66.1 (CH), 70.1 (CH), 116.5 (ArH), 118.0 (Ar), 119.7 (ArH), 
121.9 (Ar), 126.1 (ArH), 127.3 (ArH), 128.8 (ArH), 128.8 (ArH), 136.7 (Ar), 140.1 
(Ar), 158.2 (ArO), 158.4 (ArO), 165.8 (CH). Calc. m/z [C29H42N2O2 + Na]
+
 
473.3144. Found 473.3154 
 
26H2. 20H3 (0.60 g, 2.56 mmol) was dissolved in MeOH (30 ml) and 2-
hydroxybenzaldehyde (0.31 g, 2.54 mmol) was added. The solution was stirred for 2 
h then the solid was filtered and further dried in-vacuo to yield a yellow solid (0.70 g, 
2.07 mmol, 81 %). 
1
H NMR (CDCl3): δ 1.19 – 1.43 (3H, m, ring-CH2), 1.48 – 1.63 
(1H, m, ring-CH2), 1.68 (1H, br, ring-CH2), 1.72 (1H, br, ring-CH2), 1.80 (1H, m, 
ring-CH2), 1.92 (1H, m, ring-CH2), 2.16 (3H, s, CH3), 2.88 (1H, m, ring-CH), 3.25 
(1H, td, J = 10.5 Hz, J = 4.5, Hz, ring-CH), 3.61 (1H, d, J = 13.5 Hz, CH2), 3.70 (1H, 
d, J = 13.5 Hz, CH2), 6.60 – 6.68 (2H, m, ArH), 6.78 – 6.88 (2H, m, ArH), 6.94 (1H, 
d, J = 8.0 Hz, ArH), 7.02(1H, td, J = 7.5 Hz, J = 2.0 Hz ArH), 7.18 (1H, m, ArH), 
7.25 (1H, m, ArH), 8.31 (1H, s, CH), 9.5 – 14.0 (2H, br, OH). 13C{1H} NMR 
(CDCl3): δ 23.8 (CH2), 24.7 (CH2), 25.1 (CH2), 35.6 (CH2), 35.6 (CH3), 58.1 (CH2), 
66.5 (CH), 70.0 (CH), 116.3 (ArH), 117.2 (ArH), 118.7 (ArH), 118.8 (ArH), 119.0 
(Ar), 121.8 (Ar), 128.5 (ArH), 128.6 (ArH), 131.5 (ArH), 132.4 (ArH), 158.3 (ArO), 
161.2 (ArO), 164.7 (CH). Calc. m/z [C21H26N2O2 + Na]
+
 361.1892. Found 361.1895 
 
27H2. 20H3 (0.60 g, 2.56 mmol) was dissolved in MeOH (30 ml) and 3,5-dichloro-2-
hydroxybenzaldehyde (0.49 g, 2.57 mmol) was added. The solution was stirred for 2 
h then the solid was filtered and further dried in-vacuo to yield a yellow solid (0.79 g, 
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1.91 mmol, 75 %). 
1
H NMR (CDCl3): δ 1.25 – 1.50 (3H, m, ring-CH2), 1.62 (1H, m, 
ring-CH2), 1.70 (2H, br, ring-CH2), 1.90 (1H, br, ring-CH2), 2.02 (1H, m, ring-CH2), 
2.24 (3H, s, CH3), 2.92 (1H, m, ring-CH), 3.38 (1H, td, J = 10.5 Hz, J = 4.5, Hz, 
ring-CH), 3.72 (1H, d, J = 13.5 Hz, CH2), 3.87 (1H, d, J = 13.5 Hz, CH2), 6.63 – 6.77 
(2H, m, ArH), 6.92 (1H, d, J = 7.0 Hz, ArH), 7.10 (1H, td, J = 8.0 Hz, J = 1.5 Hz, 
ArH), 7.17 (1H, d, J = 2.5 Hz, ArH), 7.41 (1H, d, J = 2.5 Hz, ArH), 8.28 (1H, s, CH), 
9.0 – 11.5 (1H, br, OH), 12.5 – 15.0 (1H, br, OH). 13C{1H} NMR (CDCl3): δ 23.0 
(CH2), 24.5 (CH2), 25.0 (CH2), 35.2 (CH2), 36.3 (CH3), 57.4 (CH2), 66.7 (CH), 69.2 
(CH), 116.4 (ArH), 118.9 (ArH), 119.9 (Ar), 121.5 (Ar), 122.7 (Ar), 122.8 (Ar), 
128.6 (ArH), 128.8 (ArH), 129.3 (ArH), 132.3 (ArH), 156.6 (ArO), 158.0 (ArO), 
163.3 (CH).Calc. m/z [C21H24Cl2N2O2 + Na]
+
 429.1113. Found 429.1119 
 
28H2. 21H3 (0.75 g, 2.47 mmol) was dissolved in MeOH (30 ml) and 3,5-di-tert-
butyl-2-hydroxybenzaldehyde (0.58 g, 2.48 mmol) was added. The solution was 
stirred for 2 h then the solid was filtered and further dried in-vacuo to yield a yellow 
solid (1.08 g, 2.08 mmol, 84 %). 
1
H NMR (CDCl3): δ 1.24 – 1.44 (3H, m, ring-CH2), 
δ 1.32 (9H, s, tBu), 1.48 (9H, s, tBu), 1.60 – 2.00 (5H, m, ring-CH2), 2.28 (3H, s, 
CH3), 3.01 (1H, m, ring-CH), 3.36 (1H, td, J = 10.5 Hz, J = 4.5, Hz, ring-CH), 3.85 
(1H, d, J = 14.5 Hz, CH2), 3.95 (1H, d, J = 14.5 Hz, CH2), 6.83 (1H, d, J = 2.5 Hz, 
ArH), 7.09 (1H, d, J = 2.5 Hz, ArH), 7.19 (1H, d, J = 2.5 Hz, ArH), 7.42 (1H, d, J = 
2.5 Hz, ArH), 8.43 (1H, s, CH), 11.4 – 14.7 (1H, br, OH). 13C{1H} NMR (CDCl3): δ 
24.7 (CH2), 25.2 (CH2), 29.6 (CH3), 31.6 (CH3), 34.3 (C), 35.2 (C), 35.3 (CH3), 35.7 
(CH2), 59.5 (CH2), 66.5 (CH), 70.1 (CH), 117.9 (Ar), 121.5 (Ar), 123.1 (Ar), 124.0 
(Ar), 126.1 (ArH), 126.8 (ArH), 127.5 (ArH), 128.6 (ArH), 137.1 (Ar), 140.3 (Ar), 
153.3 (ArO), 158.1 (ArO), 166.1 (CH).Calc. m/z [C29H40Cl2N2O2 + Na]
+
 541.2365. 
Found 541.2393 
 
29H2. 21H3 (0.75 g, 2.47 mmol) was dissolved in MeOH (30 ml) and 2-
hydroxybenzaldehyde (0.30 g, 2.46 mmol) was added. The solution was stirred for 2 
h then the solid was filtered and further dried in-vacuo to yield a yellow solid (0.63 g, 
1.55 mmol, 63 %). 
1
H NMR (CDCl3): δ 1.23 – 2.05 (8H, m, ring-CH2), 2.27 (3H, s, 
CH3), 2.97 (1H, m, ring-CH), 3.35 (1H, td, J = 10.5 Hz, J = 4.5, Hz, ring-CH), 3.79 
(1H, d, J = 14.5 Hz, CH2), 3.90 (1H, d, J = 14.5 Hz, CH2), 6.80 (1H, d, J = 2.5 Hz, 
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ArH), 6.91 (1H, td, J = 7.5 Hz, J = 1.0 Hz, ArH), 7.01 (1H, m, ArH), 7.18 (1H, d, J = 
2.5 Hz, ArH), 7.26 (1H, dd, J = 7.5 Hz, J = 1.5 Hz, ArH), 7.35 (1H, ddd, J = 8.5 Hz, J 
= 7.5 Hz, J = 1.5 Hz, ArH), 8.41 (1H, s, CH), 10.5 – 14.0 (2H, br, OH). 13C{1H} 
NMR (CDCl3): δ 24.5 (CH2), 25.1 (CH2), 25.7 (CH2), 35.4 (CH2), 35.7 (CH3), 58.6 
(CH2), 66.9 (CH), 70.0 (CH), 117.2 (ArH), 118.8 (ArH), 118.8 (Ar), 121.6 (Ar), 
123.1 (Ar), 123.9 (Ar), 126.7 (ArH), 128.6 (ArH), 131.6 (ArH), 132.7 (ArH), 153.1 
(ArO), 161.2 (ArO), 165.0 (CH). Calc. m/z [C21H24Cl2N2O2 + Na]
+
 429.1113. Found 
429.1102 
 
30H2. 21H3 (0.75 g, 2.47 mmol) was dissolved in MeOH (30 ml) and 3,5-dichloro-2-
hydroxybenzaldehyde (0.46 g, 2.46 mmol) was added. The solution was stirred for 2 
h then the solid was filtered and further dried in-vacuo to yield a yellow solid (0.94 g, 
1.97 mmol, 80 %). 
1
H NMR (CDCl3): δ 1.23 – 2.06 (8H, m, ring-CH2), 2.25 (3H, s, 
CH3), 2.91 (1H, m, ring-CH), 3.37 (1H, td, J = 10.5 Hz, 4.5 Hz, ring-CH), 3.73 (1H, 
d, J = 14.5 Hz, CH2), 3.86 (1H, d, J = 14.5 Hz, CH2), 6.80 (1H, d, J = 2.5 Hz, ArH), 
7.18 (1H, m, ArH), 7.42 (1H, d, J = 2.5 Hz, ArH), 8.30 (1H, s, CH), 11.0 – 14.5 (1H, 
br, OH). 
13
C{
1
H} NMR (CDCl3): δ 24.0 (CH2), 24.4 (CH2), 25.0 (CH2), 35.1 (CH2), 
36.1 (CH3), 57.8 (CH2), 67.0 (CH), 69.4 (CH), 119.8 (Ar), 121.8 (Ar), 122.8 (Ar), 
123.0 (Ar), 123.3 (Ar), 123.6 (Ar), 126.6 (ArH), 128.8 (ArH), 129.3 (ArH), 132.4 
(ArH), 152.9 (ArO), 156.3 (ArO), 163.5 (CH). Calc. m/z [C21H22Cl4N2O2 + Na]
+
 
497.0333. Found 497.0350 
 
7.8.2 Preparation of aluminium trans-1,2-DACH salalen complexes 
Al(22)Me. 22H2 (0.45 g, 0.80 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was recrystallised from hexane 
to yield yellow crystals (0.29 g, 0.48 mmol, 60 %). 
1
H NMR (D8-Tol) (233 K): δ -
0.35 (3H, s, Al-Me), 0.50 (2H, m, ring-CH2), 0.63 (2H, br, ring-CH2), 1.05 – 1.30 
(4H, m, ring-CH2), 1.40 (9H, s, 
t
Bu), 1.49 (9H, s, 
t
Bu), 1.60 (3H, s, CH3), 1.82 (9H, s, 
t
Bu), 1.86 (9H, s, 
t
Bu), 2.35 (2H, m, ring-CH), 2.78 (1H, d, J = 13.0 Hz, CH2), 3.98 
(1H, d, J = 13.0 Hz, CH2), 6.84 (1H, s, ArH), 6.98 (1H, s, ArH), 7.52 (1H, s, ArH), 
7.58 (1H, s, ArH), 7.76 (1H, s, CH). 
13
C NMR (D8-Tol): δ 21.5 (CH2), 24.1 (CH2), 
24.8 (CH2), 30.0 (CH3), 30.1 (CH3), 31.5 (CH3), 32.1 (CH3), 33.1 (CH2), 34.1 (C), 
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34.3 (C), 35.6 (C), 35.7 (C), 36.3 (CH3), 58.5 (CH2), 60.2 (CH), 60.3 (CH), 118.1 
(Ar), 120.9 (Ar), 123.6 (ArH), 123.7 (ArH), 127.5 (ArH), 131.7 (ArH), 136.7 (Ar), 
138.1 (Ar), 138.4 (Ar), 141.7 (Ar), 157.1 (ArO), 166.0 (ArO), 171.4 (N=CH). 
Despite significant efforts elemental analysis could not be obtained for complexes 
containing ligand 1H2, clean NMRs and the single crystal data supports the complex. 
 
Al(R,R-22)Me. R,R-22H2 (0.225 g, 0.80 mmol) was dissolved in toluene (30 ml) 
then 2M AlMe3 in heptane (0.20 ml, 0.40 mmol) was slowly added and stirred (16 h). 
The solvent was removed in-vacuo and the crude mixture was recrystallised from 
hexane to yield yellow crystals (0.08 g, 0.13 mmol, 33 %). The following analysis 
shows a diastereomeric compound in an approximate 1:1 ratio. 
1
H NMR (d8-Tol): δ -
0.48 (3H, s, Al-Me), -0.41 (3H, s, Al-Me), 0.50 - 0.85 (8H, m, ring-CH2), 1.15 – 1.35 
(8H, m, ring-CH2), 1.35 (9H, s, 
t
Bu), 1.37 (9H, s, 
t
Bu), 1.41 (9H, s, 
t
Bu), 1.45 (9H, s, 
t
Bu), 1.69 (9H, s, 
t
Bu), 1.74 (9H, s, 
t
Bu), 1.76 (3H, s, CH3), 1.77 (9H, s, 
t
Bu), 1.78 
(9H, s, 
t
Bu), 1.85 (3H, s, CH3), 2.35 – 2.50 (2H, m, ring-CH), 2.59 (1H, m, ring-CH), 
2.80 (1H, d, J = 12.0 Hz, CH2), 2.83 (1H, m, ring-CH), 2.94 (1H, d, J = 13.0 Hz, 
CH2), 2.71 (1H, d, J = 12.0 Hz, CH2), 4.08 (1H, d, J = 13.0 Hz, CH2), 6.81 (1H, d, J 
= 2.5 Hz, ArH), 6.92 (1H, d, J = 2.5 Hz, ArH), 6.96 (2H, t, J = 2.5 Hz, ArH), 7.49 
(1H, d, J = 2.5 Hz, ArH), 7.54 (1H, d, J = 2.5 Hz, ArH), 7.71 (1H, d, J = 2.5 Hz, 
ArH), 7.73 (1H, d, J = 2.5 Hz, ArH), 7.74 (1H, d, J = 1.0 Hz, ArH), 7.77 (1H, d, J = 
1.0 Hz, ArH).
13
C{
1
H} NMR (d8-Tol): δ 21.2 (CH2), 21.6 (CH2), 23.1 (CH2), 24.2 
(CH2), 24.8 (CH2), 25.0 (CH2), 30.0 (CH3), 30.2 (CH3), 30.4 (CH3), 30.5 (CH3), 31.5 
(CH3), 31.6 (CH3), 32.0 (CH2), 32.1 (CH3), 32.2 (CH3), 32.6 (CH2), 33.1 (C), 34.1 
(C), 34.3 (C), 34.3 (C), 35.6 (C), 35.7 (C), 35.8 (C), 35.8 (C), 36.3 (CH3), 41.1 (CH3), 
52.3 (CH2), 58.6 (CH2), 60.3 (CH), 61.2 (CH), 66.4 (CH), 118.1 (Ar), 120.9 (Ar), 
122.2 (Ar), 123.7 (ArH), 123.7 (ArH), 123.8 (ArH), 123.9 (ArH), 127.5 (ArH), 127.8 
(ArH), 131.7 (ArH), 132.0 (ArH), 136.7 (Ar), 136.8 (Ar), 138.0 (Ar), 138.2 (Ar), 
138.4 (Ar), 141.4 (Ar), 141.8 (Ar), 157.1 (ArO), 157.4 (ArO), 166.1 (ArO), 166.5 
(ArO), 171.4 (N=CH), 171.7 (N=CH). CHN analysis - see comment for Al(21)Me 
 
Al(22)OBn. 22H2 (0.45 g, 0.80 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was briefly washed with 
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hexane to remove any traces of AlMe3. The residue was dissolved in toluene (30 ml) 
then benzyl alcohol (0.092 ml, 0.89 mmol) was slowly added and the reaction was 
stirred (16 h). The solvent was removed in-vacuo and the crude mixture was 
recrystallised from hexane to yield a yellow solid (0.06 g, 0.09 mmol, 11 %). The 
following analysis shows a diastereomeric compound in an approximate 1:1 ratio. 
1
H 
NMR (D8-Tol): δ 0.45 – 0.9 (8H, m, ring-CH2), 1.10 – 1.55 (8H, m, ring-CH2), 1.35 
(9H, s, 
t
Bu), 1.37 (9H, s, 
t
Bu), 1.39 (9H, s, 
t
Bu), 1.44 (9H, s, 
t
Bu), 1.62 (9H, s, 
t
Bu), 
1.73 (9H, s, 
t
Bu), 1.74 (9H, s, 
t
Bu), 1.78 (9H, s, 
t
Bu), 2.18 (3H, s, CH3), 2.23 (3H, s, 
CH3), 2.30 (1H, td, J = 11.5 Hz, J = 3.0 Hz, ring-CH), 2.60 – 2.80 (3H, m, ring-CH), 
2.83 (1H, d, J = 12.0 Hz, CH2), 3.00 (1H, d, J = 13.0 Hz, CH2), 3.71 (1H, d, J = 12.0 
Hz, CH2), 4.50 (1H, d, J = 13.0 Hz, CH2), 5.20 (4H, br, CH2), 6.80 (1H, d, J = 2.5 Hz, 
ArH), 6.93 (1H, d, J = 2.5 Hz, ArH), 6.96 (1H, s, ArH), 7.00 (1H, d, J = 2.5 Hz, ArH), 
7.04 (2H, br, ArH), 7.15 – 7.40 (8H, br, ArH), 7.47 (1H, d, J = 2.5 Hz, ArH), 7.54 
(1H, d, J = 2.5 Hz, ArH), 7.71 (1H, s, N=CH), 7.74 (1H, d, J = 2.5 Hz, ArH), 7.78 
(1H, d, J = 2.5 Hz, ArH), 7.80 (1H, s, N=CH). 
13
C NMR (D8-Tol): δ 24.1 (CH2), 24.8 
(CH2), 30.0 (CH3), 30.4 (CH3), 30.5 (CH3), 30.7 (CH3), 31.5 (CH3), 31.5 (CH3), 32.0 
(CH2), 32.1 (CH3), 32.2 (CH3), 32.2 (CH2), 34.1 (C), 34.2 (C), 34.3 (C), 34.3 (C), 
35.5 (C), 35.7 (C), 35.8 (C), 35.9 (C), 37.6 (CH3), 41.7 (CH3), 52.1 (CH2), 59.2 
(CH2), 60.2 (CH), 60.2 (CH), 60.7 (CH), 66.2 (CH), 118.4 (Ar), 121.2 (Ar), 122.1 
(Ar), 123.6 (ArH), 123.7 (ArH), 123.8 (ArH), 123.9 (ArH), 126.8 (ArH), 127.8 
(ArH), 128.0 (ArH), 128.2 (ArH), 132.1 (ArH), 132.3 (ArH), 137.3 (Ar), 137.3(Ar), 
138.5 (Ar), 141.4 (Ar), 141.5 (Ar), 156.9 (ArO), 157.3 (ArO), 166.4 (ArO), 171.2 
(N=CH), 171.5 (N=CH). CHN analysis - see comment for Al(21)Me 
 
Al(23)Me. 23H2 (0.45 g, 1.00 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.50 ml, 1.00 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was recrystallised from toluene 
to yield yellow crystals (0.10 g, 0.20 mmol, 20 %). 
1
H NMR (D8-Tol): δ -0.36 (3H, s, 
Al-Me), 0.70 - 1.00 (4H, br, ring-CH2), 1.30 – 1.60 (4H, m, ring-CH2), 1.45 (9H, s, 
t
Bu), 1.75 (9H, s, 
t
Bu), 1.86 (3H, s, CH3), 2.45 – 2.65 (2H, m, ring-CH), 2.72 (1H, d, 
J = 12.0 Hz, CH2), 3.49 (1H, d, J = 12.0 Hz, CH2), 6.53 (1H, ddd, J = 8.0 Hz, J = 6.5 
Hz, J = 1.5 Hz, ArH), 6.90 (1H, d, J = 1.5 Hz, ArH), 6.93 (1H, d, J = 2.0 Hz, ArH), 
7.14 (1H, d, J = 1.5 Hz, ArH), 7.18 (1H, dd, J = 6.5 Hz, J = 2.0 Hz, ArH), 7.52 (1H, d, 
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J = 2.5 Hz, ArH), 7.69 (1H, s, CH). 
13
C NMR (D8-Tol): δ 29.7 (CH2), 29.8 (CH2), 
34.8 (CH3), 37.1 (CH3), 38.0 (C), 39.1 (C), 40.3 (CH2), 45.5 (CH3), 57.2 (CH2), 66.7 
(CH), 70.9 (CH), 120.1 (ArH), 123.4 (Ar), 126.4 (Ar), 127.8 (ArH), 128.3 (ArH), 
128.6 (ArH), 138.7 (ArH), 142.1 (ArH), 142.7 (Ar), 143.3 (Ar), 162.1 (ArO), 173.9 
(ArO), 176.3 (N=CH). Calc. (%) for C30H43AlN2O2, C 73.44, H 8.83, N 5.71. Found 
(%), C 73.57, H 8.83, N 5.80. 
 
Al(23)OBn. 23H2 (0.36 g, 0.80 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo, then the residue was dissolved in toluene (30 ml). 
Benzyl alcohol (0.083 ml, 0.80 mmol) was slowly added to the reaction and allowed 
to stir (16 h). The solvent was removed in-vacuo and the crude mixture was 
recrystallised from hexane to yield a yellow solid (0.06 g, 0.09 mmol, 11 %). 
1
H 
NMR (D8-Tol) (233 K): δ 0.40 – 0.65 (4H, m, ring-CH2), 1.05 – 1.30 (4H, m, ring-
CH2), 1.46 (9H, s, 
t
Bu), 1.74 (9H, s, 
t
Bu), 2.21 (3H, s, CH3), 2.29 (2H, br, ring-CH), 
2.88 (1H, d, J = 13.5 Hz, CH2), 4.56 (1H, d, J = 13.5 Hz, CH2), 5.31 (1H, d, J = 14.0 
Hz, CH2), 5.57 (1H, d, J = 14.0 Hz, CH2), 6.56 (1H, t, J = 7.5 Hz, ArH), 6.82 (1H, s, 
ArH), 6.87 (1H, d, J = 7.5 Hz, ArH), 7.04 (1H, s, ArH), 7.20 (1H, s, ArH), 7.23 (1H, 
s, ArH), 7.29 (2H, t, J = 7.5 Hz, ArH), 7.41 (1H, s, ArH), 7.56 (1H, s, ArH), 7.60 (1H, 
s, ArH), 7.62 (1H, s, CH). 
13
C NMR (D8-Tol): δ 25.0 (CH2), 25.6 (CH2), 30.9 (CH3), 
32.7 (C), 33.2 (CH3), 36.4 (C), 38.6 (CH3), 60.3 (CH2), 60.7 (CH), 60.9 (CH), 67.5 
(CH2), 116.9 (ArH), 118.9 (Ar), 121.3 (Ar), 122.0 (Ar), 123.1 (ArH), 124.0 (ArH), 
126.0 (ArH), 126.2 (ArH), 127.3 (ArH), 128.4 (ArH), 129.7 (ArH), 134.2 (ArH), 
137.5 (ArH), 138.7 (Ar), 138.8 (Ar), 143.3 (Ar), 157.2 (ArO), 168.1 (ArO), 170.6 
(N=CH). Calc. (%) for C36H47AlN2O3, C 74.20, H 8.13, N 4.81. Found (%), C 72.31, 
H 7.86, N 4.47. 
. 
Al(24)Me. 24H2 (0.41 g, 0.79 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was recrystallised from a 
toluene:hexane mix to yield a yellow solid (0.34 g, 0.61 mmol, 77 %).
1
H NMR (D8-
Tol) (233 K): δ -0.41 (3H, s, Al-Me), 0.70 – 0.95 (4H, br, ring-CH2), 1.30 – 1.50 (4H, 
m, ring-CH2), 1.43 (9H, s, 
t
Bu), 1.73 (9H, s, 
t
Bu), 1.81 (3H, s, CH3), 2.50 (1H, m, 
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ring-CH), 2.70 (1H, br, ring-CH), 2.71 (1H, d, J = 12.0 Hz, CH2), 3.44 (1H, d, J = 
12.0 Hz, CH2), 6.65 (1H, d, J = 2.5 Hz, ArH), 6.92 (1H, d, J = 2.5 Hz, ArH), 7.34 
(1H, s, ArH), 7.35 (1H, s, CH), 7.52 (1H, d, J = 2.5 Hz, ArH).
 13
C NMR (D8-Tol): δ 
24.7 (CH2), 24.9 (CH2), 30.0 (CH3), 32.2 (CH3), 33.0 (C), 34.3 (C), 35.5 (CH2), 40.8 
(CH3), 52.3 (CH2), 62.2 (CH), 60.9 (CH), 66.0 (CH2), 116.5 (ArH), 117.9 (Ar), 120.7 
(ArH), 122.2 (Ar), 127.4 (ArH), 128.8 (ArH), 130.0 (ArH), 131.9 (ArH), 136.8 (Ar), 
141.6 (Ar), 161.5 (ArO), 166.4 (ArO), 172.1 (N=CH). Calc. (%) for 
C30H41AlCl2N2O2, C 64.40, H 7.39, N 5.01. Found (%), C 64.39, H 7.46, N 5.18. 
 
Al(24)OBn. 24H2 (0.42 g, 0.81 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was briefly washed with 
hexane to remove any traces of AlMe3. The residue was dissolved in toluene (30 ml) 
then benzyl alcohol (0.091 ml, 0.88 mmol) was slowly added and the reaction was 
stirred (16 h). The solvent was removed in-vacuo and the crude mixture was 
recrystallised from hexane to yield a yellow solid (0.22 g, 0.34 mmol, 42 %). 
1
H 
NMR (D8-Tol) (K): δ 0.65 – 0.85 (4H, br, ring-CH2), 1.30 – 1.55 (4H, m, ring-CH2), 
1.42 (9H, s, 
t
Bu), 1.74 (9H, s, 
t
Bu), 2.23 (3H, s, CH3), 2.74 (2H, br, CH2), 2.77 (1H, 
br, CH), 3.51 (1H, d, J = 12.0 Hz, CH), 5.14 (2H, br, CH2), 6.64 (1H, d, J = 2.0 Hz, 
ArH), 6.93 (1H, s, ArH), 7.03 (1H, s, ArH), 7.12 (1H, s, ArH), 7.13 (1H, s, CH), 7.30 
(1H, s, ArH), 7.33 (1H, s, ArH), 7.35 (1H, s, ArH), 7.53 (1H, d, J = 2.5 Hz, ArH). 
13
C NMR (D8-Tol): δ 24.6 (CH2), 24.7 (CH2), 30.0 (CH3), 31.8 (CH2), 32.2 (C), 34.3 
(C), 35.5 (CH2), 41.6 (CH3), 52.3 (CH2), 61.0 (CH), 65.9 (CH2), 66.2 (CH), 118.8 
(Ar), 119.1 (Ar), 121.1 (Ar), 123.4 (ArH), 124.0 (ArH), 126.0 (ArH), 127.1 (ArH), 
128.0 (ArH), 130.9 (ArH), 135.8 (ArH), 138.7 (Ar), 138.9 (Ar), 156.8 (ArO), 162.0 
(ArO), 169.7 (N=CH). Calc. (%) for C36H45AlCl2N2O3, C 66.35, H 6.96, N 4.30. 
Found (%), C 66.20, H 7.08, N 4.28 
 
Al(25)Me. 25H2 (0.36 g, 0.80 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was recrystallised from a 
toluene:hexane mix to yield a yellow solid (0.18 g, 0.37 mmol, 46 %). 
1
H NMR (D8-
Tol) (233 K): δ -0. 35 (3H, s, Al-Me), 0.70 – 0.90 (4H, br, ring-CH2), 1.35 – 1.55 
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(4H, m, ring-CH2), 1.40 (9H, s, 
t
Bu), 1.79 (9H, s, 
t
Bu), 1.86 (3H, s, CH3), 2.55 (1H, 
m, ring-CH), 2.66 (1H, d, J = 12.0 Hz, CH2), 3.49 (1H, d, J = 12.0 Hz, CH2), 6.73 
(1H, t, J = 7.0 Hz, ArH), 6.86 (1H, d, J = 7.0 Hz, ArH), 6.94 (1H, d, J = 2.5 Hz, ArH), 
7.05 (1H, d, J = 8.0 Hz, ArH), 7.19 (1H, t, J = 7.5 Hz, ArH), 7.72 (1H, s, ArH), 7.73 
(1H, s, CH). 
13
C NMR (D8-Tol): δ 24.9 (CH2), 25.0 (CH2), 29.7 (CH3), 31.6 (CH3), 
33.4 (C), 34.2 (C), 35.7 (CH2), 40.8 (CH3), 51.7 (CH2), 61.5 (CH), 66.3 (CH), 118.9 
(Ar), 119.0 (Ar), 121.3 (Ar), 123.5 (ArH), 124.0 (ArH), 128.1 (Ar), 130.9 (ArH), 
135.9 (ArH), 138.4 (Ar), 138.9 (Ar), 156.9 (ArO), 162.0 (ArO), 170.4 (N=CH). Calc. 
(%) for C30H43AlN2O2, C 73.44, H 8.83, N 5.71. Found (%), C 73.37, H 8.90, N 5.82. 
 
Al(25)OBn. 25H2 (0.36 g, 0.80 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was briefly washed with 
hexane to remove any traces of AlMe3. The residue was dissolved in toluene (30 ml) 
then benzyl alcohol (0.083 ml, 0.80 mmol) was slowly added and the reaction was 
stirred (16 h). The solvent was removed in-vacuo and the crude mixture was 
recrystallised from a toluene:hexane mix to yield a yellow solid (0.23 g, 0.39 mmol, 
49 %). 
1
H NMR (D8-Tol) (233 K): δ 0.40 – 0.80 (4H, m, ring-CH2), 1.15 – 1.55 (4H, 
m, ring-CH2), 1.48 (9H, s, 
t
Bu), 1.88 (9H, s, 
t
Bu), 2.24 (3H, s, CH3), 2.25 (1H, br, 
ring-CH), 2.59 (1H, d, J = 12.0 Hz, CH2), 2.77 (1H, t, J = 11.0 Hz, ring-CH), 3.39 
(1H, d, J = 12.0 Hz, CH2), 5.34 (1H, d, J = 13.0 Hz, CH2), 5.44 (1H, d, J = 13.0 Hz, 
CH2), 6.86 (1H, t, J = 7.0 Hz, ArH), 6.93 (1H, d, J = 7.5 Hz, ArH), 7.15 – 7.30 (5H, 
m, ArH), 7.48 (2H, d, J = 7.5 Hz, ArH), 7.60 (1H, s, ArH), 7.85 (1H, s, ArH). 
13
C 
NMR (D8-Tol): δ 24.9 (CH2), 25.0 (CH2), 30.0 (CH3), 31.6 (CH3), 32.4 (C), 34.2 (C), 
35.8 (CH2), 41.4 (CH3), 51.5 (CH2), 60.7 (CH), 66.1 (CH), 66.2 (CH2), 116.9 (ArH), 
118.2 (Ar), 120.6 (ArH), 122.1 (Ar), 125.9 (ArH), 127.3 (ArH), 128.0 (ArH), 128.7 
(ArH), 130.0 (ArH), 132.1 (ArH), 137.3 (Ar), 141.8 (Ar), 161.3 (ArO), 166.6 (ArO), 
171.8 (N=CH). Calc. (%) for C36H47AlN2O3, C 74.20, H 8.13, N 4.81. Found (%), C 
74.29, H 8.11, N 4.72. 
 
Al(26)OBn. 26H2 (0.34 g, 1.00 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.50 ml, 1.00 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was briefly washed with 
 272 
hexane to remove any traces of AlMe3. The residue was dissolved in toluene (30 ml) 
then benzyl alcohol (0.11 ml, 1.06 mmol) was slowly added and the reaction was 
stirred (16 h). The solvent was removed in-vacuo and the crude mixture was 
recrystallised from a toluene:hexane mix to yield a yellow solid (0.27 g, 0.57 mmol, 
57 %). The following analysis shows a diastereomeric compound in an approximate 
1:1 ratio. 
1
H NMR (D8-Tol): δ 0.45 – 0.90 (8H, m, ring-CH2), 1.15 – 1.55 (8H, m, 
ring-CH2), 2.16 (3H, s, CH3), 2.22 (3H, s, CH3), 2.39 (1H, td, J = 12.0 Hz, J = 2.5 Hz, 
ring-CH), 2.52 (1H, t, J = 11.0 Hz, ring-CH), 2.64 (1H, br, ring-CH), 2.67 (1H, d, J = 
12.0 Hz, CH2), 2.74 (1H, t, J = 11.0 Hz, ring-CH), 2.99 (1H, d, J = 13.5 Hz, CH2), 
3.50 (1H, d, J = 12.5 Hz, CH2), 4.51 (1H, d, J = 12.5 Hz, CH2), 5.09 (4H, br, CH2), 
6.54 (2H, t, J = 6.5 Hz, ArH), 6.70 (2H, m, ArH), 6.76 (1H, d, J = 7.5 Hz, ArH), 6.86 
(2H, t, J = 8.0 Hz, ArH), 6.92 (1H, d, J = 7.5 Hz, ArH), 7.03 – 7.09 (5H, m, ArH), 
7.16 (8H, m, ArH), 7.38 (4H, br, ArH), 7.56 (1H, s, ArH), 7.67 (1H, s, ArH). 
13
C 
NMR (D8-Tol): δ 21.3 (CH2), 23.9 (CH2), 24.6 (CH2), 24.7 (CH2), 24.8 (CH2), 31.0 
(CH2), 32.0 (CH2), 37.4 (CH3), 41.6 (CH3), 51.6 (CH2), 58.3 (CH3), 59.7 (CH), 59.8 
(CH), 60.5 (CH), 66.1 (CH), 66.2 (CH2), 115.7 (ArH), 115.7 (ArH), 117.0 (ArH), 
117.2 (ArH), 118.6 (Ar), 118.7 (Ar), 120.4 (ArH), 120.5 (ArH), 121.1 (Ar), 122.2 
(Ar), 122.6 (ArH), 122.8 (ArH), 125.9 (ArH), 127.1 (ArH), 128.1 (ArH), 130.1 
(ArH), 130.2 (ArH), 133.9 (ArH), 134.0 (ArH), 137.1 (ArH), 137.2 (ArH), 160.9 
(ArO), 161.3 (ArO), 168.4 (ArO), 168.8 (ArO), 170.8 (N=CH), 171.1 (N=CH). Calc. 
(%) for C28H31AlN2O3, C 71.47, H 6.64, N 5.95. Found (%), C 71.38, H 6.65, N 6.02. 
 
Al(27)OBn. 27H2 (0.41 g, 1.00 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.50 ml, 1.00 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was briefly washed with 
hexane to remove any traces of AlMe3. The residue was dissolved in toluene (30 ml) 
then benzyl alcohol (0.11 ml, 1.06 mmol) was slowly added and the reaction was 
stirred (16 h). The solvent was removed in-vacuo and the crude mixture was 
recrystallised from a toluene:hexane mix to yield a yellow solid (0.20 g, 0.37 mmol, 
37 %). The following analysis shows a diastereomeric compound in an approximate 
1:1 ratio. 
1
H NMR (D8-Tol): δ 0.30 – 0.80 (8H, m, ring-CH2), 1.30 – 1.50 (8H, m, 
ring-CH2), 1.66 (1H, m, CH2), 2.12 (3H, s, CH3), 2.16 (3H, s, CH3), 2.36 (1H, m, 
ring-CH), 2.57 (1H, m, ring-CH), 2.65 (1H, d, J = 12.5 Hz, CH2), 2.72 (1H, d, J = 
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12.5 Hz, ring-CH), 2.79 (1H, m, ring-CH), 2.96 (1H, d, J = 13.5 Hz, CH2), 3.51 (1H, 
d, J = 12.5 Hz, CH2), 4.45 (1H, d, J = 13.5 Hz, CH2), 5.13 (4H, br, CH2), 6.50 – 6.85 
(7H, m, ArH), 7.03 (2H, m, ArH), 7.14 (5H, m, ArH), 7.25 – 7.40 (7H, m, ArH), 
7.51 (1H, s, N=CH). 
13
C NMR (D8-Tol): δ 21.3 (CH2), 23.8 (CH2), 24.5 (CH2), 24.7 
(CH2), 24.8 (CH2), 30.9 (CH2), 32.0 (CH2), 37.5 (CH3), 41.7 (CH3), 51.6 (CH2), 58.3 
(CH3), 59.5 (CH), 60.2 (CH), 60.9 (CH), 65.9 (CH2), 66.1 (CH), 117.3 (ArH), 117.5 
(ArH), 118.9 (Ar), 119.0 (Ar), 119.2 (Ar), 119.3 (Ar), 120.4 (ArH), 120.6 (ArH), 
120.8 (Ar), 121.9 (Ar), 126.2 (ArH), 127.0 (ArH), 128.1 (ArH), 130.2 (ArH), 130.3 
(ArH), 131.0 (ArH), 131.1 (ArH), 135.7 (ArH), 135.82 (ArH), 160.5 (ArO), 160.8 
(ArO), 161.3 (ArO), 161.8 (ArO), 169.7 (N=CH), 170.3 (N=CH). Calc. (%) for 
C28H29AlCl2N2O3, C 62.34, H 5.42, N 5.19. Found (%), C 62.28, H 5.46, N 5.07. 
 
Al(28)Me. 28H2 (0.41 g, 0.79 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was recrystallised from a 
toluene:hexane mix to yield a yellow solid (0.32 g, 0.57 mmol, 72 %). 
1
H NMR (D8-
Tol): δ -0.43 (3H, s, Al-Me), 0.60 – 1.00 (4H, m, ring-CH2), 1.20 – 1.60 (4H, br, 
ring-CH2), 1.37 (9H, s, 
t
Bu), 1.63 (3H, s, CH3), 1.78 (9H, s, 
t
Bu), 2.42 (2H, m, ring-
CH), 2.61 (1H, m, CH), 3.26 (1H, d, J = 11.5 Hz, CH2), 6.65 (1H, s, ArH), 6.94 (1H, 
s, ArH), 7.34 (1H, s, ArH), 7.72 (1H, s, ArH), 7.73 (1H, s, CH).
 13
C NMR (D8-Tol): δ 
24.8 (CH2), 24.9 (CH2), 29.9 (CH3), 31.5 (CH3), 32.2 (C), 34.2 (C), 35.7 (CH2), 40.7 
(CH3), 51.0 (CH2), 61.3 (CH), 66.3 (CH), 117.8 (Ar), 120.2 (Ar), 124.7 (Ar), 125.4 
(Ar), 127.1 (ArH), 127.4 (ArH), 129.8 (ArH), 127.5 (ArH), 132.3 (ArH), 137.3 (Ar), 
141.9 (Ar), 155.7 (ArO), 166.2 (ArO), 172.3 (N=CH). Calc. (%) for 
C30H41AlCl2N2O2, C 64.40, H 7.39, N 5.01. Found (%), C 64.47, H 7.51, N 5.13. 
 
Al(28)OBn. 28H2 (0.42 g, 0.81 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was briefly washed with 
hexane to remove any traces of AlMe3. The residue was dissolved in toluene (30 ml) 
then benzyl alcohol (0.083 ml, 0.80 mmol) was slowly added and the reaction was 
stirred (16 h). The solvent was removed in-vacuo and the crude mixture was 
recrystallised from a toluene:hexane mix to yield a yellow solid (0.34 g, 0.52 mmol, 
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65 %). 
1
H NMR (D8-Tol): δ 0.65 – 0.95 (4H, m, ring-CH2), 1.30 – 1.55 (4H, br, ring-
CH2), 1.37 (9H, s, 
t
Bu), 1.75 (9H, s, 
t
Bu), 2.00 (3H, s, CH3), 2.41 (1H, d, J = 12.5 Hz, 
CH2), 2.58 (1H, m, ring-CH), 2.74 (1H, m, ring-CH), 3.23 (1H, d, J = 12.5 Hz, CH2), 
5.16 (2H, br, CH2), 6.64 (1H, d, J = 2.5 Hz, ArH), 6.97 (1H, s, ArH), 7.06 (1H, d, J = 
7.0 Hz, ArH), 7.19 (2H, t, J = 7.5 Hz, ArH), 7.34 (1H, d, J = 2.5 Hz, ArH), 7.41 (2H, 
J = 7.5 Hz, ArH), 7.75 (1H, m, ArH), 7.77 (1H, m, CH). 
13
C NMR (D8-Tol): δ 24.8 
(CH2), 24.9 (CH2), 30.2 (CH3), 31.5 (CH3), 32.3 (C), 34.2 (C), 37.8 (CH2), 41.4 
(CH3), 60.5 (CH), 65.5 (CH2), 66.2 (CH), 118.1 (Ar), 120.8 (Ar), 124.6 (Ar), 125.6 
(Ar), 126.1 (ArH), 127.0 (ArH), 127.4 (ArH), 127.5 (ArH), 128.1 (ArH), 129.3 
(ArH), 129.8 (ArH), 132.5 (ArH), 137.8 (Ar), 142.1 (Ar), 146.7 (Ar), 155.5 (ArO), 
166.4 (ArO), 172.1 (N=CH). Calc. (%) for C36H45AlCl2N2O3, C 66.35, H 6.96, N 
4.30. Found (%), C 66.45, H 7.02, N 4.40. 
 
Al(29)OBn. 29H2 (0.33 g, 0.81 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was briefly washed with 
hexane to remove any traces of AlMe3. The residue was dissolved in toluene (30 ml) 
then benzyl alcohol (0.091 ml, 0.88 mmol) was slowly added and the reaction was 
stirred (16 h). The solvent was removed in-vacuo and the crude mixture was 
recrystallised twice from a toluene / hexane mix to yield a yellow solid (0.19 g, 0.35 
mmol, 43 %). The following analysis shows a diastereomeric compound in an 
approximate 1:1 ratio. Analysis also shows impurities were present in this sample 
despite extensive efforts to isolate a pure product. 
1
H NMR (d8-Tol): δ 0.30 – 0.90 
(8H, m, ring-CH2), 1.10 – 1.65 (8H, m, ring-CH2), 2.07 (3H, s, CH3), 1.95 – 2.15 (3H, 
m, CH3), 2.30 – 2.70 (4H, m, CH), 2.73 (1H, d, J = 13.5 Hz, CH2), 3.10 – 4.10 (2H, 
m, CH2), 4.24 (1H, d, J = 13.5 Hz, CH2), 4.90 - 5.30 (4H, br, CH2), 6.45 – 6.75 (4H, 
m, ArH), 6.80 – 6.90 (2H, m, ArH), 7.05 (1H, s, ArH), 7.07 (1H, s, ArH), 7.10 – 7.23 
(6H, m, ArH), 7.29 (2H, m, ArH), 7.35 (2H, s, ArH), 7.38 (2H, s, ArH), 7.48 (1H, br, 
ArH), 7.54 (1H, s, N=CH), 7.55 – 7.90 (2H, m, ArH, N=CH). 13C{1H} NMR (d8-Tol): 
δ 21.2 (CH2), 23.7 (CH2), 24.4 (CH2), 24.6 (CH2), 24.7 (CH2), 30.7 (CH2), 31.8 
(CH2), 37.4 (CH3), 41.5 (CH3), 50.8 (CH2), 57.4 (CH2), 59.6 (CH), 60.2 (CH), 60.3 
(CH), 66.1 (CH2), 66.1 (CH), 116.0 (ArH), 118.4 (Ar), 118.5 (Ar), 120.8 (Ar), 120.9 
(Ar), 122.7 (ArH), 122.7 (ArH), 123.5 (Ar), 124.2 (Ar), 24.6 (Ar), 126.2 (ArH), 
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126.9 (ArH), 127.1 (ArH), 127.1 (ArH), 128.1 (ArH), 129.8 (ArH), 129.9 (ArH), 
133.8 (ArH), 133.9 (ArH), 137.4 (ArH), 137.6 (ArH), 155.3 (ArO), 155.5 (ArO), 
168.3 (ArO), 168.8 (ArO), 170.9 (N=CH), 171.1 (N=CH). Calc. (%) for 
C28H29AlCl2N2O3, C 62.34, H 5.42, N 5.19. Found (%), C 57.91, H 5.78, N 4.39. 
 
Al(30)OBn. 30H2 (0.38 g, 0.80 mmol) was dissolved in toluene (30 ml) then 2M 
AlMe3 in heptane (0.40 ml, 0.80 mmol) was slowly added and stirred (16 h). The 
solvent was removed in-vacuo and the crude mixture was briefly washed with 
hexane to remove any traces of AlMe3. The residue was dissolved in toluene (30 ml) 
then benzyl alcohol (0.091 ml, 0.88 mmol) was slowly added and the reaction was 
stirred (16 h). The solvent was removed in-vacuo and the crude mixture was 
recrystallised from a toluene:hexane mix to yield a yellow solid (0.16 g, 0.26 mmol, 
33 %). The major diastereomer is characterised, the minor diastereomer is present at 
an approximate 3:1 ratio. 
1
H NMR (D8-Tol): δ 0.25 – 0.40 (2H, m, ring-CH2), 0.50 – 
0.75 (2H, m, ring-CH2), 1.17 (2H, m, ring-CH2), 1.32 (1H, m, ring-CH2), 1.44 (1H, 
m, ring-CH2), 2.09 (3H, s, CH3), 2.45 (1H, m, ring-CH), 2.68 (1H, m, ring-CH), 3.22 
(1H, d, J = 12.5 Hz, CH2), 4.18 (1H, d, J = 12.5 Hz, CH2), 5.11 (2H, br, CH2), 6.56 
(2H, m, ArH), 7.05 (1H, d, J = 7.5 Hz, ArH), 7.17 (2H, t, J = 7.5 Hz, ArH), 7.25 (1H, 
s, ArH), 7.29 (2H, m, ArH), 7.37 (1H, s, ArH), 7.39 (1H, s, CH). Calc. (%) for 
C28H27AlCl4N2O3, C 55.28, H 4.47, N 4.61. Found (%), C 55.17, H 4.54, N 4.64. 
13
C{
1
H} NMR analysis was not possible due to solubility. 
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8.1 X-ray diffraction data 
8.1.1 Chapter 2 
1H2 
Empirical formula                 C22H30N2O2 
  
Formula weight                    354.48 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions              a = 8.4960(3) Å   α = 90 ° 
                                  b = 12.8830(3) Å  β = 102.393(2) ° 
                                  c = 8.9960(3) Å   γ = 90 ° 
  
Volume                            961.70(5) Å
3
 
  
Z, Calculated density             2, 1.224 Mg/m
3
 
  
Absorption coefficient            0.078 mm
-1
 
  
F(000)                            384 
  
Crystal size                      0.30 x 0.30 x 0.30 mm 
  
Theta range for data collection   4.04 to 27.53 ° 
  
Limiting indices                  -11≤h≤11, -15≤k≤16, -11≤l≤11 
  
Reflections collected / unique    17655 / 2199 [R(int) = 0.0443] 
  
Completeness to theta = 27.53     99.2 % 
  
Absorption correction             None 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    2199 / 0 / 124 
  
Goodness-of-fit on F
2
             1.040 
  
Final R indices [I>2σ(I)]         R1 = 0.0440, wR2 = 0.1186 
  
R indices (all data)              R1 = 0.0600, wR2 = 0.1293 
  
Largest diff. peak and hole       0.234 and -0.253 eÅ
-3
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3H2 
Empirical formula                 C19H31NO 
  
Formula weight                    289.41 
  
Temperature                       150(2) K 
  
Wavelength                        0.68890 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions             a = 7.229(7) Å   α = 102.458 (14) ° 
                                 b = 9.916(9) Å   β = 96.862(5) ° 
                                 c = 14.129(12) Å γ = 104.919(11) ° 
  
Volume                            939.1(14) Å
3
 
  
Z, Calculated density             2, 1.24 Mg/m
3
 
  
Absorption coefficient            0.062 mm
-1
 
  
F(000)                            320 
  
Crystal size                      0.07 x 0.06 x 0.02 mm 
  
Theta range for data collection   2.13 to 22.50 ° 
  
Limiting indices                  -8≤h≤8, -9≤k≤11, -15≤l≤15 
  
Reflections collected / unique    6488 / 2639 [R(int) = 0.0334] 
  
Data Completeness                 0.984 
  
Absorption correction             Semi-empirical from equivalents 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    2639 / 0 / 200 
  
Goodness-of-fit on F
2
             1.653 
  
Final R indices [I>2σ(I)]         R1 = 0.1211, wR2 = 0.3648 
  
R indices (all data)              R1 = 0.1391, wR2 = 0.3898 
  
Largest diff. peak and hole       1.226 and -0.367 eÅ
-3
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8H2 
Empirical formula                 C35H56N2O2 
  
Formula weight                    536.82 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions              a = 10.0750(2) Å α = 65.7700(10) ° 
                                  b = 13.3950(3) Å β = 88.2360(10) ° 
                                  c = 14.3470(3) Å γ = 71.9810(10) ° 
  
Volume                            1668.67(6) Å
-3
 
  
Z, Calculated density             2, 1.068 Mg/m
-3
 
  
Absorption coefficient            0.065 mm
-1
 
  
F(000)                            592 
  
Crystal size                      0.12 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.53 to 27.48 ° 
  
Limiting indices                  -13≤h≤13, -17≤k≤17, -18≤l≤18 
  
Reflections collected / unique    31839 / 7601 [R(int) = 0.0633] 
  
Completeness to theta = 27.48     99.3 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9935 and 0.9923 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    7601 / 0 / 364 
  
Goodness-of-fit on F
2
             1.041 
  
Final R indices [I>2σ(I)]         R1 = 0.0549, wR2 = 0.1391 
  
R indices (all data)              R1 = 0.0796, wR2 = 0.1577 
  
Largest diff. peak and hole       0.268 and -0.372 eÅ
-3
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Ti2(1)2(OiPr)4 
Empirical formula                 C59H91N4O8Ti2 
  
Formula weight                    1080.16 
  
Temperature                       150(2) K 
  
Wavelength                        0.68890 Å 
  
Crystal system, space group       Monoclinic, P21/c 
  
Unit cell dimensions              a = 23.224(6) Å  α = 90 ° 
                                  b = 16.478(5) Å  β = 96.782(3) ° 
                                  c = 31.844(9) Å  γ = 90 ° 
  
Volume                            12101(6) Å
3
 
  
Z, Calculated density             8, 1.186 Mg/m
3
 
  
Absorption coefficient            0.317 mm
-1
 
  
F(000)                            4648 
  
Crystal size                      0.08 x 0.05 x 0.02 mm 
  
Theta range for data collection   2.83 to 25.17 ° 
  
Limiting indices                  -22≤h≤28, -20≤k≤20, -39≤l≤38 
  
Reflections collected / unique    102329 / 23430 [R(int) = 0.0710] 
  
Data Completeness                 0.982 
  
Absorption correction             Semi-empirical from equivalents 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    23430 / 0 / 1365 
  
Goodness-of-fit on F
2
             1.061 
  
Final R indices [I>2σ(I)]         R1 = 0.0727, wR2 = 0.1813 
  
R indices (all data)              R1 = 0.1017, wR2 = 0.2020 
  
Largest diff. peak and hole       0.646 and -0.471 eÅ
-3
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Ti2(2)(OiPr)6  
Empirical formula                 C23H41NO4Ti 
  
Formula weight                    443.47 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/c 
  
Unit cell dimensions              a = 9.5960(5) Å   α = 90 ° 
                                  b = 23.1890(14) Å β = 91.398(3) ° 
                                  c = 11.4210(8) Å  γ = 90 ° 
  
Volume                            2540.7(3) Å
3
 
  
Z, Calculated density             4, 1.159 Mg/m
3
 
  
Absorption coefficient            0.362 mm
-1
 
  
F(000)                            960 
  
Crystal size                      0.20 x 0.15 x 0.10 mm 
  
Theta range for data collection   3.68 to 27.48 ° 
  
Limiting indices                  -12≤h≤12, -28≤k≤30, -14≤l≤14 
  
Reflections collected / unique    27064 / 5764 [R(int) = 0.0931] 
  
Completeness to theta = 27.48     98.9 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.9647 and 0.9311 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    5764 / 0 / 303 
  
Goodness-of-fit on F
2
             1.049 
  
Final R indices [I>2σ(I)]         R1 = 0.0572, wR2 = 0.1373 
  
R indices (all data)              R1 = 0.0852, wR2 = 0.1525 
  
Largest diff. peak and hole       0.575 and -0.539 e. Å
-3
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Ti2(3)(OiPr)6 
Empirical formula                 C52H94N2O8Ti2 
  
Formula weight                    971.09 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions              a = 10.8260(6) Å  α = 90 ° 
                                  b = 18.8930(9) Å  β = 104.050(2) ° 
                                  c = 14.5330(10) Å γ = 90 ° 
  
Volume                            2883.6(3) Å
3
 
  
Z, Calculated density             2, 1.118 Mg/m
3
 
  
Absorption coefficient            0.324 mm
-1
 
  
F(000)                            1056 
  
Crystal size                      0.10 x 0.05 x 0.05 mm 
  
Theta range for data collection   3.54 to 24.00 ° 
  
Limiting indices                  -12≤h≤12, -21≤k≤21, -16≤l≤16 
  
Reflections collected / unique    42193 / 4506 [R(int) = 0.1040] 
  
Completeness to theta = 24.00     99.7 % 
  
Absorption correction             None 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    4506 / 0 / 301 
  
Goodness-of-fit on F
2
             1.064 
  
Final R indices [I>2σ(I)]         R1 = 0.0434, wR2 = 0.0873 
  
R indices (all data)              R1 = 0.0682, wR2 = 0.0985 
  
Largest diff. peak and hole       0.233 and -0.354 eÅ
-3
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Ti2(4)(OiPr)6 
Empirical formula                 C52H96N2O8Ti2 
  
Formula weight                    973.11 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions              a = 9.4410(3) Å  α = 79.5090(10) ° 
                                  b = 10.0110(3) Å β = 84.6760(10) ° 
                                  c = 15.1580(5) Å γ = 87.7970(10) ° 
  
Volume                            1402.28(8) Å
3
 
  
Z, Calculated density             1, 1.152 Mg/m
3
 
  
Absorption coefficient            0.334 mm
-1
 
  
F(000)                            530 
  
Crystal size                      0.20 x 0.20 x 0.15 mm 
  
Theta range for data collection   3.72 to 27.53 ° 
  
Limiting indices                  -12≤h≤12, -12≤k≤12, -18≤l≤19 
  
Reflections collected / unique    19702 / 6423 [R(int) = 0.0458] 
  
Completeness to theta = 27.53     99.2 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.9517 and 0.9363 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    6423 / 0 / 350 
  
Goodness-of-fit on F
2
             1.025 
   
Final R indices [I>2σ(I)]         R1 = 0.0541, wR2 = 0.1354 
  
R indices (all data)              R1 = 0.0735, wR2 = 0.1509 
  
Largest diff. peak and hole       0.951 and -0.932 eÅ
-3
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Ti2(5)(OiPr)6 
Empirical formula                 C31H58NO4Ti 
  
Formula weight                    556.68 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions              a = 11.0450(10) Å α = 115.990(5) ° 
                                  b = 13.2550(11) Å β = 109.683(5) ° 
                                  c = 13.9140(14) Å γ = 91.805(5) ° 
  
Volume                            1685.0(3) Å
3
 
  
Z, Calculated density             2, 1.097 Mg/m
3
 
  
Absorption coefficient            0.285 mm
-1
 
  
F(000)                            610 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   4.09 to 27.52 ° 
  
Limiting indices                  -14≤h≤14, -16≤k≤17, -18≤l≤18 
  
Reflections collected / unique    33515 / 7641 [R(int) = 0.0614] 
  
Completeness to theta = 27.52     98.8 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9720 and 0.9720 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    7641 / 0 / 347 
  
Goodness-of-fit on F
2
             1.017 
  
Final R indices [I>2σ(I)]         R1 = 0.0590, wR2 = 0.1504 
  
R indices (all data)              R1 = 0.0903, wR2 = 0.1713 
  
Largest diff. peak and hole       0.761 and -0.626 eÅ
-3
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Ti2(8)(OiPr)6 
Empirical formula                 C56H103N2O8Ti2 
  
Formula weight                    1028.20 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions              a = 14.2220(3) Å α = 69.6250(10) ° 
                                  b = 15.3740(4) Å β = 89.943(2) ° 
                                  c = 17.4080(4) Å γ = 62.8660(10) ° 
  
Volume                            3118.09(13) Å
3
 
  
Z, Calculated density             2, 1.095 Mg/m
3
 
  
Absorption coefficient            0.303 mm
-1
 
  
F(000)                            1122 
  
Crystal size                      0.20 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.75 to 27.50 ° 
  
Limiting indices                  -18≤h≤18, -19≤k≤19, -22≤l≤22 
  
Reflections collected / unique    53817 / 14138 [R(int) = 0.0624] 
  
Completeness to theta = 27.50     98.7 % 
  
Absorption correction             None 
  
Refinement method                 Full-matrix least-squares on F
2
 
 
Data / restraints / parameters    14138 / 0 / 717 
  
Goodness-of-fit on F
2
             1.007 
  
Final R indices [I>2σ(I)]         R1 = 0.0576, wR2 = 0.1516 
  
R indices (all data)              R1 = 0.0942, wR2 = 0.1780 
  
Largest diff. peak and hole       0.706 and -0.519 eÅ
-3
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Ti2(12)(OiPr)6 
  
Empirical formula                 C53H96N2O8Ti2 
  
Formula weight                    985.12 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       monoclinic, P21/n 
  
Unit cell dimensions             a = 9.24600(10) Å α = 90 ° 
                                 b = 24.3060(3) Å  β = 91.5990(10) ° 
                                 c = 26.2840(3) Å  γ = 90 ° 
  
Volume                            5904.59(12) Å
3
 
  
Z, Calculated density             4, 1.108 Mg/m
3
 
  
Absorption coefficient            0.318 mm
-1
 
  
F(000)                            2144 
  
Crystal size                      0.20 x 0.15 x 0.10 mm 
  
Theta range for data collection   3.53 to 24.99 ° 
  
Limiting indices                  -10≤h≤10, -28≤k≤28, -31≤l≤31 
  
Reflections collected / unique    67951 / 10306 [R(int) = 0.0726] 
  
Completeness to theta = 24.99     99.4 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9689 and 0.9392 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    10306 / 93 / 589 
  
Goodness-of-fit on F
2
             1.150 
  
Final R indices [I>2σ(I)]         R1 = 0.0822, wR2 = 0.2120 
  
R indices (all data)              R1 = 0.1025, wR2 = 0.2276 
  
Largest diff. peak and hole       0.867 and -0.505 eÅ
-3
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Ti2(13)(OiPr)6 
Empirical formula                 C23.50H41.50NO4Ti 
  
Formula weight                    449.98 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions             a = 9.4140(4) Å   α = 92.550(2) ° 
                                 b = 9.9250(4) Å   β = 94.4870(10) ° 
                                 c = 13.9710(12) Å γ = 92.879(3) ° 
  
Volume                            1298.18(13) Å 
3
 
  
Z, Calculated density             2, 1.151 Mg/m
3
 
  
Absorption coefficient            0.355 mm
-1
 
  
F(000)                            487 
  
Crystal size                      0.20 x 0.10 x 0.10 mm 
  
Theta range for data collection   4.35 to 27.51 ° 
  
Limiting indices                  -12≤h≤12, -12≤k≤12, -18≤l≤18 
  
Reflections collected / unique    18880 / 5909 [R(int) = 0.0247] 
  
Completeness to theta = 27.51     99.1 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9653 and 0.9323 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    5909 / 3 / 299 
  
Goodness-of-fit on F
2
             1.056 
  
Final R indices [I>2σ(I)]         R1 = 0.0643, wR2 = 0.1731 
  
R indices (all data)              R1 = 0.0720, wR2 = 0.1823 
  
Largest diff. peak and hole       0.912 and -0.754 eÅ
-3
 
 
 
 
 
 288 
Ti(7)(OiPr)2 
Empirical formula                 C35H56N2O4Ti 
  
Formula weight                    616.72 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions              a = 11.234(1) Å α =83.037(7) º 
                                  b = 12.431(2) Å β = 71.297(6) º  
                                  c = 13.347(1) Å γ = 89.540(5) º 
  
Volume                            1751.5(4) Å
3
 
  
Z, Calculated density             2, 1.169 Mg/m
3
 
  
Absorption coefficient            0.282 mm
-1
 
  
F(000)                            668 
 
Crystal size                      0.20 x 0.15 x 0.10 mm 
  
Theta range for data collection   3.75 to 27.52 ° 
 
Limiting indices                 -14≤h≤14, -16≤k≤16, -17≤l≤17 
  
Reflections collected / unique    36743 / 7965 [R(int) = 0.0877] 
  
Completeness to theta = 27.52     98.8 % 
  
Absorption correction             None 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    7965 / 0 / 391 
  
Goodness-of-fit on F
2
             1.034 
  
Final R indices [I>2σ(I)]         R1 = 0.0564, wR2 = 0.1265 
  
R indices (all data)              R1 = 0.1066, wR2 = 0.1497 
  
Largest diff. peak and hole       0.299 and -0.473 eÅ
-3
 
 
 
 
 
 
 289 
Ti(9)(OiPr)2 
Empirical formula                 C35H56N2O4Ti 
  
Formula weight                    616.72 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/a 
  
Unit cell dimensions              a = 19.3720(7) Å α = 90 º 
                                  b = 9.6520(4) Å β = 116.015(2) º  
                                  c = 20.3950(10) Å γ = 90 º 
  
Volume                            3427.0(3) Å
3
 
  
Z, Calculated density             4, 1.195 Mg/m
3
 
  
Absorption coefficient            0.288 mm
-1
 
  
F(000)                            1336 
 
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.61 to 24.17 ° 
 
Limiting indices                 -22≤h≤22, -10≤k≤11, -23≤l≤23 
  
Reflections collected / unique    21094 / 5422 [R(int) = 0.1729] 
  
Completeness to theta = 27.52     99.0 % 
  
Absorption correction             Sortav 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    5422 / 0 / 391 
  
Goodness-of-fit on F
2
             1.079 
  
Final R indices [I>2σ(I)]         R1 = 0.0837, wR2 = 0.1960 
  
R indices (all data)              R1 = 0.1272, wR2 = 0.2254 
  
Largest diff. peak and hole       1.219 and -0.422 eÅ
-3
 
 
 
 
 
 
 290 
Ti(10)(OiPr)2 
Empirical formula                 C45H69N2O4Ti 
  
Formula weight                    749.92 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Orthorhombic, P212121 
  
Unit cell dimensions              a = 10.9250(7) Å   α = 90 ° 
                                  b = 14.7200(12) Å  β = 90 ° 
                                  c = 27.1040(14) Å  γ = 90 ° 
  
Volume                            4358.8(5) Å
3
 
  
Z, Calculated density             4, 1.143 Mg/m
3
 
  
Absorption coefficient            0.238 mm
-1
 
  
F(000)                            1628 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.66 to 24.10 ° 
  
Limiting indices                  -12≤h≤12, -16≤k≤16, -31≤l≤31 
  
Reflections collected / unique    52730 / 6899 [R(int) = 0.1339] 
  
Completeness to theta = 24.10     99.4 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9766 and 0.9766 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    6899 / 4 / 514 
  
Goodness-of-fit on F
2
             1.039 
  
Final R indices [I>2σ(I)]         R1 = 0.0607, wR2 = 0.1452 
  
R indices (all data)              R1 = 0.0918, wR2 = 0.1651 
  
Absolute structure parameter      -0.03(4) 
  
Largest diff. peak and hole       0.344 and -0.350 eÅ
-3
 
 
 
 
 
 291 
Ti(11)(OiPr)2 
Empirical formula                 C40H60N2O4Ti 
  
Formula weight                    680.80 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions              a = 14.0530(2) Å  α = 90 ° 
                                  b = 13.5820(2) Å  β = 91.528(1) ° 
                                  c = 20.1480(4) Å  γ = 90 ° 
  
Volume                            3844.24(11) Å
3
 
  
Z, Calculated density             4, 1.176 Mg/m
3
 
  
Absorption coefficient            0.263 mm
-1
 
  
F(000)                            1472 
  
Crystal size                      0.1 x 0.1 x 0.1 mm 
  
Theta range for data collection   3.58 to 25.00 ° 
  
Limiting indices                 -16≤h≤16, -16≤k≤16, -23≤l≤23 
  
Reflections collected / unique    66001 / 6743 [R(int) = 0.1218] 
  
Completeness to theta = 25.00     99.6 % 
  
Absorption correction             Multi-scan 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    6743 / 15 / 563 
  
Goodness-of-fit on F
2
             1.027 
  
Final R indices [I>2σ(I)]         R1 = 0.0503, wR2 = 0.1156 
  
R indices (all data)              R1 = 0.0830, wR2 = 0.1348 
  
Largest diff. peak and hole       0.298 and -0.371 eÅ
-3
 
 
 
 
 
 
 292 
Ti(1)(catechol) 
Empirical formula                 C58H68Cl4N4O8Ti2 
  
Formula weight                    1186.76 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/a 
  
Unit cell dimensions              a = 12.2350(4) Å  α = 90 ° 
                                  b = 17.2330(8) Å  β = 96.642(2) ° 
                                  c = 13.4000(5) Å  γ = 90 ° 
  
Volume                            2806.37(19) Å
3
 
  
Z, Calculated density             2, 1.404 Mg/m
3
 
  
Absorption coefficient            0.533 mm
-1
 
  
F(000)                            1240 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.52 to 26.76 ° 
  
Limiting indices                  -15≤h≤15, -21≤k≤21, -16≤l≤16 
  
Reflections collected / unique    48977 / 5929 [R(int) = 0.1302] 
  
Completeness to theta = 26.76     99.1 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9486 and 0.9486 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    5929 / 0 / 347 
  
Goodness-of-fit on F
2
             1.069 
  
Final R indices [I>2σ(I)]         R1 = 0.0684, wR2 = 0.1672 
  
R indices (all data)              R1 = 0.1199, wR2 = 0.2017 
  
Largest diff. peak and hole       0.556 and -1.231 eÅ
-3
 
 
 
 
 
 293 
Ti(1)(3,5-di-tert-butylcatechol) 
Empirical formula                 C37H50Cl2N2O4Ti 
  
Formula weight                    705.59 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/c 
  
Unit cell dimensions             a = 19.8000(2) Å α = 90 ° 
                                 b = 12.5740(2) Å β = 103.8080(10) ° 
                                 c = 30.7360(5) Å γ = 90 ° 
  
Volume                            7431.05(18) Å
3
 
  
Z, Calculated density             8, 1.261 Mg/m
3
 
  
Absorption coefficient            0.414 mm
-1
 
  
F(000)                            2992 
  
Crystal size                      0.50 x 0.30 x 0.10 mm 
  
Theta range for data collection   3.53 to 27.52 ° 
  
Limiting indices                  -25≤h≤25, -16≤k≤16, -39≤l≤39 
  
Reflections collected / unique    98628 / 16983 [R(int) = 0.1423] 
 
Completeness to theta = 27.52     99.2 % 
  
Absorption correction             None 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    16983 / 6 / 874 
  
Goodness-of-fit on F
2
             1.050 
  
Final R indices [I>2σ(I)]         R1 = 0.0867, wR2 = 0.2228 
  
R indices (all data)              R1 = 0.1194, wR2 = 0.2455 
 
Largest diff. peak and hole       1.155 and -1.307 eÅ
-3
 
 
 
 
 
 
 294 
Ti(1)(4-NO2-catechol)  
Empirical formula                 C28.50H32ClN3O6Ti 
  
Formula weight                    595.92 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions              a = 12.7780(2) Å α = 90 ° 
                                  b = 13.3090(2) Å β = 101.097(1)° 
                                  c = 16.4640(3) Å γ = 90 ° 
  
Volume                            2747.56(8) Å
3
 
  
Z, Calculated density             4, 1.441 Mg/m
3
 
  
Absorption coefficient            0.457 mm
-1
 
  
F(000)                            1244 
  
Crystal size                      0.20 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.58 to 27.49 ° 
  
Limiting indices                  -16≤h≤16, -17≤k≤17, -21≤l≤21 
  
Reflections collected / unique    40787 / 6270 [R(int) = 0.0700] 
  
Completeness to theta = 27.49     99.2 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9557 and 0.9141 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    6270 / 0 / 366 
  
Goodness-of-fit on F
2
             1.012 
  
Final R indices [I>2σ(I)]         R1 = 0.0638, wR2 = 0.1590 
  
R indices (all data)              R1 = 0.0785, wR2 = 0.1733 
  
Largest diff. peak and hole       1.766 and -1.588 eÅ
-3
 
 
 
 
 
 295 
Ti(6)(4-NO2-catechol) 
Empirical formula                 C43H49N3O6Ti 
  
Formula weight                    751.75 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/c 
  
Unit cell dimensions              a = 20.0540(5) Å α = 90 ° 
                                  b = 18.6670(5) Å β = 113.361(2)° 
                                  c = 22.6240(6) Å γ = 90 ° 
  
Volume                            7775.0(4) Å
3
 
  
Z, Calculated density             8, 1.284 Mg/m
3
 
  
Absorption coefficient            0.272 mm
-1
 
  
F(000)                            3184 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.51 to 27.49 ° 
  
Limiting indices                 -26≤h≤25, -24≤k≤24, -29≤l≤29 
  
Reflections collected / unique    153642 / 17723 [R(int) = 0.0657] 
  
Completeness to theta = 27.49     99.3 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9734 and 0.9734 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    17723 / 0 / 1021 
  
Goodness-of-fit on F
2
             1.054 
  
Final R indices [I>2σ(I)]         R1 = 0.0507, wR2 = 0.1190 
  
R indices (all data)              R1 = 0.0829, wR2 = 0.1357 
  
Largest diff. peak and hole       0.351 and -0.450 eÅ
-3
 
 
 
 
 
 296 
8.1.2 Chapter 3 
Zr(6)(OiPr)2 
Empirical formula                 C29H44N2O4Zr 
  
Formula weight                    575.88 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions              a = 8.5750(6) Å    α = 90 ° 
                                  b = 16.5030(14) Å  β = 99.220(5) ° 
                                  c = 20.7000(15) Å  γ = 90 ° 
  
Volume                            2891.5(4) Å
3
 
  
Z, Calculated density             4, 1.323 Mg/m
3
 
  
Absorption coefficient            0.415 mm
-1
 
  
F(000)                            1216 
  
Crystal size                      0.10 x 0.10 x 0.05 mm 
  
Theta range for data collection   3.53 to 27.49 ° 
  
Limiting indices                  -11≤h≤10, -21≤k≤21, -26≤l≤26 
  
Reflections collected / unique    45579 / 6603 [R(int) = 0.0584] 
  
Completeness to theta = 27.49     99.5 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.9795 and 0.9597 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    6603 / 0 / 333 
  
Goodness-of-fit on F
2
             1.107 
  
Final R indices [I>2σ(I)]         R1 = 0.0349, wR2 = 0.0789 
  
R indices (all data)              R1 = 0.0524, wR2 = 0.0897 
  
Largest diff. peak and hole       0.417 and -0.700 eÅ
-3
 
 
 
 
 297 
Zr(6)(OiPr)2.0.5THF.0.5IPA  
Empirical formula                 C32.50H52N2O5Zr 
  
Formula weight                    641.98 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions              a = 14.3840(2) Å α = 90 ° 
                                  b = 10.8140(2) Å β = 95.0460(10) ° 
                                  c = 20.7480(3) Å γ = 90 ° 
  
Volume                            3214.81(9) Å
3
 
  
Z, Calculated density             4, 1.326 Mg/m
3
 
  
Absorption coefficient            0.383 mm
-1
 
  
F(000)                            1364 
  
Crystal size                      0.25 x 0.20 x 0.10 mm 
  
Theta range for data collection   3.88 to 27.46 ° 
  
Limiting indices                  -18≤h≤18, -14≤k≤14, -26≤l≤26 
  
Reflections collected / unique    59866 / 7319 [R(int) = 0.0617] 
  
Completeness to theta = 27.46     99.6 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.9627 and 0.9103 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    7319 / 0 / 445 
  
Goodness-of-fit on F
2
             1.085 
  
Final R indices [I>2σ(I)]         R1 = 0.0392, wR2 = 0.0989 
  
R indices (all data)              R1 = 0.0573, wR2 = 0.1108 
  
Largest diff. peak and hole       0.473 and -0.942 eÅ
-3
 
 
 
 
 
 298 
Zr(7)(OiPr)2 
Empirical formula                 C35H56N2O4Zr 
  
Formula weight                    660.04 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Cm, monoclinic 
  
Unit cell dimensions              a = 11.7950(5) Å  α = 90 ° 
                                  b = 24.3760(10)Å  β = 124.476(2) ° 
                                  c = 7.6360(4) Å   γ = 90 ° 
  
Volume                            1809.86(14) Å
3
 
  
Z, Calculated density             2, 1.211 Mg/m
3
 
  
Absorption coefficient            0.340 mm
-1
 
  
F(000)                            704 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   4.19 to 25.04 ° 
  
Limiting indices                  -13≤h≤14, -28≤k≤28, -9≤l≤9 
  
Reflections collected / unique    7278 / 3018 [R(int) = 0.0452] 
  
Completeness to theta = 25.04     99.3 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9668 and 0.9668 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    3018 / 2 / 206 
  
Goodness-of-fit on F
2
             1.029 
  
Final R indices [I>2σ(I)]         R1 = 0.0360, wR2 = 0.0799 
  
R indices (all data)              R1 = 0.0394, wR2 = 0.0816 
  
Absolute structure parameter      -0.01(4) 
  
Largest diff. peak and hole       0.462 and -0.579 eÅ
-3
 
 
 
 
 
 299 
Zr(10)(OiPr)2  
Empirical formula                 C45H76N2O4Zr 
  
Formula weight                    800.30 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Orthorhombic, P212121 
  
Unit cell dimensions              a = 12.0070(4) Å   α = 90 ° 
                                  b = 14.6590(5) Å   β = 90 ° 
                                  c = 25.1760(10) Å  γ = 90 ° 
  
Volume                            4431.2(3) Å
3
 
  
Z, Calculated density             4, 1.200 Mg/m
3
 
  
Absorption coefficient            0.289 mm
-1
 
  
F(000)                            1728 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.52 to 24.09 ° 
  
Limiting indices                  -13≤h≤13, -16≤k≤16, -28≤l≤28 
  
Reflections collected / unique    34743 / 6996 [R(int) = 0.1963] 
  
Completeness to theta = 24.09     99.3 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.9717 and 0.9717 
  
Refinement method                 Full-matrix least-squares on F
2
 
 
Data / restraints / parameters    6996 / 0 / 485 
  
Goodness-of-fit on F
2
             1.054 
  
Final R indices [I>2σ(I)]         R1 = 0.0825, wR2 = 0.1712 
  
R indices (all data)              R1 = 0.1264, wR2 = 0.1972 
  
Absolute structure parameter      -0.10(9) 
  
Largest diff. peak and hole       1.783 and -0.723 eÅ
-3
 
 
 
 
 
 300 
Hf(6)(OiPr)2 
Empirical formula                 C29H44HfN2O4 
  
Formula weight                    663.15 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions              a = 8.5680(3) Å   α = 90 ° 
                                  b = 16.4690(7) Å  β = 99.410(3) ° 
                                  c = 20.6830(7) Å  γ = 90 ° 
  
Volume                            2879.23(19) Å
3
 
  
Z, Calculated density             4, 1.530 Mg/m
3
 
  
Absorption coefficient            3.658 mm
-1
 
  
F(000)                            1344 
  
Crystal size                      0.20 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.52 to 27.50 ° 
  
Limiting indices                  -11≤h≤11, -21≤k≤21, -26≤l≤26 
  
Reflections collected / unique    50883 / 6592 [R(int) = 0.0760] 
  
Completeness to theta = 27.50     99.6 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.7112 and 0.5282 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    6592 / 0 / 333 
  
Goodness-of-fit on F
2
             1.185 
  
Final R indices [I>2σ(I)]         R1 = 0.0414, wR2 = 0.0888 
  
R indices (all data)              R1 = 0.0614, wR2 = 0.0977 
  
Largest diff. peak and hole       1.963 and -1.601 eÅ
-3
 
 
 
 
 
 301 
Hf(7)(OiPr)2 
Empirical formula                 C17.50H26Hf0.50NO2 
  
Formula weight                    371.64 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, Cm 
  
Unit cell dimensions             a = 11.7460(2) Å α = 90 ° 
                                 b = 24.2790(5) Å β = 124.5040(10) ° 
                                 c = 7.6000(2) Å  γ = 90 ° 
  
Volume                            1786.10(7) Å
3
 
  
Z, Calculated density             4, 1.382 Mg/m
3
 
  
Absorption coefficient            2.957 mm
-1
 
  
F(000)                            760 
  
Crystal size                      0.20 x 0.15 x 0.10 mm 
  
Theta range for data collection   3.58 to 27.49 ° 
  
Limiting indices                  -15≤h≤15, -31≤k≤31, -9≤l≤9 
  
Reflections collected / unique    17045 / 4042 [R(int) = 0.0338] 
  
Completeness to theta = 27.49     99.6 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.7564 and 0.5893 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    4042 / 2 / 204 
  
Goodness-of-fit on F
2
             1.065 
  
Final R indices [I>2σ(I)]         R1 = 0.0201, wR2 = 0.0491 
  
R indices (all data)              R1 = 0.0201, wR2 = 0.0491 
  
Absolute structure parameter      0.000(8) 
  
Largest diff. peak and hole       0.789 and -1.438 eÅ
-3
 
 
 
 
 
 302 
Hf(8)(OiPr)2 
Empirical formula                 C23.50H41Hf0.50NO2 
  
Formula weight                    458.82 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions              a = 8.7915(3) Å   α = 66.874(3) ° 
                                  b = 16.8368(6) Å  β = 79.532(3) ° 
                                  c = 17.6504(6) Å  γ = 84.196(3) ° 
  
Volume                            2361.41(14) Å
3
 
  
Z, Calculated density             4, 1.291 Mg/m
3
 
  
Absorption coefficient            2.250 mm
-1
 
  
F(000)                            964 
  
Crystal size                      0.50 x 0.20 x 0.03 mm 
  
Theta range for data collection   2.88 to 27.48 ° 
  
Limiting indices                  -11≤h≤11, -21≤k≤21, -22≤l≤22 
  
Reflections collected / unique    23772 / 10822 [R(int) = 0.0696] 
  
Completeness to theta = 27.48     99.8 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9356 and 0.3992 
  
Refinement method                 Full-matrix least-squares on F
2
 
 
Data / restraints / parameters    10822 / 0 / 505 
  
Goodness-of-fit on F
2
             0.980 
  
Final R indices [I>2σ(I)]         R1 = 0.0492, wR2 = 0.0745 
  
R indices (all data)              R1 = 0.0792, wR2 = 0.0830 
  
Largest diff. peak and hole       1.101 and -1.352 eÅ
-3
 
 
 
 
 
 303 
Hf(10)(OiPr)2 
Empirical formula                 C45H76HfN2O4 
  
Formula weight                    887.57 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Orthorhombic, P212121 
  
Unit cell dimensions              a = 12.00200(10) Å  α = 90 ° 
                                  b = 14.66100(10) Å  β = 90 ° 
                                  c = 25.1240(2) Å    γ = 90 ° 
  
Volume                            4420.85(6) Å
3
 
  
Z, Calculated density             4, 1.334 Mg/m
3
 
  
Absorption coefficient            2.401 mm
-1
 
  
F(000)                            1856 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.53 to 27.49 ° 
  
Limiting indices                  -15≤h≤15, -19≤k≤19, -32≤l≤32 
  
Reflections collected / unique    71328 / 10103 [R(int) = 0.0771] 
  
Completeness to theta = 27.49     99.6 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.7953 and 0.7953 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    10103 / 0 / 493 
  
Goodness-of-fit on F
2
             1.080 
  
Final R indices [I>2σ(I)]         R1 = 0.0332, wR2 = 0.0643 
  
R indices (all data)              R1 = 0.0504, wR2 = 0.0693 
  
Absolute structure parameter      -0.034(8) 
  
Largest diff. peak and hole       1.319 and -1.303 eÅ
-3
 
 
 
 
 
 304 
Zr4(1)(OiPr)6(HOiPr)2 
Empirical formula                 C76H156N2O18Zr4 
  
Formula weight                    1750.91 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, C2/c 
  
Unit cell dimensions             a = 21.8419(4) Å α = 90 ° 
                                 b = 15.0338(3) Å β = 104.8290(10) ° 
                                 c = 29.6284(5) Å γ = 90 ° 
  
Volume                            9404.9(3) Å
3
 
  
Z, Calculated density             4, 1.237 Mg/m
3
 
  
Absorption coefficient            0.488 mm
-1
 
  
F(000)                            3720 
  
Crystal size                      0.1 x 0.1 x 0.15 mm 
  
Theta range for data collection   3.68 to 25.03 ° 
  
Limiting indices                  -25≤h≤25, -17≤k≤17, -34≤l≤35 
  
Reflections collected / unique    42398 / 7991 [R(int) = 0.0794] 
  
Completeness to theta = 25.03     96.1 % 
  
Absorption correction             None 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    7991 / 8 / 489 
  
Goodness-of-fit on F
2
             1.046 
  
Final R indices [I>2σ(I)]         R1 = 0.0541, wR2 = 0.1022 
  
R indices (all data)              R1 = 0.0916, wR2 = 0.1170 
  
Largest diff. peak and hole       0.508 and -0.653 eÅ
-3
 
 
 
 
 
 
 305 
Zr2(15)(OiPr)6 
Empirical formula                 C47H84N2O8Zr2 
  
Formula weight                    987.60 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       orthorhombic, C2cb  
  
Unit cell dimensions              a = 14.3530(6) Å   α = 90 ° 
                                  b = 39.3260(15) Å  β = 90 ° 
                                  c = 19.3250(7) Å   γ = 90 ° 
  
Volume                            10907.9(7) Å
3
 
  
Z, Calculated density             8, 1.203 Mg/m
3
 
  
Absorption coefficient            0.428 mm
-1
 
  
F(000)                            4192 
  
Crystal size                      0.20 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.76 to 25.02 ° 
  
Limiting indices                  -17≤h≤17, -46≤k≤46, -22≤l≤22 
  
Reflections collected / unique    64279 / 9549 [R(int) = 0.0949] 
  
Completeness to theta = 25.02     99.4 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9585 and 0.9193 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    9549 / 2 / 563 
  
Goodness-of-fit on F
2
             1.098 
  
Final R indices [I>2σ(I)]         R1 = 0.0536, wR2 = 0.1273 
  
R indices (all data)              R1 = 0.0889, wR2 = 0.1513 
  
Absolute structure parameter      0.00(5) 
 
Largest diff. peak and hole       0.665 and -0.561 eÅ
-3
 
 
 
 
 
 306 
Hf2(1)(OiPr)6 
Empirical formula                 C80H140Hf4N4O16 
  
Formula weight                    2127.92 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions              a = 12.8800(6) Å  α = 108.912(2) ° 
                                  b = 17.1940(9) Å  β = 93.491(3) ° 
                                  c = 21.3410(10) Å γ = 93.019(3) ° 
  
Volume                            4449.6(4) Å
3
 
  
Z, Calculated density             2, 1.588 Mg/m
3
 
  
Absorption coefficient            4.711 mm
-1
 
  
F(000)                            2128 
  
Crystal size                      0.10 x 0.05 x 0.05 mm 
  
Theta range for data collection   4.74 to 24.00 ° 
  
Limiting indices                  -14≤h≤13, -19≤k≤19, -23≤l≤24 
  
Reflections collected / unique    34810 / 13794 [R(int) = 0.1529] 
  
Completeness to theta = 24.00     98.7 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.7986 and 0.6502 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    13794 / 0 / 908 
  
Goodness-of-fit on F
2
             1.023 
  
Final R indices [I>2σ(I)]         R1 = 0.0655, wR2 = 0.1120 
  
R indices (all data)              R1 = 0.1482, wR2 = 0.1420 
  
Largest diff. peak and hole       1.145 and -1.315 eÅ
-3
 
 
 
 
 
 307 
Hf2(3)(OiPr)6 
Empirical formula                 C26H47HfNO4 
  
Formula weight                    616.14 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, Pn 
  
Unit cell dimensions              a = 10.3720(5) Å  α = 90 ° 
                                  b = 17.1010(9) Å  β = 105.698(3) ° 
                                  c = 16.7140(7) Å  γ = 90 ° 
  
Volume                            2854.0(2) Å
3
 
  
Z, Calculated density             4, 1.434 Mg/m
3
 
  
Absorption coefficient            3.683 mm
-1
 
  
F(000)                            1256 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.79 to 25.37 ° 
  
Limiting indices                  -12≤h≤12, -20≤k≤20, -20≤l≤18 
  
Reflections collected / unique    28088 / 10193 [R(int) = 0.0707] 
  
Completeness to theta = 25.37     99.1 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.7096 and 0.7096 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    10193 / 8 / 602 
  
Goodness-of-fit on F
2
             1.047 
 
Final R indices [I>2σ(I)]         R1 = 0.0414, wR2 = 0.0812 
  
R indices (all data)              R1 = 0.0752, wR2 = 0.0957 
  
Absolute structure parameter      -0.034(14) 
  
Largest diff. peak and hole       1.258 and -0.748 eÅ
-3
 
 
 
 
 
 308 
8.1.3 Chapter 4 
Al(7)Me 
Empirical formula                 C33.50H49AlN2O2 
  
Formula weight                    538.73 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Orthorhombic, P212121 
  
Unit cell dimensions              a = 14.7810(2) Å   α = 90 ° 
                                  b = 15.1010(2) Å   β = 90 ° 
                                  c = 29.1190(4) Å   γ = 90 ° 
  
Volume                            6499.59(15) Å
3
 
  
Z, Calculated density             8, 1.101 Mg/m
3
 
  
Absorption coefficient            0.092 mm
-1
 
  
F(000)                            2344 
  
Crystal size                      0.30 x 0.20 x 0.20 mm 
  
Theta range for data collection   3.69 to 27.44 ° 
  
Limiting indices                 -19≤h≤19, -19≤k≤19, -37≤l≤37 
 
Reflections collected / unique    81419 / 14759 [R(int) = 0.0780] 
  
Completeness to theta = 27.44     99.3 % 
  
Absorption correction             Multi-scan 
  
Max. and min. transmission        0.9818 and 0.9729 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    14759 / 0 / 733 
  
Goodness-of-fit on F
2
             1.091 
  
Final R indices [I>2σ(I)]         R1 = 0.0619, wR2 = 0.1606 
  
R indices (all data)              R1 = 0.0676, wR2 = 0.1651 
  
Absolute structure parameter      0.06(14) 
  
Largest diff. peak and hole       0.450 and -0.264 eÅ
-3
 
 
 
 
 309 
Al(8)Me 
Empirical formula                 C36H57AlN2O2 
  
Formula weight                    576.82 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, C2/c 
  
Unit cell dimensions             a = 35.6710(9) Å α = 90 ° 
                                 b = 10.4360(3) Å β = 116.4370(10) ° 
                                 c = 24.9340(8) Å γ = 90 ° 
  
Volume                            8311.3(4) Å
3
 
  
Z, Calculated density             8, 0.922 Mg/m
3
 
  
Absorption coefficient            0.075 mm
-1
 
  
F(000)                            2528 
 
Crystal size                      0.30 x 0.30 x 0.25 mm 
  
Theta range for data collection   3.64 to 27.49 ° 
  
Limiting indices                  -45≤h≤46, -13≤k≤13, -32≤l≤32 
  
Reflections collected / unique    70559 / 9479 [R(int) = 0.0411] 
  
Completeness to theta = 27.49     99.3 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9814 and 0.9777 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    9479 / 9 / 514 
  
Goodness-of-fit on F
2
             1.112 
  
Final R indices [I>2σ(I)]         R1 = 0.1139, wR2 = 0.3087 
  
R indices (all data)              R1 = 0.1264, wR2 = 0.3178 
  
Largest diff. peak and hole       0.630 and -0.523 eÅ
-3
 
 
 
 
 
 310 
Al(11)Me 
Empirical formula                 C34.30H47.70AlN2O2 
  
Formula weight                    547.02 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, C2/c 
  
Unit cell dimensions              a = 32.935(3) Å   α = 90 ° 
                                  b = 7.0560(10) Å  β = 114.289(5) ° 
                                  c = 31.375(4) Å   γ = 90 ° 
  
Volume                            6645.8(14) Å
3
 
  
Z, Calculated density             8, 1.093 Mg/m
3
 
  
Absorption coefficient            0.091 mm
-1
 
  
F(000)                            2372 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.53 to 24.98 ° 
  
Limiting indices                  -38≤h≤38, -8≤k≤8, -35≤l≤37 
  
Reflections collected / unique    24788 / 5755 [R(int) = 0.1342] 
  
Completeness to theta = 24.98     98.5 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9909 and 0.9909 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    5755 / 10 / 394 
  
Goodness-of-fit on F
2
             1.078 
  
Final R indices [I>2σ(I)]         R1 = 0.1279, wR2 = 0.3141 
  
R indices (all data)              R1 = 0.1946, wR2 = 0.3564 
  
Largest diff. peak and hole       0.722 and -0.458 eÅ
-3
 
 
 
 
 
 311 
8.1.4 Chapter 5 
Ti2(16)(OiPr)6 
Empirical formula                 C60H108N2O8Ti2 
  
Formula weight                    1081.28 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions              a = 17.1370(12) Å  α = 90 ° 
                                  b = 11.4570(16) Å  β = 95.355(5) ° 
                                  c = 17.2330(15) Å  γ = 90 ° 
  
Volume                            3368.7(6) Å
3
 
  
Z, Calculated density             2, 1.066 Mg/m
3
 
  
Absorption coefficient            0.284 mm
-1
 
  
F(000)                            1180 
  
Crystal size                      0.10 x 0.10 x 0.10 mm 
  
Theta range for data collection   3.52 to 25.03 ° 
  
Limiting indices                  -20≤h≤19, -12≤k≤13, -20≤l≤20 
  
Reflections collected / unique    26382 / 5924 [R(int) = 0.1132] 
  
Completeness to theta = 25.03     99.3 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9722 and 0.9722 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    5924 / 0 / 401 
  
Goodness-of-fit on F
2
             1.022 
  
Final R indices [I>2σ(I)]         R1 = 0.0576, wR2 = 0.1211 
  
R indices (all data)              R1 = 0.1157, wR2 = 0.1481 
  
Largest diff. peak and hole       0.530 and -0.357 eÅ
-3
 
 
 
 
 312 
Ti2(17)(OiPr)6 
Empirical formula                 C24H41NO4Ti 
  
Formula weight                    455.48 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/c 
  
Unit cell dimensions              a = 10.4230(2) Å α = 90 ° 
                                  b = 22.8100(5) Å β = 114.617(1) ° 
                                  c = 12.5010(2) Å γ = 90 ° 
  
Volume                            2701.97(9) Å
3
 
  
Z, Calculated density             4, 1.120 Mg/m
3
 
  
Absorption coefficient            0.342 mm
-1
 
  
F(000)                            984 
  
Crystal size                      0.40 x 0.20 x 0.20 mm 
  
Theta range for data collection   3.59 to 27.54 ° 
  
Limiting indices                 -13≤h≤13, -29≤k≤29, -16≤l≤16 
  
Reflections collected / unique    39062 / 6195 [R(int) = 0.1081] 
  
Completeness to theta = 27.54     99.4 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.9347 and 0.8753 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    6195 / 6 / 323 
  
Goodness-of-fit on F
2
             1.110 
  
Final R indices [I>2σ(I)]         R1 = 0.0691, wR2 = 0.1764 
  
R indices (all data)              R1 = 0.0892, wR2 = 0.1912 
  
Largest diff. peak and hole       0.901 and -0.656 eÅ
-3
 
 
 
 
 
 313 
Ti2(18)(OiPr)6 
Empirical formula                 C40H49Cl2NO4Ti 
  
Formula weight                    726.60 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions              a = 8.8350(2) Å  α = 95.5030(10) ° 
                                  b = 10.7560(3) Å β = 90.5850(10) °                                            
                                  c = 20.4880(7) Å γ = 97.9200(10) ° 
  
Volume                            1918.96(10) Å
3
 
  
Z, Calculated density             2, 1.258 Mg/m
3
 
  
Absorption coefficient            0.402 mm
-1
 
  
F(000)                            768 
  
Crystal size                      0.20 x 0.20 x 0.10 mm 
  
Theta range for data collection   3.52 to 25.07 ° 
  
Limiting indices                  -10≤h≤10, -12≤k≤12, -24≤l≤23 
  
Reflections collected / unique    25157 / 6767 [R(int) = 0.0538] 
  
Completeness to theta = 25.07     99.1 % 
  
Absorption correction             None 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    6767 / 0 / 440 
  
Goodness-of-fit on F
2
             1.046 
  
Final R indices [I>2σ(I)]         R1 = 0.0493, wR2 = 0.1165 
  
R indices (all data)              R1 = 0.0685, wR2 = 0.1291 
  
Largest diff. peak and hole       0.579 and -0.593 eÅ
-3
 
 
 
 
 
 
 314 
Al2(16)Me4 
Empirical formula                 C48H80Al2N2O4 
  
Formula weight                    803.10 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       triclinic, P-1 
  
Unit cell dimensions              a = 9.5690(10) Å  α = 109.497(5) ° 
                                  b = 11.6000(7) Å  β = 96.776(4) ° 
                                  c = 11.8190(13) Å γ = 93.635(5) ° 
  
Volume                            1220.6(2) Å
3
 
  
Z, Calculated density             1, 1.093 Mg/m
3
 
  
Absorption coefficient            0.101 mm
-1
 
  
F(000)                            440 
  
Crystal size                      0.20 x 0.10 x 0.05 mm 
  
Theta range for data collection   3.56 to 24.16 ° 
  
Limiting indices                  -11≤h≤11, -13≤k≤11, -13≤l≤13 
  
Reflections collected / unique    7936 / 3792 [R(int) = 0.0831] 
  
Completeness to theta = 24.16     96.9 % 
  
Absorption correction             None 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    3792 / 6 / 261 
  
Goodness-of-fit on F
2
             1.013 
  
Final R indices [I>2σ(I)]         R1 = 0.0782, wR2 = 0.1813 
  
R indices (all data)              R1 = 0.1313, wR2 = 0.2188 
  
Largest diff. peak and hole       0.490 and -0.615 eÅ
-3
 
 
 
 
 
 
 315 
Al2(17)Me4 
Empirical formula                 C34H52Al2N2O2 
 
Formula weight                    574.74 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Triclinic, P-1 
  
Unit cell dimensions              a = 6.4870(6) Å   α = 98.515(5) ° 
                                  b = 7.6680(7) Å   β = 90.729(5) ° 
                                  c = 17.3850(14) Å γ = 94.709(5) ° 
   
Volume                            852.08(13) Å
3
 
  
Z, Calculated density             1, 1.120 Mg/m
3
 
  
Absorption coefficient            0.116 mm
-1
 
  
F(000)                            312 
  
Crystal size                      0.20 x 0.20 x 0.20 mm 
  
Theta range for data collection   3.85 to 27.50 ° 
  
Limiting indices                  -8≤h≤8, -9≤k≤9, -22≤l≤22 
  
Reflections collected / unique    13796 / 3854 [R(int) = 0.0423] 
  
Completeness to theta = 27.50     98.4 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9772 and 0.9772 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    3854 / 0 / 187 
  
Goodness-of-fit on F
2
             1.040 
  
Final R indices [I>2σ(I)]         R1 = 0.0429, wR2 = 0.1084 
  
R indices (all data)              R1 = 0.0571, wR2 = 0.1198 
  
Largest diff. peak and hole       0.238 and -0.294 eÅ
-3
 
 
 
 
 
 316 
Zn2(17)Me2 
Empirical formula                 C46H68N2O4Zn2 
  
Formula weight                    843.76 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions            a = 14.2740(2) Å  α = 90 ° 
                                b = 7.98300(10) Å β = 101.4560(10) ° 
                                c = 20.1200(4) Å  γ = 90 ° 
  
Volume                            2246.98(6) Å ^3 
  
Z, Calculated density             2, 1.247 Mg/m
3
 
  
Absorption coefficient            1.109 mm
-1
 
  
F(000)                            900 
  
Crystal size                      0.20 x 0.10 x 0.10 mm 
  
Theta range for data collection   4.02 to 27.45 ° 
  
Limiting indices                  -18≤h≤18, -10≤k≤10, -26≤l≤26 
  
Reflections collected / unique    37316 / 5113 [R(int) = 0.0670] 
  
Completeness to theta = 27.45     99.2 % 
  
Absorption correction             Semi-empirical from equivalents 
  
Max. and min. transmission        0.8972 and 0.8086 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    5113 / 0 / 275 
  
Goodness-of-fit on F
2
             1.028 
  
Final R indices [I>2σ(I)]         R1 = 0.0363, wR2 = 0.0869 
  
R indices (all data)              R1 = 0.0538, wR2 = 0.0950 
  
Largest diff. peak and hole       0.283 and -0.389 eÅ
-3
 
 
 
 
 
 317 
8.1.5 Chapter 6 
Al(22)Me  
Empirical formula                 C38H59AlN2O2 
  
Formula weight                    602.85 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21/n 
  
Unit cell dimensions              a = 11.8730(6) Å   α = 90 ° 
                                  b = 10.6560(7) Å   β = 94.668(5) ° 
                                  c = 28.8840(18) Å  γ = 90 ° 
  
Volume                            3642.2(4) Å
3
 
  
Z, Calculated density             4, 1.099 Mg/m
3
 
  
Absorption coefficient            0.089 mm
-1
 
  
F(000)                            1320 
  
Crystal size                      0.10 x 0.10 x 0.02 mm 
  
Theta range for data collection   3.72 to 23.80 ° 
 
Limiting indices                  -13≤h≤13, -12≤k≤12, -29≤l≤32 
  
Reflections collected / unique    18682 / 5538 [R(int) = 0.1690] 
  
Completeness to theta = 23.80     99.2 % 
  
Absorption correction             Multi-scan 
  
Max. and min. transmission        0.9982 and 0.9912 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    5538 / 0 / 402 
 
Goodness-of-fit on F
2
             1.065 
  
Final R indices [I>2σ(I)]         R1 = 0.1076, wR2 = 0.2127 
  
R indices (all data)              R1 = 0.2002, wR2 = 0.2528 
  
Largest diff. peak and hole       0.275 and -0.246 eÅ
-3
 
 
 
 
 318 
Al(R,R-22)Me 
Identification code               h12mdj15 
  
Empirical formula                 C44H73AlN2O2 
  
Formula weight                    689.02 
  
Temperature                       150(2) K 
 
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, P21 
  
Unit cell dimensions              a = 14.159(2) Å  α = 90 ° 
                                  b = 10.235(4) Å  β = 92.574(7) ° 
                                  c = 14.801(2) Å  γ = 90 ° 
  
Volume                            2142.8(10) Å
3
 
  
Z, Calculated density             2, 1.068 Mg/m
3
 
  
Absorption coefficient            0.083 mm
-1
 
  
F(000)                            760 
  
Crystal size                      0.30 x 0.10 x 0.10 mm 
  
Theta range for data collection   4.08 to 27.49 ° 
  
Limiting indices                 -18≤h≤18, -13≤k≤13, -19≤l≤18 
  
Reflections collected / unique    38513 / 9665 [R(int) = 0.0612] 
  
Completeness to theta = 27.49     99.4 % 
  
Absorption correction             None 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    9665 / 1 / 458 
  
Goodness-of-fit on F
2
             1.033 
  
Final R indices [I>2σ(I)]         R1 = 0.0457, wR2 = 0.0993 
 
R indices (all data)              R1 = 0.0691, wR2 = 0.1097 
  
Absolute structure parameter      -0.01(13) 
  
Largest diff. peak and hole       0.308 and -0.317 eÅ
-3
 
 
 
 
 
 319 
Al(25)OBn  
Identification code               k12mdj12 
  
Empirical formula                 C39.50H51AlN2O3 
  
Formula weight                    628.80 
  
Temperature                       150(2) K 
  
Wavelength                        0.71073 Å 
  
Crystal system, space group       Monoclinic, C2/c 
  
Unit cell dimensions             a = 25.7960(3) Å   α = 90 ° 
                                 b = 12.55700(10) Å β = 100.521(1) ° 
                                 c = 21.7940(2) Å   γ = 90 ° 
  
Volume                            6940.84(12) Å
3
 
  
Z, Calculated density             8, 1.203 Mg/m
3
 
  
Absorption coefficient            0.098 mm
-1
 
  
F(000)                            2712 
  
Crystal size                      0.20 x 0.20 x 0.15 mm 
  
Theta range for data collection   3.62 to 27.45 ° 
  
Limiting indices                  -33≤h≤30, -16≤k≤16, -28≤l≤28 
  
Reflections collected / unique    55806 / 7910 [R(int) = 0.0619] 
  
Completeness to theta = 27.45     99.5 % 
  
Absorption correction             None 
  
Max. and min. transmission        0.9854 and 0.9806 
  
Refinement method                 Full-matrix least-squares on F
2
 
  
Data / restraints / parameters    7910 / 0 / 420 
  
Goodness-of-fit on F
2
             1.033 
  
Final R indices [I>2σ(I)]         R1 = 0.0422, wR2 = 0.0903 
  
R indices (all data)              R1 = 0.0634, wR2 = 0.1006 
  
Largest diff. peak and hole       0.330 and -0.293 eÅ
-3
 
 
 
